Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42679,0.142960521740021,0.00316157265880017,0.136763839328772,0.149157204151269,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GCG,Pro-glucagon,42346,-0.512784431692312,0.0121750119673106,-0.536647455148241,-0.488921408236383,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LDLR,Low-density lipoprotein receptor,42644,-0.2107588932724,0.00492641392771371,-0.220414664570719,-0.201103121974081,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MFGE8,Lactadherin,42611,-0.197941540410637,0.00413588961921905,-0.206047884064306,-0.189835196756967,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPY,Pro-neuropeptide Y,42721,-0.26027972048224,0.00621437954906376,-0.272459904398405,-0.248099536566075,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42611,0.128591229895611,0.00321693327378009,0.122286040679002,0.13489641911222,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PON3,Serum paraoxonase/lactonase 3,42676,0.110630324278033,0.00276593903712156,0.105209083765275,0.116051564790791,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRAP1,Proline-rich acidic protein 1,40527,-0.169613478961254,0.00396083470052865,-0.17737671497429,-0.161850242948218,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRSS8,Prostasin,42568,-0.170710203675666,0.00405656803388923,-0.178661077022089,-0.162759330329243,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADIPOQ,Adiponectin,40539,0.255301725328011,0.00670660954522757,0.242156770619365,0.268446680036657,1.62541981098556e-298
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGSF9,Protein turtle homolog A,40511,-0.305598472091116,0.00803856808634241,-0.321354065540347,-0.289842878641885,9.90376734913942e-298
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AGRP,Agouti-related protein,42754,-0.190674151749633,0.00504401654105162,-0.200560424170094,-0.180787879329172,2.13284108723561e-297
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LPL,Lipoprotein lipase,42636,0.159330728915885,0.00458387699627075,0.150346330003194,0.168315127828575,1.42435910236368e-253
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOF,Apolipoprotein F,40532,0.0810310465384186,0.0023408875401905,0.0764429069596452,0.085619186117192,1.1013992027116e-249
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42770,0.402130535439498,0.011847243420725,0.378909938334877,0.425351132544119,1.81454110971249e-242
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,42495,-0.101245837960472,0.003000856498868,-0.107127516698253,-0.0953641592226905,1.65342678580064e-239
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMPRSS15,Enteropeptidase,42587,-0.290619114905576,0.009027475443076,-0.308312966774005,-0.272925263037147,4.43762876681731e-219
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C9,Complement component C9,40532,0.164498909221056,0.00525548405258203,0.154198160477996,0.174799657964117,2.37288563964962e-206
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RTN4R,Reticulon-4 receptor,42721,-0.104103534699545,0.00341740249192692,-0.110801643583722,-0.0974054258153681,3.42785609572767e-197
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PYY,Peptide YY,40116,-0.310091037374949,0.010147577687787,-0.329980289643011,-0.290201785106886,7.34440533558695e-197
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INHBC,Inhibin beta C chain,42611,-0.123700208159096,0.0040699630480374,-0.131677335733249,-0.115723080584942,2.78485632119077e-196
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOM,Apolipoprotein M,42663,0.0827962067270863,0.00281228626825901,0.0772841256412986,0.0883082878128739,1.09244645822932e-184
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPR37,Prosaposin receptor GPR37,42357,-0.199057270649026,0.00681436637005888,-0.212413428734341,-0.18570111256371,8.21649244795629e-182
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,40283,0.0896756755491479,0.00310255872051188,0.0835946604569446,0.0957566906413512,3.58029717723075e-177
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LGALS4,Galectin-4,42618,-0.16248701002998,0.00564868531686959,-0.173558433251044,-0.151415586808915,1.24986533868933e-176
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPM,Carboxypeptidase M,42655,-0.0962537400418106,0.00335682765586577,-0.102833122247308,-0.0896743578363137,1.44114083068054e-175
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OXT,Oxytocin-neurophysin 1,42711,-0.394992586991124,0.0137772581747265,-0.421996013013588,-0.36798916096866,1.53537446817059e-175
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UPB1,Beta-ureidopropionase,40511,-0.256701303811516,0.00892926790705718,-0.274202668909348,-0.239199938713684,1.75393850085362e-175
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACY1,Aminoacylase-1,42636,-0.172542442271737,0.00602488600555941,-0.184351218842634,-0.160733665700841,3.84936232150092e-175
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLTP,Phospholipid transfer protein,42752,0.10190247221414,0.00356936426728947,0.0949065182502525,0.108898426178027,3.86449201577624e-174
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CES1,Liver carboxylesterase 1,42661,-0.22931248069159,0.00807149037940378,-0.245132601835222,-0.213492359547959,1.75452194001027e-172
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MVK,Mevalonate kinase,42370,-0.221300388238507,0.00796494754655256,-0.23691168542975,-0.205689091047264,3.68468125016943e-165
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,42357,-0.225047608247539,0.00813194412374142,-0.240986218730073,-0.209108997765006,6.63011467540888e-164
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAMDC4,Apical endosomal glycoprotein,40451,-0.151875976783779,0.00547926470374667,-0.162615335603122,-0.141136617964436,1.21487720617264e-163
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC39A5,Zinc transporter ZIP5,42594,-0.147359268645517,0.00536436605029859,-0.157873426104103,-0.136845111186932,1.1538588154764e-161
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCN1,CCN family member 1,42569,-0.199764826694177,0.00735244479910777,-0.214175618500428,-0.185354034887926,2.80533123593601e-158
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FURIN,Furin,42679,-0.0883250632999917,0.0032584990061121,-0.0947117213519714,-0.081938405248012,1.34331307706699e-157
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPHA1,Ephrin type-A receptor 1,42658,-0.0892761844436802,0.00330445682443145,-0.0957529198195658,-0.0827994490677945,1.34783458830548e-156
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF21,Fibroblast growth factor 21,42689,-0.311584352301484,0.0117039206945013,-0.334524036862706,-0.288644667740261,3.09678568161851e-152
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOD,Apolipoprotein D,40033,0.114979403709248,0.00435345606416824,0.106446629823478,0.123512177595018,4.9850483718503e-149
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42705,-0.123003974363684,0.00470906024806557,-0.132233732449892,-0.113774216277475,9.05518797242885e-147
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SHBG,Sex hormone-binding globulin,40532,0.130904358543309,0.00506584562409234,0.120975301120088,0.14083341596653,4.10829717642667e-143
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD300LG,CMRF35-like molecule 9,42611,0.0993552870843778,0.00385493744964159,0.0917996096830803,0.106910964485675,5.15768253194424e-143
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NTRK3,NT-3 growth factor receptor,42711,0.0559380701248419,0.00218547731856639,0.0516545345804518,0.060221605669232,3.84843878488445e-141
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42495,-0.0865573543033786,0.00341587198503482,-0.0932524633940469,-0.0798622452127104,2.17639548826432e-138
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,42370,-0.140776391673289,0.00558305111557528,-0.151719171859817,-0.129833611486762,4.74762374632307e-137
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL16,C-C motif chemokine 16,42794,-0.130558595258979,0.00524147591025887,-0.140831888043086,-0.120285302474872,5.87948531645727e-134
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42679,-0.0875320156486965,0.00352667898846198,-0.094444306466082,-0.080619724831311,5.15654956999358e-133
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLUL1,Clusterin-like protein 1,42621,0.110718952801143,0.00451206554770157,0.101875304327648,0.119562601274639,4.13177877873951e-130
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42721,-0.0801795184319826,0.00329046946158564,-0.0866288385766904,-0.0737301982872747,2.18712410427201e-128
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NHLRC3,NHL repeat-containing protein 3,40013,-0.0787155027023347,0.00324158972431701,-0.0850690185619961,-0.0723619868426734,7.09738069028703e-127
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFASC,Neurofascin,42754,-0.0701915884720158,0.00291866806788373,-0.0759121778850679,-0.0644709990589637,3.49702584161396e-125
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DSG2,Desmoglein-2,42611,0.0657649762357029,0.00273627787959331,0.0604018715917,0.0711280808797058,5.22853047331683e-125
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42585,-0.131339346782411,0.00547681909024829,-0.142073912199297,-0.120604781365524,1.81629607223269e-124
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MCAM,Cell surface glycoprotein MUC18,42689,0.0809346922301677,0.00338307536651519,0.0743038645117979,0.0875655199485375,6.52791991987373e-124
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACE2,Angiotensin-converting enzyme 2,42357,-0.129469082707779,0.00541326323178365,-0.140079078642075,-0.118859086773483,8.74223392838709e-124
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBP5,Retinol-binding protein 5,42587,-0.134010366391297,0.00560988483279258,-0.14500574066357,-0.123014992119023,1.52915662409671e-123
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MUC13,Mucin-13,42311,-0.124459131839983,0.00526167868702866,-0.134772022066559,-0.114146241613407,3.63823267731493e-121
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSD,Cathepsin D,41747,-0.100264097189941,0.00423715701541042,-0.108568924940145,-0.0919592694397364,3.80923598548595e-121
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GHR,Growth hormone receptor,40283,-0.0674961048562012,0.00285415017752747,-0.073090239204155,-0.0619019705082473,1.15369570269155e-120
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GSTA1,Glutathione S-transferase A1,42611,-0.194745968847379,0.00828693849507095,-0.210988368297718,-0.17850356939704,1.04255204688126e-119
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPY,Pancreatic prohormone,42600,-0.243299744027886,0.0104252614501352,-0.263733256470151,-0.222866231585621,4.11093957965409e-118
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD4,T-cell surface glycoprotein CD4,42570,-0.0723546920605104,0.00311488764681147,-0.0784598718482608,-0.0662495122727599,4.77326821714077e-117
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTH,Parathyroid hormone,40182,-0.191557425585165,0.0082407137436363,-0.207709224522692,-0.175405626647638,1.01229361138807e-116
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCLY,Selenocysteine lyase,42674,-0.106589741511456,0.00470150955663227,-0.115804700242456,-0.0973747827804571,1.04023486361599e-111
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLA,Alpha-galactosidase A,40267,-0.0852017752136671,0.00375663488068877,-0.0925647795798171,-0.0778387708475172,2.35534186510333e-111
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL17RB,Interleukin-17 receptor B,42416,0.121400421035263,0.00536680663590399,0.110881480028891,0.131919362041634,3.45522579324213e-111
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINF1,Pigment epithelium-derived factor,40351,-0.0604973476108175,0.00268487555787858,-0.0657597037042595,-0.0552349915173755,5.53200270688031e-110
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,42636,-0.0691149007172792,0.0030915469591144,-0.0751743327571434,-0.063055468677415,9.9892362926714e-109
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA14,Carbonic anhydrase 14,42721,0.0808611065854101,0.00363271870614709,0.0737409779213618,0.0879812352494584,7.85909096180894e-108
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,40462,-0.191563649293595,0.00860556429731662,-0.208430555316335,-0.174696743270854,1.816933574704e-107
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HGF,Hepatocyte growth factor,42754,-0.0774854901238815,0.00350828223804147,-0.0843617233104428,-0.0706092569373202,3.15191546330815e-106
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,42346,-0.143398410038531,0.00649457572538518,-0.156127778460286,-0.130669041616776,4.14468721787637e-106
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42733,-0.0699367795845592,0.00317025926251288,-0.0761504877390844,-0.0637230714300339,5.54770505329287e-106
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F9,Coagulation factor IX,42663,-0.0400874875228534,0.00182093768928908,-0.04365652539386,-0.0365184496518468,1.49604223215598e-105
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AFM,Afamin,40539,-0.0443128187032606,0.00201064253695707,-0.0482536780756964,-0.0403719593308247,1.94480241659648e-105
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,42477,-0.332311011658777,0.0151242840236567,-0.361954608345144,-0.30266741497241,3.93528270882397e-105
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42587,-0.0743565310604112,0.00338464473152851,-0.0809904347342071,-0.0677226273866153,4.07206340220671e-105
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",42587,-0.178224396332776,0.00813606701530924,-0.194171087682782,-0.16227770498277,1.56055168600215e-104
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,42587,-0.153915128042753,0.00702673555493728,-0.16768752973043,-0.140142726355076,1.60270478357938e-104
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MET,Hepatocyte growth factor receptor,42654,0.0439634496351484,0.00200835691918903,0.0400270700735379,0.0478998291967589,2.11052645244906e-104
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42794,0.0753316545342156,0.00344379306811228,0.0685818201207156,0.0820814889477157,2.81833214232368e-104
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42771,0.135745728092632,0.0062580943147443,0.123479863235734,0.148011592949531,1.35776241040443e-102
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42663,0.0660006393451738,0.00304515716669201,0.0600321312984574,0.0719691473918901,2.01275823319147e-102
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",42311,-0.119650480294046,0.00553442938828866,-0.130497961895091,-0.108802998693,7.02812559752995e-102
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GSTA3,Glutathione S-transferase A3,42346,-0.166256548067716,0.00769774168486062,-0.181344121770043,-0.151168974365389,1.08344777640931e-101
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMBP,Protein AMBP,42706,-0.0453286002014423,0.00211411109811665,-0.049472257953751,-0.0411849424491337,2.5805287294434e-100
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42679,-0.0797882956508685,0.00372595972590455,-0.0870911767136414,-0.0724854145880956,4.53743444559002e-100
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,42346,-0.126859344292243,0.00596085049927933,-0.13854261127083,-0.115176077313655,7.6563784965247e-99
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCG2,Secretogranin-2,42636,-0.073269292603713,0.00345655296245842,-0.0800441364101315,-0.0664944487972945,4.05582550986849e-98
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MME,Neprilysin,42587,-0.173600741103047,0.00820231415160431,-0.189677276840192,-0.157524205365903,7.98954138884673e-98
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,42587,-0.169467068060685,0.00801178540544474,-0.185170167455357,-0.153763968666014,1.03524712841409e-97
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,42587,-0.173141643010611,0.00821891981377209,-0.189250725845604,-0.157032560175617,6.02176847780606e-97
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,40483,-0.15989829777302,0.00759380487623755,-0.174782155330446,-0.145014440215594,1.41693390578002e-96
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CKB,Creatine kinase B-type,40527,0.127936227400882,0.00609114595237951,0.115997581334218,0.139874873467546,4.0671886157162e-96
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNTN3,Contactin-3,42611,-0.0652013234013178,0.00315193848130995,-0.0713791228246853,-0.0590235239779503,1.32599395574518e-93
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42692,-0.0506576151594348,0.00245399857628487,-0.0554674523689532,-0.0458477779499165,3.09596211803606e-93
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PGF,Placenta growth factor,42754,-0.0554673569295047,0.00268863615273308,-0.0607370837888616,-0.0501976300701479,3.92672724613865e-93
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,42443,-0.100298331087642,0.00487689383321778,-0.109857043000749,-0.0907396191745354,1.53188091178945e-92
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42636,0.0558713614393226,0.00274272970333674,0.0504956112207826,0.0612471116578626,7.12294250827001e-91
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,40527,-0.0701593647391812,0.00345528772836201,-0.0769317286867707,-0.0633870007915917,4.60717710756767e-90
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TTR,Transthyretin,40424,-0.0518155553545304,0.0025543188259092,-0.0568220202533125,-0.0468090904557484,6.97553456542548e-90
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42794,-0.0807918783953102,0.00399715015555251,-0.0886262927001931,-0.0729574640904273,1.56579593559014e-89
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42594,0.079607177014994,0.00398408934749332,0.0717983618939071,0.0874159921360809,1.50227487477314e-87
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSB,Cathepsin B,42659,0.10894464067392,0.00545376868061771,0.0982552540599096,0.119634027287931,1.64068444026618e-87
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAM20A,Pseudokinase FAM20A,40511,-0.05703812966856,0.00285916626892191,-0.0626420955556469,-0.051434163781473,4.72973454707166e-87
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,42679,-0.0449863794045315,0.00226400308992661,-0.0494238254607877,-0.0405489333482754,1.27124069373855e-86
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,40511,-0.149067696268262,0.00750631926285939,-0.163780082023467,-0.134355310513058,2.69491489722548e-86
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42754,-0.0827763916369,0.00420628625873319,-0.091020712704017,-0.0745320705697829,4.97175595971997e-85
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,42587,-0.171886428394553,0.00874571349716248,-0.189028026848991,-0.154744829940114,8.36673492264323e-85
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRIP2,Cysteine-rich protein 2,42495,-0.0724843596740936,0.00369936571145941,-0.0797351164685541,-0.0652336028796332,2.68804198521095e-84
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,42346,-0.16099534934284,0.00821812839295097,-0.177102880993024,-0.144887817692656,2.95991233179065e-84
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,40277,-0.0922248950240621,0.00471162116066266,-0.101459672498961,-0.0829901175491633,6.68083707483571e-84
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,42357,-0.109918359256782,0.00562381520382289,-0.120941037056275,-0.0988956814572893,6.97890286953538e-84
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOC1,Apolipoprotein C-I,40516,0.0728737610011296,0.00374124529382416,0.0655409202252343,0.080206601777025,3.80798058378352e-83
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL18R1,Interleukin-18 receptor 1,42754,-0.0648283861215658,0.00333778469735773,-0.0713704441283869,-0.0582863281147446,6.62676169953106e-83
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GIP,Gastric inhibitory polypeptide,40223,-0.115217297975042,0.00594384610418055,-0.126867236339236,-0.103567359610848,2.43458617367992e-82
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,42587,-0.204228557367489,0.0105697526920827,-0.224945272643971,-0.183511842091007,4.5765668611599e-82
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42754,-0.0780522183089224,0.00405843818733568,-0.0860067571561003,-0.0700976794617444,2.40743363864357e-81
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSO,Cathepsin O,42754,-0.0596895571668236,0.00311100741855296,-0.0657871317071874,-0.0535919826264598,5.65187359750345e-81
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,40283,-0.0964610295985974,0.00503937247142346,-0.106338199642587,-0.0865838595546074,2.23920453591592e-80
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPIND1,Heparin cofactor 2,40516,-0.0542154841432869,0.00284761174907591,-0.0597968031714756,-0.0486341651150981,1.41238402448029e-79
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,42408,-0.0923230097813272,0.00486135646125167,-0.10185126844538,-0.082794751117274,2.29189968119772e-79
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MEP1A,Meprin A subunit alpha,40449,-0.139385809817611,0.0073451829162151,-0.153782368333392,-0.124989251301829,4.54939377850286e-79
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F11R,Junctional adhesion molecule A,42611,-0.10613112599841,0.00561589074721541,-0.117138271862953,-0.0951239801338682,1.23180726886152e-78
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AGR3,Anterior gradient protein 3,42326,-0.114429409213104,0.00606362265799529,-0.126314109622775,-0.102544708803433,2.12657563436254e-78
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KHK,Ketohexokinase,40223,-0.119298346716649,0.00635413054278584,-0.131752442580509,-0.106844250852788,1.93982181354494e-77
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42587,-0.0756398120717498,0.00403475948942095,-0.0835479406710148,-0.0677316834724847,1.99891015093407e-77
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",40223,-0.108280424669236,0.00579246092761602,-0.119633648087363,-0.0969272012511086,8.56938063039172e-77
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,40532,-0.0421027206666377,0.00225326279582458,-0.0465191157464539,-0.0376863255868216,9.23396674973924e-77
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHI3L1,Chitinase-3-like protein 1,42416,-0.155732874486416,0.00837487756042741,-0.172147634504853,-0.139318114467978,3.2816827225328e-76
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KYNU,Kynureninase,42754,-0.0833622723721782,0.00450061051568528,-0.0921834689829213,-0.074541075761435,1.16474881905111e-75
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLAT,Tissue-type plasminogen activator,42760,-0.0944404370600754,0.00511854388325388,-0.104472783071253,-0.0844080910488978,4.2626773677149e-75
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMOT,Angiomotin,40283,-0.0726834316595331,0.00393783822477771,-0.0804015945800974,-0.0649652687389687,5.96443914577324e-75
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REN,Renin,42636,-0.160267643735735,0.00869509465267403,-0.177310029254976,-0.143225258216494,6.0867357487916e-75
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MENT,Protein MENT,40283,0.0430870280592646,0.00235790974221173,0.0384655249645296,0.0477085311539996,1.60826275425043e-73
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,40451,-0.0958059576870389,0.00526734894853591,-0.106129961626169,-0.0854819537479085,6.98771796320283e-73
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LEP,Leptin,42636,-0.122221038774554,0.00673181747610572,-0.135415401027722,-0.109026676521387,8.55233291834566e-73
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL27,C-C motif chemokine 27,42636,-0.108349843914635,0.00597870904724079,-0.120068113647227,-0.096631574182043,1.53980305149519e-72
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UMOD,Uromodulin,42764,0.101440863907444,0.00560781854051784,0.0904495395680285,0.112432188246858,2.73471075685449e-72
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HAO1,Hydroxyacid oxidase 1,42721,-0.228516084128399,0.012669095900374,-0.253347512093132,-0.203684656163666,6.89178472335789e-72
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HJV,Hemojuvelin,40482,-0.0806740671680565,0.00447733986772869,-0.0894496533088048,-0.0718984810273083,1.40275418557239e-71
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SELE,E-selectin,42794,-0.0924899297877169,0.00514932750705343,-0.102582611701542,-0.0823972478738922,2.5933680119359e-71
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPPC,C-type natriuretic peptide,42594,-0.0912037127132049,0.00507891763085765,-0.101158391269686,-0.0812490341567239,2.87320373367379e-71
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,40283,-0.0690259539390409,0.00384595257400392,-0.0765640209840885,-0.0614878868939932,5.03646527064099e-71
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPA2,Carboxypeptidase A2,42670,-0.119929017213072,0.0067032913567822,-0.133067468272365,-0.106790566153778,9.0988496683442e-71
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,42250,-0.100084206663353,0.00560954308274631,-0.111078911105536,-0.0890895022211704,2.28746780944831e-70
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BPIFB1,BPI fold-containing family B member 1,42573,0.113140165894915,0.00634551852679499,0.100702949582397,0.125577382207433,2.68785902702378e-70
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GDF15,Growth/differentiation factor 15,42794,-0.0835834383460944,0.00470622934242692,-0.0928076478572512,-0.0743592288349377,8.80898314836875e-70
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42594,-0.049173138484349,0.00278507325301776,-0.0546318820602638,-0.0437143949084342,5.52199526223016e-69
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL23,C-C motif chemokine 23,42676,-0.0752599205677058,0.00426341339299179,-0.0836162108179697,-0.0669036303174418,5.79957213133055e-69
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,42476,-0.131055683031507,0.00744987365044795,-0.145657435386385,-0.116453930676629,1.70338992003382e-68
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL15,C-C motif chemokine 15,42794,-0.0799994786768436,0.00454824560450625,-0.0889140400616758,-0.0710849172920113,1.70913152195161e-68
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42495,-0.104326031061061,0.00594522475104747,-0.115978671573114,-0.0926733905490076,3.61302511161812e-68
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTSS1,Protein MTSS 1,40449,-0.198760414558678,0.0113274201576552,-0.220962158067682,-0.176558671049674,5.04115582383431e-68
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SORD,Sorbitol dehydrogenase,42658,-0.118644292725914,0.0067721392750367,-0.131917685704986,-0.105370899746842,5.76546945139943e-68
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAM3B,Protein FAM3B,42587,-0.0628051494283259,0.00358880261430318,-0.0698392025523601,-0.0557710963042917,8.08519241905114e-68
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCS1,Neuronal calcium sensor 1,42721,-0.051300010474699,0.00293415199526317,-0.0570509483854148,-0.0455490725639832,1.05597811654637e-67
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42711,-0.0628919226657289,0.00360809194245894,-0.0699637828729484,-0.0558200624585094,2.61915652011251e-67
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD2AP,CD2-associated protein,42636,-0.112028169040239,0.00645436257085238,-0.12467871967911,-0.0993776184013686,9.32033924071567e-67
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F7,Coagulation factor VII,42671,-0.0546254914658754,0.00314978635255917,-0.0607990727168914,-0.0484519102148594,1.18523989863601e-66
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AGRN,Agrin,42676,-0.0638080210958725,0.00369867334173128,-0.0710574208456658,-0.0565586213460792,5.55336072420163e-66
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA4,Kallistatin,40342,-0.0423010770768879,0.00245034558005746,-0.0471037544138005,-0.0374983997399752,6.37321929408657e-66
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NOMO1,Nodal modulator 1,42611,-0.0404693092169198,0.00234750219159496,-0.0450704135124459,-0.0358682049213937,6.89113178284636e-66
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCHE,Cholinesterase,40346,-0.0489029222847511,0.00283765634368727,-0.0544647287183781,-0.043341115851124,1.05159127059305e-65
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,40504,0.0864470839044101,0.00503188219875191,0.0765845947948564,0.0963095730139639,2.52623365432144e-65
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",42357,-0.161088085263474,0.00939899428469859,-0.179510114061483,-0.142666056465465,3.86891650443607e-65
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42495,-0.0670946461263791,0.00394718525864603,-0.0748311292333254,-0.0593581630194329,4.02661367038603e-64
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OMD,Osteomodulin,42676,0.0730643286194803,0.00430455583287152,0.0646273991870521,0.0815012580519085,5.92462047799402e-64
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DPY30,Protein dpy-30 homolog,42651,-0.10358414656807,0.00610721049752986,-0.115554279143229,-0.0916140139929116,7.34959597575706e-64
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,POSTN,Periostin,40527,0.0664301619952647,0.00392417205057957,0.0587387847761287,0.0741215392144006,1.66938422023586e-63
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42794,-0.0880656943110618,0.00520999483753797,-0.0982772841926362,-0.0778541044294874,1.8907789958502e-63
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGA11,Integrin alpha-11,42594,0.0581920059654245,0.00344684846081622,0.0514361829822247,0.0649478289486243,2.71836178349563e-63
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPB1,Carboxypeptidase B,42794,-0.104122428122514,0.00616872440221009,-0.116213127950846,-0.0920317282941822,2.82264577517817e-63
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IDUA,Alpha-L-iduronidase,42721,-0.0793501278840624,0.00470380829707142,-0.0885695921463223,-0.0701306636218024,3.34421796918524e-63
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL6,C-X-C motif chemokine 6,42754,-0.130779037358979,0.00776188870922379,-0.145992339229057,-0.1155657354889,4.67792178808584e-63
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF23,Fibroblast growth factor 23,42711,-0.093214822152637,0.00553601278301404,-0.104065407207345,-0.0823642370979295,5.63545727467492e-63
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FUOM,Fucose mutarotase,40283,-0.108581785432631,0.0064439594416478,-0.121211945938261,-0.0959516249270016,6.32689776890791e-63
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCAM2,Neural cell adhesion molecule 2,42611,0.04646641802616,0.00276661122887515,0.0410438600175647,0.0518889760347553,1.14944967891056e-62
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,40223,0.103283724742561,0.0061704886933454,0.0911895669036037,0.115377882581518,4.0129772371725e-62
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FABP1,"Fatty acid-binding protein, liver",42618,-0.160535361144247,0.00960870644645475,-0.179368425779298,-0.141702296509196,4.9036360684277e-62
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,40451,-0.0966450775897391,0.00578381192268164,-0.107981348958195,-0.0853088062212831,6.20493105029163e-62
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGAV,Integrin alpha-V,42721,0.0276456311961612,0.00166778846789308,0.0243767657990907,0.0309144965932316,4.14344984309389e-61
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42590,-0.0846679600977542,0.00510897610539949,-0.0946815532643372,-0.0746543669311712,4.46966226129311e-61
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,40116,-0.114163365471554,0.00689688609229299,-0.127681262212448,-0.100645468730659,8.37543763287142e-61
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFI,Complement factor I,40539,-0.0329101978196016,0.00199098443957706,-0.0368125273211727,-0.0290078683180306,1.14743256708313e-60
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42721,-0.0576680865899564,0.00349874429365608,-0.0645256254055223,-0.0508105477743905,1.90178167171622e-60
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRP,Gastrin-releasing peptide,40223,-0.0938394399593927,0.00570663302890998,-0.105024440696056,-0.0826544392227291,4.79347743857463e-60
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",42346,-0.135860237282333,0.00828708085603988,-0.152102915760171,-0.119617558804495,8.23384768317834e-60
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,42370,-0.0766403430369606,0.00469023545985388,-0.0858332045382743,-0.067447481535647,1.95365781933729e-59
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AREG,Amphiregulin,42587,-0.0704467352023149,0.00434061181496469,-0.0789543343596457,-0.0619391360449842,1.12793365328609e-58
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GUSB,Beta-glucuronidase,42711,-0.0992915289818806,0.0061574111463688,-0.111360054828763,-0.0872230031349977,5.8581554191315e-58
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AGR2,Anterior gradient protein 2 homolog,42215,-0.165910131096704,0.0103479800201858,-0.186192171936268,-0.14562809025714,2.65123823772459e-57
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HEG1,Protein HEG homolog 1,40283,-0.0441292602321726,0.00275060185438848,-0.0495204398667741,-0.0387380805975712,2.79531799152621e-57
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLXNB2,Plexin-B2,42743,-0.0394089745264805,0.00245981969108853,-0.044230221121014,-0.0345877279319469,3.05293909778729e-57
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,42594,0.057158731608096,0.0035733295172238,0.0501550057543373,0.0641624574618546,4.59976906688601e-57
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,42587,-0.0584821559807006,0.00368391178036697,-0.0657026230702199,-0.0512616888911814,3.07230019656984e-56
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRSS2,Trypsin-2,42689,-0.0902847942591422,0.00568757475490594,-0.101432440778758,-0.0791371477395266,3.09213034684805e-56
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CST3,Cystatin-C,42659,-0.0488456195251823,0.00307742002908904,-0.0548773627821968,-0.0428138762681678,3.18754726488147e-56
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,42611,0.0662621794959826,0.00420231453007102,0.0580256430170433,0.0744987159749218,1.62606980877412e-55
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OCLN,Occludin,40482,-0.0723845929681762,0.00458905719028493,-0.0813791450611347,-0.0633900408752178,1.85432701240779e-55
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MLN,Promotilin,42594,-0.141610770926581,0.00900936023528467,-0.159269116987739,-0.123952424865423,3.5290559252938e-55
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EFNA4,Ephrin-A4,42475,-0.0543068552862633,0.0034554667896921,-0.0610795701940599,-0.0475341403784668,3.67506225307435e-55
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERMAP,Erythroid membrane-associated protein,40199,-0.0715733779375817,0.00456340489469979,-0.0805176515311933,-0.0626291043439701,7.59982200859609e-55
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42668,0.0487340352278286,0.00311127655082583,0.0426359331882099,0.0548321372674472,8.15098161869567e-55
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LSP1,Lymphocyte-specific protein 1,42594,-0.0630577424170225,0.00403436996335878,-0.0709651075452057,-0.0551503772888393,1.37597491547133e-54
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENO3,Beta-enolase,40223,-0.0938894578114848,0.00600374374487736,-0.105656795551444,-0.0821221200715251,1.53096722291797e-54
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GH1,Somatotropin,42613,0.272361360850358,0.0174688632470055,0.238122388886227,0.306600332814489,2.49992476035748e-54
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,40116,-0.0887488926342284,0.0057049265409112,-0.0999305486544144,-0.0775672366140425,5.44315720072104e-54
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42638,-0.0503494764890596,0.00324527280532219,-0.0567102111874911,-0.0439887417906281,8.07142459602243e-54
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42689,-0.0666332456262098,0.00429850728404352,-0.0750583199029351,-0.0582081713494845,9.84244261374793e-54
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LGALS9,Galectin-9,42620,-0.0507889616906893,0.003286929545495,-0.0572313435998595,-0.0443465797815192,2.11322016409513e-53
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA5,Plasma serine protease inhibitor,40387,-0.0496297597005994,0.0032118061011365,-0.0559248996588269,-0.0433346197423718,2.58258008349176e-53
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42594,-0.081238544923183,0.00527398411958644,-0.0915755537975724,-0.0709015360487936,4.4072990393396e-53
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,42721,-0.0569862843425083,0.00370245758905179,-0.0642431012170498,-0.0497294674679668,5.25077134379031e-53
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL32,Interleukin-32,42594,0.0692292778365707,0.00450022721447359,0.0604088324962025,0.0780497231769389,5.9837296403492e-53
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD209,CD209 antigen,42668,0.0609808658858064,0.00396494904430839,0.0532095657589619,0.0687521660126508,6.2765572562965e-53
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAM3C,Protein FAM3C,42613,-0.0487047528202228,0.00317208316003732,-0.054922035813896,-0.0424874698265497,9.32122126336445e-53
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42618,-0.0428581802237973,0.00279217187540717,-0.0483308370995953,-0.0373855233479992,1.00173662868651e-52
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,42346,-0.0587374150308374,0.00382711411143854,-0.0662385586892569,-0.0512362713724178,1.04976834388132e-52
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,40511,-0.104791702328571,0.00682364965419009,-0.118166055650783,-0.091417349006358,1.07709505140106e-52
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42711,-0.0807252254514614,0.00526766215273212,-0.0910498432708164,-0.0704006076321065,1.44638856119955e-52
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,42569,-0.0397418174392945,0.00259651139384243,-0.0448309797712257,-0.0346526551073633,1.94313707965282e-52
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEMA3F,Semaphorin-3F,42636,-0.0421506926061892,0.00276353274342464,-0.0475672167833015,-0.0367341684290769,4.32499050772859e-52
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GZMA,Granzyme A,42754,-0.0550363590947435,0.00361599282023943,-0.0621237050224127,-0.0479490131670742,6.96057457314694e-52
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTGR1,Prostaglandin reductase 1,40511,-0.13006806678326,0.00855154604000237,-0.146829097021665,-0.113307036544855,9.86048439076744e-52
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSME1,Proteasome activator complex subunit 1,42480,-0.0570696086420736,0.00377066577164725,-0.0644601135545022,-0.049679103729645,2.54208494976461e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42689,0.0577874367570353,0.00382118529562411,0.050297913577612,0.0652769599364586,3.00677137801936e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42594,-0.0985290624671767,0.00652872390490736,-0.111325361320795,-0.0857327636135583,4.82754010184659e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42587,-0.0674881011723246,0.00447882819653188,-0.0762666044375271,-0.0587095979071222,6.841335721524e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42594,-0.0596754092410691,0.00396427078585819,-0.0674453799813511,-0.051905438500787,8.53918020107263e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL12A_IL12B,Interleukin-12,42587,-0.125721763375528,0.00835529555204246,-0.142098142657532,-0.109345384093525,9.39010403658226e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HEPH,Hephaestin,40511,-0.0405902113084201,0.00270432068575343,-0.0458906798524968,-0.0352897427643434,1.94600499073993e-50
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUMB,Protein numb homolog,40199,-0.125647647362109,0.00837548561166991,-0.142063599160982,-0.109231695563236,2.24484742483949e-50
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOA1,Apolipoprotein A-I,40539,0.0422932903206726,0.00281998754483431,0.0367661147327973,0.0478204659085478,2.30718783730694e-50
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL12B,Interleukin-12 subunit beta,42754,-0.0864755026898917,0.00577894641491781,-0.0978022376631306,-0.0751487677166528,3.18025220019439e-50
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPA1,Carboxypeptidase A1,42794,-0.095223739522618,0.00636411472350801,-0.107697404380694,-0.0827500746645423,3.23240110289667e-50
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD5,T-cell surface glycoprotein CD5,42706,-0.054668204263434,0.00367407023014735,-0.0618693819145228,-0.0474670266123452,1.1078416027075e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42562,-0.106194745901197,0.00718122712011257,-0.120269951056618,-0.0921195407457768,4.28624569644623e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42495,-0.109238080532471,0.00739684269908784,-0.123735892222683,-0.0947402688422588,5.7342955949689e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REG4,Regenerating islet-derived protein 4,42638,-0.0792207317602245,0.00537792943465835,-0.0897614734521549,-0.0686799900682941,9.81315241236664e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADM,Pro-adrenomedullin,42721,-0.0400851372888947,0.00273508966876971,-0.0454459130396833,-0.034724361538106,2.89534617151412e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAXX,Protein PAXX,40283,-0.068023669594357,0.00464016983012415,-0.0771184024614003,-0.0589289367273136,3.29432629698464e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,40283,-0.110911626241671,0.00759719237902747,-0.125802123304565,-0.0960211291787776,7.90543596586777e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FETUB,Fetuin-B,42663,-0.047778914724159,0.00327591398930338,-0.0541997061431936,-0.0413581233051244,8.10761105838261e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42587,-0.0647019847203454,0.00443912870224842,-0.0734026769767523,-0.0560012924639385,9.34607979636074e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TXLNA,Alpha-taxilin,42495,-0.129566160621278,0.00890034469594824,-0.147010836225337,-0.11212148501722,1.21732912432838e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42746,-0.0563366391871549,0.00387092680630742,-0.0639236557275174,-0.0487496226467923,1.2632679429951e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BECN1,Beclin-1,40223,-0.0888823512316177,0.00610348691613486,-0.100845185587242,-0.0769195168759933,1.34267028269756e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFH,Complement factor H,39956,-0.0341584570916094,0.00234535867607611,-0.0387553600967185,-0.0295615540865002,1.34283380435149e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAT2,Linker for activation of T-cells family member 2,42587,-0.182404350356541,0.0125442859055974,-0.206991150731512,-0.157817549981571,1.53694847510328e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,42587,-0.098715282391122,0.00679728533175982,-0.112037961641371,-0.0853926031408727,1.99307552845124e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,42346,-0.100316737720008,0.00690930641028163,-0.11385897828416,-0.0867744971558558,2.13294422896664e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42676,-0.0445978795956693,0.00307367221431409,-0.0506222771357249,-0.0385734820556137,2.39293930570455e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,XCL1,Lymphotactin,42721,-0.0827613111523692,0.00572093402738728,-0.0939743418460482,-0.0715482804586901,4.43555225521742e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNASET2,Ribonuclease T2,42749,-0.0407689703335844,0.00281927444104856,-0.0462947482380396,-0.0352431924291292,4.7974568723407e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PXN,Paxillin,42311,-0.0754020093412839,0.00521633418651437,-0.0856260243468521,-0.0651779943357158,5.354613823533e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL13,C-X-C motif chemokine 13,42711,-0.0920533228741523,0.00637885532195809,-0.10455587930519,-0.0795507664431144,7.36087191394222e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNAPIN,SNARE-associated protein Snapin,40482,-0.0846883531857911,0.00586729975195102,-0.0961882606996151,-0.0731884456719671,8.25310803816669e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42613,-0.166414596255304,0.0115750065527975,-0.189101609098787,-0.14372758341182,1.59721591292164e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCARB2,Lysosome membrane protein 2,42302,-0.0511911678980222,0.00356356074311936,-0.0581757469545361,-0.0442065888415082,1.92699541069285e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LBR,Delta(14)-sterol reductase LBR,42711,-0.0969106646690282,0.00676605778839085,-0.110172137934274,-0.0836491914037821,3.41955738200727e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,40451,-0.100975496750386,0.00705882053363987,-0.11481078499632,-0.0871402085044514,5.15966614369053e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCXR,L-xylulose reductase,42679,-0.0761712831610329,0.00535104742265721,-0.086659336109441,-0.0656832302126248,1.19218709218866e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NECTIN2,Nectin-2,42613,-0.0458049694764211,0.00321942236950942,-0.0521150373206596,-0.0394949016321827,1.32320664853568e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,42587,-0.0858032585619544,0.00603406775528219,-0.0976300313623075,-0.0739764857616013,1.48095079099461e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,40449,-0.0425544026934164,0.00299392850161817,-0.048422502556588,-0.0366863028302448,1.86537335833759e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42611,-0.0660384118127208,0.00466160298911637,-0.0751751536713888,-0.0569016699540527,3.12962912370205e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,40199,-0.0643395157701591,0.00454811694660752,-0.0732538249855098,-0.0554252065548083,4.87247641145319e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,42611,-0.0771310702977822,0.00545848202111452,-0.0878296950591667,-0.0664324455363977,5.17954890315472e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EGLN1,Egl nine homolog 1,42594,-0.0795736364213368,0.00563354489684484,-0.0906153844191527,-0.068531888423521,5.60146321285823e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,40367,-0.0492901623419189,0.00349647530800326,-0.0561432539456053,-0.0424370707382325,9.56016296433768e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACAN,Aggrecan core protein,42488,0.0399928565592207,0.00283969200794399,0.0344270602236505,0.0455586528947909,1.00516084100799e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,YES1,Tyrosine-protein kinase Yes,42587,-0.162090784276013,0.0115297129726554,-0.184689021702417,-0.139492546849608,1.41623396173642e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42754,0.0365593973861485,0.00260134193108834,0.0314607672012153,0.0416580275710816,1.49392003236415e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42580,-0.0293388268255562,0.00209064364549365,-0.0334364883707238,-0.0252411652803887,2.0097545363223e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EGFR,Epidermal growth factor receptor,42794,0.0233133461820898,0.00166446010426162,0.020051004377737,0.0265756879864426,2.88510896431601e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD248,Endosialin,40527,0.0582297197665208,0.0041675585639061,0.0500613049812648,0.0663981345517768,5.33960779523327e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPO,Erythropoietin,42594,-0.10515673386025,0.00753215871355078,-0.119919764938809,-0.0903937027816904,5.47688613531375e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHMP6,Charged multivesicular body protein 6,40511,-0.0797349686459165,0.00570858755745913,-0.0909238002585365,-0.0685461370332966,5.69585966804715e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,42652,0.0508178853328714,0.00364611198988618,0.0436715058326945,0.0579642648330483,7.55358048514807e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDHR2,Cadherin-related family member 2,42587,-0.100065770063648,0.00719576800046735,-0.114169475344564,-0.0859620647827317,1.16804512379376e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,42346,-0.155345772156311,0.0111816316684326,-0.177261770226439,-0.133429774086183,1.41977838279236e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH1,Cadherin-1,42188,-0.0565468363887031,0.00407083979972761,-0.0645256823961692,-0.048567990381237,1.47671483936009e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB6A,Ras-related protein Rab-6A,42594,0.0648249965162219,0.004676576815606,0.0556589059576341,0.0739910870748096,2.15553886596031e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42618,-0.0567906137144157,0.00409824838906459,-0.0648231805569823,-0.0487580468718491,2.28528752145979e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PIGR,Polymeric immunoglobulin receptor,42464,-0.0506562722860675,0.0036565762319052,-0.0578231617006017,-0.0434893828715334,2.42738172582563e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SULT2A1,Bile salt sulfotransferase,42594,-0.079032420195732,0.0057055695354664,-0.0902153364852462,-0.0678495039062179,2.4671089756073e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,42346,-0.0720616679629536,0.00520583743537415,-0.0822651093362869,-0.0618582265896203,2.84015357599065e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL17,C-X-C motif chemokine 17,42754,-0.0572211543004863,0.00413496466011575,-0.0653256850343132,-0.0491166235666594,2.94288212195124e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DTYMK,Thymidylate kinase,40511,-0.095816908290819,0.00692773503470906,-0.109395268958849,-0.0822385476227893,3.72082687524977e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TFPI,Tissue factor pathway inhibitor,42618,0.0435470697306101,0.00315694177331126,0.03735946385492,0.0497346756063001,5.43445383848474e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,42238,-0.0278376660557452,0.00201900967184369,-0.0317949250125588,-0.0238804070989316,6.0382721220304e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TOP2B,DNA topoisomerase 2-beta,40199,-0.111871990786691,0.0081208224532507,-0.127788802795062,-0.0959551787783192,8.05529039441524e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",40482,-0.0874564971236374,0.0063515461166055,-0.0999055275121842,-0.0750074667350906,8.63815261127399e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNASE4,Ribonuclease 4,40169,-0.0413087570374047,0.00300168756271224,-0.0471920646603207,-0.0354254494144888,9.78026418202923e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL16,Pro-interleukin-16,42754,-0.0577595270653852,0.00420535353746886,-0.0660020199988242,-0.0495170341319463,1.21257492738177e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EZR,Ezrin,42711,-0.0333894780130695,0.00243134861585026,-0.038154921300136,-0.028624034726003,1.24620243237092e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,40199,-0.118228139116774,0.00861315217321155,-0.135109917376268,-0.101346360857279,1.57795141590406e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL3,C-C motif chemokine 3,42594,-0.0801899584223992,0.0058498129593166,-0.0916555918226598,-0.0687243250221387,1.75568148734057e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42587,-0.1349622251613,0.00986915049936524,-0.154305760140056,-0.115618690182544,2.74731588271731e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VEGFA,Vascular endothelial growth factor A,42716,-0.0814645983269665,0.00596161079703976,-0.0931493554891644,-0.0697798411647686,3.13939773722571e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,40483,-0.0661249482893618,0.00484925049383084,-0.0756294792572703,-0.0566204173214534,5.25105269606021e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TREH,Trehalase,40527,-0.103324116777013,0.00758281136811528,-0.118186427058519,-0.0884618064955075,5.99304273044604e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,42475,-0.122906861979225,0.00903916818105835,-0.140623631614099,-0.10519009234435,7.93155826243567e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SARG,Specifically androgen-regulated gene protein,40456,-0.150566040524558,0.0110730762991532,-0.172269270070898,-0.128862810978218,8.85046194080774e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CES3,Carboxylesterase 3,42587,-0.0973124472614383,0.00718371726182377,-0.111392533094613,-0.0832323614282637,1.564998629912e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,42370,-0.0953748880513051,0.00705699958430196,-0.109206607236537,-0.0815431688660733,2.40694715305493e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42570,-0.144581015414033,0.0106999764607784,-0.165552969277159,-0.123609061550908,2.47100207918955e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,40449,-0.0418663278615034,0.00309885770494598,-0.0479400889631975,-0.0357925667598093,2.85229351367426e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42594,-0.132042845399914,0.00979618881347318,-0.151243375474321,-0.112842315325507,3.85331498448057e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LEPR,Leptin receptor,42636,0.0428223943024634,0.00318279154065889,0.036584122882772,0.0490606657221548,5.34602921587526e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42611,-0.0443560917608463,0.00330084222071874,-0.0508257425134551,-0.0378864410082376,6.67341131312142e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GSN,Gelsolin,40488,0.0267595473035668,0.00199134720216686,0.0228565067873198,0.0306625878198139,7.46357141915193e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANG,Angiogenin,42618,-0.0459671325520941,0.00342584631317998,-0.0526817913259269,-0.0392524737782614,8.71578534713909e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42689,-0.0562644852414513,0.00419804656554116,-0.064492656509912,-0.0480363139729907,1.06367427468147e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNAP29,Synaptosomal-associated protein 29,42679,-0.124397849745282,0.00928445976612847,-0.142595390886893,-0.10620030860367,1.12284153368943e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,40116,-0.0867677046384592,0.00648232681401618,-0.0994730651939309,-0.0740623440829875,1.53747618555821e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTBS,Di-N-acetylchitobiase,40383,-0.0367177997264996,0.00274558893369866,-0.0420991540365489,-0.0313364454164502,1.76874596577075e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FYB1,FYN-binding protein 1,42590,-0.124888924307337,0.0093470261708538,-0.143209095602211,-0.106568753012464,1.84595303654944e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYH9,Myosin-9,40527,-0.15578968755313,0.0116741562881089,-0.178671033877824,-0.132908341228437,2.55681934400855e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42683,-0.0419713181008856,0.00314814574515674,-0.0481416837613928,-0.0358009524403784,2.70941713109953e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARF6,ADP-ribosylation factor 6,40449,-0.145381539655045,0.0109260830127526,-0.16679666236004,-0.12396641695005,4.29291555916513e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BACH1,Transcription regulator protein BACH1,42594,-0.0985487349111032,0.00741761291963008,-0.113087256233578,-0.0840102135886282,5.01369024728805e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUCB2,Nucleobindin-2,42683,-0.0499801989310662,0.00376246980229406,-0.0573546397435626,-0.0426057581185698,5.12095656174414e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42594,-0.142163606482661,0.0107403118454094,-0.163214617699664,-0.121112595265659,9.59674742915023e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ELN,Elastin,40511,-0.0495552237670203,0.00374857956777201,-0.0569024397198534,-0.0422080078141871,1.32637739879366e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP85,Centrosomal protein of 85 kDa,42346,-0.0860523523677575,0.00651639535150106,-0.0988244872566995,-0.0732802174788154,1.45571546324034e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSZ,Cathepsin Z,42648,-0.043383097045098,0.00329098749735828,-0.0498334325399203,-0.0369327615502758,1.94536377233588e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42689,0.05980246685703,0.00453667881048855,0.0509105763884724,0.0686943573255876,1.9523217105384e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WIF1,Wnt inhibitory factor 1,42721,0.0464305890001334,0.00352316979775378,0.039525176196536,0.0533360018037308,2.03718952755424e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STC1,Stanniocalcin-1,42711,-0.0605887833212575,0.00460735228746314,-0.0696191938046853,-0.0515583728378298,2.9458989578489e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TFF3,Trefoil factor 3,42613,-0.0578879343945249,0.00440734481475604,-0.0665263302314468,-0.0492495385576031,3.6460584775603e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FABP5,Fatty acid-binding protein 5,42678,-0.0904057700851487,0.00688732091111345,-0.103904919070931,-0.0769066210993663,4.03712434476216e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HYAL1,Hyaluronidase-1,42544,-0.0309767618313082,0.0023687481403813,-0.0356195081864556,-0.0263340154761609,7.69268960654594e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42555,-0.0436558151720865,0.00334260114045507,-0.0502073134073784,-0.0371043169367945,9.56747958649469e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSME2,Proteasome activator complex subunit 2,42441,-0.0478459065123295,0.0036855345716263,-0.0550695542727171,-0.040622258751942,2.64761615133231e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,42794,-0.0503317406939788,0.00388097697133003,-0.0579384555577857,-0.042725025830172,3.09753167391717e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNAP23,Synaptosomal-associated protein 23,42636,-0.114422869195706,0.00882503387119354,-0.131719935583246,-0.097125802808167,3.24416667496659e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42636,-0.0572983873881895,0.00443346156103736,-0.0659879720478227,-0.0486088027285562,5.54217261704288e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42794,0.0328040940888165,0.00253852061050354,0.0278285936922296,0.0377795944854035,5.61978572885068e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42636,-0.0460593745248688,0.00357002900188928,-0.0530566313685718,-0.0390621176811658,7.38686516123261e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPE,Carboxypeptidase E,42588,0.0507444804041023,0.00394377267397512,0.0430146859631111,0.0584742748450936,1.15383433243299e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,42311,-0.0378665991771848,0.00294280690797035,-0.0436345007168066,-0.0320986976375629,1.15856286481187e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NRP1,Neuropilin-1,42705,0.0363661207074288,0.00283509574857624,0.0308093330402193,0.0419229083746382,1.91113266446941e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,40223,-0.11018763789961,0.00858447532086838,-0.127013209528512,-0.0933620662707075,1.9171524648477e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42594,-0.0907918828687956,0.00707964818488157,-0.104667993311164,-0.0769157724264277,1.98809053477549e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCTN1,Dynactin subunit 1,42721,-0.0842742997405957,0.00658095841404757,-0.0971729782321289,-0.0713756212490624,2.50677586648335e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",40511,-0.0965808419360052,0.00754576084152073,-0.111370533185386,-0.0817911506866245,2.99556107541991e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THOP1,Thimet oligopeptidase,42571,-0.0402266179824388,0.00314778804880888,-0.0463962825581042,-0.0340569534067734,3.52840405756596e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AGXT,Serine--pyruvate aminotransferase,42636,-0.0982362274359944,0.00769625403040626,-0.113320885335591,-0.0831515695363981,4.26736174973446e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,42311,-0.0667235013892472,0.00522823987366838,-0.0769708515416372,-0.0564761512368572,4.4321343153622e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPL,N-acetylneuraminate lyase,40511,-0.0593528055858782,0.00465540134676575,-0.0684773922255391,-0.0502282189462173,5.65222900092826e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42611,-0.040130541418889,0.00314963008447509,-0.0463038163844602,-0.0339572664533178,5.70345273910919e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SBSN,Suprabasin,40511,0.0456774456992753,0.00358315246151508,0.0386544668747058,0.0527004245238449,5.75298402871692e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42651,-0.0756387872715394,0.00594028137049426,-0.0872817387577082,-0.0639958357853707,6.31438466326736e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNCG,Gamma-synuclein,42495,-0.0889963663997202,0.00701862058598102,-0.102752862748243,-0.0752398700511974,1.24290535834054e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAT,Linker for activation of T-cells family member 1,42754,-0.0971504317160054,0.00766566217415685,-0.112175129577353,-0.082125733854658,1.33797274336778e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,42640,-0.0519244469394964,0.00409956884489272,-0.0599596018754861,-0.0438892920035067,1.47879109928992e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAST,Gastrin,40483,-0.188377465489748,0.0148880098026628,-0.217557964702967,-0.159196966276529,1.90368834341236e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42611,0.0679311053931722,0.00538070663021938,0.0573849203979422,0.0784772903884022,2.4753711225228e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IKBKG,NF-kappa-B essential modulator,42594,-0.116626534647594,0.00924312183492957,-0.134743053444056,-0.0985100158511323,2.71398511181681e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42636,-0.0355710342757998,0.00282433088102815,-0.041106722802615,-0.0300353457489846,3.62278302873e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,42594,-0.0739902746415467,0.00587607218047054,-0.0855073761152689,-0.0624731731678244,3.75324964189634e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42760,-0.0248020663521889,0.00197069172077775,-0.0286646221249133,-0.0209395105794646,4.03959682288028e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL1R2,Interleukin-1 receptor type 2,42600,-0.0255766956946699,0.00203523558986604,-0.0295657574508074,-0.0215876339385325,5.12040365934823e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EEF1D,Elongation factor 1-delta,40511,-0.117315320582942,0.00933097035868353,-0.135604022485961,-0.0990266186799218,5.19220054083197e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH2,Cadherin-2,42636,-0.0455333509256767,0.00362776449913011,-0.0526437693439717,-0.0384229325073817,6.21380188889055e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42587,0.0320910148035582,0.00255749202887775,0.0270783304269578,0.0371036991801585,6.50277658344316e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,40449,-0.0762467259753823,0.00607346265904188,-0.0881507127871044,-0.0643427391636603,6.56735724715083e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,42587,-0.10806325963291,0.00861280385005155,-0.124944355179011,-0.0911821640868092,6.58691115482438e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42638,0.0438884660969075,0.00349928438253707,0.0370298687071348,0.0507470634866801,6.97158766165319e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL11,Eotaxin,42754,-0.0469334980632971,0.00374359365689378,-0.0542709416308089,-0.0395960544957852,7.40122004173546e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMN,Protein amnionless,42370,-0.0600590993373213,0.00480399823181631,-0.0694749358716812,-0.0506432628029613,1.16128603495172e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,42679,0.055607500170955,0.00447506162569221,0.0468363793845983,0.0643786209573117,2.9418621090226e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ESM1,Endothelial cell-specific molecule 1,42618,0.043673616604166,0.00351542723948604,0.0367833792147734,0.0505638539935587,3.0466615492617e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,40465,-0.102113857525535,0.00821508164959257,-0.118215417558737,-0.0860122974923338,3.05462071558631e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42721,-0.102567708382009,0.00825755813146758,-0.118752522319685,-0.0863828944443325,3.12576434740481e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FSTL3,Follistatin-related protein 3,42574,-0.0430183703629288,0.00346546483398675,-0.0498106814375429,-0.0362260592883148,3.45097608007644e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42636,-0.0475025858750567,0.00382976092969081,-0.0550089172972507,-0.0399962544528627,3.8922162296569e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AXIN1,Axin-1,42594,-0.119014729365122,0.0096202453703459,-0.137870410291,-0.100159048439244,5.80078613789288e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBKS,Ribokinase,42317,-0.0625765057680503,0.00505848966829964,-0.0724911455179176,-0.052661866018183,5.90413723521433e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42620,-0.0622509446753717,0.0050326843629197,-0.0721150060266943,-0.0523868833240491,5.93638798280215e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGBL1,Integrin beta-like protein 1,40527,-0.0492993023297883,0.00398407204486244,-0.0571080835377187,-0.0414905211218579,6.06634465851312e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42587,-0.0349733544629348,0.00283609319733755,-0.0405320971297164,-0.0294146117961532,9.45776470839995e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCN1,Ficolin-1,40515,-0.0705149389506766,0.00571597414939584,-0.0817182482834925,-0.0593116296178608,9.63122943351648e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42794,-0.0826641245187305,0.00673355688605731,-0.0958618960154029,-0.0694663530220582,1.84473721086546e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,40199,-0.086080198315459,0.00701369782800325,-0.0998270460583453,-0.0723333505725726,2.11816208637085e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,40116,-0.0922675413061612,0.00752887262370809,-0.107024131648629,-0.0775109509636934,2.64735760481989e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42689,-0.053501833211522,0.00436923840942853,-0.0620655404940019,-0.0449381259290421,2.71264894955954e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNASE6,Ribonuclease K6,40468,-0.0428443261120712,0.00349750164162985,-0.0496994293296657,-0.0359892228944767,2.77475936585015e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FMNL1,Formin-like protein 1,42311,-0.0773402537466598,0.00632648738030779,-0.0897401690120631,-0.0649403384812565,3.51447177020665e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ELOA,Elongin-A,42587,-0.0668169141055778,0.00546789990244315,-0.0775339979143664,-0.0560998302967892,3.70162201027466e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,40451,-0.0987210823708659,0.00807568273453877,-0.114549420530562,-0.0828927442111699,3.78562005795465e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTDH,Protein LYRIC,40199,-0.11712035857868,0.00959313788699756,-0.135922908837195,-0.098317808320165,4.63336589287794e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,40483,-0.0860315853123529,0.00705478839514974,-0.0998589705668464,-0.0722042000578594,5.42046582200887e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100A4,Protein S100-A4,42679,-0.0706846430503093,0.00580669170307932,-0.0820657587883448,-0.0593035273122738,6.52275184929472e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,40483,-0.106373127927265,0.0087483629246645,-0.123519919259608,-0.0892263365949229,8.33621716247439e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,42346,-0.0614246866971386,0.00505539277559822,-0.0713332565373111,-0.051516116856966,8.66773458305166e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD63,CD63 antigen,42475,-0.0631561189439898,0.00519859738166001,-0.0733453698120435,-0.0529668680759362,8.80645839809021e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42594,-0.0719362202651659,0.0059252040899831,-0.0835496202815327,-0.060322820248799,9.66207772107648e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,40483,0.0456848029346459,0.00378234952067246,0.0382713978741278,0.0530982079951639,2.20550828134037e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",40223,-0.0846513022165869,0.00700872615753622,-0.0983884054853579,-0.0709141989478159,2.24166009262012e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,42594,-0.0766675217457661,0.00635147656236161,-0.0891164158079949,-0.0642186276835374,2.24401391672524e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSTB,Cystatin-B,42437,-0.0525017624141946,0.00434957638607828,-0.061026932130908,-0.0439765926974812,2.26196402719179e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTSS2,Protein MTSS 2,40451,-0.121423721783767,0.0100738813101448,-0.141168529151651,-0.101678914415883,2.98406877985263e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CALCA,Calcitonin,42476,-0.0775233699734654,0.00644620854876139,-0.0901579387290377,-0.0648888012178931,3.84669864085593e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,40223,-0.088936985375593,0.00739369145292509,-0.103428620623326,-0.0744453501278598,4.04206121328092e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42794,0.0404480616298291,0.00336904177462272,0.0338447397515686,0.0470513835080896,4.86520453335297e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,40283,-0.102362670568261,0.00852342790430339,-0.119068589260696,-0.0856567518758266,5.07107553595218e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,40449,-0.0635854637715696,0.00529750910213131,-0.073968581611747,-0.0532023459313922,5.45340668552927e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGFA,Protransforming growth factor alpha,42594,-0.0579895590763112,0.00483846952548054,-0.0674729593462531,-0.0485061588063693,6.26629328663973e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,42501,-0.0358679653365477,0.00299438434140392,-0.0417369586456994,-0.029998972027396,6.80568141024668e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,40483,-0.0777812072966208,0.0064906836205496,-0.090502947192898,-0.0650594674003436,6.8618036119795e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LGALS3BP,Galectin-3-binding protein,40539,-0.0375966106124637,0.00313767652756897,-0.0437464566064989,-0.0314467646184286,6.94549443677732e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TJAP1,Tight junction-associated protein 1,42679,-0.100482167335825,0.00839084373797118,-0.116928221062248,-0.084036113609401,7.03411717758525e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,40451,-0.0812962754060245,0.00678647576115987,-0.0945977678978978,-0.0679947829141511,7.23660135181567e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,40169,-0.060276508746769,0.00503472205040302,-0.070144563965559,-0.0504084535279791,7.95777801575998e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,42346,-0.0766230456651732,0.00640842769913071,-0.0891835639554694,-0.064062527374877,8.86602630335882e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100P,Protein S100-P,42357,-0.0666947541174795,0.00558683167966508,-0.0776449442096231,-0.0557445640253359,1.10797926422368e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,40116,-0.0441898645402695,0.00370399827134105,-0.051449701152098,-0.0369300279284411,1.31115839541786e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C19orf12,Protein C19orf12,42311,-0.0775844150342614,0.00650788715766101,-0.090339873863277,-0.0648289562052459,1.34582826591841e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,YTHDF3,YTH domain-containing family protein 3,42370,-0.1030248765233,0.00864462515924292,-0.119968341835417,-0.0860814112111843,1.40556217545862e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PVR,Poliovirus receptor,42711,-0.0446262514848336,0.00375411671421959,-0.051984320244704,-0.0372681827249632,1.99907436682298e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42679,0.0291654934405922,0.00245674129574507,0.0243502805009318,0.0339807063802525,2.40855567722121e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DKK4,Dickkopf-related protein 4,42477,-0.0562079655324781,0.00473694322128325,-0.0654923742461932,-0.0469235568187629,2.59236312147061e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,42346,-0.0869613111946421,0.00734551299907986,-0.101358516672839,-0.0725641057164455,3.58658510040913e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,40449,-0.167236179830802,0.0141288167083863,-0.194928660579239,-0.139543699082365,3.91798175867638e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEZ6L2,Seizure 6-like protein 2,42587,0.0287230461641341,0.00243200716592867,0.0239563121189139,0.0334897802093543,4.97108900747033e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,40171,-0.047488418566977,0.00402694878505618,-0.0553812381856871,-0.0395955989482669,6.6331159695354e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNTN5,Contactin-5,42640,0.0458492818968047,0.00389647720179701,0.0382121865812826,0.0534863772123268,8.28320200908757e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ASAH2,Neutral ceramidase,42495,-0.0641704298004538,0.00546000128499081,-0.0748720323190358,-0.0534688272818718,9.80207919232503e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAA80,N-alpha-acetyltransferase 80,40182,-0.144751341903366,0.0123221776487653,-0.168902810094946,-0.120599873711786,1.12852319391466e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42591,-0.0525971525525075,0.00448220314144359,-0.0613822707097369,-0.043812034395278,1.20927218476871e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFHR4,Complement factor H-related protein 4,40509,0.0898236485407523,0.0076514141258418,0.0748268768541024,0.104820420227402,1.21996893941908e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCR,Breakpoint cluster region protein,42594,-0.108707489684276,0.00926474957365796,-0.126866398848646,-0.0905485805199066,1.22646430444636e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42611,-0.0359643821204758,0.00307632230216154,-0.0419939738327125,-0.0299347904082392,2.01942090590493e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,40532,0.0327916559216325,0.00281029052172628,0.027283486499049,0.038299825344216,2.78893084436277e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INSL5,Insulin-like peptide INSL5,40449,-0.117748531329107,0.0101062365494352,-0.137556754966,-0.0979403076922139,3.42106771095236e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRIM5,Tripartite motif-containing protein 5,42594,-0.100823923537581,0.00867664281391088,-0.117830143452846,-0.0838177036223154,4.58702905712032e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD207,C-type lectin domain family 4 member K,42365,-0.0471913712173277,0.00406737706130232,-0.0551634302574802,-0.0392193121771751,5.66665667273151e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",40408,-0.129159438204077,0.0111339385858294,-0.150981957832303,-0.107336918575851,6.15015885879619e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA6,Carbonic anhydrase 6,42581,0.0740863909648393,0.00639786285476461,0.0615465797695007,0.0866262021601779,7.31294496179253e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDC27,Cell division cycle protein 27 homolog,42346,-0.0710517444796943,0.00614429924860255,-0.0830945710069552,-0.0590089179524333,8.85059271286521e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP20,Centrosomal protein 20,42346,-0.0882246082016333,0.00763092124175055,-0.103181213835464,-0.0732680025678022,9.09747393812455e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FUS,RNA-binding protein FUS,42336,-0.0469522244162799,0.00406469520252086,-0.0549190270132208,-0.038985421819339,1.02388686346827e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",42587,-0.0697500455278807,0.00606228590812497,-0.0816321259078056,-0.0578679651479558,1.72001342416996e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42594,-0.121170800335225,0.0105371859552931,-0.141823684807599,-0.10051791586285,1.84689265800965e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42638,-0.0423146840555976,0.00368710990850638,-0.0495414194762701,-0.0350879486349251,2.40050432632386e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,42357,-0.110725189041448,0.00965177991536716,-0.129642677675568,-0.0918077004073285,2.54155390136779e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R9B,Neurabin-2,42754,-0.109313495131081,0.0095376053520299,-0.12800720162106,-0.0906197886411026,2.84438943794923e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",42370,-0.0697741828947892,0.00608839673879333,-0.0817074405028241,-0.0578409252867543,2.90809208362144e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCAN,Brevican core protein,42495,0.0405486763495078,0.00354067616813433,0.0336089510599645,0.0474884016390511,3.17487566222979e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFX1,Transcriptional repressor NF-X1,40116,-0.0797310992385712,0.00696102116569668,-0.0933747007233366,-0.0660874977538057,3.34141139609149e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFC1,Cryptic protein,42346,-0.0555162695558583,0.00485053833637727,-0.0650233246951577,-0.0460092144165588,3.44616243961459e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IMMT,MICOS complex subunit MIC60,40451,-0.0530040213748601,0.00463058231384237,-0.0620799627099912,-0.0439280800397291,3.59425010587332e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSS,Cathepsin S,39872,-0.0285944828189504,0.00249902318533774,-0.0334925682622124,-0.0236963973756885,3.85124216694867e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HEXIM1,Protein HEXIM1,42594,-0.0937849883903452,0.0082035703502221,-0.109863986276781,-0.0777059905039099,3.9808452943214e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD72,B-cell differentiation antigen CD72,40283,-0.0520393572167804,0.00455037022700975,-0.0609580828617195,-0.0431206315718413,4.06158100046342e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42676,-0.0471798975425344,0.00413155433892402,-0.0552777440468255,-0.0390820510382433,4.59791710443252e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,40483,-0.0958321237790562,0.0084018243279228,-0.112299699461785,-0.0793645480963275,5.68647725935212e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,40302,-0.130376541720289,0.0114342735216305,-0.152787717822685,-0.107965365617894,5.97706948918135e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTRB1,Chymotrypsinogen B,42611,-0.0675480476815779,0.00593203442104156,-0.0791748351468194,-0.0559212602163364,6.65886818328935e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SRPK2,SRSF protein kinase 2,42594,-0.096537382360757,0.00848020797921406,-0.113158590000017,-0.0799161747214975,6.90419156408486e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,40449,-0.092298924771835,0.00811816011121479,-0.108210518589816,-0.0763873309538541,8.62955818199856e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40980,0.0368394800680134,0.0032419285988459,0.0304853000142754,0.0431936601217513,9.08257626225647e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSMG3,Proteasome assembly chaperone 3,42594,-0.0592010690594959,0.00521732781074197,-0.0694270315685502,-0.0489751065504417,1.04850971028219e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42711,0.0546935565394189,0.00482040819490796,0.0452455564773993,0.0641415566014385,1.05473429945143e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP43,Centrosomal protein 43,42255,-0.0801729828704755,0.00706783056906477,-0.0940259307858424,-0.0663200349551085,1.10150229575751e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,40482,-0.112709544581496,0.0099443651066655,-0.132200500190561,-0.093218588972432,1.2868386243483e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FEN1,Flap endonuclease 1,42346,-0.0737564269481821,0.00651041456748658,-0.0865168395004558,-0.0609960143959085,1.2931571708885e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,42711,-0.109981826892322,0.00970904556526934,-0.12901155620025,-0.0909520975843945,1.30007690324804e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42654,-0.0983634326101955,0.00868392002815174,-0.115383915865373,-0.0813429493550181,1.31198374642334e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,42346,-0.0761935578898448,0.00673305300478856,-0.0893903417792304,-0.0629967740004592,1.49177426955549e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F10,Coagulation factor X,40532,-0.0329264919030256,0.00291227666802763,-0.0386345541723597,-0.0272184296336914,1.76014968110871e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42495,-0.0614362118864292,0.00544041345342241,-0.0720994222551371,-0.0507730015177213,1.94412653483637e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,42594,-0.0484873716875454,0.00429501696267993,-0.0569056049343981,-0.0400691384406927,2.01431430254382e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COLEC12,Collectin-12,42618,-0.032263650671969,0.00286817667840244,-0.0378852769616378,-0.0266420243823002,3.17084096523449e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLSCR3,Phospholipid scramblase 3,40457,-0.0666633578614217,0.00592572924203327,-0.078277787175807,-0.0550489285470365,3.32128691998125e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,42311,-0.0896692671470403,0.00797632435273075,-0.105302862878393,-0.074035671415688,3.45056927546512e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,42611,-0.0578936189279066,0.00515490279995854,-0.0679972284158253,-0.0477900094399879,3.88332885680984e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DLK1,Protein delta homolog 1,42794,-0.0631782712406031,0.00562590484806919,-0.0742050447428187,-0.0521514977383875,3.90711798085289e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GOLM2,Protein GOLM2,42711,-0.0264403595086766,0.00235638691363532,-0.0310588778594018,-0.0218218411579514,4.33764947932955e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",40209,-0.0915815721554057,0.00815879333565157,-0.107572807093283,-0.0755903372175286,4.42565233178169e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,40283,-0.0344517166771576,0.00307580637368675,-0.0404802971695836,-0.0284231361847315,5.77418324185602e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,40511,-0.0889395692006157,0.00795674924559797,-0.104534797721988,-0.0733443406792437,7.40926203120933e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42676,-0.0450199257153774,0.00403220103511065,-0.0529230397441942,-0.0371168116865605,8.08309844000292e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,QDPR,Dihydropteridine reductase,42581,-0.0484236426849492,0.00433891175829942,-0.056927909731216,-0.0399193756386823,8.5429613132615e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42611,-0.0265609674031288,0.00238139019098023,-0.0312284921774501,-0.0218934426288076,9.20571957684294e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G15,Phospholipase A2 group XV,42679,-0.0303388833396464,0.00272027758254246,-0.0356706274014296,-0.0250071392778632,9.26345722899944e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42754,-0.111307430119422,0.00998805779881579,-0.1308840234051,-0.0917308368337426,1.02021582381969e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ISM1,Isthmin-1,42594,-0.0436574287638594,0.00392336019782885,-0.0513472147516039,-0.0359676427761148,1.22976179589198e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,40451,-0.0812412810665205,0.00730648211610053,-0.0955619860140775,-0.0669205761189634,1.42701495810199e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,42587,0.0302570194377528,0.00272306410776772,0.0249198137865281,0.0355942250889775,1.47194678144532e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDHR5,Cadherin-related family member 5,42636,-0.0439991688439154,0.00396097818718336,-0.0517626860907948,-0.036235651597036,1.52406941255226e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD302,CD302 antigen,42587,-0.0364472183040821,0.00328341239657445,-0.042882706601368,-0.0300117300067962,1.66257339558319e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL18,Interleukin-18,42566,-0.052693996984939,0.00474912942423963,-0.0620022906564487,-0.0433857033134293,1.756189837864e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFNGR2,Interferon gamma receptor 2,42495,-0.059021469402419,0.00532052528806778,-0.0694496989670318,-0.0485932398378061,1.8050747452985e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,40223,-0.084309582386277,0.0076123512532143,-0.099229790842577,-0.069389373929977,2.33046014709552e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLA2,Src-like-adapter 2,40482,-0.117504016995587,0.0106108104476752,-0.138301205473031,-0.0967068285181437,2.34767151736158e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,42311,-0.0687171204441339,0.00620872595640094,-0.0808862233186798,-0.0565480175695881,2.39881487333423e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL10,C-X-C motif chemokine 10,42676,-0.0765018056554308,0.00692004556197857,-0.0900650949569088,-0.0629385163539528,2.73970069080996e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42611,-0.0687869170391596,0.00622253447003679,-0.0809830846004317,-0.0565907494778875,2.76211890466353e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GFRA1,GDNF family receptor alpha-1,42689,-0.0335447849467812,0.00303620277074096,-0.0394957423774334,-0.0275938275161289,2.95357525620647e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIAE,Sialate O-acetylesterase,42646,-0.0516905772668971,0.00468182538732834,-0.0608669550260607,-0.0425141995077336,3.21407127184589e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDT,D-dopachrome decarboxylase,40527,-0.046934223100997,0.00425374421058002,-0.0552715617537339,-0.0385968844482602,3.65859281363412e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NIT2,Omega-amidase NIT2,40462,-0.0824479361971716,0.00747235221597127,-0.0970937465404753,-0.0678021258538679,3.66121978599723e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42674,-0.08168303801702,0.00741345174502677,-0.0962134034372725,-0.0671526725967675,4.11466757416158e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL21,C-C motif chemokine 21,42676,-0.0476143558015675,0.00432705819309053,-0.056095389860025,-0.0391333217431101,4.81847969576642e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,40451,-0.127485404843364,0.0116175815377562,-0.150255864657366,-0.104714945029362,7.09428367483208e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42587,0.0465632835454331,0.00424766860138647,0.0382378530867156,0.0548887140041505,7.63533949877831e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNXB,Tenascin-X,42611,0.028959622647908,0.00264411465325175,0.0237771579275346,0.0341420873682814,8.47715703880924e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEL1L,Protein sel-1 homolog 1,40223,-0.0367059975539742,0.00335008932873098,-0.0432721726382869,-0.0301398224696615,8.57901779685478e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DAG1,Dystroglycan,42676,-0.0512722499185553,0.00468686552982942,-0.060458506357021,-0.0420859934800897,9.75165668557564e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLO1,Lactoylglutathione lyase,42357,-0.0649948244499402,0.00594290969673847,-0.0766429274555476,-0.0533467214443328,1.01451755591627e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDCD5,Programmed cell death protein 5,42711,-0.0641809480959645,0.0058723307109536,-0.0756907162894336,-0.0526711799024954,1.08913845351968e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNASE1,Ribonuclease pancreatic,40532,-0.0297371889034434,0.00271978068660027,-0.0350679590491799,-0.0244064187577069,1.09364318983815e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,42357,0.0239130926578098,0.00219825512375713,0.0196045126152458,0.0282216727003738,1.91556695948761e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERBIN,Erbin,42587,-0.113098242476481,0.0103991073664288,-0.133480492914682,-0.0927159920382809,1.95828354543337e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,40199,-0.0502439136481343,0.00462006950445128,-0.0592992498768588,-0.0411885774194098,2.08694274277811e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,40199,-0.0592875716891797,0.0054564372746289,-0.0699821887474523,-0.048592954630907,2.31398098756678e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RPL14,60S ribosomal protein L14,40223,-0.0445927101603535,0.00410715642662956,-0.0526427367565475,-0.0365426835641596,2.52999580517591e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42611,-0.0501368060937281,0.00462118873034019,-0.0591943360051949,-0.0410792761822613,2.60805133278212e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",40483,-0.0465251724076086,0.00429058089133473,-0.0549347109546247,-0.0381156338605925,2.91518024056384e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGR,Tyrosine-protein kinase Fgr,42311,-0.0635453277413879,0.00586396625570176,-0.0750387016025633,-0.0520519538802124,3.01239613249624e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42587,-0.0588029455608292,0.00544718689061645,-0.0694794318664375,-0.048126459255221,4.69139056213996e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HLA_E,,42594,-0.033963120033548,0.00314891255553082,-0.0401349886423884,-0.0277912514247076,5.1934642512914e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNST,Consortin,42636,-0.119394424811949,0.0110729431080992,-0.141097393303824,-0.0976914563200749,5.36739111161526e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP6AP2,Renin receptor,42346,-0.0445178339799741,0.0041290959738495,-0.0526108620887191,-0.0364248058712291,5.4582882581978e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STAB2,Stabilin-2,40527,-0.0309176726338175,0.00287048846057552,-0.0365438300165455,-0.0252915152510895,6.3776344822391e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOXO1,Forkhead box protein O1,42594,-0.0927909015745174,0.0086352896145787,-0.109716069219092,-0.0758657339299431,7.99846725397178e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGFBR2,TGF-beta receptor type-2,42679,-0.0394765500414688,0.0036754148120504,-0.0466803630730876,-0.03227273700985,8.4120659539998e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42595,-0.0356427162041795,0.00331924756485704,-0.0421484414312993,-0.0291369909770597,8.65575477147594e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGB1,Integrin beta-1,42638,0.0235016519894137,0.00219140203639082,0.0192065039980877,0.0277967999807397,1.00195964282067e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCAN,Neurocan core protein,42711,0.0416373810315863,0.00389085369656561,0.0340113077863177,0.0492634542768549,1.28206191788515e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCN4,CCN family member 4,42721,-0.0437110914280389,0.00409590328382874,-0.0517390618643432,-0.0356831209917346,1.75591448865945e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TDRKH,Tudor and KH domain-containing protein,42311,-0.0921334761867424,0.00864833280993562,-0.109084208494216,-0.0751827438792686,2.15688835986655e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLB1,Beta-galactosidase,42495,-0.0449270322359754,0.00422154058910282,-0.053201251790617,-0.0366528126813339,2.41645050019092e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MBL2,Mannose-binding protein C,40379,0.119054906636958,0.0111825173848483,0.0971371725626556,0.140972640711261,2.41961725840233e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,40058,-0.0579445469735172,0.00545522018494352,-0.0686367785360065,-0.0472523154110279,3.17086782237714e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42587,-0.0830610799027781,0.00782497733529587,-0.098398035479958,-0.0677241243255982,3.2304860962294e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATG16L1,Autophagy-related protein 16-1,40449,-0.0916673563559921,0.00863274375972802,-0.108587534125059,-0.0747471785869252,3.2500018610189e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH17,Cadherin-17,42636,-0.075646941097964,0.00712726346625954,-0.0896163774918327,-0.0616775047040952,3.26637700424143e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPP1,Tripeptidyl-peptidase 1,42545,-0.048984472136433,0.00461541772140564,-0.0580306908703881,-0.039938253402478,3.28966258206464e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNTN1,Contactin-1,42794,0.0302717400913189,0.00285239100750667,0.0246810537166058,0.035862426466032,3.29155661490259e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLXNA4,Plexin-A4,42594,-0.0884488480983374,0.00834456804793796,-0.104804201472296,-0.072093494724379,3.79917309196744e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TALDO1,Transaldolase,40499,-0.0477541678887584,0.00450578753500241,-0.0565855114573632,-0.0389228243201537,4.01886908193058e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APLP1,Amyloid-like protein 1,42636,0.0559073772934041,0.00528574436765781,0.0455473183327948,0.0662674362540135,4.82119543962969e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC16A1,Monocarboxylate transporter 1,42311,-0.0623694698702247,0.00589730640801019,-0.0739281904299246,-0.0508107493105247,4.90531124371038e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TCOF1,Treacle protein,40511,-0.0349331848750944,0.00330381613456254,-0.041408664498837,-0.0284577052513518,5.22343709886981e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42611,-0.0413801699674385,0.00392472512003266,-0.0490726312027025,-0.0336877087321745,6.87557881418964e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SORT1,Sortilin,42613,-0.0397673451140918,0.00377589116301301,-0.0471680917935973,-0.0323665984345863,7.76549201411587e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KAZN,Kazrin,40449,-0.112213752875262,0.010656818282864,-0.133101116709675,-0.0913263890408482,8.30304004094678e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,40283,-0.0232816256909819,0.00222033610985984,-0.0276334844663072,-0.0189297669156566,1.32493436007547e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PALM2,Paralemmin-2,40483,-0.0405251683592467,0.00386735024080927,-0.0481051748312329,-0.0329451618872605,1.41640041450748e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42495,-0.0465744002605563,0.00444769685871446,-0.0552918861036367,-0.037856914417476,1.46688190452225e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,40199,-0.134968224017438,0.0128933505418873,-0.160239191079537,-0.109697256955339,1.5959573565467e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42654,-0.0554156154106498,0.0053017566470498,-0.0658070584388674,-0.0450241723824322,1.78991285144557e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EHBP1,EH domain-binding protein 1,40511,-0.0793286939051168,0.00759288842459148,-0.0942107552173161,-0.0644466325929175,1.95800661790869e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ULBP2,UL16-binding protein 2,42495,-0.0426717851288975,0.00408904064821434,-0.0506863047993976,-0.0346572654583974,2.13619213720226e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42674,0.025902639277849,0.00248354610358333,0.0210348889148257,0.0307703896408723,2.26630752549941e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42746,-0.0431050027292471,0.0041338436833838,-0.0512073363486794,-0.0350026691098149,2.32003812992906e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDGFC,Platelet-derived growth factor C,42346,-0.030399049369451,0.00291860114532369,-0.0361195076142854,-0.0246785911246165,2.63924210077009e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42711,-0.0554514909202287,0.00532456407795719,-0.0658876365130248,-0.0450153453274326,2.66027118295602e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINH1,Serpin H1,40302,-0.137364307678655,0.013200566464343,-0.163237417948768,-0.111491197408543,3.0424148184237e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNMBP,Dynamin-binding protein,42495,-0.0635474051038027,0.00611360078268177,-0.075530062637859,-0.0515647475697465,3.28270888157449e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,40290,-0.047118188308728,0.00453160989161035,-0.0560001436962843,-0.0382362329211717,3.31646227792002e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,POF1B,Protein POF1B,40199,-0.0498545107979046,0.0047977136830606,-0.0592580296167034,-0.0404509919791058,3.55089760171614e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSNL1,Visinin-like protein 1,40483,-0.0408291381535249,0.00393294306177922,-0.0485377065546121,-0.0331205697524376,3.91250373546002e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DGKA,Diacylglycerol kinase alpha,40199,-0.0581107004709785,0.00560174487977342,-0.0690901204353344,-0.0471312805066226,4.26351195569069e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,40511,-0.0670825254042402,0.00646822347676875,-0.079760243418707,-0.0544048073897735,4.34768094736586e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TAX1BP1,Tax1-binding protein 1,40483,-0.0669505781719813,0.00646239871542898,-0.0796168796542221,-0.0542842766897405,4.8792077243742e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,40451,-0.0508365702089202,0.00491146023854787,-0.0604630322764741,-0.0412101081413664,5.3827537715214e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,40483,-0.113330784413286,0.010960869924136,-0.134814089464592,-0.0918474793619791,6.02832499412963e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUSD2,Sushi domain-containing protein 2,42611,0.0305496168690934,0.00295734192750449,0.0247532266911846,0.0363460070470022,6.38663612676362e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",42311,-0.0543898424978032,0.00526726593463597,-0.0647136837296897,-0.0440660012659167,6.69464913522558e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,40283,-0.0827044233524631,0.00800751132100494,-0.0983991455416328,-0.0670097011632934,6.80051305402592e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSE,Cathepsin E,40283,-0.0543995287154253,0.0052671126456002,-0.0647230695008017,-0.0440759879300489,6.81496419735584e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CES2,Cocaine esterase,42587,-0.0579113842207498,0.0056125360158991,-0.068911954811912,-0.0469108136295876,7.22332905600413e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL22,C-C motif chemokine 22,42509,-0.0560610697405601,0.00543384473322391,-0.0667114054176789,-0.0454107340634412,7.32281950766727e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DPP4,Dipeptidyl peptidase 4,42441,0.0297766703085392,0.00289039598752073,0.0241114941729986,0.0354418464440799,8.56580336802778e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ASPN,Asporin,40511,0.029742536412273,0.00288771012754654,0.0240826245622818,0.0354024482622642,9.09153362949473e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,40483,-0.0420622709174404,0.00408569243798754,-0.050070228095896,-0.0340543137389848,9.54621156068019e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYN,Tyrosine-protein kinase Lyn,42587,-0.0881640914118022,0.00856725520147514,-0.104955911606694,-0.071372271216911,9.58330063962577e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,42587,-0.14363185487435,0.0139744459804905,-0.171021768996112,-0.116241940752589,1.09159069235558e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,42613,-0.0852543544509693,0.0082961944382424,-0.101514895549924,-0.0689938133520142,1.11221410392132e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OGFR,Opioid growth factor receptor,42587,-0.0341529979938613,0.00332531241381112,-0.0406706103249311,-0.0276353856627915,1.17995506629128e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CBS,Cystathionine beta-synthase,40223,-0.0541494118756184,0.00527198276197237,-0.0644824980890842,-0.0438163256621525,1.22708175776264e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DKK1,Dickkopf-related protein 1,42711,-0.0614967762094081,0.00599098567387537,-0.0732391081302039,-0.0497544442886124,1.24915215981477e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP1,Interstitial collagenase,42136,-0.0960175979994671,0.00935915323819539,-0.11436153834633,-0.0776736576526041,1.3362626978703e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLRD1,Natural killer cells antigen CD94,42754,-0.0493836986467563,0.00481420669161413,-0.05881954376232,-0.0399478535311926,1.34109737295021e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,40483,-0.0929349611320874,0.00906663751449904,-0.110705570660505,-0.0751643516036692,1.51254372135187e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RLN2,Prorelaxin H2,40257,-0.0525349808391481,0.00512968304795047,-0.062589159613131,-0.0424808020651652,1.66430412850837e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42636,-0.0660771683170824,0.00645593831958687,-0.0787308074234726,-0.0534235292106921,1.69788601294609e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK14,Kallikrein-14,42721,0.0493715943253907,0.00483055829731705,0.0399037000626492,0.0588394885881321,1.96560611038675e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,40511,-0.0309266478614002,0.00302510608390213,-0.0368558557858484,-0.024997439936952,1.9906014376662e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REG1B,Lithostathine-1-beta,42794,-0.06135088288415,0.00600415483846494,-0.0731190263675413,-0.0495827394007587,2.0166148328837e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100A14,Protein S100-A14,40482,-0.057566249840621,0.00563597657244888,-0.0686127639226208,-0.0465197357586212,2.18952262394453e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,40030,-0.0350397694136055,0.00343369686906989,-0.0417698152769825,-0.0283097235502285,2.43429750789323e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANGPT2,Angiopoietin-2,42721,-0.0394158034531116,0.0038704755167315,-0.0470019354659054,-0.0318296714403179,2.8680281611477e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,42357,-0.0605173798373635,0.00594698850772197,-0.0721734773124986,-0.0488612823622285,3.11545691042082e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADD1,Alpha-adducin,40283,-0.07426773240763,0.00729587895336789,-0.0885676551562311,-0.0599678096590289,3.13139059912847e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42586,-0.019754495151907,0.001942433039809,-0.0235616639099326,-0.0159473263938814,3.30579507839244e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,40116,-0.0645294232705449,0.00634563421041531,-0.0769668663229589,-0.0520919802181309,3.49044632066763e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HNMT,Histamine N-methyltransferase,42439,-0.0497525156817047,0.00489935139400557,-0.0593552444139556,-0.0401497869494538,3.86197174973126e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH15,Cadherin-15,42692,-0.064750817489295,0.0063804284430652,-0.0772564572377027,-0.0522451777408872,4.11318093413712e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PENK,Proenkephalin-A,40283,-0.0341955021070315,0.00336819329149063,-0.0407971609583531,-0.0275938432557099,4.11779472582618e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42636,-0.0360331472959643,0.003552562358277,-0.0429961695181872,-0.0290701250737414,4.35274507782869e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",40449,-0.108546762079237,0.0107046966697257,-0.1295279675519,-0.087565556606575,4.65209069088124e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BMPER,BMP-binding endothelial regulator protein,40283,-0.0241789948108109,0.00238479347368824,-0.0288531900192399,-0.019504799602382,4.72983275118061e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,40287,-0.0672562890889917,0.00664561803779527,-0.0802817004430705,-0.054230877734913,5.70017942618352e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,42311,-0.068872365014351,0.00681255048746695,-0.0822249639697862,-0.0555197660589157,6.12770673795079e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,40283,-0.0598394968106306,0.00592305816928305,-0.0714486908224253,-0.0482303027988358,6.81097759895457e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COCH,Cochlin,40511,-0.0484207043655264,0.00480643949282776,-0.0578413257714688,-0.039000082959584,9.0540865047194e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42711,-0.0668802234915256,0.00664552096284206,-0.079905444578696,-0.0538550024043551,9.66545057720296e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,METAP2,Methionine aminopeptidase 2,42689,-0.0584587793506155,0.00581143417345626,-0.0698491903305898,-0.0470683683706413,1.01362789619688e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42587,-0.034986311198167,0.00348347010420918,-0.041813912602417,-0.0281587097939171,1.18958682834768e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42706,-0.0681372736514189,0.00678466657210129,-0.0814352201327374,-0.0548393271701004,1.19585253285802e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,40283,-0.0681270434724579,0.0067842692227564,-0.0814242111490604,-0.0548298757958553,1.25807358972979e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA9,Serpin A9,42538,-0.0737297388791247,0.0073497255497752,-0.0881352009566841,-0.0593242768015653,1.34168675334564e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,A1BG,Alpha-1B-glycoprotein,40539,-0.0174804309416372,0.00174398637952641,-0.020898644245509,-0.0140622176377654,1.50932140023893e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,40527,0.0340805042441424,0.00340194814675727,0.0274126858764982,0.0407483226117866,1.59247725187508e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42495,-0.0966962236579146,0.00965771926512244,-0.115625353417555,-0.0777670938982746,1.62980861751958e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42587,0.0201892110716561,0.00201710076465568,0.016235693572931,0.0241427285703812,1.68247738403e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SELP,P-selectin,42689,-0.0572387285786805,0.00571975732241896,-0.0684494529306216,-0.0460280042267393,1.71118790657411e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GOLGA3,Golgin subfamily A member 3,40482,-0.0802597742033297,0.00802116633700743,-0.0959812602238643,-0.0645382881827952,1.79648106187444e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BRAP,BRCA1-associated protein,40342,-0.111401541185821,0.0111512134825495,-0.133257919611618,-0.0895451627600241,2.11255497276293e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,42370,-0.0692859460736273,0.00694936805690539,-0.0829067074651619,-0.0556651846820927,2.49183090907696e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42679,-0.0287868527893359,0.00288791681804138,-0.034447169752697,-0.0231265358259748,2.53299133740731e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAMR1,Inactive serine protease PAMR1,42611,-0.0272293526345468,0.0027354021020855,-0.0325907407546344,-0.0218679645144592,2.90444734172757e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AP3B1,AP-3 complex subunit beta-1,40449,-0.0778799122636549,0.00782375598019729,-0.0932144739848415,-0.0625453505424682,3.0134294613447e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42569,-0.0777327595447511,0.00782103018060783,-0.0930619786987425,-0.0624035403907598,3.39129160448386e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD27,CD27 antigen,42679,-0.0451175167646849,0.00454036200309311,-0.0540166262907474,-0.0362184072386224,3.4527895308447e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,40483,-0.0912212146958732,0.00919265543293163,-0.109238819344419,-0.0732036100473272,4.10018888546159e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,40482,-0.0539165589572753,0.00543743124771683,-0.0645739242028003,-0.0432591937117503,4.41546819130755e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLIN1,Perilipin-1,42311,-0.0354439770456866,0.00357712211525508,-0.0424551363915866,-0.0284328176997867,4.60657998274385e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SYTL4,Synaptotagmin-like protein 4,40511,-0.0746839695031216,0.00755055475978651,-0.0894830568323032,-0.05988488217394,5.63362147204979e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,40449,-0.0475026450119184,0.00481186980524513,-0.0569339098301989,-0.038071380193638,6.82152737977277e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42754,-0.0553643065146882,0.00561500286550926,-0.0663697121310863,-0.04435890089829,7.40134752306786e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL3A1,Collagen alpha-1(III) chain,40527,-0.0236530767831665,0.00239823958589151,-0.0283536263715139,-0.0189525271948191,7.46639693987957e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42611,0.0453078557329609,0.00459698275351084,0.0362977695360797,0.0543179419298422,7.71959868000742e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SHISA5,Protein shisa-5,40527,-0.0281562893195096,0.00285761329387902,-0.0337572113755125,-0.0225553672635067,8.20899331703142e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,42495,-0.0576530612770266,0.00586262787869302,-0.069143811919265,-0.0461623106347883,9.60738659790394e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,40283,-0.0386987264532802,0.00393661857716788,-0.0464144988645292,-0.0309829540420311,1.03075249134115e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,40199,-0.0492773359566001,0.0050211301562389,-0.0591187510628283,-0.0394359208503718,1.21381005742877e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NIT1,Deaminated glutathione amidase,40223,-0.0475419377515675,0.0048639981478588,-0.0570753741213708,-0.0380085013817643,1.79163234886449e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PQBP1,Polyglutamine-binding protein 1,42346,-0.0569401600022104,0.00582850390116394,-0.0683640276484918,-0.0455162923559291,1.81906605103277e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NRP2,Neuropilin-2,42611,0.0287095602379884,0.0029429260048547,0.0229414252684732,0.0344776952075036,2.0753216460743e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DOK2,Docking protein 2,42636,-0.119589367377145,0.0122825950746018,-0.143663253723364,-0.0955154810309251,2.49715437326467e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL9,C-X-C motif chemokine 9,42676,-0.0676879454739687,0.00695259249073157,-0.0813150267558025,-0.0540608641921348,2.51668989760856e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB27B,Ras-related protein Rab-27B,40511,-0.0820735616724033,0.00843138461955231,-0.0985990755267258,-0.0655480478180807,2.63349147798429e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42495,-0.0570986527924472,0.00588036371632627,-0.0686241656764467,-0.0455731399084477,3.2375468320675e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SH2B3,SH2B adapter protein 3,42346,-0.0964028768912606,0.00994282168369862,-0.11589080739131,-0.0769149463912113,3.72924464146873e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB8,Serpin B8,42754,-0.057120076073566,0.00590293399329527,-0.0686898267004247,-0.0455503254467072,4.47013814182309e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IDS,Iduronate 2-sulfatase,42754,0.00864410328408763,0.000894937404159868,0.00689002597193428,0.010398180596241,5.3058557365759e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,40482,-0.0479356938701004,0.00496733353270121,-0.0576716675941948,-0.038199720146006,5.96376749005016e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD6,T-cell differentiation antigen CD6,42746,-0.0519875495790281,0.00539316629555111,-0.0625581555183082,-0.0414169436397479,6.40114374016758e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SFRP4,Secreted frizzled-related protein 4,40283,-0.0399290977283153,0.00414082955943679,-0.0480451236648114,-0.0318130717918192,6.42891078466923e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LGALS8,Galectin-8,42711,-0.0587777022895881,0.00610954371264814,-0.0707524079663785,-0.0468029966127977,7.68626058307185e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RASSF2,Ras association domain-containing protein 2,42346,-0.0558491156023507,0.00581203862742655,-0.0672407113121067,-0.0444575198925946,8.62027758131396e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPARCL1,SPARC-like protein 1,42644,0.0272872172570334,0.00284021496634537,0.0217203959229965,0.0328540385910704,8.73644162020886e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NSFL1C,NSFL1 cofactor p47,42711,-0.0635778648236131,0.00662126970376558,-0.0765555534429936,-0.0506001762042325,9.19445157748239e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCK2,Cytoplasmic protein NCK2,42676,-0.102528470787691,0.0106892549438897,-0.123479410477715,-0.0815775310976672,1.01609776789258e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,42676,-0.120889893592419,0.0126324232268627,-0.14564944311707,-0.0961303440677684,1.2545833074266e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",40223,-0.0363821540498855,0.00380370352479475,-0.0438374129584833,-0.0289268951412878,1.361527564705e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,42476,-0.108209707062351,0.0113182819048205,-0.130393539595799,-0.0860258745289027,1.37367119795795e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THBS2,Thrombospondin-2,42611,-0.0380135232741404,0.00397999204680344,-0.0458143076858752,-0.0302127388624057,1.50171077426982e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CMIP,C-Maf-inducing protein,40451,-0.0809881080875901,0.00848207918168084,-0.0976129832836845,-0.0643632328914956,1.59289069938328e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OSM,Oncostatin-M,42534,-0.0683246093563755,0.00715913761194487,-0.0823565190757874,-0.0542926996369635,1.61452244351911e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RFC4,Replication factor C subunit 4,40451,-0.0206959917795388,0.00216794061680484,-0.0249451553884763,-0.0164468281706013,1.61995719536813e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,JAM3,Junctional adhesion molecule C,40283,-0.0497317101927687,0.00521011940512173,-0.0599435442268073,-0.0395198761587301,1.64280128597594e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNC,Tenascin,42689,0.0472658961344994,0.00495547686958007,0.0375531614701224,0.0569786307988763,1.70009217466601e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OTUD7B,OTU domain-containing protein 7B,40482,-0.0605003598276003,0.00634142724450025,-0.0729295572268208,-0.0480711624283798,1.7129599903225e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,42654,0.0438212087249146,0.00459780896991146,0.0348095031438881,0.052832914305941,1.82253829300883e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MFAP5,Microfibrillar-associated protein 5,42794,-0.0401353845355552,0.00421175432978939,-0.0483904230219424,-0.031880346049168,1.84619654163772e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42594,-0.0369743117422553,0.00388086075420895,-0.0445807988205048,-0.0293678246640058,1.88665195604095e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42654,0.0849469386645017,0.00892011128255121,0.0674635205507013,0.102430356778302,1.96388211208329e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",40136,-0.0792987224216239,0.00834850994063043,-0.0956618019052595,-0.0629356429379882,2.57129262876775e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42679,-0.0926140287752141,0.00975999924639898,-0.111743627298156,-0.0734844302522721,2.71440968490933e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OGA,Protein O-GlcNAcase,40449,-0.0680261840254241,0.00717042343546848,-0.0820802139589423,-0.0539721540919059,2.85368751286575e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGA5,Integrin alpha-5,42611,-0.0242526924805869,0.00256136641004473,-0.0292729706442746,-0.0192324143168993,3.30147263596336e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AAMDC,Mth938 domain-containing protein,40223,-0.0515139828385862,0.00544656041362623,-0.0621892412492937,-0.0408387244278788,3.77189185146212e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCAM1,Neural cell adhesion molecule 1,42689,0.0293295378541182,0.00310216472739055,0.0232492949884327,0.0354097807198037,3.77202305606423e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,B2M,Beta-2-microglobulin,40539,-0.0305074779828211,0.00322692772992513,-0.0368322563334744,-0.0241826996321678,3.89940390177035e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STK11,Serine/threonine-protein kinase STK11,42357,-0.0701066611528068,0.00741886112098581,-0.084647628949939,-0.0555656933556746,3.96098786761512e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COMMD1,COMM domain-containing protein 1,40223,-0.0582947360337648,0.00618714043619988,-0.0704215312887166,-0.046167940778813,5.31153998135977e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNCA,Alpha-synuclein,40283,-0.111172204378514,0.0118213013340901,-0.134341954993331,-0.0880024537636977,6.26103733522169e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSF,Cathepsin F,42679,-0.0381539118570256,0.00405930729608772,-0.0461101541573576,-0.0301976695566937,6.37545115475389e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,42192,-0.0824541531269392,0.00877230248597417,-0.0996478659994485,-0.0652604402544298,6.39515054258715e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,42370,-0.0374007371097171,0.00398535597291312,-0.0452120348166268,-0.0295894394028073,7.34047754614974e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL25,C-C motif chemokine 25,42754,-0.0460410987755107,0.00490706755664015,-0.0556589511865254,-0.036423246364496,7.44384772481448e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',40483,-0.0415165522671125,0.00443072217687954,-0.0502007677337964,-0.0328323368004286,8.6164449230961e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL20,C-C motif chemokine 20,42754,-0.0878856337144577,0.00938508083893783,-0.106280392158776,-0.0694908752701395,8.836418567644e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,42357,-0.0887231463774745,0.0094836438400414,-0.107311088303956,-0.0701352044509934,9.65957880829069e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,40449,-0.104090887481946,0.0111335206718567,-0.125912587998786,-0.0822691869651071,1.04837118260274e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42594,-0.03657077773075,0.0039147011781114,-0.0442435920398484,-0.0288979634216517,1.09345305270547e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42495,-0.0432671667822546,0.00463922028571107,-0.0523600385422483,-0.0341742950222609,1.26611612245553e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,42754,-0.0635666949386382,0.00681837450233409,-0.076930708963213,-0.0502026809140634,1.30516372473341e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,40449,-0.0381513583344871,0.00409264311157898,-0.0461729388331819,-0.0301297778357922,1.35499550995842e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TFF1,Trefoil factor 1,42556,-0.0792709344413243,0.00850650358126917,-0.0959436814606119,-0.0625981874220367,1.35768897756827e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,P4HB,Protein disulfide-isomerase,42563,-0.0364513327576352,0.00391195474471236,-0.0441187640572714,-0.028783901457999,1.36944720234412e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNF,Tumor necrosis factor,42339,-0.0368006344810953,0.00395227355255868,-0.0445470906441103,-0.0290541783180803,1.46128779459891e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL7,C-C motif chemokine 7,42594,-0.0561858338760301,0.00603973511911471,-0.068023714709495,-0.0443479530425653,1.57869038181137e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHCHD6,MICOS complex subunit MIC25,40451,-0.0275762989393319,0.0029687252922386,-0.0333950005121196,-0.0217575973665443,1.84402118846887e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLF4,Krueppel-like factor 4,40136,-0.0382893956372156,0.00412321620013821,-0.0463708993894865,-0.0302078918849447,1.89912733944189e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL4,C-C motif chemokine 4,42642,-0.0650475039760589,0.00701247103488594,-0.0787919472044354,-0.0513030607476825,2.0249544109896e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AZI2,5-azacytidine-induced protein 2,40482,-0.052290757835359,0.00564078800415486,-0.0633467023235026,-0.0412348133472155,2.1963055613729e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEMIP2,Cell surface hyaluronidase,40199,-0.032789901537222,0.00353770711250372,-0.0397238074777293,-0.0258559955967147,2.23518247402089e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLAU,Urokinase-type plasminogen activator,42611,0.0279826112466292,0.00302246596791761,0.0220585779495106,0.0339066445437477,2.39014434676216e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,40532,-0.0622205251935277,0.00671928453385995,-0.0753903228798932,-0.0490507275071621,2.41136542502497e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",40482,-0.0754154745403706,0.00814713000791699,-0.0913838493558879,-0.0594470997248533,2.48828312183228e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BMP10,Bone morphogenetic protein 10,40283,0.0273866126685029,0.00296181662127083,0.021581452090812,0.0331917732461937,2.74186959105251e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,L1CAM,Neural cell adhesion molecule L1,42679,0.0277257515744351,0.00300347691999428,0.0218389368112464,0.0336125663376239,3.06916752001994e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ESYT2,Extended synaptotagmin-2,40483,-0.0776526421418528,0.00841937598375695,-0.0941546190700164,-0.0611506652136892,3.39831385329007e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADA,Adenosine deaminase,42754,-0.0327018067169132,0.00354748095442371,-0.0396548693875837,-0.0257487440462428,3.45655712606683e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42594,-0.104330470176461,0.0113204715218119,-0.126518594359212,-0.0821423459937094,3.53437776594998e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IMPACT,Protein IMPACT,40483,-0.052858482620896,0.00573659567503793,-0.0641022101439703,-0.0416147550978216,3.68762065645451e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATXN3,Ataxin-3,40483,-0.058686918402682,0.00637275563046037,-0.0711775194383844,-0.0461963173669797,3.8702439827288e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,42676,-0.0262993930701692,0.00285760502975575,-0.0319002989284905,-0.0206984872118479,3.97533960386611e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,40449,-0.0715132132705563,0.00777677480237504,-0.0867556918832114,-0.0562707346579013,4.37806021595741e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,40199,-0.0837970434815238,0.00912234453620052,-0.101676838772477,-0.0659172481905708,4.81129443634733e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CETN2,Centrin-2,42311,-0.0632016245757861,0.00688652156490377,-0.0766992068429974,-0.0497040423085747,5.06022428253176e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TFF2,Trefoil factor 2,42654,-0.0548610559855725,0.00597983969362712,-0.0665815417850816,-0.0431405701860633,5.19591043295731e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCGN,Secretagogin,42370,-0.0425282039331052,0.00463909304450401,-0.0516208263003331,-0.0334355815658774,5.55733908747972e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD83,CD83 antigen,42594,-0.0331129551528217,0.00361278513975097,-0.0401940140267336,-0.0260318962789098,5.64060311759267e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,42357,-0.0461769093284122,0.00504012121204678,-0.0560555469040239,-0.0362982717528005,5.84632956311747e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NADK,NAD kinase,42636,-0.05133909554794,0.00560451023750742,-0.0623239356134545,-0.0403542554824255,5.91352371154391e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAM13A,Protein FAM13A,40449,-0.0631555115855514,0.00689337578242283,-0.0766665281191002,-0.0496444950520027,5.98774221501918e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SOST,Sclerostin,42613,-0.0364954289007035,0.00398849749747638,-0.0443128839957572,-0.0286779738056498,6.49400301716358e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WDR46,WD repeat-containing protein 46,40451,-0.0337406714109527,0.00368991551594002,-0.0409729058221951,-0.0265084369997103,7.04832597668384e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42676,-0.026518958658212,0.00290188826504766,-0.0322066596577054,-0.0208312576587186,7.22383290880206e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42657,-0.0958304487421903,0.0105018446813199,-0.116414064317577,-0.0752468331668033,8.17203931616291e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ICAM4,Intercellular adhesion molecule 4,42594,0.0492401967645562,0.00539815178806175,0.0386598192599552,0.0598205742691572,8.4383945743192e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,40223,-0.0711404230446889,0.00781464442573242,-0.0864571261191244,-0.0558237199702533,1.02525514777748e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCF2,Neutrophil cytosol factor 2,42578,-0.0770256391768365,0.00846919377594883,-0.0936252589776961,-0.0604260193759768,1.07950873468299e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42676,-0.0261702711342645,0.00287845298099827,-0.0318120389770211,-0.0205285032915078,1.10867406465631e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATRN,"Attractin, Isoform 2",40539,-0.0156370138211764,0.00171976347250645,-0.019007750227289,-0.0122662774150637,1.12806385081753e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMSB10,Thymosin beta-10,42611,-0.0688399523677477,0.0075738541172219,-0.0836847064375026,-0.0539951982979928,1.13631928520645e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42721,-0.0324101588915901,0.00357073532476361,-0.0394088001281268,-0.0254115176550534,1.27302333372004e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANXA2,Annexin A2,40054,-0.0676119894139796,0.00745266221574377,-0.0822192073568374,-0.0530047714711218,1.36735628477209e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GMPR,GMP reductase 1,42754,-0.0457024246733312,0.00504495669750135,-0.0555905398004338,-0.0358143095462285,1.49386383522865e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,40449,-0.0766016643917594,0.00846133567742217,-0.0931858823195068,-0.0600174464640119,1.61733319744273e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TADA3,Transcriptional adapter 3,40451,-0.0366825479554474,0.00405582818938331,-0.0446319712066387,-0.0287331247042561,1.75098300354202e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,40532,-0.0252361412751632,0.00279305014638551,-0.0307105195620788,-0.0197617629882477,1.89928095719858e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42594,-0.0725405816389768,0.0080316599349396,-0.0882826351114584,-0.0567985281664952,1.91622984278465e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHAD,Chondroadherin,40283,0.0483258664373815,0.00535204788069149,0.0378358525912262,0.0588158802835369,2.01078112882757e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GMPR2,GMP reductase 2,40283,-0.0623689840881164,0.00691045305460918,-0.0759134720751504,-0.0488244961010824,2.0870585078099e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,40302,-0.048818664505088,0.00540921863320164,-0.0594207330261632,-0.0382165959840127,2.09076310301193e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BOC,Brother of CDO,42357,0.0217436217400003,0.00241119002577193,0.0170176892894873,0.0264695541905133,2.18147676742763e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42679,-0.030460596900797,0.00337822963042718,-0.0370819269764343,-0.0238392668251597,2.19591288819397e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42611,-0.0359313487500335,0.00398616656768424,-0.0437442352226946,-0.0281184622773724,2.25223186554714e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EREG,Proepiregulin,42476,-0.0739505976294189,0.00820685328976021,-0.0900360300773489,-0.0578651651814889,2.32097240984223e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATXN2L,Ataxin-2-like protein,40482,-0.044593352639093,0.00494761996132271,-0.0542906877632855,-0.0348960175149005,2.32520447106998e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,40527,0.0251426261147556,0.00278988041049525,0.0196744605101849,0.0306107917193263,2.34522020511775e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",40482,-0.0714635969959896,0.00793202417790661,-0.0870103643846865,-0.0559168296072926,2.40199790900692e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,40199,-0.0405471670409315,0.00450234966029279,-0.0493717723751053,-0.0317225617067576,2.49380024271239e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDHD2,Phospholipase DDHD2,40482,-0.0604302168444013,0.00671758597622884,-0.0735966853578098,-0.0472637483309928,2.71842042267061e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STAMBP,STAM-binding protein,42476,-0.057848110332292,0.00644073121533685,-0.0704719435143522,-0.0452242771502318,3.02373852635279e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,40223,-0.0942173748253237,0.0104894736998989,-0.114776743277126,-0.0736580063735218,3.08810658076439e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42495,-0.0658675593002634,0.0073383485944798,-0.0802507225454438,-0.051484396055083,3.18594212962134e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAM3D,Protein FAM3D,40449,-0.0791742742158621,0.00881959502419398,-0.0964606804632823,-0.0618878679684419,3.22094731441993e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39983,-0.0454255744504869,0.00506429827053693,-0.0553515990607393,-0.0354995498402345,3.46250537256397e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,42370,-0.0548592159933892,0.00613911641403161,-0.0668918841648912,-0.0428265478218873,4.56506386765968e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARSA,Arylsulfatase A,42611,-0.0407296259825392,0.00455809260293919,-0.0496634874843,-0.0317957644807783,4.56887126186866e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CALB2,Calretinin,42311,-0.0294103117303189,0.00329159909907047,-0.035861845964497,-0.0229587774961408,4.61091149622499e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCN2,CCN family member 2,42624,-0.0503360648778357,0.00564499788251841,-0.0614002607275718,-0.0392718690280996,5.40587156541492e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,42346,-0.0529674791529821,0.00594537524545757,-0.064620414634079,-0.0413145436718853,5.81801175893498e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42587,-0.0404542033242961,0.00454145582804695,-0.0493554567472681,-0.0315529499013241,5.87127528850553e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCBP2,Poly(rC)-binding protein 2,40482,-0.0656848262401161,0.00737786985170009,-0.0801454511494483,-0.051224201330784,6.26758382882719e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,40283,-0.0648452868132782,0.00728387647214845,-0.0791216846986891,-0.0505688889278672,6.30453572854209e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NME3,Nucleoside diphosphate kinase 3,42638,0.0218843092416526,0.00246062470275821,0.0170614848242466,0.0267071336590587,6.65027056696978e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL18BP,Interleukin-18-binding protein,42689,-0.0294830122549879,0.00331759519633693,-0.0359854988398083,-0.0229805256701676,7.07313907965653e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,42357,-0.0385343292688364,0.00433667266678915,-0.0470342076957431,-0.0300344508419296,7.16890528664807e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WASHC3,WASH complex subunit 3,40483,-0.0680720395295399,0.0076603276766791,-0.0830862817758309,-0.0530577972832489,7.27322920797664e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNM3,Dynamin-3,40482,-0.0500236424755039,0.00563056506139136,-0.061059549995831,-0.0389877349551768,7.40487314654285e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD160,CD160 antigen,42754,-0.0446114628475537,0.00502792368862767,-0.054466193277264,-0.0347567324178435,8.02015845448841e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,42586,-0.0585884254322558,0.0066067962473554,-0.0715377460770724,-0.0456391047874392,8.38639074208878e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42611,-0.0333469893248817,0.00376859677816071,-0.0407334390100767,-0.0259605396396867,9.95488854142652e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZNRD2,Protein ZNRD2,40449,-0.0632078031835055,0.00715015649966201,-0.077222109922843,-0.0491934964441679,1.09875801081976e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,42295,-0.0520249004627863,0.00589200236911142,-0.0635732251062446,-0.0404765758193279,1.18107725464996e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,40449,-0.0928720584816632,0.0105179997249832,-0.11348733794263,-0.0722567790206962,1.20337096100618e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TF,Serotransferrin,40539,-0.0193418869236938,0.002190837881817,-0.0236359291720551,-0.0150478446753325,1.21587916523516e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",40223,-0.0876199358782209,0.00994913455021211,-0.107120239596637,-0.0681196321598051,1.48015411935895e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GASK1A,Golgi-associated kinase 1A,40116,-0.039133010519326,0.00444742114320137,-0.0478499559600006,-0.0304160650786513,1.5874796388748e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OPLAH,5-oxoprolinase,40223,-0.0609396450544571,0.00694078686070942,-0.0745435873014476,-0.0473357028074667,1.87689659678934e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,42357,-0.0342423815181444,0.00390980779029135,-0.0419056047871155,-0.0265791582491734,2.22644353387699e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL5,C-C motif chemokine 5,42689,-0.0890930820653477,0.0101857913326622,-0.109057233077366,-0.0691289310533297,2.45214128225799e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,40283,-0.0483478031620326,0.00552891902430998,-0.0591844844496801,-0.037511121874385,2.56219130974088e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42658,-0.062596199462443,0.00716282743960702,-0.0766353412440728,-0.0485570576808132,2.62632375771545e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,40449,-0.0573276841398612,0.00655851020550051,-0.0701823641426422,-0.0444730041370802,2.6386795487697e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,40199,-0.08674610285263,0.00992900328085599,-0.106206949283108,-0.0672852564221523,2.74910991240104e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PROC,Vitamin K-dependent protein C,42663,-0.0224331976356277,0.00257174871100931,-0.027473825109206,-0.0173925701620495,3.02559280025148e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,40182,-0.0621433473840556,0.00712243104396918,-0.0761033122302351,-0.048183382537876,3.04503779407968e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MDK,Midkine,42638,-0.045579369496444,0.00522607886543939,-0.0558224840727052,-0.0353362549201828,3.06397343880709e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYDGF,Myeloid-derived growth factor,40511,-0.087668675387879,0.0100584759140133,-0.107383288179345,-0.0679540625964129,3.28582029339738e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,40223,-0.0290335588704629,0.00333358240079965,-0.0355673803760302,-0.0224997373648956,3.48973568265047e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRAF2,TNF receptor-associated factor 2,42594,-0.0616478230694138,0.00708237786209164,-0.0755292836791134,-0.0477663624597142,3.56215893704263e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DBI,Acyl-CoA-binding protein,42562,-0.0678498216633537,0.00780707974740152,-0.0831516979682607,-0.0525479453584467,4.01353789007836e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42676,-0.0925525130138527,0.010656804774992,-0.113439850372837,-0.0716651756548684,4.22524663147182e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATOX1,Copper transport protein ATOX1,42679,-0.0617789269423911,0.00711603296682332,-0.0757263515573648,-0.0478315023274174,4.34412272619484e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",40223,-0.057435358184467,0.00661547861563408,-0.0704016962711098,-0.0444690200978242,4.43693978272609e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42673,0.0289084459416186,0.00333098889462636,0.0223797077081509,0.0354371841750863,4.46037698952974e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,40483,-0.0274998888746967,0.00318262469908944,-0.033737833284912,-0.0212619444644814,6.34209110837476e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42587,-0.0312390179252797,0.00361884250456957,-0.0383319492342361,-0.0241460866163233,6.68424830337428e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NBN,Nibrin,42370,-0.0472724655665533,0.00548041412389926,-0.0580140772493958,-0.0365308538837108,7.09206295352378e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD36,Platelet glycoprotein 4,40199,-0.0396082766624338,0.00459875019089241,-0.0486218270365829,-0.0305947262882846,8.09912537114594e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP7,Matrilysin,42333,-0.0446504967445435,0.00518991739457497,-0.0548227348379104,-0.0344782586511766,8.61612476888899e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CX3CL1,Fractalkine,42495,0.0302918557531957,0.00352668949357639,0.023379544345786,0.0372041671606054,9.71417144527539e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,42476,-0.0205595110560463,0.00239413009046971,-0.0252520060333669,-0.0158670160787256,9.87253147144887e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LARP1,La-related protein 1,40451,-0.0538699046207989,0.0062843676532188,-0.0661872652211077,-0.04155254402049,1.14922727884758e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL1A1,Collagen alpha-1(I) chain,42794,0.0220462727939239,0.00257353447520653,0.0170021452225191,0.0270904003653287,1.180169005051e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",40481,-0.0349313465839712,0.0040849669178965,-0.0429378817430483,-0.026924811424894,1.37508497155902e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATG4A,Cysteine protease ATG4A,42346,-0.0514284804067982,0.00602382358556233,-0.0632351746345003,-0.039621786179096,1.52073720760308e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42611,-0.0494436687237663,0.00580102866917569,-0.0608136849153507,-0.038073652532182,1.71554273934935e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,42587,-0.0293889179783888,0.00345076736724748,-0.0361524220181939,-0.0226254139385837,1.81632098849063e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42754,-0.0418225631623074,0.00491251723823917,-0.0514510969492561,-0.0321940293753586,1.86401828358738e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",40267,-0.0741405011354018,0.00871439896533899,-0.0912207231074662,-0.0570602791633374,2.000408715054e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,USO1,General vesicular transport factor p115,42587,-0.0781625370852051,0.00919306302740872,-0.0961809406189262,-0.060144133551484,2.05323949867022e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPI,Glucose-6-phosphate isomerase,40532,-0.0409976528015364,0.00482511699070966,-0.0504548821033273,-0.0315404234997455,2.19364964251579e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VEGFD,Vascular endothelial growth factor D,42734,0.0314005668515144,0.00369739657912308,0.0241536695564331,0.0386474641465956,2.22918069644493e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BTD,Biotinidase,40539,-0.0179543388117372,0.00211424577456074,-0.0220982605298762,-0.0138104170935981,2.28229826828525e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,40482,-0.0583767325494952,0.00687840602933432,-0.0718584083669905,-0.0448950567319999,2.38584874117327e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,42346,-0.034580152819241,0.00408134539616124,-0.042579589795717,-0.026580715842765,2.64991193935848e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42676,-0.0240394978889343,0.00283999197516666,-0.0296058821602609,-0.0184731136176076,2.83267502453941e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,42600,-0.0417764095299857,0.0049481530883118,-0.0514747895830768,-0.0320780294768945,3.41317782202588e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPHA2,Ephrin type-A receptor 2,42125,-0.0292749592686411,0.00346770709452262,-0.0360716651739055,-0.0224782533633768,3.44469832849623e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,42307,-0.0675397160124475,0.00800254920941017,-0.0832247124628915,-0.0518547195620036,3.51061942820579e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DTNB,Dystrobrevin beta,40430,-0.0370815867538976,0.00439335737730926,-0.0456925672134237,-0.0284706062943714,3.55078376107959e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,40451,-0.0330647600586174,0.00391767767649981,-0.040743408304557,-0.0253861118126777,3.56477644801553e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42562,-0.0582860086771159,0.00690809936716039,-0.0718258834367502,-0.0447461339174815,3.57726161194796e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42760,-0.0288715330081566,0.00342195997468516,-0.0355785745585395,-0.0221644914577737,3.57860943664718e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASP10,Caspase-10,42311,-0.0618221268057262,0.00732813391848575,-0.0761852692859583,-0.0474589843254942,3.61672670169142e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COMP,Cartilage oligomeric matrix protein,42511,0.0291561558977785,0.00345936606386052,0.0223757984126119,0.0359365133829451,3.8686088899679e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NGRN,Neugrin,40483,-0.0200403476609594,0.00237847949045054,-0.0247021674622424,-0.0153785278596763,4.02016205994645e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42711,-0.0575492469410707,0.00683284061283551,-0.0709416145422283,-0.0441568793399131,4.05581717647544e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSAP,Prosaposin,40440,-0.0250650724667713,0.00297542936058262,-0.0308969140135133,-0.0192332309200294,4.07961083276555e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,42346,-0.0665487258713657,0.00790535771920211,-0.0820432270010018,-0.0510542247417295,4.21658615500114e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,42346,-0.0538682033984239,0.00640738726956463,-0.0664266824467705,-0.0413097243500772,4.62809573581753e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BID,BH3-interacting domain death agonist,42594,-0.0575173118729009,0.00685392970232613,-0.0709510140894601,-0.0440836096563416,5.26036734024284e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STAT2,Signal transducer and activator of transcription 2,40199,-0.0653774308461996,0.00779806482073085,-0.080661637894832,-0.0500932237975671,5.74857250293112e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ASS1,Argininosuccinate synthase,40116,-0.0669671216315534,0.00799449911952004,-0.0826363399058127,-0.0512979033572941,6.11165509222882e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42611,-0.0833776097042507,0.00996040311345012,-0.102899999806613,-0.0638552196018884,6.27966045684365e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42721,-0.0458123371660082,0.00547793834988581,-0.0565490963317844,-0.035075578000232,6.70442347443561e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,40173,-0.0236016271628043,0.00282247239532413,-0.0291336730576396,-0.018069581267969,6.90876077907501e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SH3GLB2,Endophilin-B2,40483,-0.0571130228598962,0.00683092447269076,-0.0705016348263701,-0.0437244108934223,6.95075553307125e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,40502,0.0130725617590501,0.0015637105706444,0.0100076890405871,0.0161374344775132,7.00756462943393e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42594,-0.0301839627582715,0.00361270464891228,-0.0372648638701396,-0.0231030616464035,7.18536619390331e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42594,-0.085487713820431,0.0102392490811441,-0.105556642019473,-0.0654187856213885,7.55326696688197e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UROD,Uroporphyrinogen decarboxylase,40283,-0.0590569149159853,0.00707705473137703,-0.0729279421894843,-0.0451858876424863,7.97574932978703e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OPHN1,Oligophrenin-1,40483,-0.0912767765049563,0.0109392086776241,-0.112717625513099,-0.0698359274968131,8.01655650978179e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARSB,Arylsulfatase B,42587,-0.0469255576138173,0.00562533716076372,-0.0579512184489142,-0.0358998967787205,8.02565850853249e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MITD1,MIT domain-containing protein 1,42495,-0.0814679310487546,0.00976780437791682,-0.100612827629472,-0.0623230344680376,8.12365399526298e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,40511,-0.022935039279717,0.00274967820520098,-0.0283244085619109,-0.0175456699975231,8.21988755074682e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,40223,-0.0500425188516287,0.00600247662436187,-0.0618073730353779,-0.0382776646678794,8.52595023576229e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42594,-0.060511863104917,0.00726885341172278,-0.0747588157918936,-0.0462649104179403,9.2586269306087e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCDH17,Protocadherin-17,42636,-0.0318319621986652,0.00382376015932882,-0.0393265321109497,-0.0243373922863807,9.25873216284568e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VCAN,Versican core protein,42711,0.0260992216821311,0.00313521711960166,0.0199541961277118,0.0322442472365503,9.27318149684076e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42636,-0.0668525500743324,0.00804619853757987,-0.082623099207989,-0.0510820009406759,1.06060495343623e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,40483,-0.02777008718818,0.00334286841086559,-0.0343221092734765,-0.0212180651028834,1.09111179548256e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,42346,-0.0552514145423445,0.00665368204067467,-0.0682926313420669,-0.0422101977426222,1.10543726605494e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRKL,Crk-like protein,42636,-0.0888422890767961,0.0107048023506863,-0.109823701684141,-0.067860876469451,1.14650381863329e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINE2,Glia-derived nexin,40511,-0.0546680498387322,0.00658707193100476,-0.0675787108235015,-0.0417573888539629,1.16605131343904e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,40482,-0.0518547572320554,0.006254169610597,-0.0641129296688255,-0.0395965847952853,1.24773704780589e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,40539,0.022767577051765,0.00274748659859658,0.0173825033185157,0.0281526507850143,1.29525221864992e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,40183,-0.0710350002869474,0.00859251167300516,-0.0878763231660375,-0.0541936774078573,1.53072150210287e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DAB2,Disabled homolog 2,42721,-0.092046303277399,0.0111419036301548,-0.113884434392502,-0.0702081721622957,1.57432128521983e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,42370,-0.0326449403742712,0.00395252238922798,-0.0403918842571581,-0.0248979964913844,1.60460759624106e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNX15,Sorting nexin-15,40283,-0.0459274294289734,0.00557406256931251,-0.0568525920648259,-0.0350022667931208,1.92385928099633e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,40482,-0.0705538459742649,0.00857357343153464,-0.0873580499000728,-0.053749642048457,2.09112430966041e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41948,-0.0369359593144779,0.00449039406830253,-0.0457371316883508,-0.0281347869406049,2.13030851128617e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,40116,-0.0562492015454149,0.0068393541071798,-0.0696543355954873,-0.0428440674953425,2.18505094422994e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,42346,-0.040154241359542,0.00488382150545907,-0.0497265315102418,-0.0305819512088423,2.18992281332523e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,42346,-0.0278013960915855,0.00338346967422243,-0.0344329966530615,-0.0211697955301096,2.28378394022645e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEC31A,Protein transport protein Sec31A,40223,-0.064549126493438,0.00786080707960772,-0.0799563083694691,-0.0491419446174068,2.42760799518508e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STX4,Syntaxin-4,42587,-0.0499224609361794,0.00608320958203768,-0.0618455517169733,-0.0379993701553856,2.4819414143143e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,40116,-0.0565377680059472,0.00690197348296476,-0.0700656360325581,-0.0430098999793362,2.86661695129414e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD69,Early activation antigen CD69,42585,-0.073211186012749,0.00895342246881014,-0.0907598940516169,-0.0556624779738811,3.17301829187729e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42611,-0.036121301595387,0.00441753443274041,-0.0447796690835582,-0.0274629341072158,3.17491877582668e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LMNB2,Lamin-B2,40483,-0.0240003321434358,0.00294692490354525,-0.0297763049543845,-0.0182243593324871,4.21949297784749e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42594,-0.0861832166816517,0.0105875532527002,-0.106934821056944,-0.0654316123063593,4.29776366637149e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCARF1,Scavenger receptor class F member 1,42794,-0.034821414881109,0.00428465778033432,-0.0432193441305643,-0.0264234856316537,4.77810107104526e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LPP,Lipoma-preferred partner,40116,-0.0548908729865571,0.00675651260846484,-0.0681336376991482,-0.041648108273966,4.99067082747214e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,40223,-0.045156946227931,0.00556171328614188,-0.0560579042687691,-0.034255988187093,5.18959949076479e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFNLR1,Interferon lambda receptor 1,42594,-0.030186023128522,0.0037213840157992,-0.0374799357994884,-0.0228921104575555,5.43202257648647e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42794,-0.0269778698963257,0.00332923785956529,-0.0335031761010736,-0.0204525636915777,5.8015888195477e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOXO3,Forkhead box protein O3,42346,-0.0786877065383937,0.00971746823589363,-0.0977339442807452,-0.0596414687960422,6.09853765190526e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSPAN8,Tetraspanin-8,40449,-0.0853300880638628,0.0105412417886394,-0.105990921969596,-0.0646692541581296,6.32157260784782e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,40451,-0.0285872108136893,0.00353160777249885,-0.0355091620477871,-0.0216652595795916,6.33215220643955e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VASN,Vasorin,42449,0.0228879259790713,0.00282862665909571,0.0173438177272437,0.0284320342308989,6.40193928048331e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAMB1,Laminin subunit beta-1,40223,-0.0252877586431042,0.0031250805583985,-0.0314129165375653,-0.0191626007486431,6.49159958720699e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42618,0.0315338451154516,0.00389927826829856,0.0238912597095865,0.0391764305213168,6.63124058699762e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,40482,-0.0546511419017233,0.0067581654532679,-0.0678971461901284,-0.0414051376133182,6.75713815331306e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AP2B1,AP-2 complex subunit beta,40182,-0.0400906048399928,0.00495834042380307,-0.0498089520706468,-0.0303722576093388,6.84136516549324e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C4BPB,C4b-binding protein beta chain,42679,0.0333385056631501,0.0041323512719348,0.0252390971701579,0.0414379141561423,7.76636453320788e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,YJU2,Splicing factor YJU2,40451,-0.0268767881112902,0.00333071694649961,-0.0334049933264294,-0.0203485828961509,7.7833220496627e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSC22D1,TSC22 domain family protein 1,40482,-0.0539523591679953,0.00668753470597764,-0.0670599271917115,-0.0408447911442792,7.89418646000358e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,42547,-0.0232926995579928,0.00288823363618691,-0.0289536374849192,-0.0176317616310665,7.96469130716825e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,40482,-0.0622042607415467,0.00771279638507824,-0.0773213416563001,-0.0470871798267934,8.05833074851638e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,40223,0.029260948033493,0.00363464984562806,0.022137034336062,0.036384861730924,9.08832440260385e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FKBPL,FK506-binding protein-like,40449,-0.048298405444894,0.00600365353836049,-0.0600655663800805,-0.0365312445097074,9.50183854720623e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HPSE,Heparanase,40408,-0.0772827469298852,0.00960700714441196,-0.0961124809329326,-0.0584530129268377,9.53769774545616e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,40511,-0.0400832196541745,0.00498579924919684,-0.0498553861826003,-0.0303110531257487,9.91902539631826e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,40511,-0.0496903262721239,0.00618252854786948,-0.0618080822259481,-0.0375725703182997,1.01025527845294e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F12,Coagulation factor XII,40539,-0.0342046631349997,0.00426406730010958,-0.0425622350432145,-0.025847091226785,1.14625350945988e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",40449,-0.119738769654151,0.0149273756239262,-0.148996425877046,-0.0904811134312554,1.14881532399796e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSL,Cathepsin L1,42636,-0.0204108931977338,0.00254528993594204,-0.0253996614721802,-0.0154221249232874,1.15298544863566e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAS6,Growth arrest-specific protein 6,42718,0.0208436143675188,0.00259927771452486,0.0157490300470501,0.0259381986879876,1.15319420609162e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP12,Macrophage metalloelastase,42592,-0.0460746264580914,0.0057475203321198,-0.0573397663090463,-0.0348094866071366,1.17828932014218e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,42346,-0.049525665482166,0.00618063478182213,-0.0616397096545374,-0.0374116213097946,1.21293446068286e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VWC2,Brorin,42456,-0.0337586313682675,0.00421470007766787,-0.0420194435204965,-0.0254978192160385,1.24497250056099e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,40182,-0.066219306612902,0.00826650307366517,-0.0824216526372857,-0.0500169605885183,1.25721063467596e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,42676,-0.0700427209581333,0.00874933573986753,-0.0871914190082737,-0.052894022907993,1.28680211659515e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDA,Cytidine deaminase,40494,-0.0385542045519679,0.00482025035941986,-0.0480018952564308,-0.029106513847505,1.38352285333131e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,40223,-0.0358475613547433,0.00448257390906952,-0.0446334062165195,-0.027061716492967,1.40117984340982e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOXJ3,Forkhead box protein J3,40199,-0.0358985593116543,0.00448948776694113,-0.0446979553348589,-0.0270991632884497,1.4123274673822e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPR,Nucleoprotein TPR,40116,-0.0398828024256965,0.004994458798759,-0.0496719416712642,-0.0300936631801289,1.54106490530352e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DPEP1,Dipeptidase 1,42476,0.0407952273042827,0.00511499786877022,0.0307698314814931,0.0508206231270724,1.63978568022406e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL14,C-C motif chemokine 14,42618,-0.0330045939506256,0.00413969327228758,-0.0411183927643093,-0.024890795136942,1.67710162799427e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HS1BP3,HCLS1-binding protein 3,40223,-0.0721956016729957,0.00907548647463997,-0.08998355516329,-0.0544076481827013,1.96624384441096e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ST13,Hsc70-interacting protein,40283,-0.0460558342898049,0.00579541667164789,-0.0574148509662347,-0.034696817613375,2.0967919982749e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,42351,-0.0447374671237459,0.00563741148373285,-0.0557867936318623,-0.0336881406156295,2.25962979111623e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMPRSS5,Transmembrane protease serine 5,42438,0.0309520974065287,0.00390256035766769,0.0233030791055001,0.0386011157075574,2.34312550697327e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD80,T-lymphocyte activation antigen CD80,40511,-0.0284177592590344,0.00358741037616855,-0.0354490835963248,-0.0213864349217441,2.56559309555179e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,40199,-0.0462739854450719,0.00584141690274399,-0.0577231625744501,-0.0348248083156936,2.56835600898763e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42602,-0.0283196013612926,0.00357873670905506,-0.0353339253110405,-0.0213052774115447,2.70240348962857e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLIN3,Perilipin-3,42636,-0.0341321095328711,0.00431698091376718,-0.0425933921238548,-0.0256708269418875,2.85328251185451e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,42370,-0.0430140847559425,0.00544112057145517,-0.0536786810759947,-0.0323494884358904,2.88290709886991e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,40483,-0.0521130041586915,0.00659453859843738,-0.0650382998116288,-0.0391877085057543,2.98867675169001e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42794,0.0234856272245792,0.00297272124603665,0.0176590935823474,0.0293121608668111,2.99311707709603e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,40383,-0.0482905602395698,0.00611539849185688,-0.0602767412836093,-0.0363043791955303,3.13512190695544e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAYN,Layilin,42476,-0.030545672283576,0.0038762110296328,-0.0381430459016563,-0.0229482986654957,3.51942561251346e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42620,-0.0456797040194877,0.00579708003856511,-0.0570419808950754,-0.0343174271439001,3.53102612367504e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TBCC,Tubulin-specific chaperone C,42495,-0.0643973534190357,0.00818337839917777,-0.0804367750814241,-0.0483579317566473,3.84124021911393e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,40451,-0.0707254532774907,0.00898792837139457,-0.0883417928854241,-0.0531091136695574,3.90393288950942e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",42476,-0.0766344510361196,0.00974566664163891,-0.0957359576537319,-0.0575329444185074,4.02454320737939e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,YWHAQ,14-3-3 protein theta,40283,-0.0593109505029354,0.00754702796857731,-0.0741031253213469,-0.0445187756845239,4.23527013563931e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSNAX,Translin-associated protein X,40116,-0.0318514618865513,0.0040603610235943,-0.0398097694927962,-0.0238931542803065,4.75246495469674e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,42346,-0.0349925512873027,0.00446561482849123,-0.0437451563511455,-0.0262399462234599,5.00735262983881e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,40511,-0.0856643019511744,0.0109362946990198,-0.107099439561253,-0.0642291643410956,5.18794396260862e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOBR,Apolipoprotein B receptor,40223,0.0343672721703266,0.00438782882254098,0.0257671276781462,0.0429674166625069,5.22500916966698e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RRAS,Ras-related protein R-Ras,40182,-0.103962722183206,0.0132907831801617,-0.130012657216323,-0.077912787150089,5.66764108810703e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STX8,Syntaxin-8,42594,-0.0381472110628771,0.00488389658740727,-0.0477196483741954,-0.0285747737515589,6.10300487446875e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCN2,Ficolin-2,42597,-0.0328476549503291,0.00420825345522067,-0.0410958317225616,-0.0245994781780966,6.36289355551643e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRTAC1,Cartilage acidic protein 1,42794,0.0239377638959793,0.0030674338970293,0.0179255934578019,0.0299499343341567,6.44177649844707e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42495,-0.0621865809908867,0.00796860511536078,-0.0778050470169939,-0.0465681149647796,6.44642377062394e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,42240,-0.0323313398702197,0.00414540656185937,-0.0404563367314641,-0.0242063430089753,6.69565886725324e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42778,-0.0229002942390565,0.00293665311402284,-0.0286561343425412,-0.0171444541355717,6.74115320683192e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,40209,-0.0445546464738995,0.00571430065062664,-0.0557546757491277,-0.0333546171986713,6.90874934757899e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VNN1,Pantetheinase,40532,-0.058435634435854,0.00749490617825888,-0.0731256505452414,-0.0437456183264666,6.90975757650597e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL11,C-X-C motif chemokine 11,42711,-0.0636376211102455,0.00817371391045714,-0.0796581003747415,-0.0476171418457495,7.43867002349378e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACYP1,Acylphosphatase-1,40250,-0.0524557754761738,0.0067362811260271,-0.0656588864831869,-0.0392526644691607,7.47171282491835e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPPK1,Epiplakin,40223,-0.0580376365903019,0.00745893652587772,-0.0726571521810222,-0.0434181209995816,7.84052721724801e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCTN2,Dynactin subunit 2,42587,-0.0746123536817708,0.00959760913997024,-0.0934236675961125,-0.0558010397674292,8.15405155335875e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD274,Programmed cell death 1 ligand 1,42495,-0.0277439363241487,0.00358499982228432,-0.034770535975826,-0.0207173366724714,1.07496574520727e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42566,-0.0306730933225039,0.00396483454470279,-0.0384441690301214,-0.0229020176148865,1.09674115411813e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42495,-0.0848819531073473,0.0109911946869013,-0.106424694693674,-0.0633392115210207,1.21989801240761e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,40199,0.0260831670328708,0.0033818318871978,0.0194547765339632,0.0327115575317785,1.33778803125765e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RTBDN,Retbindin,42587,-0.0236053790823116,0.00306484827749992,-0.0296124817062115,-0.0175982764584118,1.43363596015721e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,40449,-0.0499152286843455,0.00649592817124436,-0.0626472478999845,-0.0371832094687066,1.66896516517377e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASC3,Protein CASC3,40182,-0.0330581259948466,0.00430390384777617,-0.0414937775364879,-0.0246224744532053,1.71316277335114e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42711,-0.0248487235773236,0.00323639931014209,-0.0311920662252021,-0.0185053809294451,1.72804764223396e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42711,-0.0362331593298716,0.00471934157682101,-0.0454830688204407,-0.0269832498393024,1.73213359501435e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",40283,-0.0817080094462615,0.0106420460460662,-0.102566419696551,-0.0608495991959718,1.75380536812244e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL8,Interleukin-8,42494,-0.0548253256836574,0.00714356934204027,-0.0688267215940564,-0.0408239297732585,1.77223156283803e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUB1,NEDD8 ultimate buster 1,42594,-0.0650002332965601,0.00847475171744454,-0.0816107466627514,-0.0483897199303688,1.84020197885175e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REG1A,Lithostathine-1-alpha,42575,-0.0411219370237719,0.0053660921923688,-0.0516394777208147,-0.030604396326729,1.93670702461485e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLRX,Glutaredoxin-1,42546,-0.0440032694276349,0.00574524292852094,-0.0552639455675359,-0.0327425932877338,2.00131945272461e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,42587,-0.0303262071508046,0.00396216098781283,-0.0380920426869178,-0.0225603716146915,2.08193943985455e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42794,-0.0185159210877194,0.0024205736534312,-0.0232602454484445,-0.0137715967269942,2.15466179298024e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,40421,-0.0237504558709664,0.00310713076331749,-0.0298404321670686,-0.0176604795748641,2.27991006955485e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB33A,Ras-related protein Rab-33A,40116,-0.0515283323758536,0.00674309943827201,-0.0647448072748667,-0.0383118574768404,2.32434326896557e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ING1,Inhibitor of growth protein 1,42292,-0.0369229617822531,0.00483391244745577,-0.0463974301792665,-0.0274484933852398,2.3532416257593e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42679,-0.01844168985592,0.00241564534578703,-0.0231763547336626,-0.0137070249781774,2.42338486362084e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,JAM2,Junctional adhesion molecule B,42711,-0.0222210019111205,0.0029172048473052,-0.0279387234118387,-0.0165032804104023,2.76379318056489e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,40483,-0.0252346998604462,0.00331402319114534,-0.0317301853150911,-0.0187392144058014,2.85780183069172e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,40449,-0.0348917298190576,0.00458367250109757,-0.0438757279212089,-0.0259077317169064,2.91051582989092e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RALY,RNA-binding protein Raly,40451,-0.0370988730196725,0.00487818316875775,-0.0466601120304377,-0.0275376340089073,3.07437289960228e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH5,Cadherin-5,42794,0.0235051680905914,0.00309264849380378,0.017443577042736,0.0295667591384468,3.14653467980413e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,40451,-0.0527172958974643,0.00693629841708839,-0.0663124407949576,-0.0391221509999711,3.19129651978617e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL2,C-C motif chemokine 2,42475,-0.041336426312777,0.00544329429211832,-0.0520052831253289,-0.0306675695002251,3.30844833734528e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F2R,Proteinase-activated receptor 1,42654,-0.0434046482236262,0.0057339401669321,-0.0546431709508131,-0.0321661254964393,3.98145316745561e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CIT,Citron Rho-interacting kinase,40182,-0.0353186400136108,0.0046646222870731,-0.044461299696274,-0.0261759803309475,3.98212305390205e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCL2L15,Bcl-2-like protein 15,40199,-0.0438703013558479,0.00579594842888638,-0.0552303602764652,-0.0325102424352306,4.05751406745367e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42594,-0.0736740469828837,0.00974344711074049,-0.092771203319935,-0.0545768906458323,4.24670865412875e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,42311,-0.0296216489240721,0.00392560165010472,-0.0373158281582774,-0.0219274696898669,4.79260733864903e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RILP,Rab-interacting lysosomal protein,42674,-0.045893872013438,0.0060871043680206,-0.0578245965747583,-0.0339631474521176,5.01782163925299e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TP53,Cellular tumor antigen p53,42346,-0.0332359276574427,0.00440891258941425,-0.0418773963326946,-0.0245944589821907,5.07079322045772e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DBNL,Drebrin-like protein,42676,-0.0706947822861444,0.00937860265960959,-0.0890768434989792,-0.0523127210733096,5.08116679118453e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLXNB3,Plexin-B3,42597,-0.0360994955133451,0.00479505228732276,-0.0454977979964977,-0.0267011930301924,5.46058598794889e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD300C,CMRF35-like molecule 6,42711,-0.0277444235276884,0.00368682826145966,-0.0349706069201494,-0.0205182401352275,5.59278484659141e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STX7,Syntaxin-7,40199,-0.0387089287870738,0.00514533781006562,-0.0487937908948024,-0.0286240666793452,5.76591433835606e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,40449,-0.0239420613528571,0.00318274162338172,-0.0301802349346853,-0.017703887771029,5.78457546193872e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,40511,-0.0697633549878704,0.00927678478778596,-0.0879458531719309,-0.0515808568038099,5.88242175534171e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42611,-0.0586241029724105,0.00781189857881782,-0.0739354241868934,-0.0433127817579275,6.55612939032748e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APP,Amyloid-beta precursor protein,42592,-0.0509886173141757,0.00680164371255028,-0.0643198389907743,-0.0376573956375772,6.96486744760548e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,42346,-0.0352667076739562,0.00470506000333444,-0.0444886252804917,-0.0260447900674207,7.02745447192353e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,42587,-0.0263761542972495,0.00352623878413555,-0.0332875823141552,-0.0194647262803439,7.89642936824778e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,40449,-0.069227915282779,0.00925987282065028,-0.0873772660112535,-0.0510785645543044,8.22328641713113e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNTN4,Contactin-4,42611,0.0184552591896894,0.00246924216638138,0.0136155445435819,0.0232949738357969,8.25708884855554e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD164,Sialomucin core protein 24,42611,-0.0209553439616243,0.00280438037061258,-0.026451929488025,-0.0154587584352237,8.36382913792965e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OLFM4,Olfactomedin-4,39870,-0.0949850542935844,0.0127288688803571,-0.119933637299084,-0.0700364712880845,9.17281126941013e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPOCK1,Testican-1,42495,0.0196892691217513,0.00263959798155127,0.0145156570779108,0.0248628811655918,9.24464127091428e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRSS22,Brain-specific serine protease 4,40199,-0.0280962956062184,0.00376656172360357,-0.0354787565844814,-0.0207138346279554,9.3461291702379e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLIT2,Slit homolog 2 protein,42311,-0.0402141578017476,0.00540132255713872,-0.0508007500137395,-0.0296275655897557,1.02800354499157e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,42676,-0.099266732684355,0.0133403835819803,-0.125413884505036,-0.0731195808636737,1.05913663440592e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD226,CD226 antigen,40199,-0.0324305524021367,0.00435738505069742,-0.0409710271015037,-0.0238900777027698,1.06037550180313e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DHPS,Deoxyhypusine synthase,40451,-0.0309466736873346,0.00416016113003582,-0.0391005895022048,-0.0227927578724644,1.08981169816206e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,40223,-0.0374558595938282,0.00503508675239714,-0.0473246296285266,-0.0275870895591298,1.09012498563356e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RETN,Resistin,42598,-0.0330080272201413,0.00444521759096018,-0.0417206536984232,-0.0242954007418593,1.19120641962299e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,40482,-0.086316194796706,0.0116238711854458,-0.10909898232018,-0.0635334072732322,1.20200490130833e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD300E,CMRF35-like molecule 2,42677,-0.0329332315734804,0.00443624057971156,-0.041628263109715,-0.0242382000372457,1.20734580498165e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,40116,-0.0217574122092465,0.00293067440379994,-0.0275015340406944,-0.0160132903777986,1.22067043432096e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,40527,0.0161951040880158,0.00218436966442781,0.0119137395457373,0.0204764686302943,1.311940834111e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,40182,-0.0544989905537541,0.00736880298786934,-0.068941844409978,-0.0400561366975302,1.5067554888556e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RWDD1,RWD domain-containing protein 1,42711,-0.0475200561102756,0.00642793224292509,-0.0601188033064088,-0.0349213089141424,1.52280613400072e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PARK7,Parkinson disease protein 7,42611,-0.0391696167439715,0.00530051254530031,-0.0495586213327601,-0.0287806121551829,1.55766694702926e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCARA5,Scavenger receptor class A member 5,42711,-0.0233763294720037,0.00316378027017003,-0.029577338801537,-0.0171753201424705,1.56924734253748e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANGPT1,Angiopoietin-1,42554,-0.0634124699484404,0.00859076906764963,-0.0802503773210337,-0.0465745625758472,1.65808629580472e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,42357,-0.0570362153323864,0.00773339649635032,-0.072193672465233,-0.0418787581995398,1.73766122358277e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSPB6,Heat shock protein beta-6,42721,-0.0298360788162832,0.00404600685082363,-0.0377662522438975,-0.0219059053886689,1.74939405021857e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRAP2,GRB2-related adapter protein 2,42636,-0.095377520565078,0.0129930917773419,-0.120843980448668,-0.0699110606814879,2.24794716516001e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRG3,Proteoglycan 3,40527,0.0376285905329013,0.00512621235532039,0.0275812143164733,0.0476759667493292,2.27483108538428e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HRG,Histidine-rich glycoprotein,40479,-0.0232873367259989,0.00317738249470176,-0.0295150064156144,-0.0170596670363835,2.47540041169496e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUDC,Nuclear migration protein nudC,42754,-0.0464253641534151,0.00633617374683069,-0.0588442646972033,-0.034006463609627,2.48594334806832e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD244,Natural killer cell receptor 2B4,42754,-0.0205592568484607,0.0028061401417632,-0.0260592915263166,-0.0150592221706048,2.49536612483104e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH3,Cadherin-3,42711,-0.0281732223383144,0.00384809347391923,-0.0357154855471961,-0.0206309591294327,2.59367532888766e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GTPBP2,GTP-binding protein 2,40182,-0.06049914323144,0.00828186926440172,-0.0767316069896674,-0.0442666794732127,2.96451571354456e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42737,-0.0319461661201493,0.00437493130327983,-0.0405210314745778,-0.0233713007657209,2.99127877825974e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,40302,-0.0424503983591711,0.00581243098381432,-0.0538427630874472,-0.031058033630895,2.99832174940981e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RGCC,Regulator of cell cycle RGCC,40482,-0.0564677774050959,0.00773318373574854,-0.071624817527163,-0.0413107372830287,3.02573277222378e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LGALS1,Galectin-1,42636,-0.0261606952565736,0.00359733387774896,-0.0332114696569615,-0.0191099208561856,3.7311340113538e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LGALS3,Galectin-3,42669,-0.0223077227858362,0.00307098488576441,-0.0283268531619345,-0.016288592409738,3.96360707435796e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,40302,-0.0490232609360892,0.00675342474589861,-0.0622599734380505,-0.0357865484341279,4.15933857851379e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,40482,-0.0692970252046348,0.00955682145446137,-0.0880283952553791,-0.0505656551538906,4.4058272677404e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42654,-0.0562352393027264,0.00776200190480381,-0.0714487630361419,-0.041021715569311,4.56164167560758e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TLR3,Toll-like receptor 3,42754,-0.045129437195919,0.00625623300554119,-0.0573916538867797,-0.0328672205050582,5.74178763762447e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",40482,-0.0318729120121284,0.0044188190023929,-0.0405337972568185,-0.0232120267674383,5.82387546035313e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VEGFC,Vascular endothelial growth factor C,42679,-0.0409776651554095,0.00568372212571733,-0.0521177605218154,-0.0298375697890035,5.90809038665378e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFHR5,Complement factor H-related protein 5,40382,0.0314437009251234,0.0043606830536273,0.0228967621400139,0.0399906397102329,5.92440063089478e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,40511,-0.0297488334417549,0.00412713086714337,-0.037838009941356,-0.0216596569421539,6.03437639774771e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD46,Membrane cofactor protein,42580,-0.0213821165762487,0.00297014414458091,-0.0272035990996272,-0.0155606340528701,6.38823686076795e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD58,Lymphocyte function-associated antigen 3,42600,0.01313217034421,0.00182443438310325,0.00955627895332764,0.0167080617350924,6.43813701582957e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,42495,-0.0173920733753155,0.00241860076666215,-0.0221325308779733,-0.0126516158726577,6.77724317399441e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42721,-0.0292597158696664,0.00407094935909829,-0.037238776613499,-0.0212806551258337,6.94761519925211e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ICA1,Islet cell autoantigen 1,42370,-0.0577753629230111,0.00804236264733638,-0.0735383937117904,-0.0420123321342318,7.140183269694e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SELL,L-selectin,40539,0.0176500822931017,0.0024574608330855,0.0128334590602541,0.0224667055259493,7.28688343206654e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TWF2,Twinfilin-2,40527,-0.0610530444265811,0.00850075230895118,-0.0777145189521254,-0.0443915699010367,7.29627984156375e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],42365,-0.0352965653405859,0.00492096490879399,-0.0449416565618221,-0.0256514741193497,7.74655953788775e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,40482,-0.0858721704262424,0.0119743227125422,-0.109341842942825,-0.0624024979096597,7.89000685632042e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,40283,-0.0309322434812267,0.0043164664789103,-0.0393925177798909,-0.0224719691825625,8.20622363275292e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,42587,-0.0403159429101958,0.00562986240341492,-0.051350473220889,-0.0292814125995025,8.42148707552339e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SH3BP1,SH3 domain-binding protein 1,40449,-0.0351319266550415,0.00491439371338944,-0.0447641383332848,-0.0254997149767982,9.29732464908366e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EFNA1,Ephrin-A1,42590,-0.0222339722892476,0.00311131205536722,-0.0283321439177674,-0.0161358006607279,9.38465630215135e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DLG4,Disks large homolog 4,40483,-0.0512772548670357,0.00717837078132669,-0.0653468615984361,-0.0372076481356354,9.67241377912871e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,42346,-0.038363088949216,0.00537307168943223,-0.0488943094605032,-0.0278318684379289,9.83183625614674e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,40199,-0.0367178504179844,0.00514181851420489,-0.046795814705826,-0.0266398861301428,9.84829379075017e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,40482,-0.0787711889274317,0.0110363126947931,-0.100402361809226,-0.0571400160456372,1.00906878013377e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OGN,Mimecan,42611,-0.0324747147993356,0.00455129463425605,-0.0413952522824775,-0.0235541773161937,1.01555641547056e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UBXN1,UBX domain-containing protein 1,40283,-0.050086949185095,0.00702797648525686,-0.0638617830961984,-0.0363121152739915,1.09112514508287e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,42346,-0.0660628664867071,0.00928191580938612,-0.0842554214731039,-0.0478703115003103,1.1570732586188e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLAMF6,SLAM family member 6,42346,-0.028322135753761,0.0039836281835392,-0.0361300469934979,-0.0205142245140242,1.22359203168622e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C2,Complement C2,42663,-0.0167079967154909,0.00235076450420057,-0.021315495143724,-0.0121004982872578,1.24134522046112e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,42794,-0.0521519173246247,0.00734109979340049,-0.0665404729196897,-0.0377633617295598,1.27131673149421e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,40449,-0.0647446889037637,0.00911259875506822,-0.0826053824636974,-0.04688399534383,1.27623876517197e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MIF,Macrophage migration inhibitory factor,42586,-0.0492018025952737,0.0069264692502881,-0.0627776823258384,-0.035625922864709,1.27829828918175e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COMT,Catechol O-methyltransferase,42214,-0.0606045265522286,0.00853778719738737,-0.0773385894591078,-0.0438704636453493,1.32763311552764e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GIMAP8,GTPase IMAP family member 8,40080,-0.0385210614678595,0.00542904778520105,-0.0491619951268536,-0.0278801278088655,1.37033800589322e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BOLA1,BolA-like protein 1,40136,-0.0395472106501846,0.00557807796754315,-0.0504802434665692,-0.0286141778338,1.42631032809312e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPART,Spartin,40283,-0.0556845516294828,0.00787111806847668,-0.0711119430436971,-0.0402571602152685,1.5898271454465e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CETN3,Centrin-3,40449,-0.0548914936887606,0.00776864595943721,-0.0701180397692576,-0.0396649476082637,1.69159221155884e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,40449,-0.0556120598237599,0.00787615915156788,-0.0710493317608329,-0.0401747878866868,1.75286588819964e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MINK1,Misshapen-like kinase 1,40483,-0.0670511165996716,0.00949702565171454,-0.0856652868770321,-0.0484369463223111,1.75994902817849e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPBP,Platelet basic protein,40471,-0.0609746297451231,0.00863878018015601,-0.0779066388982288,-0.0440426205920173,1.78516668106734e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42590,-0.0602288569968717,0.00853506746915221,-0.07695758923641,-0.0435001247573333,1.78970538336193e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,40229,-0.0410231584029868,0.00581240546044084,-0.0524154731054509,-0.0296308437005228,1.79230239729135e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42636,-0.0482754703701463,0.00684229764634418,-0.0616863737569808,-0.0348645669833117,1.80470887578633e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,40199,-0.0243404585955039,0.00345068834503592,-0.0311038077517743,-0.0175771094392335,1.84551949112201e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THY1,Thy-1 membrane glycoprotein,42711,-0.0217777246885619,0.00309198422713164,-0.0278380137737399,-0.0157174356033839,1.9683901932353e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,40451,-0.0373495620653494,0.00530641407068492,-0.0477501336438919,-0.0269489904868069,2.05518601436908e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,40483,-0.0380125880020242,0.00540064178297224,-0.0485978458966498,-0.0274273301073986,2.05540773373931e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPD52L2,Tumor protein D54,40283,-0.0775043090218504,0.0110112636348838,-0.0990863857462228,-0.0559222322974781,2.05591544591612e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C3,Complement C3,39989,-0.0341261466518962,0.00485406511954061,-0.0436401142861958,-0.0246121790175966,2.18345283277949e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,40199,-0.0635162181271294,0.00903749632618838,-0.0812297109264586,-0.0458027253278002,2.21788171873751e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REEP4,Receptor expression-enhancing protein 4,40482,-0.0446722374712469,0.0063602674049281,-0.0571383615849059,-0.0322061133575878,2.28587210673284e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,40302,-0.0328803091854917,0.0046878685201525,-0.0420685314849906,-0.0236920868859928,2.45210913372659e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPARC,SPARC,42679,-0.0501878378140617,0.00716671101087129,-0.0642345913953694,-0.0361410842327539,2.62572911148634e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,42713,-0.0207828323248335,0.00297025404678969,-0.0266045302565413,-0.0149611343931257,2.73836931070255e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42587,-0.0628315097990287,0.00898565263860626,-0.080443388970697,-0.0452196306273604,2.82982731232013e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL5A1,Collagen alpha-1(V) chain,40283,-0.0297989935600759,0.00426110568536613,-0.0381507607033935,-0.0214472264167583,2.84037042255283e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42611,-0.0214952648748545,0.00308134576677741,-0.0275347025777382,-0.0154558271719708,3.18089326032449e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GDF2,Growth/differentiation factor 2,42636,0.0256762264470915,0.00368103916470464,0.0184613896842704,0.0328910632099126,3.19572469476661e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GET3,ATPase GET3,40511,-0.0387139448424345,0.00555255515880119,-0.0495969529536848,-0.0278309367311842,3.29217111950091e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ASAH1,Acid ceramidase,40418,-0.0327434408823842,0.004696636018367,-0.0419488474783835,-0.0235380342863848,3.30757451814453e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRSF1,G-rich sequence factor 1,40014,-0.057923610889552,0.00830821467903056,-0.0742077116604519,-0.0416395101186521,3.31035151217557e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,42495,-0.0561553878533279,0.00805987494639575,-0.0719527427482635,-0.0403580329583922,3.38339450995803e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA2,Carbonic anhydrase 2,42573,-0.0494978513520389,0.00712164109923695,-0.0634562679065433,-0.0355394347975344,3.81279886370622e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CACYBP,Calcyclin-binding protein,40267,-0.0727798076567688,0.0104794178070406,-0.0933194665585684,-0.0522401487549692,3.99601933139917e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DOK1,Docking protein 1,40483,-0.0966005320256852,0.0139177483404588,-0.123879318772984,-0.069321745278386,4.11208153550479e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,40482,-0.0414240276899407,0.0059726538111057,-0.0531304291597079,-0.0297176262201735,4.2656094095645e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,42311,-0.0452977186845088,0.00653585893712838,-0.0581080022012804,-0.0324874351677372,4.38505598633982e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GIMAP7,GTPase IMAP family member 7,40283,0.0227168509916234,0.00328405946497219,0.0162800944402779,0.0291536075429689,4.85653479501534e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,40223,-0.0649428356305013,0.0093980620214455,-0.0833630371925344,-0.0465226340684681,5.1052647479282e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASP2,Caspase-2,42594,-0.0474729492725807,0.00687307590830101,-0.0609441780528506,-0.0340017204923107,5.17015241465683e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C8B,Complement component C8 beta chain,40539,0.0215603245095596,0.00312796506060941,0.0154295129907651,0.027691136028354,5.76204511624214e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,40482,-0.0473101520216893,0.00687251804953174,-0.0607802873987715,-0.0338400166446071,6.12974936210562e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,40283,-0.059666849762164,0.00866911799888145,-0.0766583210399717,-0.0426753784843564,6.19024308557888e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEPTIN8,Septin-8,40470,-0.0229731811416471,0.00333813615800196,-0.0295159280113309,-0.0164304342719632,6.2131008968321e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,40482,-0.0284796326504445,0.00413960950949949,-0.0365932672890635,-0.0203659980118254,6.31131334089992e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL19,C-C motif chemokine 19,42711,-0.0924572455857679,0.0134422654240539,-0.118804085816914,-0.0661104053546221,6.33229948793726e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CENPF,Centromere protein F,40302,-0.0385790850958899,0.00561473627614385,-0.0495839681971319,-0.027574201994648,6.71451360849039e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,42587,-0.0149624172253747,0.00218094904336236,-0.0192370773503649,-0.0106877571003844,7.16306778649465e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,42443,-0.0806860980725656,0.0117612666066333,-0.103738180621567,-0.0576340155235643,7.17559248665509e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,42346,-0.041743003676561,0.00608536523365429,-0.0536703195345234,-0.0298156878185986,7.21560732329873e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PF4,Platelet factor 4,40463,-0.0691147962006149,0.0100755466630394,-0.0888628676601721,-0.0493667247410576,7.26411731023322e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42495,-0.0653907110596567,0.00953472692134895,-0.0840787758255006,-0.0467026462938127,7.28332551156207e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,40223,-0.0224502997706826,0.00327973670053185,-0.028878583703725,-0.0160220158376401,8.04497095519546e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42579,-0.0171612048038352,0.00251021263822149,-0.0220812215747493,-0.012241188032921,8.46369508536886e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DENR,Density-regulated protein,40199,-0.0400681115151109,0.0058644945794148,-0.0515625208907639,-0.0285737021394579,8.79634893872923e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,42370,-0.030153868269012,0.00442212696882124,-0.0388212371279016,-0.0214864994101223,9.57655913740757e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTN,Pleiotrophin,42357,-0.0347145870914318,0.00509194941706971,-0.0446948079488885,-0.0247343662339752,9.66484273233702e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",40302,-0.0344035199655677,0.00504571267837159,-0.044293116815176,-0.0245139231159594,9.6858290495527e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PI3,Elafin,42446,-0.0397692372693654,0.00583912726099844,-0.0512139267009224,-0.0283245478378085,1.01230826208302e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,40199,-0.0246410416109307,0.00362083706423749,-0.0317378822568361,-0.0175442009650252,1.06047556006917e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,42587,-0.0803092707384109,0.0118106942901025,-0.103458231547012,-0.05716030992981,1.09275772689763e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL5,C-X-C motif chemokine 5,42605,-0.078827629660237,0.0115937394463044,-0.101551358974994,-0.0561039003454804,1.0968846936435e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTGES2,Prostaglandin E synthase 2,40102,-0.0379168021107658,0.0055984651968102,-0.0488897938965138,-0.0269438103250178,1.32891035239488e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",40223,-0.0602494456521449,0.00890882010886885,-0.0777107330655278,-0.042788158238762,1.42098548801378e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,42370,0.0275181301195026,0.0040713742509109,0.0195382365877173,0.035498023651288,1.44865394382292e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TBCB,Tubulin-folding cofactor B,42495,-0.0685477791320386,0.0101651451807453,-0.0884714636862994,-0.0486240945777779,1.61097123412177e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42636,-0.0403038242723187,0.00598414972365937,-0.0520327577306911,-0.0285748908139463,1.70481946772865e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,42346,-0.020694795022618,0.00307812547521535,-0.0267279209540401,-0.0146616690911959,1.8513837116471e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEMA7A,Semaphorin-7A,42760,-0.0196387880817788,0.00292350851746529,-0.0253688647760108,-0.0139087113875468,1.92183959527948e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CIAPIN1,Anamorsin,42679,-0.0426179997966548,0.00634602939242736,-0.0550562174058124,-0.0301797821874972,1.94669856923185e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOA4,Apolipoprotein A-IV,40539,-0.0249579836051319,0.00371670699506532,-0.0322427293154599,-0.0176732378948039,1.96940261014577e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STK24,Serine/threonine-protein kinase 24,42311,-0.0423033720527213,0.00630461826349368,-0.054660423849169,-0.0299463202562737,2.02752232391213e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,42311,-0.0459175668507811,0.00684483858533563,-0.059333450478039,-0.0325016832235233,2.04914010502173e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD59,CD59 glycoprotein,42130,-0.0172504563230821,0.00257203766819572,-0.0222916501527457,-0.0122092624934185,2.07036220738276e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42594,-0.0420027955126282,0.00626422592414512,-0.0542806783239526,-0.0297249127013037,2.09210810829104e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPRR3,Small proline-rich protein 3,40483,-0.0482900324612437,0.00721089214941326,-0.0624233810740937,-0.0341566838483938,2.23120068229182e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TBCA,Tubulin-specific chaperone A,40283,-0.0582807078108652,0.00871102115658134,-0.0753543092777646,-0.0412071063439658,2.33192255701003e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,40135,-0.0293771831772352,0.00439131320376635,-0.0379841570566172,-0.0207702092978531,2.34321174059056e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42495,0.0820409749059872,0.0122674492863022,0.057996774304835,0.106085175507139,2.35768986972693e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42679,-0.0414833190724967,0.00620380862959351,-0.0536427839865,-0.0293238541584934,2.37165817540868e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,42679,-0.0169050420896488,0.00253092654625521,-0.021865658120309,-0.0119444260589886,2.49347779878296e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42582,-0.0468113848880288,0.00701185094015428,-0.0605546127307312,-0.0330681570453264,2.55163729854182e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAP2,Microtubule-associated protein 2,40483,-0.0318059741798048,0.00476834610793827,-0.0411519325513638,-0.0224600158082458,2.673343692062e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,42357,-0.0239875183703279,0.00359938143344732,-0.0310423059798846,-0.0169327307607711,2.76435203009846e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCRG1,Scrapie-responsive protein 1,40511,-0.0195783526730125,0.00293836646478495,-0.025337550943991,-0.013819154402034,2.80734232029675e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGAL,Integrin alpha-L,40199,-0.0306059246455748,0.0045941082339599,-0.0396103767841362,-0.0216014725070134,2.83027858551111e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRN,Progranulin,42552,-0.0167749995119025,0.0025203928386732,-0.0217149694757019,-0.011835029548103,2.92942195981742e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42594,-0.0289554348321904,0.00435457374991666,-0.0374903993820271,-0.0204204702823538,3.05632880918533e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGAM,Integrin alpha-M,42611,0.0215738709945972,0.00324865182099019,0.0152065134254564,0.027941228563738,3.23847655888395e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,42569,-0.0602368808675251,0.00907440680839777,-0.0780227182119848,-0.0424510435230655,3.2999210067271e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD93,Complement component C1q receptor,42141,0.0220030215431291,0.00331494312179364,0.0155057330244135,0.0285003100618446,3.31703468609498e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THTPA,Thiamine-triphosphatase,40436,-0.0598403657180702,0.00902508387701612,-0.0775295301170218,-0.0421512013191186,3.49999777708423e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AZU1,Azurocidin,42216,-0.0518975464797722,0.00782833620511334,-0.0672410854417944,-0.0365540075177501,3.50229038654118e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,42190,-0.0821363927096356,0.0124024333184812,-0.106445162013859,-0.0578276234054124,3.6681316184255e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERI1,3'-5' exoribonuclease 1,40302,-0.0234563693420424,0.00354206792138388,-0.0303988224679548,-0.01651391621613,3.70163720060861e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,40511,-0.0413407542315244,0.00624728763140952,-0.053585437989087,-0.0290960704739617,3.82097437134894e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42746,-0.0356033766005934,0.00538374751659304,-0.0461555217331158,-0.0250512314680711,3.90405983777347e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42658,-0.0347479693387296,0.00526066814297038,-0.0450588788989516,-0.0244370597785077,4.1178307652595e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,42346,-0.057132909204106,0.00864989480217713,-0.0740867030163732,-0.0401791153918388,4.12691654441503e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MPO,Myeloperoxidase,42611,-0.031507394361737,0.00477186661418182,-0.0408602529255334,-0.0221545357979406,4.18817796139912e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42681,-0.0184903934144449,0.00280135669251426,-0.0239810525317729,-0.012999734297117,4.25053887743857e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GBP1,Guanylate-binding protein 1,40466,-0.0444099537963487,0.00673806185424235,-0.0576165550306637,-0.0312033525620337,4.56644854701823e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42636,-0.0493885763159805,0.00750197876402298,-0.0640924546934656,-0.0346846979384955,4.76860646738677e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LIPF,Gastric triacylglycerol lipase,40223,-0.0422063807564995,0.00641496780756227,-0.0547797176593215,-0.0296330438536774,4.93881854669196e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BAP18,Chromatin complexes subunit BAP18,40483,-0.0457456549240059,0.0069542417187556,-0.0593759686927668,-0.0321153411552449,4.9758078491669e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,40199,-0.0609186448159533,0.00926229176694302,-0.0790727366791616,-0.0427645529527449,5.01597456386561e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EGF,Pro-epidermal growth factor,42597,-0.0691236527409062,0.0105228755634519,-0.0897484888452719,-0.0484988166365405,5.25614900552221e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHRDL2,Chordin-like protein 2,42636,-0.0318429212076806,0.00484958327913369,-0.0413481044347826,-0.0223377379805785,5.35424687205891e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42545,-0.0191160055864198,0.00291159823916547,-0.0248227381351841,-0.0134092730376555,5.37878417888207e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FIS1,Mitochondrial fission 1 protein,42624,-0.0506639874294531,0.00772070952475091,-0.0657965780979649,-0.0355313967609413,5.50054023453096e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SYAP1,Synapse-associated protein 1,40283,-0.0386302764801812,0.00589023758442303,-0.0501751421456503,-0.0270854108147121,5.68239395048429e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,40482,0.0181139258889746,0.0027620871080141,0.012700235157267,0.0235276166206822,5.68939035169233e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINI2,Serpin I2,40449,-0.0377775544513299,0.00576507972396282,-0.049077110710297,-0.0264779981923628,5.89240950276604e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,40223,-0.0351815180950639,0.00536885772117065,-0.0457044792285584,-0.0246585569615694,5.89509036854159e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,40199,-0.0365459618415024,0.00557882242385082,-0.04748045379225,-0.0256114698907548,5.9768041777274e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GFAP,Glial fibrillary acidic protein,42326,0.0329255937451585,0.00502903071680357,0.0230686935402235,0.0427824939500935,6.08447481925929e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GNAS,Neuroendocrine secretory protein 55,40482,-0.0578524367916061,0.00883955442890173,-0.0751779634722535,-0.0405269101109588,6.21877129194515e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,40449,-0.0330637585796101,0.00505849220066667,-0.0429784032929168,-0.0231491138663035,6.57906550751262e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPAG1,Sperm-associated antigen 1,40482,-0.0384797086795164,0.00589829224315926,-0.0500403614761085,-0.0269190558829243,7.14451990216295e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMED8,Protein TMED8,40449,-0.0682885816726946,0.010470630630729,-0.0888110177089235,-0.0477661456364657,7.23887193855241e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCRL6,Fc receptor-like protein 6,42594,-0.0468254318648619,0.00718315411410913,-0.0609044139285158,-0.032746449801208,7.3417911358817e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BGN,Biglycan,42328,0.0804069011655343,0.0123424819798478,0.0562156364850326,0.104598165846036,7.5517604609384e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCRLB,Fc receptor-like B,42346,-0.0434989946260313,0.00667904596754464,-0.0565899247224188,-0.0304080645296438,7.64676182767134e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,40116,-0.0461667021450366,0.00709698363683054,-0.0600767900732244,-0.0322566142168487,8.1028008457996e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,40283,-0.0549736052290474,0.0084644027787856,-0.0715638346754672,-0.0383833757826276,8.67686199964625e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CST7,Cystatin-F,42642,-0.0625636211538228,0.00963931942842555,-0.0814566872335369,-0.0436705550741088,8.85755964305932e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD200,OX-2 membrane glycoprotein,42594,0.0182537435361959,0.00281389144532937,0.0127385163033503,0.0237689707690414,9.06315101940042e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,40449,-0.0389617546558279,0.00600610271211196,-0.0507337159715673,-0.0271897933400884,9.12179428546134e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD7,T-cell antigen CD7,40166,-0.0298679274496153,0.00460513972348882,-0.0388940013076534,-0.0208418535915773,9.20698923863667e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCRIB,Protein scribble homolog,40223,-0.0604898236128517,0.0093376279820888,-0.0787915744577457,-0.0421880727679576,9.68579965772231e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAX,Protein max,42311,-0.0695293716795956,0.0107435463241077,-0.0905867224748468,-0.0484720208843445,1.0032979502345e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,40449,-0.0340166719201398,0.00526023568311211,-0.0443267338590396,-0.0237066099812401,1.04275016706024e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,42311,-0.0345733118904079,0.00535730466466155,-0.0450736290331445,-0.0240729947476712,1.13146550440299e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,40189,-0.0233065246948661,0.00361780566780166,-0.0303974238037574,-0.0162156255859748,1.22696551211899e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP9,Matrix metalloproteinase-9,42594,-0.0395740628935275,0.00617009183703244,-0.0516674428941111,-0.0274806828929439,1.46650981522529e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,40451,-0.0540191722984186,0.00842643983521475,-0.0705349943754396,-0.0375033502213977,1.50671289780985e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL13,C-C motif chemokine 13,42734,-0.0453113598590322,0.00706979759283339,-0.0591681631409856,-0.0314545565770787,1.51185540138515e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAP3,Cytosol aminopeptidase,42370,-0.0318020735341693,0.00496526209557829,-0.0415339872415028,-0.0220701598268359,1.55565329312375e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,40182,-0.0282437399226766,0.00441616480489663,-0.036899422940274,-0.0195880569050792,1.66482866645003e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DXO,Decapping and exoribonuclease protein,40483,-0.0299630751738102,0.00468612054001411,-0.0391478714322379,-0.0207782789153826,1.67975674431405e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TCTN3,Tectonic-3,40511,-0.0196939455943808,0.00308205670773175,-0.025734776741535,-0.0136531144472266,1.72545853180036e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SWAP70,Switch-associated protein 70,40449,-0.0234066640697132,0.00366757827861713,-0.0305951174958028,-0.0162182106436237,1.81601392129981e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPP1,Osteopontin,42771,0.0309815884886136,0.00485529128283732,0.0214652175742525,0.0404979594029748,1.81653060857556e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL19,Interleukin-19,42261,-0.04746550830145,0.00744170848938178,-0.0620512569406383,-0.0328797596622617,1.85088194141495e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,40223,0.0137995225883002,0.00216465867599333,0.0095567915833533,0.0180422535932472,1.9037220268629e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,40500,-0.0311745969600175,0.00489329108971974,-0.0407654474958682,-0.0215837464241668,1.95241381054482e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ALPP,"Alkaline phosphatase, placental type",42587,-0.065929035168721,0.0103579773926033,-0.0862306708582235,-0.0456273994792185,2.01589952576071e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",40199,-0.0239050161168003,0.0037556132942707,-0.0312660181735709,-0.0165440140600297,2.02870562298989e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB10,Ras-related protein Rab-10,40511,-0.0349489146963094,0.0054932459348565,-0.0457156767286282,-0.0241821526639907,2.06613767468908e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TBC1D23,TBC1 domain family member 23,42587,-0.0582074869704294,0.00915705270091163,-0.0761553102642162,-0.0402596636766426,2.12990778204587e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MGLL,Monoglyceride lipase,42654,-0.0558759637347916,0.00879069235811323,-0.0731057207566935,-0.0386462067128897,2.13385931597839e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42636,-0.044353576500638,0.00697927597975587,-0.0580329574209595,-0.0306741955803165,2.15096653385221e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDCP1,CUB domain-containing protein 1,42495,-0.0352496127092185,0.00556690558095408,-0.0461607476478885,-0.0243384777705486,2.49793458529581e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUSD5,Sushi domain-containing protein 5,40235,0.0227460111735908,0.0035917198665598,0.0157062402351336,0.029785782112048,2.49941845690903e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,40185,-0.0181016046527502,0.00286313699151223,-0.0237133531561142,-0.0124898561493863,2.67696589099947e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,42346,-0.063517252308153,0.0100493573027535,-0.0832139926215499,-0.0438205119947562,2.69085668032337e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FABP3,"Fatty acid-binding protein, heart",40511,-0.0341575021616276,0.00540432438286356,-0.0447499779520402,-0.023565026371215,2.70693835765385e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUSD1,Sushi domain-containing protein 1,42357,-0.0319774370490344,0.00506496592181825,-0.0419047702557982,-0.0220501038422706,2.81636250481149e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNX5,Sorting nexin-5,40223,-0.0188653742031355,0.00299161903315087,-0.0247289475081112,-0.0130018008981598,2.97148660019705e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,40511,0.0208868640768723,0.00331314894970484,0.0143930921354508,0.0273806360182938,3.00404254132859e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42660,-0.0342512072811879,0.00543735563138583,-0.0449084243187041,-0.0235939902436716,3.08412354053945e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FST,Follistatin,42654,0.0317788629414612,0.00504872402205828,0.0218833638582269,0.0416743620246954,3.18094066148896e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CAT,Catalase,40361,-0.0351950345268879,0.00559190898700624,-0.0461551761414202,-0.0242348929123557,3.21148435022974e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42737,-0.0201560877881994,0.00320302313089238,-0.0264340131247485,-0.0138781624516503,3.21326092566414e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,40449,-0.0561036457454364,0.00892111074120069,-0.0735890227981898,-0.0386182686926831,3.31653610839621e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42754,-0.0223497802333472,0.00355479658282867,-0.0293171815356914,-0.015382378931003,3.33113010991412e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPRY2,Protein sprouty homolog 2,42370,-0.0591597830150376,0.0094112556459576,-0.0776058440811145,-0.0407137219489607,3.35877802903752e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCN3,CCN family member 3,42779,-0.0228894383921139,0.00364542589229525,-0.0300344731410126,-0.0157444036432153,3.51247269455975e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MATN3,Matrilin-3,42475,0.0210516587234425,0.00335904422011373,0.0144679320520196,0.0276353853948654,3.79064663772984e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOLR1,Folate receptor alpha,42600,-0.0195032350832379,0.00311520292705755,-0.0256090328202707,-0.0133974373462051,3.95034379452871e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMPD3,AMP deaminase 3,40483,-0.0455986840910565,0.00728474254003266,-0.0598767794695205,-0.0313205887125925,4.00280531999346e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,40116,-0.0236995151238239,0.0037868116746928,-0.0311216660062217,-0.016277364241426,4.03437380290077e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OPTC,Opticin,42587,0.0298037150938252,0.00476348453949869,0.0204672853964077,0.0391401447912426,4.05169417956259e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42495,-0.0233935493470975,0.00374042380535431,-0.030724780005592,-0.0160623186886031,4.11656069716236e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASP7,Caspase-7,40483,-0.0535918209238771,0.00856979226731263,-0.0703886137678099,-0.0367950280799444,4.15664889995147e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZBP1,Z-DNA-binding protein 1,40199,-0.0257443861291102,0.00412353717628327,-0.0338265189946254,-0.017662253263595,4.44283986430886e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",40483,-0.0621821293012713,0.0099604446326598,-0.0817046007812845,-0.0426596578212581,4.4492970980534e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42721,-0.0219221236554209,0.00351398889556701,-0.0288095418907323,-0.0150347054201096,4.54864586079673e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,40182,-0.0413396480878829,0.00663042157054484,-0.0543352743661508,-0.028344021809615,4.68825822271645e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PKD2,Polycystin-2,40116,-0.0373779717313534,0.00599970670264462,-0.0491373968685368,-0.0256185465941699,4.83710804899212e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,42711,-0.0294212109368785,0.00472754878483006,-0.0386872065551454,-0.0201552153186116,5.01008852863709e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TTF2,Transcription termination factor 2,40182,-0.0312932244347792,0.00503256558952363,-0.0411570529902456,-0.0214293958793129,5.21334903294924e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",40511,-0.0464163005367877,0.00747804095555904,-0.0610732608096834,-0.031759340263892,5.58907569286167e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,40511,-0.020823134751286,0.00336468363610846,-0.0274179146780586,-0.0142283548245135,6.27467515633062e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPME1,Protein phosphatase methylesterase 1,42587,-0.0378433687609227,0.00612015498203547,-0.0498388725257123,-0.0258478649961332,6.45584336062363e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42495,-0.0192533773838276,0.00311523216663608,-0.0253592324304343,-0.0131475223372209,6.58073819075219e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,40199,-0.0578253077275282,0.00936011972711744,-0.0761711423926784,-0.039479473062378,6.72814592498917e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB6,Serpin B6,42679,-0.03650855699482,0.0059207288150579,-0.0481131854723335,-0.0249039285173065,7.1935063365853e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,42346,-0.0366848017679721,0.00595414312508134,-0.0483549222931316,-0.0250146812428127,7.42919033972733e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,40511,-0.0570465952649034,0.00926303810339988,-0.0752021499475672,-0.0388910405822396,7.59193788370754e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42602,0.0360605602751054,0.00585769124464836,0.0245794854355946,0.0475416351146162,7.66826130442783e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,40482,-0.053616011850921,0.00872492720482787,-0.0707168691723836,-0.0365151545294584,8.2580328681134e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,40223,-0.03310793934148,0.00539329734107555,-0.0436788021299881,-0.0225370765529719,8.60494657550238e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,40223,-0.0332387185555231,0.00542226518418289,-0.0438663583165216,-0.0226110787945247,9.0859021177668e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",40511,-0.0191386821057195,0.00312243970760056,-0.0252586639326166,-0.0130187002788224,9.11478460326062e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42679,-0.0450236956251887,0.00735113183954977,-0.0594319140307062,-0.0306154772196711,9.33622669042069e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,42357,-0.0340519491802972,0.00556365317993741,-0.0449567094129746,-0.0231471889476199,9.59737731622636e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,40283,-0.0377751674324437,0.0061713567853422,-0.0498710267317144,-0.025679308133173,9.61047349840609e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,40283,-0.0744106854026967,0.0121661374710324,-0.0982563148459202,-0.0505650559594733,9.90545192486199e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42638,-0.0218970579189451,0.0035835493135557,-0.0289208145735142,-0.0148733012643759,1.02102186583765e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AIF1,Allograft inflammatory factor 1,42346,-0.0326226465553607,0.00534145965837534,-0.0430919074857764,-0.0221533856249451,1.04095395288276e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42705,0.0126787392616534,0.00207716132595559,0.00860750306278049,0.0167499754605264,1.06358527354595e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NRGN,Neurogranin,40532,-0.0570528413964893,0.00934674851822508,-0.0753724684922105,-0.0387332143007682,1.06807185933706e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NEXN,Nexilin,40532,-0.0433172160367729,0.00709778070470549,-0.0572288662179957,-0.0294055658555501,1.07547332183931e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYO9B,Unconventional myosin-IXb,42370,-0.041244877188481,0.00675999520706489,-0.0544944677943282,-0.0279952865826339,1.08145838462894e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP8,Neutrophil collagenase,42681,-0.0457143183570252,0.00749520403595749,-0.0604049182675019,-0.0310237184465486,1.09553601273702e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAS2,Growth arrest-specific protein 2,40302,-0.0330911743538121,0.00542653869969661,-0.0437271902052174,-0.0224551585024067,1.10956358536605e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42636,-0.0518055354258533,0.00849718355438646,-0.0684600151924508,-0.0351510556592559,1.11183620442815e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCTN6,Dynactin subunit 6,42311,-0.0448916820931218,0.00736781051885412,-0.0593325907100759,-0.0304507734761678,1.13954306954221e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LEFTY2,Left-right determination factor 2,42689,-0.0311736876445342,0.00511674454486845,-0.0412025069524764,-0.0211448683365921,1.14195202704633e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,40199,-0.0498915760625261,0.00820517913056407,-0.0659737271584317,-0.0338094249666205,1.23785158528343e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,40223,-0.0457412976879437,0.00752452523334319,-0.0604893671452963,-0.030993228230591,1.24964349020397e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LACTB2,Endoribonuclease LACTB2,42636,-0.0404190436826762,0.00666571070665153,-0.0534838366677132,-0.0273542506976392,1.36568342614776e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DSC2,Desmocollin-2,42488,-0.0220734370438018,0.00364037814142123,-0.0292085782009874,-0.0149382958866162,1.36799214281764e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF2,Fibroblast growth factor 2,42594,-0.0423691645501365,0.00700031883853234,-0.0560897894736599,-0.0286485396266132,1.46455855544578e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IST1,IST1 homolog,40375,-0.061310765654122,0.0101314571404699,-0.0811684216494431,-0.0414531096588009,1.48078177953863e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,42311,-0.0237884727138446,0.00393391552483067,-0.0314989471425127,-0.0160779982851765,1.51557610662891e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFNG,Interferon gamma,42370,-0.0700708623915151,0.0116013547573554,-0.0928095177159318,-0.0473322070670984,1.58375748327538e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42676,-0.0678197221211058,0.0112305401806419,-0.089831580875164,-0.0458078633670476,1.5928198846421e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,42794,-0.0142769336995317,0.00237096391380011,-0.0189240229705799,-0.00962984442848348,1.77180308316064e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",40482,-0.0297286008077528,0.00493799977792347,-0.0394070803724828,-0.0200501212430228,1.79425864959926e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC3B,Tetranectin,40269,0.0130303809699068,0.00216525720919956,0.00878647683987561,0.0172742850999379,1.82244638565604e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,40223,-0.0344813316961171,0.00573531482956973,-0.0457225487620738,-0.0232401146301604,1.88923874559904e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,40449,-0.0722821737857091,0.0120283169169128,-0.0958576749428582,-0.0487066726285599,1.92054073097389e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CAPG,Macrophage-capping protein,42461,-0.0361131502781477,0.00601128287954432,-0.0478952647220545,-0.0243310358342408,1.93265263870953e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL17,C-C motif chemokine 17,42604,-0.0564377939216934,0.00940111692555364,-0.0748639830957785,-0.0380116047476083,1.98331277361005e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,40449,-0.0284226565361257,0.00474021126804507,-0.037713470621494,-0.0191318424507573,2.08348816633593e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL12,Stromal cell-derived factor 1,42370,0.0247400302978749,0.00413075387908269,0.0166437526948729,0.032836307900877,2.16330063110442e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BAG6,Large proline-rich protein BAG6,42357,-0.021874875619751,0.00365875301678133,-0.0290460315326424,-0.0147037197068596,2.30637795615737e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PGA4,Pepsin A-4,40532,-0.0497857437144372,0.00833532422033754,-0.0661229791862988,-0.0334485082425756,2.401200562724e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,40182,-0.0422058530212498,0.00706903533568717,-0.0560611622791967,-0.028350543763303,2.43803109903195e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APRT,Adenine phosphoribosyltransferase,42480,-0.0289150369600799,0.00484476715381471,-0.0384107805815568,-0.0194192933386031,2.45841564835846e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL17C,Interleukin-17C,42370,-0.0457009124071693,0.00767647362954457,-0.0607468007210767,-0.0306550240932619,2.69353175327273e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNPEP,Aspartyl aminopeptidase,40483,-0.0349736938933148,0.0058790029086503,-0.0464965395942694,-0.0234508481923602,2.77929103225473e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PROS1,Vitamin K-dependent protein S,40539,-0.0159814860272568,0.002688442545646,-0.0212508334167229,-0.0107121386377906,2.85435138730591e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BPIFA2,BPI fold-containing family A member 2,39838,0.0691511708037598,0.0116394164886626,0.0463379144859811,0.0919644271215385,2.91945663812969e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APCS,Serum amyloid P-component,40419,-0.0208613588355771,0.00351345944520745,-0.0277477393481837,-0.0139749783229705,2.97868148005482e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,40511,-0.0173509054875298,0.0029238437638418,-0.0230816392646597,-0.0116201717103999,3.03785245747392e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB44,Ras-related protein Rab-44,40451,-0.0256446542193497,0.00432460454920978,-0.0341208791358009,-0.0171684293028986,3.11941554159568e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDCD6,Programmed cell death protein 6,42636,0.0429196009334455,0.00724158157512872,0.0287261010461932,0.0571131008206978,3.16408982094448e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GGH,Gamma-glutamyl hydrolase,42437,-0.0208086625435277,0.00351135486781942,-0.0276909180844538,-0.0139264070026016,3.17911454729646e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,40199,-0.0212406654877191,0.00358929382384704,-0.0282756813824593,-0.0142056495929789,3.36034442190606e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL15,Interleukin-15,42594,-0.0201236080446334,0.00340236087946283,-0.0267922353683805,-0.0134549807208862,3.40788787843829e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,40223,-0.025334514835689,0.00428711960097627,-0.0337372692536025,-0.0169317604177755,3.53406047598856e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA7,Thyroxine-binding globulin,40539,-0.0112416845886947,0.00190300138262197,-0.0149715672986337,-0.0075118018787556,3.5764520340782e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,42475,-0.0161487025790332,0.00273719772476961,-0.0215136101195817,-0.0107837950384848,3.72983500826918e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42681,-0.0181805864064522,0.00308542614411293,-0.0242280216489135,-0.0121331511639909,3.89691126942005e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HMOX1,Heme oxygenase 1,42500,0.0292543307572378,0.00496484417811727,0.019523236168128,0.0389854253463477,3.90077446568982e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYZL2,Lysozyme-like protein 2,40080,-0.0218905766316465,0.00371457399193842,-0.0291711416558458,-0.0146100116074472,3.90112569126625e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNX9,Sorting nexin-9,42636,-0.0404231718546952,0.00686507905039442,-0.0538787267934683,-0.0269676169159222,3.99669578499881e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BSG,Basigin,42746,-0.0131015394687443,0.00223054253141066,-0.0174734028303092,-0.00872967610717939,4.36164842763584e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSPN,Persephin,42594,-0.056028279538706,0.00953935727562571,-0.0747254197989324,-0.0373311392784796,4.37120092980112e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,42721,0.0352638701776843,0.00600708462949865,0.023489984303867,0.0470377560515017,4.449882520859e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,42357,-0.0659464672345752,0.0112479137246993,-0.0879923781349859,-0.0439005563341646,4.65489265879176e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,40482,-0.0288485724072171,0.00493071442622707,-0.0385127726826221,-0.019184372131812,5.02833770608594e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HDGF,Hepatoma-derived growth factor,42700,-0.0557381080774084,0.00953280359218357,-0.0744224031180882,-0.0370538130367286,5.12147132998114e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,42346,-0.0339276873563848,0.00580745098703907,-0.0453102912909814,-0.0225450834217882,5.2767654095836e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL2A1,Collagen alpha-1(II) chain,40223,-0.0485877975874026,0.00832165233357338,-0.0648982361612064,-0.0322773590135988,5.40870594610946e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA6,Corticosteroid-binding globulin,40539,0.00944364079083363,0.00161810636478593,0.00627215231585321,0.0126151292658141,5.48562999648181e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BST2,Bone marrow stromal antigen 2,42711,-0.0306247245546416,0.00524986400150793,-0.0409144579975971,-0.0203349911116861,5.55411620354133e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ICAM1,Intercellular adhesion molecule 1,42595,-0.0174734041948466,0.00299708483246136,-0.0233476904664709,-0.0115991179232224,5.66585650531079e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42587,-0.023719304834786,0.00406909165376415,-0.0316947244761637,-0.0157438851934083,5.69967454623125e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42587,-0.0410141165543664,0.00703931872448101,-0.0548111812543492,-0.0272170518543836,5.79262856308309e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,40116,-0.0414071889137838,0.0071071214213442,-0.0553371468996184,-0.0274772309279492,5.83209787459556e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,42587,-0.0334923964776672,0.00575541620770598,-0.0447730122447709,-0.0222117807105635,6.0452503586591e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRLF1,Cytokine receptor-like factor 1,42676,-0.0150275823885846,0.00258437852426432,-0.0200929642961427,-0.00996220048102653,6.20905452424365e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BLVRB,Flavin reductase,42611,-0.0392530935596004,0.00675069555221136,-0.0524844568419347,-0.0260217302772662,6.21350954238736e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPXM1,Probable carboxypeptidase X1,42679,-0.041417632373367,0.00713082247985185,-0.0553940444338766,-0.0274412203128574,6.45509480016232e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANPEP,Aminopeptidase N,42666,0.0165550563744861,0.0028536331876746,0.0109619353266439,0.0221481774223283,6.72425662847461e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MICALL2,MICAL-like protein 2,40182,-0.0410269457258044,0.00707275999954564,-0.0548895553249139,-0.027164336126695,6.78615209698487e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPQ,Carboxypeptidase Q,40516,-0.0212834985205975,0.00367499533785175,-0.0284864893827869,-0.0140805076584081,7.164373204443e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42721,-0.0244252368610049,0.00422336947791705,-0.0327030410377224,-0.0161474326842875,7.48446004874267e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,40511,-0.0577272116467483,0.00998575368060379,-0.0772992888607317,-0.0381551344327648,7.62395636958438e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,40449,-0.0312649512801824,0.00541136431672064,-0.0418712253409549,-0.0206586772194099,7.77609118775129e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,40255,0.0288542591259568,0.00499539090341548,0.0190632929552624,0.0386452252966511,7.84769953008208e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOA2,Apolipoprotein A-II,40532,0.0293003941692744,0.00507450224077934,0.0193543697773469,0.0392464185612019,7.94231951411071e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,42754,-0.0360374745953341,0.0062448425594084,-0.0482773660117746,-0.0237975831788937,8.06408673042803e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD86,T-lymphocyte activation antigen CD86,40449,0.0180516378687449,0.00312913576997133,0.011918531759601,0.0241847439778887,8.18985415241443e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,40483,-0.0226754352851589,0.00393566560651752,-0.0303893398739333,-0.0149615306963846,8.55364107448325e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIFBP,KIF-binding protein,42587,-0.0479785307785724,0.00835847842414509,-0.0643611484898968,-0.031595913067248,9.6669762993337e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,40116,-0.0404811092227277,0.00706054234967888,-0.0543197722280983,-0.026642446217357,1.01030570972597e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42667,-0.0650792845104707,0.0113530936222173,-0.0873313480100166,-0.0428272210109248,1.01204108915211e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CALB1,Calbindin,42587,-0.0268867642321216,0.00469067664133835,-0.0360804904491448,-0.0176930380150984,1.01417566188708e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAL,Galanin peptides,42676,0.0378113995240941,0.00660977692614747,0.024856236748845,0.0507665622993431,1.08451053984071e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42721,-0.0359249082488675,0.00628288121449446,-0.0482393554292767,-0.0236104610684584,1.10125832416435e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LGMN,Legumain,42676,-0.0209485832309483,0.0036652120476452,-0.0281323988443329,-0.0137647676175637,1.11686388327375e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,40302,-0.061661815432088,0.0108069346357786,-0.0828434073182141,-0.0404802235459619,1.18784652059664e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,42721,0.0347734672229458,0.00610017060205801,0.0228171328429121,0.0467298016029795,1.22016341256743e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DPEP2,Dipeptidase 2,42587,0.017270368661088,0.00303525145992429,0.0113212757996364,0.0232194615225396,1.29752996510443e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP3,Stromelysin-1,42611,0.029475019546557,0.0051851742410893,0.019312078034022,0.0396379610590921,1.33943878767156e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBM17,Splicing factor 45,40482,-0.0445750531935234,0.00784231932065162,-0.0599459990620006,-0.0292041073250463,1.3491095741818e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FN1,Fibronectin,40539,-0.0155766405804787,0.00274094696747388,-0.0209488966367275,-0.0102043845242299,1.35660447027613e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,42311,-0.0366687654587185,0.00645961202057666,-0.0493296050190488,-0.0240079258983883,1.40293190655817e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42679,-0.0483477599591983,0.00854474295414091,-0.0650954561493145,-0.0316000637690821,1.56092411207561e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACHE,Acetylcholinesterase,40283,-0.0193536695413142,0.00343438171958461,-0.0260850577117001,-0.0126222813709284,1.79048107125641e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,40302,-0.0427774632792425,0.0075914236891655,-0.0576566537100069,-0.0278982728484782,1.79349652365399e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BLNK,B-cell linker protein,40199,-0.0236797611979238,0.00420334074069115,-0.0319183090496784,-0.0154412133461691,1.80864589844892e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,40332,-0.0329475338227897,0.00587011461637552,-0.0444529584708858,-0.0214421091746937,2.03887880271645e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,42346,-0.0292181238555867,0.00521126699528917,-0.0394322071663534,-0.0190040405448199,2.10345992133024e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",42370,-0.0411154467974316,0.00733622853406626,-0.0554944547242014,-0.0267364388706617,2.13122171892819e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,40511,-0.0404351747203724,0.00721458103800757,-0.0545757535548672,-0.0262945958858775,2.13562737935611e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,40116,-0.0215827617864295,0.00385654831181137,-0.0291415964775797,-0.0140239270952792,2.24133237844968e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLG,Plasminogen,40285,-0.0123519852768017,0.0022072316224339,-0.0166781592567721,-0.00802581129683127,2.24374016136457e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HEPACAM2,HEPACAM family member 2,40483,0.0242524651262085,0.00433995653832189,0.0157461503110976,0.0327587799413194,2.34779505454955e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HMBS,Porphobilinogen deaminase,42721,-0.0247311653111545,0.00443229083591064,-0.0334184553495394,-0.0160438752727696,2.45461241609847e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42594,-0.0862202957475995,0.0154702987467006,-0.116542081291133,-0.0558985102040664,2.54812874666767e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BIN2,Bridging integrator 2,42611,-0.0514547287100601,0.00924576552985311,-0.0695764291485722,-0.033333028271548,2.66838302574717e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYL4,Myosin light chain 4,40223,-0.0299322771882877,0.00538037766231322,-0.0404778174064216,-0.0193867369701538,2.71003394784944e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GMFG,Glia maturation factor gamma,40511,-0.0408188179183391,0.00733869119432016,-0.0552026526592067,-0.0264349831774716,2.72539432102955e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMOTL2,Angiomotin-like protein 2,40404,-0.0276455973664004,0.00497162595405111,-0.0373899842363405,-0.0179012104964602,2.74887263366351e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,40482,-0.0459384426029175,0.00827474279567503,-0.0621569384824405,-0.0297199467233944,2.89387134567934e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMEM106A,Transmembrane protein 106A,40451,-0.0399343127125481,0.0072033031018624,-0.0540527867921984,-0.0258158386328978,3.02493277743339e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTF1,Cardiotrophin-1,42357,-0.047771222015019,0.00863234047783925,-0.0646906093515839,-0.0308518346784541,3.1902306824147e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,40136,-0.0561208289118634,0.0101793575419086,-0.0760723696940042,-0.0361692881297226,3.60364412668358e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TBC1D17,TBC1 domain family member 17,42311,-0.0257251633056556,0.00466700532257748,-0.0348724937379075,-0.0165778328734038,3.6120194103852e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42611,-0.0304936570353074,0.00554956587777184,-0.0413708061557402,-0.0196165079148746,3.98325352718355e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB9,Serpin B9,42495,-0.0184423420193077,0.00336260408253394,-0.0250330460210742,-0.0118516380175412,4.2211260509456e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NID2,Nidogen-2,42611,-0.0415957298991478,0.00758607140577949,-0.0564644298544755,-0.02672702994382,4.25322615637913e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,40302,-0.0386974218325421,0.00705828611291197,-0.0525316626138495,-0.0248631810512346,4.2840072273812e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SOD3,Extracellular superoxide dismutase,40532,0.0330879218190394,0.00603601102267276,0.0212573402146008,0.044918503423478,4.30147119801104e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYOC,Myocilin,42611,0.0251635333189658,0.00459336985320852,0.0161605284066771,0.0341665382312545,4.37344632001314e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,40483,-0.021819582176591,0.0039864068225179,-0.0296329395487261,-0.0140062248044559,4.50673968181926e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANXA10,Annexin A10,42311,-0.0485581247674775,0.00888715879182407,-0.0659769559994527,-0.0311392935355024,4.7441211451553e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRADD,Death domain-containing protein CRADD,42476,-0.0417323419545766,0.00764211270312326,-0.0567108828526982,-0.026753801056455,4.82411857384197e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GZMH,Granzyme H,42357,-0.0435388111669855,0.00800031728416782,-0.0592194330439544,-0.0278581892900165,5.35880361598452e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,42587,0.0370188602212264,0.00680709059248081,0.023676962659964,0.0503607577824888,5.47413731379326e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC51B,Organic solute transporter subunit beta,40116,-0.0431862683647294,0.00795645951538724,-0.0587809290148884,-0.0275916077145705,5.82649641178648e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD84,SLAM family member 5,42594,-0.0174119548840121,0.00321067513036363,-0.0237048781395248,-0.0111190316284994,5.95753229714407e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLGN,Calmegin,40182,-0.0259811775440704,0.00479080898022517,-0.0353711631453117,-0.0165911919428291,5.98052026322485e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFB,Complement factor B,40344,-0.0180545685446083,0.00333340583102215,-0.0245880439734117,-0.0115210931158049,6.21251877553918e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,40451,-0.0598804303335522,0.0110605104711591,-0.0815590308570241,-0.0382018298100803,6.29351885011791e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42664,-0.0658318846168611,0.0121618422196786,-0.0896690953674312,-0.0419946738662911,6.30438664805634e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC1,Sialoadhesin,42676,-0.0240570443187516,0.00444493737016839,-0.0327691215642816,-0.0153449670732215,6.33075749809094e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DMD,Dystrophin,40223,-0.0285803820913076,0.005305610284107,-0.0389793782481574,-0.0181813859344579,7.31883985248668e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STX16,Syntaxin-16,42346,-0.0319143637282362,0.00593832234987708,-0.0435534755339953,-0.0202752519224771,7.81896048003217e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BAX,Apoptosis regulator BAX,42292,-0.0490087212342543,0.00913374459906066,-0.0669108606484132,-0.0311065818200955,8.20191774000853e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,40302,-0.0385730967947677,0.00719000026286186,-0.0526654973099769,-0.0244806962795585,8.2655086956998e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,40116,-0.021617435270428,0.00403322839484084,-0.0295225629243161,-0.01371230761654,8.49941302467542e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,40482,-0.0199767685307411,0.00372850699662034,-0.027284642244117,-0.0126688948173652,8.58757523417732e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCDH9,Protocadherin-9,40449,-0.0189989750003345,0.00354756237270257,-0.0259521972508315,-0.0120457527498375,8.69992834976122e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LTA,Lymphotoxin-alpha,42594,-0.022397292607866,0.00418371302893187,-0.0305973701445725,-0.0141972150711595,8.77165669501673e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD300A,CMRF35-like molecule 8,40283,-0.0172038089329691,0.00321672298481013,-0.023508585983197,-0.0108990318827413,9.05788342155354e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,40223,-0.0130834075467821,0.00244796610522292,-0.017881421113019,-0.00828539398054517,9.2421774137465e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GFRAL,GDNF family receptor alpha-like,40109,0.0346439595817169,0.0064825836050914,0.0219380957157378,0.0473498234476961,9.26670058335048e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,40329,-0.0305740067801322,0.00574999547525463,-0.0418439979116313,-0.0193040156486331,1.0740202836828e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSDE1,Cold shock domain-containing protein E1,40116,-0.0637226403263445,0.0120137898439754,-0.0872696684205364,-0.0401756122321527,1.15427445130678e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,40283,-0.046970222208756,0.00886131667108165,-0.0643384028840761,-0.029602041533436,1.17643752529292e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANXA3,Annexin A3,42681,-0.0376356629217708,0.00711205468163448,-0.0515752900977744,-0.0236960357457672,1.23006307264252e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD101,Immunoglobulin superfamily member 2,40449,-0.0237254721794971,0.00448961608168359,-0.0325251196995969,-0.0149258246593972,1.28389212970946e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,40483,-0.0265657067211939,0.00502875607215252,-0.0364220686226128,-0.016709344819775,1.29620562624747e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASP3,Caspase-3,42794,-0.0469033932897133,0.00888291457420041,-0.0643139058551461,-0.0294928807242804,1.31043609839152e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFNL1,Interferon lambda-1,42311,-0.0248534679626538,0.00471734106993246,-0.0340994564597215,-0.0156074794655862,1.39695124629227e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSC,Dipeptidyl peptidase 1,42616,-0.0238380840726431,0.0045284627369829,-0.0327138710371295,-0.0149622971081566,1.43083484380142e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA1,Carbonic anhydrase 1,42362,-0.0325307889469299,0.00618606074611273,-0.0446554680093109,-0.020406109884549,1.47328850358768e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCL2L1,Bcl-2-like protein 1,40483,-0.0534452324587862,0.0101663502739714,-0.0733712789957702,-0.0335191859218022,1.49039486954908e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HPCAL1,Hippocalcin-like protein 1,42754,-0.038897580980316,0.00741646624188216,-0.053433854814405,-0.024361307146227,1.58840348161259e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSPB1,Heat shock protein beta-1,42448,-0.036342115841974,0.00693607446276518,-0.0499368217889938,-0.0227474098949542,1.63410322269814e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UNC79,Protein unc-79 homolog,40080,-0.0299674414365279,0.00573091319099508,-0.0412000312908782,-0.0187348515821775,1.73509197498055e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,42636,0.0213881831218256,0.00409967511401838,0.0133528198983496,0.0294235463453016,1.84504217336366e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,40451,-0.0504352630283247,0.0096703352773919,-0.0693891201720128,-0.0314814058846365,1.86614760222076e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDIA4,Protein disulfide-isomerase A4,40527,-0.032010370638701,0.00614521700405205,-0.044054995966643,-0.019965745310759,1.93203351562008e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",40511,-0.0477259802224554,0.00917806803499701,-0.0657149935710496,-0.0297369668738613,2.02763566076406e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,42370,-0.023062142205053,0.00444442234325179,-0.0317732099978266,-0.0143510744122795,2.14557665781273e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,42346,-0.0401196483251904,0.00774105972531861,-0.0552921253868149,-0.024947171263566,2.21926577124291e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA11,Serpin A11,42794,0.0217738649819458,0.00420228689276267,0.0135373826721309,0.0300103472917606,2.23338413186779e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RSPO3,R-spondin-3,42721,-0.015812643903633,0.00305422335117559,-0.0217989216719371,-0.00982636613532883,2.28342614438451e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK11,Kallikrein-11,42543,-0.0174131223956235,0.00336372061284829,-0.0240060147968061,-0.0108202299944408,2.29070576895413e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,40182,-0.0258088966023524,0.00498888580223345,-0.03558711277473,-0.0160306804299748,2.3407499168931e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42794,0.0168528046937638,0.00325836405697829,0.0104664111420863,0.0232391982454412,2.34681234346246e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,40482,-0.0351328960449595,0.00681790232516995,-0.0484959846022927,-0.0217698074876264,2.6063188217975e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",42357,-0.0488793893395266,0.00948829527124229,-0.0674764480711615,-0.0302823306078917,2.62082108661851e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSV,Cathepsin L2,42677,0.0221429407477442,0.00429878825177483,0.0137173157742656,0.0305685657212229,2.62793656386845e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TXN,Thioredoxin,40384,-0.0236387969800096,0.00459040515643367,-0.0326359910866196,-0.0146416028733996,2.65464771747778e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OBP2B,Odorant-binding protein 2b,42462,0.0324315139295082,0.00630071237736127,0.0200821176698802,0.0447809101891363,2.68072046785134e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLAMF8,SLAM family member 8,42346,-0.0292703673268239,0.00569099941674686,-0.0404247261836477,-0.01811600847,2.73873406687994e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,40527,-0.0123154205001476,0.00239642788099431,-0.0170124191468965,-0.00761842185339877,2.80691496269745e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,42346,-0.0199755242697547,0.00390265072068963,-0.0276247196823064,-0.012326328857203,3.12402395212661e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,42311,-0.0383553572380124,0.00750543500450042,-0.0530660098468332,-0.0236447046291915,3.26093336740374e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCRL2,Fc receptor-like protein 2,42681,-0.0276203799098923,0.00540589510014716,-0.0382159343061807,-0.0170248255136039,3.27759037117485e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,40182,-0.0329351068125237,0.00644620466873924,-0.0455696679632526,-0.0203005456617948,3.28914401188805e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42679,0.023497664410662,0.00461036685404569,0.0144613453767324,0.0325339834445915,3.50299485754427e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",40482,-0.0248639465016451,0.00488025538571558,-0.0344292470576476,-0.0152986459456426,3.5474306605724e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPHB4,Ephrin type-B receptor 4,42794,-0.01380465470612,0.00271334323870896,-0.0191228074539896,-0.00848650195825045,3.67277174974829e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLSTN2,Calsyntenin-2,42754,0.0207072647494565,0.00407313526204711,0.0127239196358441,0.0286906098630688,3.74761685858237e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,40449,-0.0214132864151035,0.00421206430505264,-0.0296689324530067,-0.0131576403772003,3.75906363004929e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DPT,Dermatopontin,42794,-0.013204468663297,0.00259849195014826,-0.0182975128855876,-0.00811142444100641,3.79254587364602e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD48,CD48 antigen,42654,-0.0161937048063352,0.00319205662149445,-0.0224501357844643,-0.00993727382820605,3.96544537382735e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,42565,-0.0225423941149022,0.00444471906268071,-0.0312540434777564,-0.013830744752048,3.99504087025113e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RCOR1,REST corepressor 1,42357,-0.0231227072556543,0.00456588860535871,-0.0320718489221574,-0.0141735655891512,4.1560185220232e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42618,-0.0272207995798775,0.00537750599821719,-0.0377607113363832,-0.0166808878233718,4.20428986000165e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,42346,-0.0437565018031257,0.00864957812354917,-0.0607096749252821,-0.0268033286809694,4.27586443937928e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRYBB1,Beta-crystallin B1,40511,-0.0331232715604734,0.00655664337509841,-0.0459742925756662,-0.0202722505452805,4.44342768183957e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NRCAM,Neuronal cell adhesion molecule,42636,-0.0150921091699203,0.002988835762926,-0.0209502272652553,-0.00923399107458537,4.48781663089604e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,40449,0.0265776093616964,0.00526667871943817,0.0162549190715976,0.0369002996517952,4.57315201341551e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCN5,CCN family member 5,42611,-0.0200138035790853,0.00396738043138257,-0.0277898692245951,-0.0122377379335754,4.60437330611082e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TREML2,Trem-like transcript 2 protein,42611,-0.0180089221489785,0.00357107375199912,-0.0250082267028968,-0.0110096175950603,4.64273402976085e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,40482,0.0232514868251505,0.00461487180360778,0.0142063380900792,0.0322966355602217,4.76749393382635e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCTD,Deoxycytidylate deaminase,40283,-0.0487292371423304,0.00967325218688914,-0.0676888114286331,-0.0297696628560277,4.79018279680435e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,42495,0.0188228949031465,0.00373790396795913,0.0114966031259466,0.0261491866803464,4.82385702945485e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42676,0.0107353049637228,0.00213272521951671,0.00655516353347006,0.0149154463939756,4.87538333418483e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLMP,CXADR-like membrane protein,42721,-0.0113336203985188,0.00225634723578086,-0.0157560609806493,-0.00691117981638835,5.15204751293454e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,40283,-0.0168837252181485,0.00336152046550042,-0.0234723053305293,-0.0102951451057676,5.17578505390866e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,42346,-0.0380153655834103,0.00757723829405559,-0.0528667526397593,-0.0231639785270614,5.31565175902831e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,40302,-0.0197202905958058,0.00393336541448429,-0.0274296868081951,-0.0120108943834166,5.42474161204773e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,42458,-0.0178539405580645,0.00356238388603545,-0.024836212974694,-0.010871668141435,5.4619535823712e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIF22,Kinesin-like protein KIF22,40116,-0.0644617583808517,0.0128735895617758,-0.0896939939219323,-0.0392295228397712,5.60646957165671e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100A12,Protein S100-A12,42434,-0.0385462956305917,0.00773309521834017,-0.0537031622585385,-0.023389429002645,6.28790395662842e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100G,Protein S100-G,40482,0.024814416582851,0.0049778863634032,0.0150577593105807,0.0345710738551212,6.29044885422976e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,40283,-0.0637733841802403,0.0127965990868948,-0.0888547183905541,-0.0386920499699265,6.33480173422026e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,40532,-0.0208688804498854,0.00419952058577652,-0.0290999407980074,-0.0126378201017634,6.81593528374228e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BDNF,Brain-derived neurotrophic factor,40527,-0.042812478705712,0.00861709472319558,-0.0597019843631753,-0.0259229730482487,6.85215750343869e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAGED1,Melanoma-associated antigen D1,42346,-0.0246298081909723,0.0049609345567319,-0.0343532399221668,-0.0149063764597778,6.96512445993888e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,40451,-0.0282063674745205,0.00568332601714614,-0.039345686468127,-0.0170670484809141,7.04272404053522e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HMOX2,Heme oxygenase 2,42311,-0.0232783689571156,0.00469478657084948,-0.0324801506359805,-0.0140765872782506,7.1985496634312e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCN4B,Sodium channel subunit beta-4,40223,-0.0224946517501382,0.00453784787240265,-0.0313888335800474,-0.013600469920229,7.26102330203038e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADA2,Adenosine deaminase 2,42572,-0.0226298479585696,0.00456802902802591,-0.0315831848535004,-0.0136765110636389,7.36054016901261e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42636,0.0168096648091417,0.00340123694903827,0.0101432403890267,0.0234760892292567,7.81681578363984e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNR,Tenascin-R,42495,0.0214822935834082,0.0043505090773786,0.0129552957917461,0.0300092913750702,7.99346424357916e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPA33,Cell surface A33 antigen,42587,-0.0705131200446362,0.0142876546779182,-0.0985169232133559,-0.0425093168759166,8.10116741056367e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRUNE2,Protein prune homolog 2,40302,-0.015306182077888,0.0031023181375681,-0.0213867256275214,-0.0092256385282545,8.18189842972857e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,40283,-0.0192035281715256,0.00389246488321253,-0.0268327593426222,-0.0115742970004291,8.19361420025282e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42587,-0.0276232101545125,0.00560597414769304,-0.0386109194839909,-0.0166355008250342,8.43014962092312e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,40223,-0.0230577634354967,0.00470126113005207,-0.0322722352503987,-0.0138432916205946,9.4958218715092e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,40302,-0.0384536760897651,0.00784460372903217,-0.0538290993986681,-0.023078252780862,9.62428123356937e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPTX1,Neuronal pentraxin-1,42611,0.020187235177999,0.00411943646252149,0.0121131397114569,0.0282613306445412,9.67172303018437e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PKN3,Serine/threonine-protein kinase N3,40302,-0.0376985805673439,0.00769843183175441,-0.0527875069575825,-0.0226096541771052,9.8723003559162e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP170,Centrosomal protein of 170 kDa,40223,-0.0387904297232149,0.00793593258643959,-0.0543448575926365,-0.0232360018537933,1.03327223729819e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42594,-0.0434788840330012,0.0089003640384779,-0.0609235975484179,-0.0260341705175845,1.04587751294367e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BMP6,Bone morphogenetic protein 6,42342,-0.020377802251789,0.00417627450139566,-0.0285633002745245,-0.0121923042290535,1.07645040433206e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMS,Spermine synthase,40136,-0.0319910412670397,0.00657495082786014,-0.0448779448896455,-0.0191041376444338,1.1570507558875e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,42346,-0.0331562141060618,0.00681904427266552,-0.0465215408804862,-0.0197908873316373,1.1737329914506e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,40451,-0.0275769459315791,0.00567799436910458,-0.0387058148950241,-0.0164480769681341,1.20896965293643e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STX6,Syntaxin-6,42346,-0.032971535155769,0.0067914484311937,-0.0462827740809086,-0.0196602962306293,1.21856165019276e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42636,0.0394447422682541,0.00813119253819937,0.0235076048933833,0.0553818796431249,1.2419245667988e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COMMD9,COMM domain-containing protein 9,40451,-0.0198665091796444,0.00409640349035553,-0.0278954600207413,-0.0118375583385476,1.25275351286472e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATXN10,Ataxin-10,42311,-0.0360486851483438,0.0074358522103222,-0.0506229554805753,-0.0214744148161123,1.26169686972657e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CST5,Cystatin-D,42357,-0.0283664124668807,0.00585131695747427,-0.0398349937035302,-0.0168978312302311,1.26220575817941e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,40223,-0.0303551807955586,0.00626207167299429,-0.0426288412746274,-0.0180815203164898,1.26753692592333e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EDF1,Endothelial differentiation-related factor 1,40482,-0.0334277428261586,0.00689755253198988,-0.0469469457888588,-0.0199085398634584,1.2744710828095e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,40166,-0.027971704991563,0.00578190014121746,-0.0393042292683492,-0.0166391807147767,1.33066761098783e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMTN,Smoothelin,40460,-0.0457550448407879,0.00947127083218456,-0.0643187356718697,-0.0271913540097062,1.37687184590189e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSPAN1,Tetraspanin-1,42357,-0.0337955216839439,0.00699940405767015,-0.0475143536369774,-0.0200766897309104,1.39221949612874e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,40449,-0.0106980429409996,0.00221948315514046,-0.0150482299250749,-0.00634785595692425,1.45390826840246e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRG2,Bone marrow proteoglycan,40527,0.0262037286179063,0.00544184628313185,0.0155377099029679,0.0368697473328447,1.48933563442948e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,40182,-0.0301006846581672,0.00626496000378783,-0.0423800062655913,-0.017821363050743,1.5710485465996e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,42439,0.0294885841739291,0.00614524821706078,0.0174438976684899,0.0415332706793682,1.61522232267202e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CREG1,Protein CREG1,42445,-0.0189432031761844,0.00394868126594426,-0.0266826184574351,-0.0112037878949336,1.62530658195974e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,40302,-0.0334228928626841,0.00696712348783637,-0.0470784548988434,-0.0197673308265248,1.62967183309597e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VEGFB,Vascular endothelial growth factor B,40199,-0.0146424113170026,0.00305234497851013,-0.0206250074748825,-0.00865981515912274,1.63090388371111e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNPY4,Protein canopy homolog 4,42587,-0.036304022899194,0.00757786690231859,-0.0511566420277385,-0.0214514037706496,1.67901067111918e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UROS,Uroporphyrinogen-III synthase,40182,-0.0334998992168157,0.00700080810989146,-0.0472214831122029,-0.0197783153214284,1.73086546051729e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,40199,-0.0425290292652666,0.00890543564195846,-0.0599836831235051,-0.025074375407028,1.81460282688304e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,40449,0.0346749018819811,0.00726903435208234,0.0204275945518997,0.0489222092120625,1.86334602742386e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NT5E,5'-nucleotidase,42679,-0.0276903681252363,0.00580822406684105,-0.0390744872962447,-0.0163062489542278,1.88529751054318e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNX2,Sorting nexin-2,40451,-0.0403129317911704,0.00846114377050652,-0.0568967735813632,-0.0237290900009777,1.91709574071485e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EDN1,Endothelin-1,40223,-0.0149478910502741,0.00313816222443849,-0.0210986890101736,-0.0087970930903747,1.92915189033659e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANXA11,Annexin A11,42570,-0.0323905226147184,0.00681226717413451,-0.045742566276022,-0.0190384789534147,2.0077905483538e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,40511,0.0181185353246248,0.00381396854905057,0.0106431569684857,0.0255939136807639,2.05334330176787e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TST,Thiosulfate sulfurtransferase,42277,-0.0363520225325055,0.00765891371617084,-0.0513634934162003,-0.0213405516488106,2.09294761049612e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFP,Properdin,40539,-0.0108932799117726,0.00229552394311141,-0.015392506840271,-0.00639405298327423,2.10589805907124e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,42370,-0.0320039675135502,0.00675331842518831,-0.0452404716269193,-0.0187674634001811,2.17021420887947e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DKK3,Dickkopf-related protein 3,42794,0.0146687346871706,0.00310263624485694,0.00858756764725099,0.0207499017270902,2.2920935853503e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42711,-0.0278881833678834,0.00590113545098533,-0.0394544088518146,-0.0163219578839521,2.31405790995932e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYOM3,Myomesin-3,40283,0.045095372265146,0.00956289627450079,0.0263520955671245,0.0638386489631676,2.43865407921468e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42689,-0.0209610946458977,0.00444756520683119,-0.0296783224512868,-0.0122438668405085,2.46610488006641e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KEL,Kell blood group glycoprotein,42311,-0.017598283182661,0.00373529251567207,-0.0249194565133782,-0.0102771098519437,2.48602711842533e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AKAP12,A-kinase anchor protein 12,40283,0.0107206463614722,0.0022771599842961,0.00625741279225182,0.0151838799306925,2.53311409745002e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,40482,-0.0199313657858446,0.00424034173183291,-0.0282424355802371,-0.011620295991452,2.62704252080725e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PADI4,Protein-arginine deiminase type-4,42292,-0.0347514013960965,0.00740179161881387,-0.0492589129689717,-0.0202438898232213,2.69312402776187e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,40116,-0.0265662994182095,0.00566211889597722,-0.0376640524543248,-0.0154685463820941,2.73917617266767e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",40483,-0.0507743604498393,0.0108280519867197,-0.0719973423438098,-0.0295513785558687,2.7755687970927e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CERT,Ceramide transfer protein,42311,-0.0294003010421617,0.00627487035670406,-0.0416990469413016,-0.0171015551430217,2.82215933391924e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MESD,LRP chaperone MESD,42611,-0.0576528381736633,0.0123154346831482,-0.0817910901526338,-0.0335145861946927,2.87784235621539e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ELOB,Elongin-B,40116,-0.0193585407708482,0.00413677922173679,-0.0274666280454523,-0.0112504534962441,2.90866172610437e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,40283,0.0134848545649674,0.00288190962262302,0.00783631170462624,0.0191333974253085,2.91491313830704e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PEPD,Xaa-Pro dipeptidase,40532,0.0127581676531973,0.0027317468027387,0.00740394391982943,0.0181123913865651,3.04166054024088e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,42587,-0.0152871891763565,0.00327849048512215,-0.0217130305271959,-0.00886134782551705,3.14834913233147e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA4,Carbonic anhydrase 4,42794,0.0115409692840224,0.00247829333092949,0.00668351435540058,0.0163984242126442,3.24167881829773e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PARD3,Partitioning defective 3 homolog,40302,-0.0356312028785132,0.0076511819904401,-0.0506275195797758,-0.0206348861772506,3.24643910279434e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",40483,0.0288391235415883,0.00619366323050997,0.0166995436097888,0.0409787034733878,3.25723995853084e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,40482,-0.0155937703430231,0.00335584201505537,-0.0221712206925316,-0.00901631999351453,3.41015447578585e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSNK1D,Casein kinase I isoform delta,40199,-0.0300870174421053,0.00648043097950219,-0.0427886621619296,-0.017385372722281,3.47780737998244e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCDH7,Protocadherin-7,40449,-0.0173498436750717,0.00373722768161267,-0.0246748099310325,-0.0100248774191109,3.48217548304358e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42594,-0.0385606667463112,0.00832499795588165,-0.0548776627398392,-0.0222436707527831,3.65711178260495e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",42292,-0.0223523626306919,0.00482667782412655,-0.03181265116598,-0.0128920740954039,3.67397929420968e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,40451,-0.0207048904140447,0.00447250774540946,-0.0294710055950472,-0.0119387752330422,3.70883139589782e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,40451,-0.0280774614210316,0.00606980009472327,-0.0399742696066892,-0.016180653235374,3.77382129224664e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,40449,-0.0450639753348193,0.00975177099631791,-0.0641774464876024,-0.0259505041820362,3.85938648832224e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PMVK,Phosphomevalonate kinase,42303,-0.0512203118855123,0.0110882191251126,-0.072953221370733,-0.0294874024002916,3.88617105084839e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,42311,-0.0344886682828523,0.00747792317829383,-0.0491453977123082,-0.0198319388533964,4.02457766302392e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EHD3,EH domain-containing protein 3,40223,-0.0555335851228432,0.0120547640596894,-0.0791609226798345,-0.0319062475658519,4.13543897357049e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DBN1,Drebrin,40199,-0.0236955073773061,0.00514553234331175,-0.0337807507701971,-0.013610263984415,4.16961434634673e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42587,-0.021573635209554,0.00468742184655992,-0.0307609820288114,-0.0123862883902966,4.21380675976384e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,40283,-0.0334122765741537,0.00726981145882821,-0.047661107033457,-0.0191634461148504,4.35370427187941e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,40080,-0.0197841848762304,0.00431900832254925,-0.0282494411884269,-0.0113189285640339,4.68515247676756e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F3,Tissue factor,42636,0.0128305869241877,0.00280358866317248,0.00733555314436965,0.0183256207040058,4.7708350002562e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42587,-0.0435683753328599,0.00954200747661303,-0.0622707099870214,-0.0248660406786984,5.01655307598441e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DLL1,Delta-like protein 1,42679,-0.0147756656973859,0.00323608543922094,-0.0211183931582589,-0.00843293823651284,5.01738866284326e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,40199,-0.0189488370223208,0.00415297622480427,-0.0270886704229372,-0.0108090036217045,5.1043288898153e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LGALS7_LGALS7B,Galectin-7,42524,-0.0202825581047119,0.00444891966779497,-0.02900244065359,-0.0115626755558337,5.18588238933053e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,40116,-0.0214397553890094,0.00471427152729902,-0.0306797275825155,-0.0121997831955033,5.47826972522044e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDK1,Cyclin-dependent kinase 1,40080,-0.0172851491887372,0.00380874187987463,-0.0247502832732914,-0.00982001510418289,5.73217697043504e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",42495,-0.0273472838343074,0.00603230088459898,-0.0391705935681214,-0.0155239741004934,5.85275818524e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LPA,Apolipoprotein(a),40324,0.0850381575623459,0.0187618938921455,0.0482648455337407,0.121811469590951,5.88994015868135e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PMM2,Phosphomannomutase 2,40116,-0.0278117651525028,0.00619148045136023,-0.0399470668371689,-0.0156764634678368,7.13015465226177e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AGT,Angiotensinogen,40532,-0.0110759478281457,0.00246882245068635,-0.015914839831491,-0.0062370558248005,7.31741835722296e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL6,Interleukin-6,42587,-0.0354192635040713,0.00790996732156076,-0.0509227994543304,-0.0199157275538122,7.60390418599668e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,42311,-0.0508795115440625,0.0113682086030487,-0.073161200406038,-0.028597822682087,7.68402849519956e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C7orf50,Uncharacterized protein C7orf50,40483,-0.0104674317348641,0.00234159298141134,-0.0150569539784303,-0.00587790949129783,7.89015449134285e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRYM,Ketimine reductase mu-crystallin,40136,-0.0349159998908962,0.0078202386702485,-0.0502436676845833,-0.0195883320972092,8.09364065578979e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,40302,-0.0160452593812947,0.00359433848978354,-0.0230901628212704,-0.00900035594131897,8.12223907188695e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,40428,-0.0190373026942638,0.00426665063698585,-0.0273999379427561,-0.0106746674457715,8.20321691829392e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TBC1D5,TBC1 domain family member 5,42594,-0.0357472473850338,0.0080157861580143,-0.0514581882547418,-0.0200363065153258,8.27783204388773e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,40457,-0.0174083231434595,0.00390564279223434,-0.0250633830162388,-0.00975326327068018,8.38302411850393e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FRMD4B,FERM domain-containing protein 4B,40116,-0.032045596650254,0.00722588419356676,-0.0462083296696448,-0.0178828636308631,9.30439228646133e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SATB1,DNA-binding protein SATB1,40482,-0.0133973552445906,0.00302229935732869,-0.0193210619849549,-0.00747364850422642,9.38798545066471e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANXA1,Annexin A1,40235,-0.0190223097113588,0.00429139930823874,-0.0274334523555067,-0.0106111670672108,9.39762697368198e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCARF2,Scavenger receptor class F member 2,42711,0.0137744721708918,0.00311256276747445,0.00767384914664193,0.0198750951951418,9.69975727888119e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42676,-0.0129000228529216,0.00291720270016066,-0.0186177401452365,-0.00718230556060672,9.85329030368064e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,42679,0.0114086373396588,0.00258918222337145,0.00633384018185075,0.0164834344974668,1.0597722920066e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LACRT,Extracellular glycoprotein lacritin,40419,-0.0234027461846245,0.00532029785636121,-0.0338305299830925,-0.0129749623861565,1.09871426050176e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GUCA2A,Guanylin,42563,-0.0164551400527511,0.00374448790650966,-0.02379433634951,-0.00911594375599215,1.11885173028057e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",42476,-0.0326379698354538,0.00745198088975658,-0.0472438523793767,-0.0180320872915309,1.19713761509458e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TK1,"Thymidine kinase, cytosolic",40302,-0.0205168356252047,0.00468510169363689,-0.029699634944733,-0.0113340363056764,1.20225413687056e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP3R1,Calcineurin subunit B type 1,42495,-0.0179570672826736,0.00410177511839816,-0.025996546514734,-0.00991758805061324,1.20755683792719e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,42370,-0.0272637793245186,0.00622931015048382,-0.0394732272194669,-0.0150543314295703,1.21420945667769e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",40223,-0.0219228332473408,0.00500894729339754,-0.0317403699424,-0.0121052965522816,1.21579049373131e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD22,B-cell receptor CD22,42754,-0.0195678423334094,0.00447198565762486,-0.0283329342223541,-0.0108027504444646,1.2197606931137e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,40483,-0.0211488898754359,0.00483329922562094,-0.0306221563576529,-0.0116756233932188,1.22151050747409e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42636,-0.0169055482979932,0.00386645728159153,-0.0244838045699126,-0.00932729202607381,1.23833753088579e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,42357,-0.028043104159853,0.00641996304353759,-0.0406262317251867,-0.0154599765945193,1.26284905858011e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LPO,Lactoperoxidase,42134,-0.0271798886022344,0.00623514791876551,-0.0394007785230148,-0.0149589986814541,1.31581908661794e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,40482,-0.0443904613725043,0.0102022559645995,-0.0643868830631194,-0.0243940396818892,1.36681978788401e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GBP4,Guanylate-binding protein 4,42311,-0.0221235209311573,0.00508628560420066,-0.0320926407153906,-0.012154401146924,1.37389726308631e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,XRCC4,DNA repair protein XRCC4,42311,-0.0164742239032581,0.00379208636781466,-0.0239067131841748,-0.00904173462234138,1.40726176813155e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,40223,-0.045485857442642,0.0104693453632073,-0.0660057743545283,-0.0249659405307557,1.40732675379569e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,40116,-0.0204702185710119,0.00471884471708945,-0.0297191542165072,-0.0112212829255166,1.45094671829764e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCAM,Basal cell adhesion molecule,42611,0.0109883574717762,0.00253406658814878,0.00602158695900459,0.0159551279845478,1.45988513191099e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,42370,-0.0161256809257738,0.00371912946306254,-0.0234151746733763,-0.00883618717817118,1.46259579925568e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB37,Ras-related protein Rab-37,42370,-0.0359239164589584,0.00830779692401154,-0.052207198430021,-0.0196406344878958,1.54267052657043e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACE,Angiotensin-converting enzyme,40532,-0.0119442466399924,0.00277519956933847,-0.0173836377958958,-0.00650485548408902,1.69208081204005e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,40483,-0.0168540902689377,0.00391609727915435,-0.0245296409360803,-0.0091785396017952,1.69310253865404e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,40451,-0.0152387973604079,0.003541702728318,-0.0221805347079112,-0.0082970600129046,1.70173009105369e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GP6,Platelet glycoprotein VI,42590,-0.0383281615595423,0.00891289626346234,-0.0557974382359285,-0.0208588848831561,1.71771379489757e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEMA4C,Semaphorin-4C,42587,0.0123074729627288,0.00286203873368496,0.0066978770447063,0.0179170688807514,1.7181575321209e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL16,C-X-C motif chemokine 16,42778,-0.0105261572474964,0.0024526186822122,-0.0153332898646323,-0.00571902463036053,1.78455505995037e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42658,0.0287458613050995,0.0066984507412141,0.0156168978523198,0.0418748247578791,1.78775040585557e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNX18,Sorting nexin-18,40449,-0.0193779973109892,0.00451944286273023,-0.0282361053219405,-0.010519889300038,1.82040572882143e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PROCR,Endothelial protein C receptor,40116,0.0154712820306859,0.00360943068079759,0.00839679789632263,0.0225457661650492,1.83191259545844e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPTXR,Neuronal pentraxin receptor,42636,0.0149796605299815,0.00349560641457808,0.00812827195740848,0.0218310491025546,1.8377748223831e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,42357,-0.0244074660083965,0.00572092627984045,-0.0356204815168838,-0.0131944504999092,2.00086834272147e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CR2,Complement receptor type 2,42689,-0.0210010014349736,0.00493002003022911,-0.0306638406942227,-0.0113381621757246,2.0597736922213e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRDX1,Peroxiredoxin-1,42261,0.0390698905537176,0.00917289982888191,0.0210910068891091,0.0570487742183262,2.06527018687988e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",40116,-0.0272441352534669,0.00639899241156895,-0.039786160380142,-0.0147021101267918,2.08392182357937e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DAPK2,Death-associated protein kinase 2,40199,-0.023734835788771,0.00558027349342504,-0.0346721718358841,-0.0127974997416579,2.12340368139716e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STK4,Serine/threonine-protein kinase 4,42636,-0.0372853485143956,0.00878789114416835,-0.0545096151569656,-0.0200610818718257,2.22217746397085e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PREB,Prolactin regulatory element-binding protein,42370,-0.0128345853994898,0.00303053905525345,-0.0187744419477866,-0.00689472885119304,2.30017909626259e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ROBO1,Roundabout homolog 1,42638,-0.0106674773723367,0.00252284044846005,-0.0156122446513184,-0.00572271009335505,2.36957634998208e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",40527,-0.0178790958954301,0.00422938135911691,-0.0261686833592992,-0.00958950843156093,2.38308559933274e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDCD1,Programmed cell death protein 1,42689,-0.019534683185352,0.00463206379852277,-0.0286135282304566,-0.0104558381402473,2.48885896416291e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,42346,-0.0248511882098466,0.00590824218571345,-0.0364313428938449,-0.0132710335258482,2.61432833206406e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NID1,Nidogen-1,42652,-0.0165362405467328,0.00393897026408276,-0.024256622264335,-0.00881585882913061,2.70878731728004e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SAFB2,Scaffold attachment factor B2,40482,-0.0118882098317681,0.00283487129858295,-0.0174445575769907,-0.00633186208654551,2.76703952949623e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACRBP,Acrosin-binding protein,40451,-0.0168961718946183,0.00403636223346276,-0.0248074418722053,-0.00898490191703128,2.86084584374465e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,40449,-0.0128236430939168,0.00306416934939649,-0.0188294150187339,-0.00681787116909963,2.8729379000538e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,40451,-0.0124131082187606,0.00297594427483111,-0.0182459589974296,-0.00658025744009165,3.05340312865615e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MPI,Mannose-6-phosphate isomerase,42587,-0.0360038804823283,0.00865368939222961,-0.0529651116910983,-0.0190426492735583,3.19500148477269e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DGKZ,Diacylglycerol kinase zeta,42370,-0.0148758702629682,0.00358156064508532,-0.0218957291273354,-0.00785601139860097,3.29549052754497e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42583,-0.0140399800769825,0.00338600344844194,-0.0206765468359287,-0.00740341331803631,3.39713178580244e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,40302,-0.0387989611992826,0.00936055120597645,-0.0571456415629964,-0.0204522808355687,3.42419147701869e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42594,-0.0207434172558583,0.00500496830384604,-0.0305531551313965,-0.0109336793803201,3.42551934159893e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLTA,Clathrin light chain A,42357,-0.0202836255358098,0.00490882567057795,-0.0299049238501426,-0.010662327221477,3.61730398405127e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGA,Fibrinogen alpha chain,40284,0.0131411607355519,0.00319434319223958,0.00688024807876228,0.0194020733923414,3.91865548989261e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,42676,-0.0365320260885545,0.00888610206282751,-0.0539487861316965,-0.0191152660454126,3.96039573343527e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL1,Growth-regulated alpha protein,42607,-0.0403317937444807,0.00981818968149318,-0.0595754455202073,-0.021088141968754,4.01704782508727e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LIF,Leukemia inhibitory factor,42311,-0.0217664276882204,0.00529875483306202,-0.032151987161022,-0.0113808682154188,4.0180417898478e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42794,-0.0123326981301013,0.00300330787777781,-0.0182191815705458,-0.00644621468965683,4.04272661509432e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TG,Thyroglobulin,40451,0.0488244451001093,0.0118908556281722,0.0255183680688919,0.0721305221313267,4.05326171353808e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD70,CD70 antigen,42594,0.0182146435876884,0.00444258034346152,0.0095071861145038,0.0269221010608729,4.15561487940689e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,JUN,Transcription factor AP-1,42370,-0.020186682648493,0.00492502638813573,-0.029839734369239,-0.0105336309277469,4.17792268295048e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEMA4D,Semaphorin-4D,42711,-0.0125521660931537,0.00306363419047285,-0.0185568891064805,-0.00654744307982693,4.20709091494301e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",40451,-0.0159013024902167,0.00388537433766319,-0.0235166361920365,-0.00828596878839686,4.29530030919587e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRSS53,Serine protease 53,40483,0.0157140357346986,0.00384586738511828,0.00817613565986674,0.0232519358095304,4.4199657717808e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPM1F,Protein phosphatase 1F,40511,-0.0218493365803526,0.00535395537563726,-0.0323430891166017,-0.0113555840441036,4.51558414067588e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPMT,Thiopurine S-methyltransferase,42346,-0.0305004586399887,0.00747457661084796,-0.0451506287972507,-0.0158502884827267,4.51925295595057e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42656,-0.0388909142561909,0.00954147314012059,-0.0575922016108273,-0.0201896269015546,4.60828169969457e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDZD2,PDZ domain-containing protein 2,40116,-0.0253681871239109,0.00622714393797891,-0.0375733892423496,-0.0131629850054722,4.65775088839023e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIL1,Nucleotide exchange factor SIL1,40223,-0.0130022847230663,0.0031941649158789,-0.019262847958189,-0.0067417214879437,4.72119612509394e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASP1,Caspase-1,42311,-0.028944763205087,0.00712042284313184,-0.0429007919776254,-0.0149887344325486,4.83055597653466e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",42346,-0.0207894074727327,0.00511569200503656,-0.0308161638026043,-0.010762651142861,4.85502791698266e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBP7,Retinoid-binding protein 7,40449,-0.0251414121655032,0.00618888605896697,-0.0372716288410785,-0.0130111954899279,4.89110510681641e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MSTN,Growth/differentiation factor 8,42357,-0.0223078614858948,0.00549365163354598,-0.033075418687645,-0.0115403042841447,4.92171092059736e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINF2,Alpha-2-antiplasmin,40317,-0.00564038684354009,0.00138984458618075,-0.00836448223245436,-0.00291629145462582,4.97722681969908e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,42594,-0.0137595265811806,0.00339282719283683,-0.0204094678791408,-0.00710958528322039,5.03156305734407e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,40451,-0.0203584155155338,0.005021122594213,-0.0301998158001913,-0.0105170152308764,5.05681506464944e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANXA5,Annexin A5,42261,-0.0127610286410379,0.00316516910177314,-0.0189647600805132,-0.0065572972015625,5.56879118934823e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LMOD1,Leiomodin-1,40482,0.0148646538101889,0.00368921477930901,0.00763379284274324,0.0220955147776346,5.63294403774925e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD40LG,CD40 ligand,42754,-0.0319991924190927,0.00794519220611187,-0.047571769143072,-0.0164266156951135,5.6682248547677e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42594,-0.0407090580509622,0.0101205692357654,-0.0605453737530623,-0.0208727423488621,5.79222076655022e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,40483,-0.0292763376960315,0.00728601981760876,-0.0435569365385446,-0.0149957388535183,5.90368454664177e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,42594,0.0200349337802733,0.00498716502537097,0.0102600903305462,0.0298097772300005,5.91903836706593e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,40482,-0.0518307767459058,0.0129192429013669,-0.0771524928325849,-0.0265090606592268,6.06192337405982e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",42357,-0.036069387684527,0.00902602005031574,-0.0537603869831459,-0.0183783883859082,6.47299544278263e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,40080,-0.0329116895699547,0.00824504913185654,-0.0490719858683935,-0.0167513932715159,6.60342966281851e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,40483,0.0290768886630644,0.00728707661965929,0.0147942184885322,0.0433595588375966,6.64349146055976e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL14,C-X-C motif chemokine 14,42370,-0.0231531973203335,0.00580538278382907,-0.0345317475766385,-0.0117746470640285,6.69279154137885e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,42311,-0.0172026792772319,0.00431501446338471,-0.025660107625466,-0.00874525092899789,6.73609410812467e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C2orf69,UPF0565 protein C2orf69,40182,-0.0250533218412646,0.00628571170698768,-0.0373733167869604,-0.0127333268955687,6.77000681702547e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,42292,-0.0176323944050188,0.00442682689558177,-0.0263089751203591,-0.00895581368967858,6.83964357289812e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,42521,-0.0234567695508095,0.00594745735387477,-0.0351137859644041,-0.011799753137215,8.0544029364802e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42676,-0.0476524513615871,0.012092814543335,-0.0713543678665237,-0.0239505348566506,8.17019153849435e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42594,-0.0482344651475992,0.012248427771473,-0.0722413835796863,-0.0242275467155121,8.25751372505085e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUGT1,Protein SGT1 homolog,42346,-0.0321835708246079,0.00821098703152772,-0.0482771054064023,-0.0160900362428136,8.91551271754743e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AHNAK2,Protein AHNAK2,40223,-0.012218848575895,0.00311836746754076,-0.0183308488122749,-0.00610684833951508,8.96962512592541e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NXPH3,Neurexophilin-3,40199,0.0124245372542147,0.0031740240462497,0.00620345012356531,0.0186456243848641,9.11592158477271e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,42346,-0.0207316680309618,0.00529823674533616,-0.0311162120518207,-0.010347124010103,9.16392958967453e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,40428,-0.0277288210747203,0.00711282168778388,-0.0416699515827767,-0.0137876905666639,9.7382186519031e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TEK,Angiopoietin-1 receptor,42679,-0.00878862255218997,0.00225636599085428,-0.0132110998942644,-0.00436614521011557,9.86587184538027e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIF1C,Kinesin-like protein KIF1C,40116,-0.0144441832529986,0.00371017041045575,-0.0217161172574918,-0.00717224924850529,9.95470144113094e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPHB6,Ephrin type-B receptor 6,42476,-0.013414502293358,0.00344622935285087,-0.0201691118249457,-0.00665989276177033,9.96949313423095e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GZMB,Granzyme B,42594,-0.0264930469023555,0.006809483024912,-0.039839633631183,-0.0131464601735279,0.000100475805572129
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,42346,-0.0186219258880557,0.00479299480523145,-0.0280161957063094,-0.00922765606980208,0.000102730712881652
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42653,0.0196130568406722,0.00506398586632431,0.00968764454267651,0.0295384691386678,0.000107991638057383
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,42370,-0.0171592021900073,0.00443689086213486,-0.0258555082797916,-0.00846289610022295,0.000110533808140069
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42619,-0.0231773775334989,0.00601862606038388,-0.0349738846118513,-0.0113808704551465,0.000118210891777762
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCGB1A1,Uteroglobin,42646,-0.0220846336085296,0.00573813433526103,-0.0333313769056412,-0.010837890311418,0.000119271978813174
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42636,0.0101265379673305,0.00263156722226411,0.00496866621169289,0.0152844097229682,0.000119587174936609
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LY96,Lymphocyte antigen 96,42495,-0.0141025962673794,0.00366646216898153,-0.0212888621185832,-0.00691633041617556,0.000120436498105746
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42594,0.0236816128170489,0.00617425810616507,0.0115800669289654,0.0357831587051324,0.000125862878030299
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,40116,-0.0243448440898909,0.00635114670876204,-0.0367930916390645,-0.0118965965407173,0.000127226923879964
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",40449,-0.0346076998391466,0.00902870826859527,-0.0523039680455933,-0.0169114316326998,0.000127241172374114
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HMCN2,Hemicentin-2,40269,-0.0231702240323823,0.00604526216591273,-0.0350189378775713,-0.0113215101871933,0.000127398525939485
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42594,-0.0468566850145742,0.0122263252673684,-0.0708202825386163,-0.0228930874905322,0.000127456992000526
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASP9,Caspase-9,40199,-0.0247037307305263,0.00644787399437713,-0.0373415637595054,-0.0120658977015471,0.000128177129665833
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STXBP1,Syntaxin-binding protein 1,40482,-0.030213082647139,0.007894430450765,-0.0456861663306384,-0.0147399989636396,0.000130340863611793
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PXDNL,Peroxidasin-like protein,40451,0.0220118853050768,0.00575543262481986,0.0107312373604299,0.0332925332497237,0.000131723298585509
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRDX2,Peroxiredoxin-2,40333,-0.0246609886724299,0.00645495148174335,-0.0373126935766469,-0.012009283768213,0.000133917820917596
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSMG4,Proteasome assembly chaperone 4,40199,-0.0224083159186527,0.00587962895799967,-0.0339323886763321,-0.0108842431609734,0.000139059354229413
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK1,Kallikrein-1,42505,0.0507549010583486,0.0133212101964896,0.0246453290732291,0.0768644730434682,0.0001395456894802
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,40199,-0.0152605391654913,0.00400557168217152,-0.0231114596625474,-0.00740961866843508,0.000139820164560535
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,42587,-0.0164505059673947,0.00432119897342755,-0.0249200559553127,-0.00798095597947667,0.000141329091804759
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,42292,-0.025836138008854,0.00682404945088591,-0.0392112749325904,-0.0124610010851177,0.000153749026390266
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KITLG,Kit ligand,42636,0.0145956826158626,0.00385801313810749,0.00703397686517195,0.0221573883665533,0.000155488716014742
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,40283,-0.014268711720133,0.00377226157042055,-0.0216623443981572,-0.00687507904210869,0.000156055043055513
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AK1,Adenylate kinase isoenzyme 1,42636,-0.0244621226907512,0.00647104233131339,-0.0371453656601254,-0.0117788797213769,0.000157351862913992
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42594,-0.0314955993982228,0.00834643095333534,-0.0478546040667601,-0.0151365947296855,0.000161640246546088
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,40302,-0.0144845877953835,0.00383852382447013,-0.022008094491345,-0.00696108109942208,0.000161823979743093
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,40519,-0.0098199038553941,0.00261332518517584,-0.0149420212183387,-0.00469778649244946,0.000172392570562868
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAA10,N-alpha-acetyltransferase 10,40116,-0.0198963484778031,0.00530105897252275,-0.0302864240639477,-0.00950627289165854,0.000175441487690942
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,42370,-0.0126124827048949,0.00336721461145581,-0.0192122233433483,-0.00601274206644154,0.000180677966273281
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,40482,-0.0146745252428515,0.0039207700153453,-0.0223592344729283,-0.00698981601277468,0.000182908525229112
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42618,-0.114226314864502,0.0305355987904614,-0.174076088493807,-0.054376541235198,0.000184228997836575
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,40080,-0.0251379989469069,0.00674370538137743,-0.0383556614944067,-0.0119203363994072,0.000194272688911016
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,40483,-0.0207772792938327,0.00557434626729278,-0.0317029979777265,-0.00985156060993882,0.000194484699751428
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINC1,Antithrombin-III,40516,-0.00564100143917599,0.00151595848268474,-0.00861228006523809,-0.00266972281311389,0.00019933320624743
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,40449,-0.0432176406502306,0.011642729348296,-0.0660373901728908,-0.0203978911275703,0.000206631751352675
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,40483,0.0119559685234025,0.00323334081490415,0.00561862052619038,0.0182933165206146,0.000218581163765561
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCRL3,Fc receptor-like protein 3,42370,-0.0214418927734102,0.0058038624459727,-0.0328174631675166,-0.0100663223793037,0.000221282921804553
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RGMB,RGM domain family member B,42711,-0.0108051149219108,0.00292671731582841,-0.0165414808609345,-0.00506874898288714,0.000223470441694261
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,42346,0.0145553981313553,0.00394310723693954,0.00682690794695384,0.0222838883157568,0.000223966286372176
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL8,C-C motif chemokine 8,42706,-0.0228695080950324,0.0062021254315456,-0.0350256739408617,-0.010713342249203,0.000227474707353612
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LXN,Latexin,42461,0.0256273546924666,0.00695267064994303,0.0120001202185783,0.0392545891663549,0.000228738397282233
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,40451,-0.0155795128729305,0.00423174582202914,-0.0238737346841076,-0.00728529106175337,0.000232876332823757
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STX3,Syntaxin-3,40483,-0.0147050468655649,0.00400013321124289,-0.0225453079596009,-0.00686478577152879,0.000237888120613104
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GP5,Platelet glycoprotein V,40283,-0.0136825737385666,0.00372711219015256,-0.0209877136312656,-0.00637743384586761,0.000242649994287016
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FABP6,Gastrotropin,42334,-0.0222129089981547,0.00605613280854862,-0.03408292930291,-0.0103428886933994,0.000245576780028928
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42754,0.0106039389659197,0.00289116832822083,0.00493724904260684,0.0162706288892325,0.000245678122783901
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLKB1,Plasma kallikrein,40293,-0.00926328660174013,0.00253413075746671,-0.0142301828863749,-0.00429639031710537,0.000257956854775051
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PI16,Peptidase inhibitor 16,40532,0.00948751144717912,0.00259624909446364,0.00439886322203038,0.0145761596723279,0.000259033817038651
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD2,T-cell surface antigen CD2,40116,-0.0145061704436436,0.00398096115993197,-0.0223088543171102,-0.0067034865701769,0.000269797045751795
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL18,C-C motif chemokine 18,42477,-0.0260434291665505,0.00716555900499359,-0.040087924816338,-0.0119989335167631,0.00027954056625235
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,42721,-0.0313850603494155,0.0086354978157189,-0.0483106360682245,-0.0144594846306064,0.000279634914850111
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,40199,-0.0112829974018351,0.00311071315159623,-0.0173799951789637,-0.00518599962470646,0.00028787208519657
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PODXL,Podocalyxin,42587,0.00568552132831012,0.00157138934379685,0.0026055982144683,0.00876544444215194,0.000297809307985725
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COPB2,Coatomer subunit beta',40116,-0.016159720257796,0.00447397733311711,-0.0249287158307055,-0.00739072468488644,0.000305282752889765
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,40283,-0.0232345778029813,0.00643357171652277,-0.0358443783673659,-0.0106247772385966,0.000305824254781751
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",40511,-0.0195207096764308,0.00541017831329504,-0.0301246591704891,-0.00891676018237251,0.000309723486872778
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPCAM,Epithelial cell adhesion molecule,42616,-0.0366691756921199,0.0101719224986804,-0.0566061437895335,-0.0167322075947064,0.000313355534128758
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TYMP,Thymidine phosphorylase,42563,-0.0240371822318081,0.00667603814632501,-0.0371222169986051,-0.0109521474650111,0.000318736077163252
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APPL2,DCC-interacting protein 13-beta,40283,-0.0410936264161675,0.0114199195907573,-0.0634766688140518,-0.0187105840182832,0.000321555419223246
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPON2,Spondin-2,42562,-0.0132480307555845,0.0036870707280775,-0.0204746893826164,-0.00602137212855255,0.000327935365905834
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGFBR1,TGF-beta receptor type-1,40199,-0.00801994561328953,0.00223255788062824,-0.0123957590593209,-0.00364413216725817,0.000329242608014597
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,POMC,Pro-opiomelanocortin,40223,-0.025866363214695,0.00720834194916686,-0.039994713435062,-0.0117380129943279,0.000334164801439274
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,40527,-0.0234144927072727,0.00653724545898506,-0.0362274938068834,-0.010601491607662,0.00034278739842411
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,40482,0.0167222644019478,0.00467939527548034,0.00755064966200638,0.0258938791418893,0.000353581454073422
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,40429,-0.0316519793457434,0.00889458363739949,-0.0490853632750464,-0.0142185954164404,0.000374420259361248
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ICAM3,Intercellular adhesion molecule 3,42794,0.00984513534281072,0.00276714040691865,0.00442154014525016,0.0152687305403713,0.000375141876351516
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNN,Tenascin-N,40527,-0.0161338755728584,0.00454286225818919,-0.0250378855989092,-0.00722986554680756,0.00038462844101563
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRK5,G protein-coupled receptor kinase 5,42357,-0.0185712506196108,0.00523270663110618,-0.028827355616579,-0.00831514562264271,0.000387938914397509
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCT,Secretin,40182,-0.018290306984392,0.00515524806705886,-0.0283945931958274,-0.00818602077295664,0.000389934129107924
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACTN2,Alpha-actinin-2,40116,0.0217852191193835,0.00614619268340767,0.00973868145990449,0.0338317567788626,0.00039499320010491
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,40199,-0.00758061999410575,0.00213874999616831,-0.0117725699865956,-0.00338867000161585,0.000395115850756203
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,40223,-0.0122468646518117,0.00345962177590634,-0.0190277233325881,-0.0054660059710353,0.000401861803452874
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STX5,Syntaxin-5,40199,-0.0149943125318421,0.00423941225921807,-0.0233035605599095,-0.00668506450377469,0.000406542449505901
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,40532,-0.0262108962941713,0.00742929033748674,-0.0407723053556454,-0.0116494872326973,0.000420292044268186
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RILPL2,RILP-like protein 2,40511,-0.0351008450410656,0.00995115973137051,-0.0546051181145518,-0.0155965719675794,0.000421464711017922
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TLR1,Toll-like receptor 1,40199,-0.0097531383905283,0.00276550421244927,-0.0151735266469289,-0.00433275013412773,0.000422466231118709
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,40483,-0.0171077645078028,0.00485323036276626,-0.0266200960188247,-0.00759543299678092,0.000425118243190125
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DRAXIN,Draxin,42495,-0.0158628150476539,0.00450267985057106,-0.0246880675547732,-0.00703756254053465,0.000428167821679302
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCRN1,Secernin-1,42594,-0.0198810977839626,0.00565845650104471,-0.0309716725260102,-0.00879052304191495,0.000443669415206341
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,42357,-0.0210701843174979,0.0059991746595429,-0.0328285666502019,-0.00931180198479378,0.000445935282231304
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1RL,Complement C1r subcomponent-like protein,40519,-0.00715221272616244,0.00204277519046024,-0.0111560520994645,-0.00314837335286038,0.000464910178924217
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA3,Carbonic anhydrase 3,42770,-0.021389375976146,0.00612878304391686,-0.033401790742223,-0.00937696121006895,0.000484575809304022
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STC2,Stanniocalcin-2,42591,-0.00892610964455142,0.00255831487517599,-0.0139404067998963,-0.00391181248920648,0.000486282449133051
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MANSC1,MANSC domain-containing protein 1,42679,0.0100718159197625,0.00288868245736043,0.00440999830333606,0.015733633536189,0.000490673337844291
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MIA,Melanoma-derived growth regulatory protein,42679,-0.0135031504191541,0.00387439974807751,-0.021096973925386,-0.00590932691292214,0.000493288181075116
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRIM26,Tripartite motif-containing protein 26,40080,-0.0202217780924387,0.00581148185236622,-0.0316122825230765,-0.00883127366180093,0.000504081229774668
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42794,-0.0233954959314543,0.00672830028149216,-0.0365829644831789,-0.0102080273797296,0.000508304809224456
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NECTIN4,Nectin-4,42679,-0.0123485916869388,0.00355214114983969,-0.0193107883406246,-0.00538639503325301,0.000509831936330209
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL17A,Interleukin-17A,42347,-0.0154283167359243,0.00444092085792293,-0.0241325216174532,-0.00672411185439538,0.000514171296992238
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,40449,-0.0346286171645776,0.00999384446686547,-0.0542165523196339,-0.0150406820095213,0.000532218110180297
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA9,Carbonic anhydrase 9,42721,-0.0172531485536294,0.00498261636054881,-0.027019076620305,-0.0074872204869537,0.000536500883436113
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DPP7,Dipeptidyl peptidase 2,42551,-0.0214055740063727,0.00619158848170159,-0.0335410874305079,-0.00927006058223762,0.000547514207376008
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42674,-0.0254135831281604,0.00736626110021185,-0.0398514548845756,-0.0109757113717451,0.000562307494940166
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",40223,-0.0324844150022126,0.00941864506370156,-0.0509449593270676,-0.0140238706773575,0.000564879054758369
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENSA,Alpha-endosulfine,40451,-0.0188862344357787,0.00547774773274759,-0.029622619991964,-0.00814984887959345,0.00056721809000717
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42794,0.00975078503977384,0.00283149233283405,0.00420106006741911,0.0153005100121286,0.000575559979267263
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,42459,-0.0105322927187214,0.00305898204269343,-0.0165278975224005,-0.00453668791504229,0.000576923779697482
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LY6D,Lymphocyte antigen 6D,42548,-0.0144549031022678,0.0042050030811543,-0.0226967091413302,-0.00621309706320537,0.000588794550885895
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VIM,Vimentin,42357,-0.041053120452925,0.011955613417533,-0.0644861227512896,-0.0176201181545603,0.000597028453309937
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,40199,-0.0131166788651972,0.00382087187177043,-0.0206055877338672,-0.00562776999652712,0.00059935618353911
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100A11,Protein S100-A11,42531,-0.01604853997909,0.00468304777943371,-0.02522731362678,-0.00686976633139988,0.000612258086828509
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,42370,-0.0233089943078534,0.00681054735208091,-0.036657667117932,-0.00996032149777483,0.000622401987627224
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,40302,-0.0155335717730002,0.00454518197615081,-0.0244421284462558,-0.00662501509974462,0.000634046543220379
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNU13,NHP2-like protein 1,40116,-0.022304990691519,0.00654482672899984,-0.0351328510803586,-0.00947713030267927,0.000656690250504111
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,40302,-0.025688159042237,0.00754183975257669,-0.0404701649572873,-0.0109061531271867,0.000661347218088918
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL34,Interleukin-34,42292,-0.0128214299537,0.00376930702712507,-0.0202092717268651,-0.00543358818053486,0.000672088043328245
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINI1,Neuroserpin,40267,0.0106200343630786,0.00312376714224966,0.00449745076426929,0.016742617961888,0.000676849540989025
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,40439,0.00960213140933673,0.00282450787672422,0.00406609597095726,0.0151381668477162,0.000677247057685934
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRSS27,Serine protease 27,42603,-0.0140939470801232,0.00414647496869968,-0.0222210380187746,-0.00596685614147182,0.000678249104302831
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THBD,Thrombomodulin,42636,-0.0105413642481187,0.00310571897822558,-0.0166285734454408,-0.00445415505079655,0.000690336865474909
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,40223,-0.0173248725679737,0.00510570029134013,-0.0273320451390004,-0.00731769999694709,0.000693137747626721
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PER3,Period circadian protein homolog 3,40199,-0.0430552458593362,0.0126989486113557,-0.0679451851375933,-0.018165306581079,0.000700213170915039
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42582,-0.00942974922366016,0.00278182424935423,-0.0148821247523944,-0.00397737369492587,0.000701527535395985
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRELP,Prolargin,42618,-0.0084878259032372,0.00250695000757011,-0.0134014479180746,-0.00357420388839978,0.00071195742548798
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,42517,-0.0144729668270287,0.00428839818119931,-0.0228782272621794,-0.00606770639187811,0.000740499833767607
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42587,-0.00869433653824519,0.0025771159986696,-0.0137454838956376,-0.00364318918085277,0.000743837457279797
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MST1,Hepatocyte growth factor-like protein,40370,-0.0227639856524827,0.00675840477800603,-0.0360104590173745,-0.00951751228759084,0.000759029201553169
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,40511,-0.0098547660335765,0.00292949148214365,-0.0155965693385781,-0.00411296272857495,0.00077080695265153
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL22,Interleukin-22,40451,-0.0242932180097341,0.00722914091120795,-0.0384623341957017,-0.0101241018237665,0.00078072294170491
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UNC5D,Netrin receptor UNC5D,40199,0.00908010849831152,0.00270282153545634,0.0037825782888171,0.0143776387078059,0.000783510458217242
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42618,-0.025798052794026,0.00768043220760696,-0.0408516999209356,-0.0107444056671163,0.000784619204258756
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL1R1,Interleukin-1 receptor type 1,42590,-0.00813307223394885,0.00242298800055801,-0.0128821287150426,-0.00338401575285515,0.000791182968961118
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VGF,Neurosecretory protein VGF,40482,-0.0109022879971647,0.00325441623041633,-0.0172809438087807,-0.00452363218554874,0.000810769621937297
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UBQLN3,Ubiquilin-3,40116,-0.0187556083086059,0.00560681158234922,-0.0297449590100104,-0.00776625760720144,0.000825160565085495
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MKI67,Proliferation marker protein Ki-67,40199,-0.0133754787093073,0.00400004750697503,-0.0212155718229784,-0.00553538559563625,0.000829062312443972
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL3,C-X-C motif chemokine 3,42620,-0.0319604979642481,0.00956332006400788,-0.0507046052897035,-0.0132163906387926,0.000834078692230099
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CABP2,Calcium-binding protein 2,40182,-0.0222073471295676,0.00666342852799039,-0.0352676670444288,-0.00914702721470646,0.000862852207574488
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,40527,0.013529892904932,0.00408235094636687,0.00552848505005298,0.0215313007598111,0.000921806642955667
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CORO1A,Coronin-1A,42353,-0.0302781585364335,0.00913740959139359,-0.048187481335565,-0.0123688357373021,0.00092335944282495
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,40116,0.0133580459144443,0.00403159979070195,0.00545611032466846,0.0212599815042201,0.000924898180268608
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTX3,Pentraxin-related protein PTX3,42594,0.0166014022936122,0.00501686740468783,0.00676834218042406,0.0264344624068003,0.00093837471519722
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLNS1A,Methylosome subunit pICln,40182,-0.0113756541101669,0.00344462279422044,-0.018127114786839,-0.00462419343349487,0.000961542063697399
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCRL1,Fc receptor-like protein 1,42636,-0.0159341926115003,0.00483362033229179,-0.0254080884627922,-0.00646029676020843,0.000981395884528195
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA12,Serpin A12,42249,-0.0349672711186144,0.0106246530452655,-0.0557915910873348,-0.014142951149894,0.00100045270331556
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MB,Myoglobin,42794,-0.0179654302582304,0.00546060130086876,-0.0286682088079332,-0.00726265170852761,0.00100438794506566
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,42311,-0.0171113238449357,0.0052042025826421,-0.0273115609069142,-0.00691108678295717,0.00101173824358555
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GSTP1,Glutathione S-transferase P,42237,0.0237895745008353,0.00723976453194819,0.00959963601821685,0.0379795129834538,0.0010190386322556
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDHR1,Cadherin-related family member 1,42311,-0.0144729465099138,0.00441151186816546,-0.0231195097715181,-0.00582638324830946,0.00103811741136664
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SELENOP,Selenoprotein P,40539,0.00778885180547553,0.00237489821968718,0.00313405129488866,0.0124436523160624,0.00104246575296694
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGB5,Integrin beta-5,42679,0.0125221655407993,0.00382603999290211,0.00502312715471115,0.0200212039268874,0.00106725923732503
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEZ6,Seizure protein 6 homolog,40182,0.0105958018296248,0.00324055721714634,0.00424430968401797,0.0169472939752316,0.00107975012908782
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SFRP1,Secreted frizzled-related protein 1,42457,-0.0147942952526121,0.00453520356346885,-0.0236832942370111,-0.00590529626821319,0.00110868928247615
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FADD,FAS-associated death domain protein,42636,-0.0252247634643362,0.00774483240119225,-0.040404634970673,-0.0100448919579994,0.00112883546543129
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,40116,-0.0337814870566507,0.0103748200108754,-0.0541161342779665,-0.0134468398353349,0.00113296918755094
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSBP1,Heat shock factor-binding protein 1,40223,-0.0316621237484333,0.0097504009623423,-0.0507729096346243,-0.0125513378622424,0.00116868581246768
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NEDD9,Enhancer of filamentation 1,40199,-0.0111588359557579,0.0034386572450943,-0.0178986041561427,-0.00441906775537306,0.00117754247991068
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,42346,-0.0181140334214326,0.00558938401129967,-0.02906922608358,-0.00715884075928528,0.00119494436386168
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,40223,-0.0133530368866426,0.00412808983689212,-0.0214440929669512,-0.00526198080633405,0.00122139215684483
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,40182,-0.0183784092395996,0.00568349862117723,-0.029518066537107,-0.00723875194209223,0.00122582836765442
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,40449,-0.0166728957236783,0.00516231381301841,-0.0267910307971944,-0.00655476065016226,0.00124261511683741
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INSL4,Early placenta insulin-like peptide,40451,-0.0162178226025778,0.00502915157947228,-0.0260749596983435,-0.00636068550681213,0.00126436727116345
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,40116,-0.0134344133617861,0.00417330344635125,-0.0216140881166345,-0.00525473860693762,0.00128955186655703
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",40283,-0.0291990874162155,0.00909029530893292,-0.0470160662217241,-0.011382108610707,0.0013213715612984
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENO2,Gamma-enolase,42711,-0.0212021632341149,0.00660770445401802,-0.0341532639639903,-0.00825106250423962,0.00133646053772426
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,42490,-0.0332644009931801,0.0103696106181641,-0.0535888378047817,-0.0129399641815785,0.00134037058484384
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPING1,Plasma protease C1 inhibitor,40516,0.00604353214345539,0.00188714607089749,0.00234472584449631,0.00974233844241446,0.00136630449995809
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK13,Kallikrein-13,42381,-0.0151569458765432,0.00474454347661394,-0.0244562510907065,-0.0058576406623799,0.00140351418010646
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42587,-0.0124298708976018,0.00389171459164777,-0.0200576314972314,-0.00480211029797218,0.00140674158824027
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,42297,-0.0185267020119702,0.0058126112249143,-0.0299194200128023,-0.0071339840111382,0.00143930701718373
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DGCR6,Protein DGCR6,40136,-0.0145689928331518,0.00457928396758882,-0.0235443894096258,-0.00559359625667766,0.00146923677459469
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,40065,-0.0287305697273278,0.0090682205244064,-0.0465042819551643,-0.0109568574994913,0.00153773682969284
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GNLY,Granulysin,42611,-0.0173917622492223,0.00550485937707635,-0.028181286628292,-0.00660223787015268,0.00158473973018561
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TCN2,Transcobalamin-2,42771,-0.0100191956598769,0.00317372843590075,-0.0162397033942424,-0.00379868792551144,0.00159795774599138
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100A16,Protein S100-A16,42292,-0.0197517499302195,0.00626168111243539,-0.0320246449105929,-0.00747885494984616,0.00161200636120652
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,40483,-0.00652856621117587,0.00207033842903104,-0.0105864295320767,-0.00247070289027504,0.00161813806107804
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42613,-0.0105446587286968,0.00334414058530264,-0.01709917427589,-0.00399014318150364,0.0016186112976673
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AOC3,Membrane primary amine oxidase,42689,0.00980141123799351,0.00310969397078126,0.00370641105526224,0.0158964114207248,0.00162572651498778
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGA6,Integrin alpha-6,42594,-0.0163486690407065,0.00521084447402336,-0.0265619242097923,-0.00613541387162072,0.00170804164678212
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,40417,-0.0140183486459395,0.00447314443837745,-0.0227857117451593,-0.00525098554671967,0.00172949130730179
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PADI2,Protein-arginine deiminase type-2,42370,-0.0179552680596324,0.00573004823901996,-0.0291861626081115,-0.00672437351115325,0.00173097094665652
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,42587,-0.0169236335967924,0.00543027832897466,-0.0275669791215827,-0.00628028807200205,0.00183379132630173
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK8,Kallikrein-8,42154,-0.0119503377302186,0.00383617663863511,-0.0194692439419434,-0.00443143151849375,0.0018424084395032
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LY75,Lymphocyte antigen 75,42594,-0.0124419454122183,0.00399511617998685,-0.0202723731249925,-0.00461151769944405,0.00184777675815649
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PZP,Pregnancy zone protein,40539,-0.0163641570686561,0.00525675310097189,-0.026667393146561,-0.0060609209907512,0.00185670320584901
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLIC5,Chloride intracellular channel protein 5,40182,0.0101605810141413,0.00326709259355523,0.00375707953077308,0.0165640824975096,0.00187580930832832
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCGB2A2,Mammaglobin-A,40116,0.0101921364385986,0.00328568168381338,0.00375220033832443,0.0166320725388729,0.0019271757418792
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,42587,-0.0145005745118162,0.00468493600864637,-0.0236830490887631,-0.00531809993486936,0.00197119773300228
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,40511,-0.0087239059660169,0.00281987941378729,-0.01425086961704,-0.00319694231499381,0.00198148251572336
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SDC1,Syndecan-1,42636,-0.0129242558043769,0.00418374794388209,-0.0211244017743858,-0.00472410983436798,0.00201134577829904
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ABHD14B,Protein ABHD14B,42460,-0.0180172109013773,0.00583433932164532,-0.0294525159718021,-0.00658190583095245,0.00201834731113205
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEZ6L,Seizure 6-like protein,42679,0.0089106082462458,0.00288809800353693,0.00324993615931341,0.0145712803331782,0.0020376816793502
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPB2,Carboxypeptidase B2,40516,-0.00704675774822321,0.00228594503645941,-0.0115272100196837,-0.00256630547676277,0.00205662689728732
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,42587,-0.00634684597776813,0.0020591793434168,-0.0103828374908651,-0.0023108544646712,0.00205879418515193
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRYGD,Gamma-crystallin D,40483,-0.0308650887796723,0.0100221832399496,-0.0505085679299735,-0.0112216096293711,0.00207722879283099
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDIA5,Protein disulfide-isomerase A5,40080,-0.0195001033670172,0.00633505960109007,-0.0319168201851538,-0.00708338654888067,0.00208825705985033
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NOS1,"Nitric oxide synthase, brain",42311,-0.017211053389625,0.00559249252679245,-0.0281723387421382,-0.00624976803711183,0.00209155474256561
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPR15L,Protein GPR15L,40449,-0.01929085060161,0.00627134964999631,-0.0315826959156028,-0.00699900528761723,0.00210281008126901
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,40182,0.0201395891313291,0.00654932320368515,0.00730291565210617,0.032976262610552,0.00210973832962601
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,40302,-0.0274056567680311,0.00891798079528053,-0.0448848991267809,-0.00992641440928124,0.00212375788765611
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",40451,-0.0167611727088482,0.00547126307449473,-0.0274848483348579,-0.0060374970828385,0.00219286716530778
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SF3B4,Splicing factor 3B subunit 4,42587,-0.0227632313942686,0.00747007247481003,-0.0374045734448962,-0.00812188934364091,0.00231389865812864
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,40451,-0.0143710059301726,0.00471686518021651,-0.023616061683397,-0.00512595017694829,0.00231882612665417
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,40482,-0.00925152207978109,0.0030423259765662,-0.0152144809938508,-0.00328856316571134,0.00236383965169943
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBM25,RNA-binding protein 25,40080,0.0149269718245478,0.00490872201133348,0.00530587668233418,0.0245480669667614,0.00236426853176586
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",40527,-0.0197213453461983,0.00650494305111733,-0.0324710337263882,-0.00697165696600829,0.00243691753089494
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,42357,-0.0104711001478614,0.00345734484772617,-0.0172474960494047,-0.00369470424631808,0.00246122110123706
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHGB,Secretogranin-1,42664,-0.0133012479629995,0.00441498630886224,-0.0219546211283695,-0.00464787479762953,0.00259373369888892
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,42370,-0.0179692996021618,0.00596713722321943,-0.0296648885596719,-0.00627371064465173,0.00260558789670981
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,42587,-0.00672231890567891,0.0022350226387739,-0.0111029632776758,-0.00234167453368206,0.00263705572449523
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,42346,-0.0161224039057361,0.00536125588490138,-0.0266304654401428,-0.00561434237132935,0.00264158752436683
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RPA2,Replication protein A 32 kDa subunit,40199,-0.00983995241430588,0.0032725738528255,-0.0162541971658439,-0.00342570766276791,0.00264615398891136
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,YAP1,Transcriptional coactivator YAP1,40483,-0.00891199290275375,0.00296439411103089,-0.0147222053603743,-0.0031017804451332,0.00264989905194325
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPL,Periplakin,40199,-0.0103342550567647,0.00343886769718588,-0.017074435743249,-0.00359407437028035,0.00266062719635003
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CBX2,Chromobox protein homolog 2,40116,0.0124646261980085,0.00414884648932545,0.00433288707893065,0.0205963653170864,0.00266744240471684
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPC1,Glypican-1,42721,-0.00920983618634129,0.0030726479029125,-0.0152322260760498,-0.00318744629663279,0.00272822037486998
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42638,-0.00797993203913114,0.00266384445061349,-0.0132010671623336,-0.0027587969159287,0.00274364336302942
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFIC,Nuclear factor 1 C-type,40482,-0.0146740977673401,0.00490110834307344,-0.024280270119764,-0.00506792541491614,0.00275909471060644
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPTX2,Neuronal pentraxin-2,40527,0.0101067804272871,0.00338669331648199,0.00346886152698241,0.0167446993275918,0.00284869403209623
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TJP3,Tight junction protein ZO-3,40136,0.0129690686717971,0.00435055485033411,0.0044419811651422,0.0214961561784519,0.00287926927866789
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LUZP2,Leucine zipper protein 2,40451,-0.0141379528957711,0.00474460018490964,-0.023437369258194,-0.00483853653334825,0.00289053883395461
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBP2,Retinol-binding protein 2,42587,0.0235758826412409,0.00794533151150949,0.00800303287868232,0.0391487324037995,0.00300995500771368
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42721,0.00811925913136564,0.00273699334546766,0.00275475217424903,0.0134837660884822,0.00301748232050311
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CST1,Cystatin-SN,39042,-0.0336779579779435,0.0113764078324629,-0.0559757173295707,-0.0113801986263163,0.00308038893472627
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STXBP3,Syntaxin-binding protein 3,42346,-0.0131663832550152,0.0044493935214432,-0.0218871945570439,-0.00444557195298654,0.00309047473905249
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,XG,Glycoprotein Xg,42734,-0.0104876356597261,0.00354712560709725,-0.0174400018496367,-0.00353526946981547,0.00311529898842986
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PMS1,PMS1 protein homolog 1,40182,-0.015842864037714,0.00536844499001036,-0.0263650162181343,-0.00532071185729372,0.00317304270175811
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FSHB,Follitropin subunit beta,40223,0.0164478046035661,0.00558928029656722,0.0054928152222944,0.0274027939848379,0.00325997824887185
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",42603,-0.0328034519212269,0.0111593770913307,-0.054675831020235,-0.0109310728222188,0.00329258954837655
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL10,Interleukin-10,42370,-0.0256119536929518,0.00873897156183899,-0.0427403379541562,-0.00848356943174735,0.0033869890496224
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,42566,-0.00911832598759083,0.00311320043772417,-0.0152201988455302,-0.00301645312965144,0.00340712302182652
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,42113,0.0112977815353078,0.00387875632460929,0.00369541913907364,0.0189001439315421,0.00358894357073735
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,40116,-0.020114654939991,0.00691087679155921,-0.0336599734514471,-0.00656933642853498,0.00361488260771424
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,40223,0.0118957886334419,0.00408962403006798,0.00388012553450866,0.0199114517323751,0.00363574355073706
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RRP15,RRP15-like protein,40136,0.0276083538259235,0.00949623922139216,0.00899572495199486,0.0462209826998521,0.00365303247847044
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,40116,0.00622915451214803,0.00214749041751132,0.00202007329382584,0.0104382357304702,0.00373112445576654
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRDX6,Peroxiredoxin-6,42721,0.0180431642076751,0.00622994313979995,0.00583247565366724,0.0302538527616831,0.00378316137016236
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDIA3,Protein disulfide-isomerase A3,40283,-0.00739106217609949,0.00255432252294824,-0.012397534321078,-0.00238459003112093,0.0038165456626037
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BTC,Probetacellulin,42346,-0.0221972989020094,0.00768040219248187,-0.0372508871992739,-0.00714371060474499,0.00385722119571578
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NRTN,Neurturin,42370,-0.0146202288953266,0.00506208894714865,-0.024541923231738,-0.00469853455891528,0.00388107796883887
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",40116,0.0142857017915024,0.00495380747049899,0.00457623914932443,0.0239951644336805,0.00393698044627612
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPSAB1,Tryptase alpha/beta-1,42741,-0.015489345417217,0.00538460089229973,-0.0260431631661245,-0.00493552766830951,0.0040261159964915
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EGFLAM,Pikachurin,40449,-0.00917140637933851,0.0031968249052538,-0.0154371831936359,-0.00290562956504106,0.00412653920941835
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,40136,0.019025555906773,0.00665449985108036,0.00598273619865546,0.0320683756148905,0.0042571328487267
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NTF3,Neurotrophin-3,42594,-0.0105007713989069,0.00368279136709643,-0.0177190424784159,-0.00328250031939793,0.00436063483469178
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPM3,Tropomyosin alpha-3 chain,40116,0.0129081901320576,0.00453008426758001,0.00402922496760081,0.0217871552965145,0.00438785911511738
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,40223,-0.0190393807474009,0.00668233211823964,-0.0321367516991506,-0.00594200979565119,0.00439088318982025
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",40182,-0.0113774060275054,0.00399395803261746,-0.0192055637714357,-0.00354924828357524,0.00439860994098355
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHGA,Chromogranin-A,40527,-0.0287296305351612,0.0100928487485957,-0.0485116140824087,-0.00894764698791366,0.00442774823619129
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCDHB15,Protocadherin beta-15,40451,-0.0118243327420937,0.00416096297429091,-0.0199798201717039,-0.00366884531248356,0.00449501314102834
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42676,0.0123520501780205,0.0043545466096378,0.00381713882313045,0.0208869615329106,0.00456665297310665
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF19,Fibroblast growth factor 19,42676,-0.0226047208793792,0.00797118647527402,-0.0382282463709162,-0.0069811953878421,0.00457785890589525
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,40451,-0.0122721960957548,0.004332597663645,-0.020764087516499,-0.00378030467501056,0.00462638196742058
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,40136,0.00849865228471116,0.00300089117662344,0.00261690557852923,0.0143803989908931,0.00463361218818813
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PALM,Paralemmin-1,40384,-0.0092012333888865,0.00325145822202942,-0.0155740915040642,-0.00282837527370884,0.00466485337107861
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42594,-0.0262051439924086,0.00926136064963791,-0.0443574108656989,-0.00805287711911826,0.00466881388122577
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCDH12,Protocadherin-12,40482,-0.00752781692032191,0.00266338976875122,-0.0127480608670743,-0.00230757297356951,0.00471565062189777
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HBQ1,Hemoglobin subunit theta-1,42721,0.017467409518749,0.00619544674282357,0.00532433390281482,0.0296104851346832,0.00481842486600752
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFHR2,Complement factor H-related protein 2,40451,-0.0167930592356084,0.00596439923900051,-0.0284832817440494,-0.00510283672716739,0.00487785780548971
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1QL2,Complement C1q-like protein 2,40199,0.0128123846175244,0.00455329001866753,0.003887936180936,0.0217368330541127,0.00490352377425482
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACRV1,Acrosomal protein SP-10,40199,-0.023293328314531,0.00828242194535802,-0.0395268753274327,-0.0070597813016293,0.00492632473327896
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,40080,0.0138634001582107,0.00492973769987202,0.00420111426646158,0.0235256860499599,0.00492922066406586
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42636,0.00821485162192566,0.00292155573622785,0.00248860237891907,0.0139411008649322,0.00493353691595875
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LIFR,Leukemia inhibitory factor receptor,42594,-0.00696097617224951,0.00247816578550911,-0.0118181811118474,-0.00210377123265165,0.00497795337087335
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK6,Kallikrein-6,42656,-0.00915437318882604,0.00326351131980002,-0.0155508553756341,-0.00275789100201799,0.00503779973254334
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,40451,-0.0150943391319021,0.00538406037534561,-0.0256470974675795,-0.00454158079622471,0.00506340721370491
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42636,-0.0141562614481716,0.00505180317740356,-0.0240577956758826,-0.00425472722046063,0.00508249370580817
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTRC,Chymotrypsin-C,42626,0.0190414909721726,0.00681775306434067,0.00567869496606483,0.0324042869782803,0.00523072681907995
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AHCY,Adenosylhomocysteinase,42636,-0.0191932662690456,0.00689224395810751,-0.0327020644269363,-0.00568446811115484,0.00536417807132166
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNTN2,Contactin-2,42721,0.012763038362312,0.00458477569713836,0.00377687799592083,0.0217491987287032,0.00538029143840825
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RGS10,Regulator of G-protein signaling 10,40482,-0.0169945579483672,0.0061094280659794,-0.0289690369576868,-0.00502007893904753,0.00541657617432169
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",40482,-0.0262874854500245,0.00945076680771955,-0.0448109883931549,-0.00776398250689422,0.00541949487662749
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,40199,-0.0101816710026735,0.00366218476903768,-0.0173595531499874,-0.00300378885535969,0.00544147368165467
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,40451,-0.0143465375934108,0.00516192683152741,-0.0244639141832045,-0.00422916100361704,0.00545667260815
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERC2,ERC protein 2,40182,-0.0217730618508107,0.00783642884593265,-0.0371324623888387,-0.00641366131278275,0.0054712997512857
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEPTIN9,Septin-9,42587,-0.00811984411707608,0.0029247045836559,-0.0138522651010416,-0.00238742313311052,0.00550585610427863
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLU,Clusterin,40539,0.00903148533322625,0.00325390444618448,0.00265383261870466,0.0154091380477478,0.00551928996024019
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,40449,-0.0123812921644715,0.00447529064256417,-0.0211528618238973,-0.00360972250504574,0.00567384613570459
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNASE3,Eosinophil cationic protein,42578,-0.0312591460998642,0.0113036597708995,-0.0534143192508272,-0.00910397294890115,0.00569308366198955
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",40080,-0.0165920865164838,0.00600414477867365,-0.0283602102826842,-0.00482396275028344,0.00572919177284261
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA13,Carbonic anhydrase 13,42483,-0.0291501629861397,0.0105574632778832,-0.0498427910107908,-0.00845753496148862,0.00576868909238983
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42636,0.00494520282457907,0.00180061185511004,0.00141600358856339,0.00847440206059475,0.00603331771809858
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARFIP1,Arfaptin-1,40482,-0.0192763832559907,0.00703568613315627,-0.033066328076977,-0.00548643843500442,0.00615728817201361
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42754,-0.0185353813011868,0.00676996485528442,-0.0318045124175443,-0.00526625018482934,0.00619164608568028
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42618,-0.00825237879437332,0.00302020818152034,-0.0141719868301532,-0.00233277075859345,0.00629594092325075
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDI2,Protein DDI1 homolog 2,40283,-0.0220672303661828,0.0080962305591308,-0.0379358422620792,-0.00619861847028648,0.00642820027895381
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RELB,Transcription factor RelB,40199,-0.0139866639469249,0.00513405882463991,-0.0240494192432191,-0.00392390865063066,0.00645416798329561
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL7,Interleukin-7,42594,-0.017672740024479,0.00649445385344813,-0.0304018695772373,-0.00494361047172068,0.00651284104870882
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENPEP,Glutamyl aminopeptidase,40116,0.0134104292560653,0.0049308275885182,0.0037460071825696,0.023074851329561,0.00654421815540507
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42711,0.00795295621305551,0.00292705670136206,0.00221592507838587,0.0136899873477252,0.00659507291155231
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MDM1,Nuclear protein MDM1,40182,-0.00875289526191721,0.00323084079447945,-0.0150853432190969,-0.00242044730473748,0.00675564243477477
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42558,-0.00976486584979657,0.003608820052125,-0.0168381531519616,-0.00269157854763158,0.00682196578698818
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,40483,-0.0668420910263057,0.0247123585300643,-0.115278313745232,-0.0184058683073798,0.00684471745220339
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CILP,Cartilage intermediate layer protein 1,40527,-0.015358206333408,0.00568835730356806,-0.0265073866484014,-0.00420902601841461,0.00694555616454056
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",40482,-0.0201105304210943,0.00748081903776206,-0.034772935735108,-0.00544812510708067,0.00719267066783008
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENG,Endoglin,42794,0.00480579414594078,0.00178900198501174,0.00129935025531778,0.00831223803656379,0.00723361768222903
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PKLR,Pyruvate kinase PKLR,42636,-0.0180380475896956,0.00671572029055332,-0.0312008593591801,-0.00487523582021108,0.0072414088788844
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,42346,-0.0120313455670845,0.00449934814041881,-0.0208500679223054,-0.00321262321186361,0.00750406597245719
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,40116,-0.0110471375497329,0.00413270880745524,-0.0191472468123452,-0.00294702828712063,0.00752658837574323
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRTAP,Cartilage-associated protein,40182,-0.0132184629651489,0.00494723364661753,-0.0229150409125193,-0.00352188501777855,0.00755366652571366
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",40116,-0.0107808172969497,0.00403558265362245,-0.0186905592980497,-0.00287107529584966,0.00756385521923805
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PODXL2,Podocalyxin-like protein 2,42679,0.00776662365883754,0.00291095125039348,0.00206115920806633,0.0134720881096088,0.00763794180789589
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPHA4,Ephrin type-A receptor 4,40283,-0.00803475021493451,0.00301439529433243,-0.0139429649918261,-0.00212653543804295,0.00769944638977585
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42794,-0.00861438826876306,0.00323464082008644,-0.0149542842761325,-0.00227449226139363,0.00775001803755681
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,40136,0.00935918058365829,0.0035180704849715,0.00246376243311416,0.0162545987342024,0.00781811215954311
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C9orf40,Uncharacterized protein C9orf40,40449,-0.0222241415997878,0.00838442228844042,-0.038657609285131,-0.00579067391444453,0.00804502427659081
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFNW1,Interferon omega-1,40116,0.0100877855533474,0.00381046255465297,0.0026192789462276,0.0175562921604672,0.00812318839027531
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42722,-0.00773641354348866,0.00292273704033774,-0.0134649781425506,-0.00200784894442669,0.00813093024414303
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FMR1,Synaptic functional regulator FMR1,42346,-0.00964502857262857,0.00364755138473127,-0.0167942292867019,-0.00249582785855529,0.0081969967730615
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F13B,Coagulation factor XIII B chain,40479,-0.00705030650531454,0.00266845993667237,-0.0122804879811924,-0.00182012502943669,0.00825102717391543
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42679,0.007480806959293,0.00283333654528737,0.00192746733052976,0.0130341465880562,0.0082932512823733
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HCG22,Protein PBMUCL2,40116,0.0155375723090611,0.00589240397319507,0.00398846052159872,0.0270866840965234,0.00837904373560429
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GBA,Lysosomal acid glucosylceramidase,40182,-0.015063296495744,0.00572381175754293,-0.0262819675405282,-0.00384462545095991,0.00850801193320896
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TXNL1,Thioredoxin-like protein 1,40124,-0.0268312480046403,0.01019588829088,-0.0468151890547651,-0.00684730695451544,0.00851093776945852
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,40483,-0.00766279464126696,0.00291765872054084,-0.013381405733527,-0.00194418354900692,0.00864223935088767
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,40532,-0.0073988362140762,0.00281725398951382,-0.0129206540335233,-0.00187701839462912,0.0086445348793084
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FBLN2,Fibulin-2,40527,0.00875915055664154,0.00336763645120675,0.00215858311227631,0.0153597180010068,0.00930789931460051
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",40116,-0.0105239050671515,0.00404974945798782,-0.0184614140048076,-0.00258639612949535,0.00937153073109312
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SAA4,Serum amyloid A-4 protein,40539,-0.0086828112807624,0.00334192699674307,-0.0152329881943788,-0.00213263436714599,0.00938500348353219
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,40116,-0.0119963459374026,0.00462198969569139,-0.0210554457409577,-0.00293724613384743,0.00945814546830354
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP13,Collagenase 3,42311,0.00890899394307403,0.00343858506313435,0.00216936721933071,0.0156486206668174,0.00958341861645699
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BPIFB2,BPI fold-containing family B member 2,40473,-0.0183579182460165,0.00709150751797928,-0.0322572729812559,-0.00445856351077709,0.0096457393811418
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RCC1,Regulator of chromosome condensation,40451,-0.0140193808007886,0.0054200027127804,-0.0246425861178382,-0.00339617548373902,0.0097052236473895
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCDH1,Protocadherin-1,42721,-0.00575624236472836,0.00222906160823169,-0.0101252031168625,-0.00138728161259425,0.00982309023814402
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",42311,-0.00745069056813967,0.00289282182600645,-0.0131206213471123,-0.00178075978916702,0.0100180929449201
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,40136,0.00862759289659216,0.00335711191582429,0.00204765354157655,0.0152075322516078,0.0101845806282491
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,QSOX1,Sulfhydryl oxidase 1,40342,-0.0114830952943049,0.0044742387637638,-0.0202526032712819,-0.00271358731732783,0.0102862555859024
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPON1,Spondin-1,42638,-0.00894249059616634,0.00349101242275136,-0.015784874944759,-0.00210010624757367,0.0104306775478703
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ELAVL4,ELAV-like protein 4,40136,-0.0224933545317057,0.00878274786233941,-0.0397075403418909,-0.00527916872152042,0.0104479029693641
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC39A14,Zinc transporter ZIP14,42311,-0.00906279126428228,0.0035589652299883,-0.0160383631150594,-0.00208721941350522,0.010893244913567
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,40539,0.00670157120023699,0.00263850264611291,0.00153010601385568,0.0118730363866183,0.011101180435332
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,40182,-0.0134370698631204,0.00529130089946621,-0.0238080196260742,-0.00306612010016661,0.0111158996989113
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NDRG1,Protein NDRG1,42311,-0.0170262003823338,0.00671354898601256,-0.0301847563949185,-0.00386764436974923,0.0112211220728803
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLXDC1,Plexin domain-containing protein 1,42346,-0.0082311681906826,0.00324647316264331,-0.0145942555894635,-0.00186808079190172,0.0112427872650471
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLB,Beta-klotho,42311,0.019421811266581,0.00768353881926215,0.00436207518082722,0.0344815473523348,0.0114923292246376
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,42292,-0.0125673376771664,0.00498162855928435,-0.0223313296533637,-0.00280334570096907,0.0116562953712566
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAMA4,Laminin subunit alpha-4,42676,-0.00856756415520719,0.00340662107184813,-0.0152445414560295,-0.00189058685438485,0.0119156455591398
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42706,-0.00762638511553318,0.00303243556184904,-0.0135699588167573,-0.00168281141430907,0.0119168691261899
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42698,-0.0168603896223597,0.0067269969851924,-0.0300453037133368,-0.00367547553138257,0.0122092131056099
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42611,-0.0305795275034844,0.0122070566557316,-0.0545053585487183,-0.00665369645825036,0.0122544842812046
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRND,Prion-like protein doppel,40483,-0.0134632966533926,0.00539881970556753,-0.024044983276305,-0.00288161003048025,0.012654418039186
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYOM2,Myomesin-2,40116,0.012982228374786,0.00520977329192767,0.0027710727226078,0.0231933840269643,0.0127209333828959
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCL2,Apoptosis regulator Bcl-2,40449,-0.0146846445445952,0.0059018336563652,-0.026252238511071,-0.00311705057811942,0.0128553268838872
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MSMB,Beta-microseminoprotein,42559,-0.0185263695637225,0.0074495549910051,-0.0331274973460926,-0.00392524178135254,0.01289792279843
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,42311,-0.0123533877502237,0.00498792077327485,-0.0221297124658424,-0.00257706303460494,0.0132743009804739
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42711,-0.00592597323039932,0.00239466691221687,-0.0106195203783444,-0.00123242608245425,0.0133486889027444
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NXPH1,Neurexophilin-1,42311,-0.00992476988398472,0.00401067406616899,-0.0177856910536759,-0.0020638487142935,0.0133515073241732
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CGN,Cingulin,40182,-0.0105271986504906,0.00425753527938834,-0.0188719677980917,-0.00218242950288942,0.0134282906218417
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CGA,Glycoprotein hormones alpha chain,42611,0.0160202485126044,0.00648137509327052,0.00331675332979414,0.0287237436954146,0.013458191208365
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RP2,Protein XRP2,42587,-0.0106409090751569,0.00430941834306624,-0.0190873690275667,-0.00219444912274705,0.013553112686824
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,40449,-0.0142277311969231,0.00579418341227466,-0.0255843306849814,-0.00287113170886473,0.0140831164960896
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,40116,-0.011163662101759,0.00455307504573149,-0.0200876891913928,-0.00223963501212532,0.014226154391025
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASP8,Caspase-8,42674,-0.015402256349114,0.00628518873355051,-0.027721226266873,-0.00308328643135498,0.0142758820979947
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,40482,-0.00985642775917156,0.00403357587116093,-0.017762236466647,-0.00195061905169614,0.0145569287828853
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,40283,0.0109300742054837,0.00447480794578828,0.00215945063173863,0.0197006977792287,0.0145982183824111
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DLGAP5,Disks large-associated protein 5,40482,0.0128092669620155,0.00524783040134999,0.00252351937536956,0.0230950145486615,0.0146672282422363
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRH,Corticoliberin,42322,-0.0215605251824504,0.00883675086225078,-0.0388805568724619,-0.00424049349243886,0.0147056802596092
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCND2,G1/S-specific cyclin-D2,40302,0.00929089798654382,0.0038127202736161,0.00181796625025626,0.0167638297228314,0.0148328082327359
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42689,0.00900268791828289,0.00370470798419108,0.00174146026926837,0.0162639155672974,0.0151089896657781
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,42346,-0.0200586960112008,0.00828726728874743,-0.0363017398971458,-0.00381565212525585,0.0155158995739839
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TEX101,Testis-expressed protein 101,40182,-0.0131674481448727,0.00546674113906597,-0.023882260777442,-0.00245263551230345,0.0160281426730224
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,40482,-0.00807791059569526,0.00335514386744578,-0.014653992575889,-0.00150182861550154,0.0160728361826594
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42674,-0.00861984130092293,0.0035843868050746,-0.0156452394388692,-0.00159444316297671,0.0161933815095633
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB2B,Ras-related protein Rab-2B,40451,-0.0149669178053365,0.00623356416227128,-0.0271847035633882,-0.00274913204728481,0.0163655225582577
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",40136,-0.0080368253945047,0.00335286581485112,-0.0146084423916129,-0.0014652083973965,0.0165465112623042
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39940,-0.0262910199121852,0.0109839028851516,-0.0478194695670824,-0.00476257025728812,0.0167011860403638
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,40136,0.0152023147366345,0.0063716106042788,0.00271395795224801,0.0276906715210209,0.0170521848261284
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,42311,-0.0366643133700049,0.0153896398196968,-0.0668280074166106,-0.00650061932339929,0.0172142575007107
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARG1,Arginase-1,42488,-0.0126607295681506,0.00531619708681073,-0.0230804758582997,-0.00224098327800161,0.017254463776037
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42572,0.00836280412837378,0.00351662542329898,0.00147021829870777,0.0152553899580398,0.0174171779791417
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,40116,-0.0204936297777448,0.00863925460780471,-0.037426568809042,-0.00356069074644754,0.0177020145681992
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,42346,0.00748813630646557,0.00316184392299978,0.00129092221738601,0.0136853503955451,0.017885309156541
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,42587,0.0099418758867995,0.00422634028716072,0.0016582489239645,0.0182255028496345,0.0186690778613823
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GSR,"Glutathione reductase, mitochondrial",40490,-0.00546029300309128,0.00232363735448246,-0.0100146222178769,-0.000905963788305653,0.0187960564454502
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK3,Prostate-specific antigen,40527,0.0237321924595164,0.0101272228891618,0.00388283559675916,0.0435815493222736,0.0191257806263598
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42794,0.00832857248091403,0.00355709060451855,0.00135667489605767,0.0153004700657704,0.0192259239408296
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD99,CD99 antigen,42611,0.00485309814669569,0.0020783682518582,0.000779496373053622,0.00892669992033776,0.0195553652598446
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LBP,Lipopolysaccharide-binding protein,42689,0.0141086264403319,0.00604218794899337,0.00226593806030485,0.0259513148203589,0.0195569859240598
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLC,Galectin-10,42611,0.0158020151892711,0.00677974693188273,0.00251371120278095,0.0290903191757612,0.0197803522326007
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ROBO2,Roundabout homolog 2,42711,0.00560235153712415,0.00240652572406672,0.000885561117953373,0.0103191419562949,0.0199276731189158
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42636,0.027569368428327,0.0118647176616963,0.00431452181140227,0.0508242150452518,0.0201594706788248
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,40199,-0.0199713717531878,0.00860297168709505,-0.0368331962598941,-0.00310954724648154,0.0202807184588136
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G1B,Phospholipase A2,42782,0.0108843816850932,0.00469410918717938,0.00168392767822157,0.0200848356919648,0.0204243273499942
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,40199,-0.00580977408834573,0.00251399347795038,-0.0107372013051285,-0.000882346871562993,0.0208526693571718
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RPS10,40S ribosomal protein S10,40116,0.00969380414584644,0.00420910338046776,0.00144396152012963,0.0179436467715632,0.0212943458111933
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,42311,0.0133481557569731,0.00579850380511858,0.0019830882989407,0.0247132232150055,0.0213507597293585
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42689,-0.0161890620095411,0.0070330965392813,-0.0299739312265325,-0.0024041927925498,0.0213593579448395
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GC,Vitamin D-binding protein,40539,-0.00612817999214122,0.00266896124536137,-0.0113593440330495,-0.000897015951232923,0.0216887773201852
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLSTN3,Calsyntenin-3,40483,-0.00725560796563566,0.00316050955324702,-0.0134502066899998,-0.00106100924127149,0.0217108077840521
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NLGN2,Neuroligin-2,40136,0.0114048391170707,0.00497051988682344,0.0016626201388968,0.0211470580952447,0.021780857273678
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42495,-0.0144713456739741,0.00634369508968896,-0.0269049880497645,-0.00203770329818378,0.0225513382186914
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,40470,-0.00961983474708438,0.00422403993514774,-0.017898953019974,-0.0013407164741948,0.0227809014097349
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,40283,0.00628731780395047,0.00276253298066772,0.000872753161841733,0.0117018824460592,0.022869484457267
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INHBB,Inhibin beta B chain,40283,0.0128049681413206,0.00563926230706035,0.00175201401948235,0.0238579222631589,0.023185364046749
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA1,Alpha-1-antitrypsin,40327,0.00191300914532081,0.000843256494052074,0.000260226416978746,0.00356579187366288,0.0233119060091293
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EDNRB,Endothelin receptor type B,40199,-0.0104509720949253,0.00460739520465773,-0.0194814666960544,-0.00142047749379614,0.0233299850439406
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SDHB,Succinate dehydrogenase,40449,-0.0155075545581004,0.00684187060298816,-0.0289176209399572,-0.00209748817624357,0.0234356181212485
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,40483,-0.00791420879063969,0.00349289133304806,-0.0147602758034139,-0.00106814177786549,0.0234822126625651
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,42425,0.0399020321541806,0.0176845217212881,0.00524036958045592,0.0745636947279053,0.024066524382082
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GJA8,Gap junction alpha-8 protein,40080,-0.0152221551271513,0.00674938506150472,-0.0284509498477005,-0.00199336040660206,0.024131798277534
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLSTN1,Calsyntenin-1,42311,0.0123362478542667,0.00547993852655294,0.0015955683422229,0.0230769273663104,0.0243915496586908
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42586,0.0138966908037897,0.00623660398458423,0.0016729469940046,0.0261204346135748,0.0258806224752257
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42611,0.00543986652556991,0.00244157013400709,0.000654389062916022,0.0102253439882238,0.0258957083765934
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42754,-0.00815368326508264,0.00366866506626204,-0.0153442667949562,-0.000963099735209049,0.0262645812485861
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC4A1,Band 3 anion transport protein,40527,-0.0107387349859242,0.00483644564692937,-0.0202181684539057,-0.00125930151794259,0.0264128567330287
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,42495,0.0118147796322967,0.00534283172902249,0.00134282944341261,0.0222867298211808,0.0270297335260381
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INSL3,Insulin-like 3,40483,0.0177868072056473,0.00806356297194801,0.00198222378062923,0.0335913906306654,0.0274163408576726
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEMA3G,Semaphorin-3G,40283,-0.0101820809836703,0.00462797333566681,-0.0192529087215773,-0.00111125324576339,0.0278191735317927
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42495,0.0155753201384447,0.00708193787926304,0.00169472189508913,0.0294559183818002,0.0278736020656425
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTNNA1,Catenin alpha-1,40136,0.00797799222249016,0.00363746356565188,0.000848563633812479,0.0151074208111678,0.0283078598512373
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANXA4,Annexin A4,42584,-0.0160347255659401,0.00732860715996843,-0.0303987955994783,-0.00167065553240202,0.0286894785386737
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDIA2,Protein disulfide-isomerase A2,40080,0.00948591932312365,0.00435885165590689,0.000942570077546154,0.0180292685687011,0.0295585403184391
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,40182,0.00833979681298533,0.00384175664148928,0.000809953795666341,0.0158696398303043,0.0299654368279408
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,40199,-0.0139030323756868,0.0064182619481654,-0.0264828257940909,-0.00132323895728258,0.0303197654165546
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,42611,-0.00741674891797114,0.00343175386928418,-0.0141429865017681,-0.000690511334174154,0.0306965717493548
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",40483,-0.0121000712539201,0.0056073503716057,-0.0230904779822672,-0.00110966452557288,0.0309570479320776
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",40302,-0.0157406175001014,0.00730424375907677,-0.0300569352678919,-0.00142429973231095,0.0311835550603632
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PALM3,Paralemmin-3,40116,-0.0159277789476822,0.00739652737131448,-0.0304249725954586,-0.00143058529990578,0.0313080466519487
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,40451,-0.0103236528177026,0.00482442863681814,-0.0197795329458661,-0.000867772689539021,0.0323866631281692
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MRC1,Macrophage mannose receptor 1,40532,-0.00645691971072191,0.00302086121577912,-0.012377807693649,-0.000536031727794834,0.0325832768369935
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEMA6C,Semaphorin-6C,40199,-0.00579421634766236,0.00271219633310233,-0.0111101211605429,-0.000478311534781788,0.0326724193447274
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42781,-0.0130248934346819,0.00610857514748099,-0.0249977007237446,-0.00105208614561913,0.0330057402174941
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH6,Cadherin-6,42636,0.00847680337819994,0.00398378199942359,0.000668590659329705,0.0162850160970702,0.0333694814846947
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,40302,-0.00982727870522972,0.00461997007727558,-0.0188824200566899,-0.000772137353769589,0.0334312229818575
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,40182,-0.0234910346654622,0.0110975537976081,-0.045242240108774,-0.00173982922215044,0.0343012841905645
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42582,-0.00741569926045737,0.00350531388276262,-0.0142861144706721,-0.000545284050242638,0.0344007249758389
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD99L2,CD99 antigen-like protein 2,42611,-0.0052421202178713,0.00249018047018568,-0.0101228739394352,-0.000361366496307368,0.0352997024617327
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP10,Stromelysin-2,42608,0.0126891109284831,0.0060447941314211,0.000841314430897768,0.0245369074260685,0.0358196765331821
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,42315,0.00627927714865991,0.002992125791431,0.000414710597455147,0.0121438436998647,0.0358711840347982
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSF3,Granulocyte colony-stimulating factor,42370,-0.0105023497457725,0.0050245922257694,-0.0203505505082806,-0.000654148983264496,0.0366199037668781
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,42311,0.0132097973928025,0.00632486914689907,0.000813053864880342,0.0256065409207247,0.0367675975941583
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,40527,0.0110538568735317,0.0052955815066327,0.000674517120531576,0.0214331966265318,0.0368766612815701
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCG3,Secretogranin-3,42638,0.00733250716161956,0.00351953672272201,0.000434215185084429,0.0142307991381547,0.0372360986952919
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ALCAM,CD166 antigen,42794,-0.00420638855625584,0.00202187856292478,-0.00816927053958841,-0.000243506572923265,0.0375042520702176
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100A13,Protein S100-A13,40199,-0.00762310853904247,0.00367507437058809,-0.0148262543053951,-0.000419962772689812,0.0380771324642328
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL31,Interleukin-31,40199,0.0120590029613109,0.00582399736952897,0.000643968117034099,0.0234740378055877,0.0384221211508216
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MUC16,Mucin-16,42587,-0.0408518408943309,0.0197600932283085,-0.0795816236218155,-0.00212205816684632,0.038716480034903
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,40116,-0.0128853116472563,0.00623638745276208,-0.02510863105467,-0.000661992239842634,0.0388378458150801
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THBS4,Thrombospondin-4,42652,0.0097109138357335,0.00470922495354833,0.000480832926778781,0.0189409947446882,0.0392169424518966
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CBLN4,Cerebellin-4,42721,-0.00688628882828106,0.0033429668021941,-0.0134385037605815,-0.000334073895980624,0.0394239990023249
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EFHD1,EF-hand domain-containing protein D1,40482,0.00767392718692365,0.00372723502164824,0.000368546544493111,0.0149793078293542,0.0395286904300993
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MSLN,Mesothelin,42553,-0.0126328204926728,0.00613789397573534,-0.0246630926851141,-0.000602548300231513,0.0395933078312234
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GFRA3,GDNF family receptor alpha-3,42474,0.00608176793986135,0.00295656765072385,0.000286895344442603,0.0118766405352801,0.0397021891787797
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CST6,Cystatin-M,42332,-0.0106952429100854,0.00521352158970216,-0.0209137452259017,-0.000476740594269194,0.040243597979929
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL1B,Interleukin-1 beta,42293,-0.0119171286954475,0.00584544260062984,-0.023374196192682,-0.000460061198213011,0.0414995894761688
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,H2AP,Huntingtin-interacting protein M,40080,0.011103666887846,0.00544793874720863,0.000425706943317087,0.0217816268323749,0.0415599621355642
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,40199,-0.0123133079694704,0.00604185282900082,-0.024155339514312,-0.000471276424628809,0.0415735977140195
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,40116,0.00819709526682167,0.00404903394537886,0.000260988733879104,0.0161332017997642,0.042947435599535
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GKN1,Gastrokine-1,42017,-0.00585476563223061,0.00289630089601063,-0.0115315153884115,-0.000178015876049772,0.0432525719148616
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,42559,0.00449875072774893,0.00222667526563473,0.000134467207104873,0.008863034248393,0.0433629366023715
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MSLNL,Mesothelin-like protein,40182,0.0082153500853493,0.00406693673542206,0.000244154083922048,0.0161865460867765,0.0434040909729155
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRR5,Proline-rich protein 5,40199,-0.0099736886294005,0.00493939273702761,-0.0196548983939746,-0.000292478864826381,0.0434892279648398
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FBN2,Fibrillin-2,40182,-0.0126902917349531,0.00629129025498955,-0.0250212206347326,-0.000359362835173608,0.043707191382082
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL36G,Interleukin-36 gamma,40154,-0.0143355687166442,0.00711047523437484,-0.0282721001760188,-0.000399037257269473,0.0438118185665397
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LCN15,Lipocalin-15,40482,-0.0130078849983189,0.00646553552043577,-0.025680334618373,-0.000335435378264746,0.0442562484876037
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,42448,-0.00451495543273749,0.00224595530043642,-0.00891702782159288,-0.000112883043882107,0.0444238365974001
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IMPA1,Inositol monophosphatase 1,42495,-0.0124521187766169,0.0061971936592023,-0.0245986183486534,-0.00030561920458038,0.0445238228337993
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GM2A,Ganglioside GM2 activator,40269,-0.00844084154093844,0.00422091068603901,-0.0167138264855749,-0.000167856596301988,0.0455497165171845
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCRL5,Fc receptor-like protein 5,42611,-0.0121001572022978,0.00606534983402304,-0.023988242876983,-0.000212071527612677,0.046066950690249
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC1A4,Neutral amino acid transporter A,40182,-0.0107325844416015,0.0053842086941962,-0.0212856334822261,-0.000179535400976965,0.0462483861881916
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRNN,Cornulin,42209,0.0141610676193812,0.00710907352277058,0.000227283514750829,0.0280948517240115,0.0463951087297262
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VCAM1,Vascular cell adhesion protein 1,42663,-0.00570811888261474,0.00287655386602688,-0.0113461644600274,-7.00733052020602e-05,0.0472359645607492
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CBLN1,Cerebellin-1,40136,0.0194416710417475,0.00981478175730586,0.000204698797428057,0.038678643286067,0.047632403508057
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,40287,0.0102570003245883,0.00518606002412436,9.23226773045446e-05,0.020421677971872,0.0479757468385119
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RGMA,Repulsive guidance molecule A,42711,0.00651026357066266,0.00329382758569251,5.4361502705335e-05,0.01296616563862,0.048118012206441
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGB7,Integrin beta-7,42721,0.00935913882612919,0.00473842193931416,7.18318250734346e-05,0.0186464458271849,0.0482703551777731
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",40482,0.00912284446912143,0.00462510128488512,5.7645950746598e-05,0.0181880429874963,0.0485810621333609
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,42357,0.00624556071621345,0.00317050270073315,3.13754227764763e-05,0.0124597460096504,0.0488712181866475
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB39B,Ras-related protein Rab-39B,40116,-0.0187779081666902,0.00954308916888288,-0.0374823629377006,-7.34533956797435e-05,0.0491281714554292
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,40482,-0.010038338186563,0.00510529878579145,-0.0200447238067142,-3.19525664117248e-05,0.0492932009979989
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RLN1,Prorelaxin H1,40482,-0.00982246545834395,0.00500131644483904,-0.0196250456902285,-1.98852264594266e-05,0.0495573784186873
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EP300,Histone acetyltransferase p300,40199,-0.00628021140175989,0.00319910657187009,-0.0125504602826253,-9.96252089452594e-06,0.0496580580342203
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD109,CD109 antigen,42611,0.00673623214894058,0.00346065866036318,-4.66588253712633e-05,0.0135191231232524,0.0516134688712156
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GHRL,Appetite-regulating hormone,42636,-0.0169786821816164,0.00872838726122816,-0.0340863212136236,0.000128956850390813,0.0517686559891734
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",42346,-0.0154686130500577,0.00795363596551861,-0.0310577395424742,0.000120513442358769,0.0518145600981416
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",40223,-0.0051390769138406,0.00264707141632176,-0.0103273368898313,4.91830621500468e-05,0.052232812891865
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PFDN2,Prefoldin subunit 2,42311,-0.0110778856445728,0.00570717925995833,-0.0222639569940911,0.000108185704945543,0.052274341952698
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ABO,Histo-blood group ABO system transferase,40532,0.0291595231982461,0.0150297396077456,-0.000298766432935232,0.0586178128294274,0.0523896706914961
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,40199,-0.0127960811806149,0.0065957224809679,-0.025723697243312,0.000131534882082189,0.0523982099913678
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERVV_1,,40116,0.0087502691505658,0.00451195442851747,-9.31615293284314e-05,0.01759369983046,0.052484174274843
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FXN,"Frataxin, mitochondrial",42721,-0.0145432196459063,0.0075041586753186,-0.0292513706495308,0.000164931357718156,0.052641401470272
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TUBB3,Tubulin beta-3 chain,40136,0.00563154606676135,0.00290923246630723,-7.05495672008111e-05,0.0113336417007235,0.0529240835821855
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PALLD,Palladin,40199,0.00777494347894681,0.00402781663074024,-0.000119577117304067,0.0156694640751977,0.0535938332236601
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,40199,-0.00888765316002086,0.00460987678297089,-0.0179230116546438,0.000147705334602094,0.0538859330849004
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42611,-0.0074707103515736,0.003880383096739,-0.015076261221182,0.000134840518034843,0.0542191126501597
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,40080,-0.00575835404276325,0.00299180262820603,-0.0116222871940471,0.000105579108520571,0.0542916118780618
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42613,-0.00938402246436786,0.00488718243678025,-0.0189629000404571,0.000194855111721428,0.0548627352702086
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,40182,0.00722695345299529,0.00376591040612186,-0.000154230943003564,0.0146081378489941,0.0550044485621231
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNNI3,"Troponin I, cardiac muscle",42357,-0.0166953585966535,0.00870720637516423,-0.0337614830919754,0.000370765898668423,0.0552064044720399
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",40482,0.00808579696709132,0.00421818550061429,-0.000181846614112687,0.0163534405482953,0.0552771445338257
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,40136,0.00627358760152539,0.0032736049687842,-0.000142678137291646,0.0126898533403424,0.0553382399357277
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,40116,0.00812370356035992,0.00424327702676103,-0.000193119412091708,0.0164405265328115,0.0555839111056235
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42649,0.00422119134010863,0.00220637638037231,-0.000103306365421095,0.00854568904563836,0.0557464357712258
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1S,Complement C1s subcomponent,40539,-0.00409722596257554,0.00214363422719914,-0.00829874904788585,0.000104297122734779,0.0559853461778804
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,40302,-0.0106618343690064,0.00558455979550465,-0.0216075715681955,0.000283902830182684,0.0562668198703176
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,40199,-0.00610665728886561,0.00320908033499879,-0.0123964547454632,0.000183140167732018,0.0570756671827817
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,40451,0.0103569618607657,0.00544356139073958,-0.000312418465083923,0.0210263421866152,0.0571172441768476
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,42587,0.00664043588869059,0.00349068455495103,-0.000201305839013416,0.0134821776163946,0.0571493826488476
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,40182,-0.0150417145517774,0.00796092350364636,-0.0306451246189243,0.000561695515369482,0.0588587401503276
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42794,0.00441564452935606,0.00234118580227317,-0.000173079643099352,0.00900436870181147,0.0593065685700751
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TAGLN3,Transgelin-3,40080,-0.0118850926973163,0.00634043967119043,-0.0243123544528495,0.000542169058216954,0.06088963441241
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,42495,-0.011268961267208,0.00604031599500185,-0.0231079806174117,0.000570058082995577,0.0621159220841632
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,40080,-0.00519053846846919,0.00278220597801217,-0.0106436621853731,0.000262585248434668,0.0621214592417811
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD300LF,CMRF35-like molecule 1,42721,-0.0116538685220659,0.0062630113617032,-0.0239293707910042,0.00062163374687233,0.0628018448335289
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,40182,-0.0145976894310173,0.00785541821333589,-0.0299943091291556,0.000798930267121065,0.0631537660127692
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STAM,Signal transducing adapter molecule 1,40451,-0.00717017506420433,0.00385876089288822,-0.0147333464142652,0.000392996285856576,0.0631731218713702
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,40136,0.0113793767826513,0.00612425759546846,-0.000624168104466879,0.0233829216697695,0.0631841170043237
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,40511,-0.00567252708582127,0.00305348991461161,-0.01165736731846,0.000312313146817495,0.0632348431021773
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL17RA,Interleukin-17 receptor A,42611,-0.00840383076927392,0.00452544155176616,-0.0172736962107356,0.000466034672187759,0.0633303555736197
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBP1,Retinol-binding protein 1,40182,-0.0130559375598035,0.00706094435327813,-0.0268953884922286,0.000783513372621629,0.0644795129674588
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,40449,-0.00521076754688533,0.00282035440335497,-0.0107386621774611,0.000317127083690406,0.0646925747557972
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42611,0.00651831646805421,0.00354436560479801,-0.000428640117349885,0.0134652730534583,0.0659278046195077
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,40511,0.00745673134198138,0.00407454466351714,-0.00052937619851221,0.015442838882475,0.067264682275311
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF16,Fibroblast growth factor 16,40199,-0.00892863005745393,0.0048922880728319,-0.0185175146802044,0.000660254565296592,0.0680218205590521
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,40116,0.0112759765886933,0.00619324278455911,-0.000862779269042515,0.0234147324464292,0.0686813097528205
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,42292,0.010525577945765,0.00580205165539053,-0.000846443298800426,0.0218975991903305,0.0696831844962348
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SAT1,Diamine acetyltransferase 1,40116,0.00963674881813027,0.00531264563287311,-0.000776036622301026,0.0200495342585616,0.0697164676073062
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CYB5A,Cytochrome b5,40080,-0.0136599534858284,0.0075605669930044,-0.028478664792117,0.00115875782046024,0.0708309512666128
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL20,Interleukin-20,42370,0.00913378513633309,0.00506027404810427,-0.000784351997951276,0.0190519222706175,0.0710977963776046
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,40511,-0.0138477872008862,0.00768824110808494,-0.0289167397727327,0.00122116537096033,0.0717035600953471
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,42346,-0.00883865025951353,0.00490938541736456,-0.0184610456775481,0.00078374515852102,0.071827065917703
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SH3GL3,Endophilin-A3,40250,-0.0158622100952717,0.0088185619416405,-0.0331465915008871,0.00142217131034368,0.0720886974067138
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42635,0.00692903471726261,0.00387233093619137,-0.000660733917672483,0.0145188033521977,0.0735776751584925
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,40136,0.00557513180107335,0.00312145852937149,-0.000542926916494761,0.0116931905186415,0.0741162100836148
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL33,Interleukin-33,42370,-0.00712052305633406,0.00398837133504663,-0.0149377308730255,0.000696684760357338,0.0742322609727499
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,42311,-0.0156941410250394,0.00882008354026638,-0.0329815047639615,0.00159322271388269,0.0752032181095995
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,40451,-0.006132117799974,0.00345717010193527,-0.0129081711997671,0.000643935599819143,0.0761333431571976
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,40136,0.0143906347322023,0.00811403848654543,-0.00151288070142677,0.0302941501658313,0.076165794400969
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPC5,Glypican-5,42495,-0.010230045842958,0.00577240377160812,-0.0215439572353099,0.00108386554939388,0.0763787346919637
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,40080,-0.00672279984768679,0.00380217156266611,-0.0141750561105124,0.000729456415138773,0.0770642653024744
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BRDT,Bromodomain testis-specific protein,40116,-0.00678262188710304,0.00384057757725849,-0.0143101539385297,0.000744910164323598,0.0774167093755171
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ECE1,Endothelin-converting enzyme 1,42311,0.00644429494102587,0.00366584980569793,-0.000740770678142067,0.0136293605601938,0.0787833178026341
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,42370,-0.00670024106657284,0.00381516079797606,-0.0141779562306059,0.000777474097460232,0.079075003804896
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,40302,-0.010356142115283,0.00591964264453504,-0.0219586416985716,0.00124635746800569,0.0802401994550378
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPESP1,Sperm equatorial segment protein 1,40511,-0.00573100651282727,0.00327878823126636,-0.0121574314461093,0.000695418420454793,0.0805077990601206
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",40199,-0.00782174451686474,0.00447558053294731,-0.0165938823614415,0.000950393327711978,0.0805526877313242
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ICAM2,Intercellular adhesion molecule 2,42794,-0.00582371100123691,0.00333671669306468,-0.0123636757196437,0.000716253717169855,0.0809479797127337
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TREML1,Trem-like transcript 1 protein,40532,-0.00939086797352029,0.00541568803823172,-0.0200056165284545,0.00122388058141388,0.0829431380267508
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCC,Netrin receptor DCC,40182,-0.00415075102881499,0.00239395885952842,-0.00884291039349069,0.000541408335860715,0.0829738281255808
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,YY1,Transcriptional repressor protein YY1,40199,-0.00504979856213723,0.00291347056360883,-0.0107602008668105,0.000660603742536068,0.0830776861362844
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,40182,0.00678227863262379,0.00391541830331656,-0.000891941241876669,0.0144564985071243,0.0832664282193923
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42607,0.00396852371857425,0.00229214052913016,-0.00052407171852087,0.00846111915566937,0.0834103144384507
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGL1,Fibrinogen-like protein 1,40532,0.0117336227837737,0.00679096571126383,-0.00157667001030337,0.0250439155778508,0.0840462407515183
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SDK2,Protein sidekick-2,40283,-0.00721285232869055,0.00417832001646522,-0.0154023595609624,0.000976654903581283,0.0843291206701291
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA12,Carbonic anhydrase 12,42587,-0.0058772268831342,0.00340810500308873,-0.0125571126891881,0.000802658922919715,0.0846433487910064
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NTF4,Neurotrophin-4,42346,-0.00690419872251225,0.00401887051892831,-0.0147811849396117,0.000972787494587237,0.0858301761047151
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,40116,-0.00714630585923509,0.0041626313546803,-0.0153050633144085,0.0010124515959383,0.0860484490519499
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42711,-0.0081918557284465,0.00478609560518565,-0.0175726031146104,0.00118889165771738,0.0869943314931862
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,40302,-0.0115049846125477,0.00673228489524126,-0.0247002630072205,0.00169029378212519,0.0874923741276912
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,40182,-0.00703239026729331,0.00412602607924093,-0.0151194013826055,0.00105462084801892,0.088335043336362
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC13A1,Solute carrier family 13 member 1,40451,-0.0110108190028005,0.00646415088641298,-0.0236805547401699,0.00165891673456898,0.0885270783123966
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,42346,-0.00831750194043188,0.00488792182916338,-0.0178978287255921,0.00126282484472834,0.08884579424062
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK10,Kallikrein-10,42636,-0.00709023411598012,0.00417627505336509,-0.0152757332205757,0.00109526498861545,0.089579769509848
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42676,-0.0100406683149088,0.00591599150491567,-0.0216360116645435,0.00155467503472595,0.0896804175577145
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOE,Apolipoprotein E,40539,0.0126557412143406,0.00749804226865522,-0.00204042163222362,0.0273519040609048,0.0914631452201394
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TOP1,DNA topoisomerase 1,40449,-0.0195429577493957,0.0115830448895516,-0.0422457257329168,0.00315981023412536,0.0915918746215938
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL11,Interleukin-11,42370,0.0108635030267822,0.00644910260250809,-0.00177673807413368,0.023503744127698,0.0921090720582619
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",40199,-0.0111572799305329,0.00665531564822474,-0.0242016986010534,0.00188713873998757,0.093679190988054
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,40302,0.0120965734410307,0.00721693477314712,-0.00204861871433764,0.0262417655963991,0.0937394471747705
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL17D,Interleukin-17D,42370,-0.00592315336024932,0.00354273747146048,-0.0128669188043119,0.00102061208381322,0.0945649714561338
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARG2,"Arginase-2, mitochondrial",40451,-0.00737803324523182,0.0044140754755006,-0.016029621177213,0.00127355468674936,0.0946549522065362
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,42311,0.00678722868895023,0.00407961351960608,-0.00120881380947769,0.0147832711873782,0.0961974761898388
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,40223,-0.0048516016486778,0.00291727623862617,-0.0105694630763851,0.000866259779029495,0.0963290980115645
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,40199,0.0155223618283944,0.00936054271270393,-0.00282430188850535,0.0338690255452941,0.0972903023884984
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPN1,Epsin-1,40302,-0.00762362999092259,0.00459910021821839,-0.0166378664186306,0.00139060643678547,0.0974193767581022
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,40302,0.00495264406844291,0.00299285426281942,-0.000913350286683153,0.010818638423569,0.0979886584426369
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DKKL1,Dickkopf-like protein 1,42587,0.0149548988695826,0.00905214706175188,-0.00278730937145111,0.0326971071106163,0.0985410603734709
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,40199,-0.00915431476602653,0.00554480734806327,-0.0200221371682305,0.00171350763617748,0.0987730804418451
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,40116,0.0082550137154118,0.00500419814025856,-0.00155321463949497,0.0180632420703186,0.0990499135151878
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",40116,0.0073847374022854,0.00447768322840828,-0.00139152172539483,0.0161609965299656,0.0991289214152759
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGB2,Integrin beta-2,42569,0.00484475243575059,0.00294172873635229,-0.000921035887499889,0.0106105407590011,0.09960073995606
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EFNB2,Ephrin-B2,40182,-0.00926707405490982,0.00563767456453991,-0.020316916201408,0.00178276809158841,0.100251093017487
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC12A2,Solute carrier family 12 member 2,40116,0.00462295558775574,0.00281620235465361,-0.000896801027365335,0.0101427122028768,0.10071071759956
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGB6,Integrin beta-6,42370,0.00526916226494117,0.00321125481183776,-0.00102489716626085,0.0115632216961432,0.10085405367821
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFD,Complement factor D,40539,-0.00354151375990963,0.00216412424450405,-0.00778319727913757,0.000700169759318317,0.101770025370619
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,40116,0.00546522554980862,0.00335769103377562,-0.0011158488763916,0.0120462999760088,0.103622926703849
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,42592,0.00818368359509809,0.00504268504752925,-0.00169997909805923,0.0180673462882554,0.104638125237537
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAP,Prolyl endopeptidase FAP,42794,0.00455635419976956,0.00280871627151195,-0.000948729692393857,0.010061438091933,0.104779545243647
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OTOA,Otoancorin,40136,0.00915839987857102,0.00565171223044431,-0.00191895609309982,0.0202357558502419,0.105161317643574
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",42311,-0.00882921190192924,0.00545653292904633,-0.01952401644286,0.00186559263900156,0.105665251321032
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,42357,-0.00463051522748782,0.00286190673335371,-0.0102398524248611,0.000978821969885447,0.10569031274026
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRP2BP,LRP2-binding protein,40182,-0.0144173549250132,0.00891665948748041,-0.0318940075204748,0.00305929767044841,0.105928375691325
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NEFL,Neurofilament light polypeptide,42262,-0.00770627821504504,0.00477051369330227,-0.0170564850539175,0.00164392862382741,0.106248676522237
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,42173,0.0143153628527584,0.00887498559138156,-0.00307960890634948,0.0317103346118662,0.106768548062549
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,40116,0.00889429233236122,0.00551890405372537,-0.0019227596129405,0.0197113442776629,0.107076857266532
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPRING1,SREBP regulating gene protein,40080,-0.00986282840099308,0.00612032425041199,-0.0218586639318006,0.00213300712981443,0.107102415330181
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42689,-0.00524752026988939,0.00325904931856021,-0.0116352569342674,0.00114021639448861,0.10739104665767
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,40116,0.00845595135418447,0.00526286230880855,-0.00185925877108029,0.0187711614794492,0.108144493682457
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",40182,0.0130643370157588,0.00814416228532776,-0.00289822106348365,0.0290268950950012,0.108713004706905
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RALB,Ras-related protein Ral-B,40199,-0.00496690987948583,0.00309776489063556,-0.0110385290651315,0.00110470930615986,0.108878369430692
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SAG,S-arrestin,40136,0.00868836686049152,0.00541961533345333,-0.001934079193077,0.01931081291406,0.108934048044927
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,40116,0.0122704574358101,0.00770156173877156,-0.0028246035721822,0.0273655184438023,0.111134680323408
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DSG4,Desmoglein-4,42543,0.00820873953573662,0.00515696480672624,-0.0018989114854468,0.01831639055692,0.111458429692768
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOL1,Apolipoprotein L1,40532,0.00952023574949409,0.0060104455282952,-0.00226023748596451,0.0213007089849527,0.113233345530739
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,42357,0.00516782832131016,0.00326635051737016,-0.00123421869273535,0.0115698753353557,0.113641323882661
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MN1,Transcriptional activator MN1,40182,0.00966897049656625,0.00612649386377718,-0.00233895747643701,0.0216768984695695,0.114543287561026
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNTF,Ciliary neurotrophic factor,40136,0.00558564573584116,0.0035548247255086,-0.0013818107261557,0.012553102197838,0.116145183872624
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENO1,Alpha-enolase,42588,-0.0126996283891159,0.00808901214938895,-0.0285540922019183,0.00315483542368641,0.116442203890943
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCP2,Non-specific lipid-transfer protein,42346,-0.0119473367770517,0.00761434250006791,-0.0268714480771848,0.00297677452308136,0.116658733880743
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DUSP29,Dual specificity phosphatase 29,40182,0.0108808680175764,0.00695852467514938,-0.00275784034571639,0.0245195763808692,0.117922812563639
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RYR1,Ryanodine receptor 1,40116,0.00556478752085565,0.00356615506026306,-0.00142487639725995,0.0125544514389712,0.118683817630364
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCUN1D2,DCN1-like protein 2,40080,0.0129160002755008,0.0082899229438677,-0.00333224869447994,0.0291642492454814,0.119253729866328
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLASP1,CLIP-associating protein 1,40080,-0.0116858646766423,0.00751209037867091,-0.0264095618188373,0.00303783246555265,0.119830506837033
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,40527,-0.00449062710167504,0.00288723469069123,-0.0101496070954299,0.00116835289207978,0.119893410097307
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP164,Centrosomal protein of 164 kDa,42370,-0.0105285806259724,0.00679212855006621,-0.0238411525841021,0.00278399133215742,0.121137923885366
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,42370,-0.00714328811538559,0.00462697171806285,-0.0162121526827888,0.00192557645201759,0.122651946817458
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAMA1,Laminin subunit alpha-1,40116,0.00858447780241621,0.00557466287420964,-0.00234186143103469,0.0195108170358671,0.123611319394487
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LEG1,Protein LEG1 homolog,39926,0.0110918209388626,0.00722049013258129,-0.00306033972099674,0.0252439815987219,0.124528867047742
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NLGN1,Neuroligin-1,40182,0.0110852036622031,0.00722046034504497,-0.00306689861408506,0.0252373059384912,0.124751497476057
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VIT,Vitrin,40511,0.00608071796675387,0.00397604513981541,-0.00171233050728433,0.0138737664407921,0.126208557687254
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDSN,Corneodesmosin,42710,0.00699245155318151,0.00458003980389038,-0.00198442646244364,0.0159693295688067,0.126853335055587
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,40136,0.0115313160358336,0.00758618896976061,-0.00333761434489724,0.0264002464165643,0.128529639152629
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTTG1,Securin,40302,-0.0064269007499639,0.00423233797830119,-0.0147222831874342,0.00186848168750643,0.12891117328582
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,40116,0.0112415085786061,0.00741011934081765,-0.00328232532939648,0.0257653424866087,0.129283444038721
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCS,Copper chaperone for superoxide dismutase,42495,-0.00738672918616199,0.00487241265848994,-0.0169366579968023,0.00216319962447829,0.129535249030719
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,40451,-0.0103055486673194,0.00680863299845843,-0.0236504693442979,0.00303937200965912,0.130155329614948
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,42346,-0.00639605796267747,0.00423464120113917,-0.0146959547169102,0.00190383879155531,0.130962046594039
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UPK3A,Uroplakin-3a,40136,0.00798026495748515,0.00528685584183022,-0.00238197249250208,0.0183425024074724,0.131211711825674
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DEFB116,Beta-defensin 116,40136,0.0120097862484094,0.00796451249851558,-0.00360065824868117,0.0276202307454999,0.131605848289552
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42594,0.00550940339051629,0.00368922809132538,-0.00172148366848145,0.012740290449514,0.135362428214299
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NECTIN1,Nectin-1,40199,-0.00504641155997988,0.00337969671320098,-0.0116706171178538,0.00157779399789403,0.135425246127879
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STX1B,Syntaxin-1B,40182,-0.00624959064273451,0.00419209580542626,-0.01446609842137,0.00196691713590095,0.136041826181294
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NRXN3,Neurexin-3,40182,-0.00546361440325949,0.00367312991197006,-0.0126629490307208,0.00173572022420183,0.136923449936968
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REST,RE1-silencing transcription factor,40080,0.00527212040447208,0.00354850809561866,-0.0016829554629405,0.0122271962718847,0.137379847614738
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42636,0.00442028128128545,0.00297673311524932,-0.00141411562460321,0.0102546781871741,0.137582170688086
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPA4,Carboxypeptidase A4,40060,-0.00679260046707186,0.00457671912366719,-0.0157629699494595,0.00217776901531583,0.137794498710836
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,40451,-0.00820738071837976,0.00554643622928284,-0.0190783957277741,0.00266363429101461,0.138965952733666
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,40302,-0.0079890076997771,0.00540776786386051,-0.0185882327129437,0.00261021731338949,0.139618027493828
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CYTL1,Cytokine-like protein 1,40527,0.00388248655777148,0.00263698276360507,-0.00128599965889446,0.00905097277443742,0.140961834852154
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PROK1,Prokineticin-1,42594,-0.00835051023185504,0.00567276080131823,-0.0194691214024388,0.0027681009387287,0.141034540532006
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",40080,-0.00843734454710168,0.00574391793433378,-0.0196954236983959,0.00282073460419253,0.141883922507555
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,42346,-0.00593861016655749,0.00407235708860973,-0.0139204300602326,0.00204320972711759,0.144789067681101
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSCA,Prostate stem cell antigen,40449,-0.0399848800785642,0.0274785459471726,-0.0938428301350226,0.0138730699778942,0.145660927399917
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH4,Cadherin-4,40136,0.00747062292268804,0.00514529022297625,-0.0026141459143454,0.0175553917597215,0.146548569034062
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,42689,-0.00687949689902442,0.00474347741084834,-0.0161767126242872,0.00241771882623834,0.146996262379921
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TP53BP1,TP53-binding protein 1,40199,-0.0129998731702609,0.00897188311621997,-0.0305847640780521,0.0045850177375302,0.147378073665289
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,40136,0.00912258011762137,0.00630941444387006,-0.00324387219236395,0.0214890324276067,0.148242883964681
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF7,Fibroblast growth factor 7,40080,0.0118019908128126,0.0082016523687462,-0.00427324782992998,0.0278772294555551,0.150185731775303
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DENND2B,DENN domain-containing protein 2B,40116,0.00740882670812036,0.00516461307520285,-0.00271381491927722,0.0175314683355179,0.151447810805064
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",40116,-0.00836938900835687,0.00583587205028523,-0.0198076982269159,0.00306892021020218,0.151564294360152
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FSTL1,Follistatin-related protein 1,40223,-0.00335110954341422,0.0023381307022471,-0.00793384571981853,0.00123162663299009,0.151816740980817
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCN3B,Sodium channel subunit beta-3,40136,0.00712241761284641,0.00498014252793041,-0.00263866174189718,0.01688349696759,0.152698677937233
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,40182,-0.00727005791422541,0.00509056503498658,-0.0172475653827991,0.00270744955434828,0.153278949615012
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",40449,-0.01493386353648,0.0104998653670762,-0.0355135996559493,0.00564587258298927,0.154969515810499
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LTB,Lymphotoxin-beta,40451,-0.0052447539670277,0.00369798592008178,-0.012492806370388,0.00200329843633259,0.156138728271808
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PFDN4,Prefoldin subunit 4,40080,0.00766077765827934,0.00543200096831103,-0.00298594423961029,0.018307499556169,0.15847824001629
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNPO1,Transportin-1,40302,0.00513113527506156,0.00366145878269372,-0.00204532393901814,0.0123075944891413,0.161125129542842
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MELTF,Melanotransferrin,40511,0.00435258740852372,0.00311564836920394,-0.001754083395116,0.0104592582121634,0.162438391310417
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,40136,0.00604073814810011,0.00433589516096286,-0.00245761636738709,0.0145390926635873,0.163589781288918
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,40080,-0.0206445604593743,0.0148237290937671,-0.0496990694831577,0.00840994856440914,0.163748094499168
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,40199,0.00626261133643237,0.00449739830263445,-0.00255228933673116,0.0150775120095959,0.163800238161201
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,40080,-0.00849682801077089,0.00611063560994593,-0.0204736738062649,0.00348001778472314,0.164406061194811
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSH,Pro-cathepsin H,42332,-0.0106804477882673,0.00768148568471462,-0.0257361597303079,0.00437526415377336,0.164426649263695
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,40080,-0.00649778840621624,0.00467817487762958,-0.0156670111663702,0.00267143435393775,0.164873936097157
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF20,Fibroblast growth factor 20,40199,0.00647692114473262,0.00466430782868668,-0.00266512219949327,0.0156189644889585,0.16497839196748
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,42311,-0.0120232364406714,0.00868892939820434,-0.0290535380611519,0.0050070651798091,0.166461017567342
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,40449,0.00664858919525624,0.00480794470091269,-0.00277498241853263,0.0160721608090451,0.166743218159041
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,42357,-0.00692130639813297,0.00501318579059857,-0.0167471505477062,0.00290453775144023,0.167419160302354
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL5,Interleukin-5,42370,0.0197224389377107,0.0143469456752276,-0.00839757458573534,0.0478424524611567,0.169254491576864
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP15,Matrix metalloproteinase-15,40511,-0.00692205729291812,0.00504266283546506,-0.0168056764504296,0.00296156186459339,0.169873199060955
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,40302,-0.00768652938506957,0.00561041908991542,-0.0186829508013038,0.00330989203116466,0.17070039113952
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASQ2,Calsequestrin-2,40116,0.00693322709342144,0.00507744313456457,-0.00301856145032512,0.016885015637168,0.172125404504721
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF5,Fibroblast growth factor 5,42370,-0.00461453779746146,0.00340037575117084,-0.0112792742697563,0.00205019867483339,0.174783161698137
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42654,-0.0122305984405659,0.00909010830987606,-0.0300472107279229,0.00558601384679122,0.17849153790609
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GBP2,Guanylate-binding protein 2,42370,-0.00839434863426204,0.00624622323507356,-0.0206369461750062,0.00384824890648214,0.179001317569145
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,40182,-0.00754176683556832,0.0056324218445818,-0.0185813136509486,0.00349777997981201,0.180601031309227
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRC1,Protein regulator of cytokinesis 1,40451,-0.00615691493573985,0.00460026480826966,-0.0151734339599484,0.00285960408846868,0.180798739193334
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KCNIP4,Kv channel-interacting protein 4,42311,0.00680547933823484,0.00508666028144898,-0.00316437481340516,0.0167753334898748,0.180949888587736
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TEX33,Testis-expressed protein 33,40302,0.00527141920970869,0.00394228877071623,-0.00245546678089513,0.0129983052003125,0.181202071612417
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,40532,-0.00371176247716082,0.0027858493022676,-0.00917202710960532,0.00174850215528368,0.182767718546206
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,40136,-0.00833330509084525,0.00626315828533668,-0.0206090953301051,0.00394248514841464,0.183372219469642
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PGM2,Phosphoglucomutase-2,40182,0.00817384630001718,0.00617827615038748,-0.00393557495474229,0.0202832675547766,0.18586361073222
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAD1,Glutamate decarboxylase 1,40080,0.00358172933902942,0.00270738482360459,-0.00172474491523557,0.00888820359329441,0.185880459048186
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1QA,Complement C1q subcomponent subunit A,42701,-0.00299014248347335,0.00226483783269007,-0.00742922463554589,0.0014489396685992,0.186775359471475
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL28,C-C motif chemokine 28,42538,-0.00795041333539441,0.00602736391751493,-0.0197640466137237,0.00386321994293486,0.187173980056648
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH23,Cadherin-23,40483,0.00354691946546884,0.00269404938474953,-0.00173341732864024,0.00882725625957792,0.188007677159758
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C5,Complement C5,40539,-0.00203689083121452,0.00155295805015666,-0.00508068860952158,0.00100690694709254,0.189674924588453
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",40199,-0.00383052114079077,0.00293643707783596,-0.00958593781334924,0.00192489553176771,0.192097520518842
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,40080,-0.0116775895186661,0.00895519526557083,-0.029229772239185,0.0058745932018527,0.192260587426777
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EXOSC10,Exosome component 10,40116,0.0081375181946906,0.00624488109321053,-0.00410244874800205,0.0203774851373832,0.1925782806956
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA8,Carbonic anhydrase-related protein,40199,-0.00385450131052143,0.00295998015383658,-0.00965606241204112,0.00194705979099825,0.192873528357531
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,40451,-0.00539596513409935,0.00414633072737913,-0.0135227733597624,0.00273084309156374,0.193153955864922
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RSPO1,R-spondin-1,42495,0.00453175853963184,0.00348450549266542,-0.00229787222599237,0.0113613893052561,0.193436545593722
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYOM1,Myomesin-1,40136,-0.00646693181968767,0.00497832500097313,-0.016224448821595,0.00329058518221967,0.193965259312119
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MARCO,Macrophage receptor MARCO,42636,-0.00348521169654825,0.00269766571586192,-0.00877263649963762,0.00180221310654112,0.196401489448749
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,40223,0.00312987861033356,0.00243618805649975,-0.00164504998040596,0.00790480720107307,0.198908649824547
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,40116,0.00343514737847441,0.00267439713775156,-0.00180667101151865,0.00867696576846746,0.199009440015194
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100A3,Protein S100-A3,40451,-0.00577427019234089,0.00449625868745232,-0.0145869372197474,0.00303839683506565,0.19908481656109
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP112,Centrosomal protein of 112 kDa,40116,-0.00593926916701904,0.00463852522115491,-0.0150307786004827,0.00315224026644458,0.200423995551203
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,40527,-0.00333364980534577,0.00260733841977009,-0.00844403310809516,0.00177673349740361,0.201076712709357
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,40539,-0.00246310691604271,0.00193359804376172,-0.00625295908181567,0.00132674524973025,0.202743951266614
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,40080,-0.00449003778373048,0.00353462422138054,-0.0114179012576363,0.00243782569017539,0.204004470314141
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,40199,-0.0133150258727063,0.0104998370852425,-0.0338947065597816,0.00726465481436898,0.204782863253883
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLXDC2,Plexin domain-containing protein 2,40483,0.00356586311073354,0.0028156886309223,-0.00195288660587417,0.00908461282734124,0.205386505935154
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TFRC,Transferrin receptor protein 1,42673,-0.00493565303483269,0.00389778315432039,-0.0125753080173007,0.00270400194763527,0.205437659155443
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42587,0.00725506285240046,0.00574176511738251,-0.00399879677766927,0.0185089224824702,0.206410109487115
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSHB,Thyrotropin subunit beta,42636,0.0102775249582779,0.0081586148908407,-0.00571336022776987,0.0262684101443257,0.207794266720137
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WNT9A,Protein Wnt-9a,42370,-0.00384356607113931,0.00305481236531003,-0.00983099830714696,0.00214386616486834,0.208341593863352
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCLN,Nicalin,42370,-0.00670317797007512,0.00533582847866636,-0.0171614017882612,0.00375504584811095,0.209044665951326
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSPAN7,Tetraspanin-7,40136,0.0122382656765573,0.00974923662616597,-0.00687023811072799,0.0313467694638426,0.209394860927476
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAEP,Glycodelin,42495,-0.0116159854067802,0.00925502622522984,-0.0297558368082307,0.00652386599467026,0.209464433075044
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGLON5,IgLON family member 5,40080,0.0122968410050131,0.00980360554118347,-0.00691822585570647,0.0315119078657327,0.209753297283186
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HLA_DRA,,42549,-0.00474102607411168,0.00379214211538878,-0.0121736246202737,0.00269157247205033,0.211239735098097
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPM1B,Protein phosphatase 1B,40199,-0.0078754828865962,0.00630511821409957,-0.0202335145862314,0.00448254881303896,0.211669004607259
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SKIV2L,Helicase SKI2W,40116,-0.00514167777399567,0.00411666052413755,-0.0132103324013053,0.00292697685331392,0.211694615878235
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,40182,0.00656687733771311,0.00526393684434595,-0.00375043887720495,0.0168841935526312,0.21223272322183
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CADPS,Calcium-dependent secretion activator 1,40182,0.00551850708530939,0.00442591350186833,-0.00315628337835253,0.0141932975489713,0.212474371005086
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP290,Centrosomal protein of 290 kDa,40302,-0.00701612426177238,0.00563463061215179,-0.0180600002615899,0.00402775173804513,0.213092190832919
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,42357,0.00426490437202699,0.00343409328691144,-0.00246591847031943,0.0109957272143734,0.214284421289309
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DAND5,DAN domain family member 5,40199,-0.00711159840705902,0.00572893853191581,-0.018340317929614,0.00411712111549597,0.21450419225297
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,40482,-0.0147311276189578,0.0119059973056107,-0.0380668823379548,0.00860462710003912,0.216006541531869
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSP90B1,Endoplasmin,42247,0.00850321545973794,0.00687851013487065,-0.00497866440460853,0.0219850953240844,0.216406408415858
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,40451,0.00573074719157608,0.00463869545813916,-0.00336109590637668,0.0148225902895288,0.216699209388152
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDCL2,Phosducin-like protein 2,40080,-0.00676334739807088,0.00548812664793547,-0.0175200756280244,0.00399338083188263,0.217841275676123
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,40080,0.00390971482336678,0.00318074336608067,-0.00232454217415133,0.0101439718208849,0.219029869429497
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL1A,Interleukin-1 alpha,42370,-0.00737005622296951,0.00599996493692272,-0.019129987499338,0.00438987505339903,0.219337593375333
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,40136,-0.0153052739327038,0.0124842907259022,-0.0397744837554722,0.00916393589006458,0.220239120919254
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,40136,0.00650802176964831,0.0053130205059854,-0.00390549842208307,0.0169215419613797,0.220631966948256
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,40223,0.00495750575450361,0.0040879762214184,-0.00305492763947645,0.0129699391484837,0.225268924981626
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD55,Complement decay-accelerating factor,42201,0.00340065891611379,0.00280830848603094,-0.00210362571650686,0.00890494354873444,0.225945064979419
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,40136,0.00414649520821019,0.00344061283598248,-0.00259710595031547,0.0108900963667358,0.228166903468202
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCNE1,G1/S-specific cyclin-E1,40199,-0.0110208275890577,0.00915958305205619,-0.0289736103710879,0.0069319551929724,0.228924088711817
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VWF,von Willebrand factor,42794,-0.00887697632334308,0.00739280838309411,-0.0233668807542075,0.00561292810752138,0.229865869177553
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AFP,Alpha-fetoprotein,42459,0.00814407878929375,0.0068756660187411,-0.00533222660743879,0.0216203841860263,0.236244911727971
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOH,Beta-2-glycoprotein 1,42611,-0.00441262091826533,0.00374705786313195,-0.0117568543300039,0.00293161249347329,0.238967888718554
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRTN3,Myeloblastin,42276,-0.00589094633435197,0.0050090805467592,-0.015708744206,0.00392685153729607,0.239594928541802
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,40182,0.00450645400509246,0.00383435256953357,-0.00300887703119334,0.0120217850413783,0.239906498298613
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",40268,-0.0077052935165541,0.00656279696068575,-0.0205683755594982,0.00515778852638998,0.240385494091249
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,42346,0.0038440298459024,0.00328086375586667,-0.00258646311559627,0.0102745228074011,0.241358116343554
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BRD3,Bromodomain-containing protein 3,40116,-0.00602408847785572,0.00514188593139702,-0.0161021849033939,0.00405400794768244,0.241394578292432
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,40182,-0.00815495968987465,0.00697401710933999,-0.021824033224181,0.00551411384443174,0.242294202569605
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MUC2,Mucin-2,40527,-0.0111950480145704,0.00958861666960639,-0.0299887366869989,0.00759864065785813,0.243018842319194
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LTO1,Protein LTO1 homolog,42370,-0.00502896847678798,0.00433254865868218,-0.0135207638478051,0.0034628268942291,0.245768120881844
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",40182,-0.00994931935015893,0.00868670202502073,-0.0269752553191996,0.00707661661888171,0.25208889945835
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TCP11,T-complex protein 11 homolog,40302,0.00700406956184053,0.00611704152877877,-0.00498533183456586,0.0189934709582469,0.252229966174384
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EBI3_IL27,Interleukin-27,42689,-0.00362842877796017,0.00317024196946799,-0.00984210303811744,0.0025852454821971,0.252425283078535
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SHC1,SHC-transforming protein 1,40080,0.013983390364229,0.012220991885781,-0.00996975373190184,0.0379365344603598,0.252561401658252
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,42603,0.00350890379564746,0.00310349086362615,-0.00257393829705979,0.00959174588835472,0.258230545382115
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,40449,-0.00298596971002662,0.00264874140839311,-0.0081775028704771,0.00220556345042387,0.25963275037321
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,40136,0.00667337310841024,0.00595211203856611,-0.00499276648717934,0.0183395127039998,0.262236990653192
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BLMH,Bleomycin hydrolase,42794,-0.00360282889382103,0.00321495951619843,-0.00990414954556995,0.00269849175792789,0.262458712660295
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,40451,-0.0104659437315155,0.00935988140402195,-0.0288113112833985,0.00787942382036751,0.263518021282562
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANK2,Ankyrin-2,40116,0.00850642660665911,0.00761301547886991,-0.0064150837319259,0.0234279369452441,0.263867948535684
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMEM25,Transmembrane protein 25,40482,-0.00525823596735246,0.00471119090012011,-0.0144921701315879,0.00397569819688295,0.264396203830169
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,40136,0.00463959451305664,0.0042023074646667,-0.00359692811769008,0.0128761171438034,0.269591912676478
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,40199,-0.00331156618593662,0.00300649368870001,-0.00920429381578864,0.0025811614439154,0.270715725514306
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATXN2,Ataxin-2,40136,-0.0125577479911492,0.0114137217664167,-0.0349286426533259,0.00981314667102754,0.271255024140257
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,40182,-0.0116713281275775,0.0106310814043219,-0.0325082476800485,0.00916559142489345,0.27229423939197
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,40116,0.00546877441962304,0.00498600787662206,-0.0043038010185562,0.0152413498578023,0.272742403087977
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA7,Carbonic anhydrase 7,40302,0.0039886113652457,0.00363852992162882,-0.00314290728114678,0.0111201300116382,0.273008427497493
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,40136,-0.00502054716280419,0.00459355953867693,-0.014023923858611,0.00398282953300259,0.274438260432007
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPHS2,Podocin,40199,0.0118357305683507,0.0108569472420493,-0.009443886026066,0.0331153471627674,0.275669745266652
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,40302,0.00832229268797783,0.00765214935945273,-0.00667592005654952,0.0233205054325052,0.276806003306685
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,40080,0.00343717306655927,0.00316819098887663,-0.00277248127163893,0.00964682740475747,0.27798960093291
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,42439,0.00324152996713954,0.00298973015663605,-0.00261834113986711,0.00910140107414619,0.278286298826648
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAG,Myelin-associated glycoprotein,40182,0.00547919193228821,0.00506946887406776,-0.0044569670608846,0.015415350925461,0.279800157806057
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,40302,0.00905662272062301,0.00838291306073469,-0.00737388687841698,0.025487132319663,0.280002236127827
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,40302,0.00786007966039236,0.00728548019813269,-0.00641946152794771,0.0221396208487324,0.280669499596646
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GFRA2,GDNF family receptor alpha-2,42587,0.00236421025339465,0.00219282347408266,-0.00193372375580736,0.00666214426259666,0.280982652695826
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK7,Kallikrein-7,40009,-0.00436244868958985,0.00404997409478706,-0.0123003979153725,0.00357550053619279,0.281435178664477
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ALMS1,Alstrom syndrome protein 1,40302,0.00495756245972039,0.00460831973116241,-0.00407474421335793,0.0139898691327987,0.282046669027441
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,40451,-0.0107117375488959,0.00998321648178798,-0.0302788418532004,0.00885536675540853,0.283305520396185
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KHDC3L,KH domain-containing protein 3,40080,0.00766059277428201,0.00714017600664464,-0.00633415219874148,0.0216553377473055,0.283346182764461
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HGFAC,Hepatocyte growth factor activator,40428,0.00307409766173592,0.00286946066532269,-0.00255004524229656,0.00869824056576839,0.284050611515713
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIF20B,Kinesin-like protein KIF20B,40136,-0.00865873375866648,0.00809297793487971,-0.0245209705110307,0.00720350299369775,0.284684771371685
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,40451,-0.00489899362591657,0.00458529596104862,-0.0138861737095719,0.00408818645773873,0.285356790950267
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,42370,-0.0040251250306354,0.00376914113829527,-0.0114126416616941,0.00336239160042333,0.285578101021568
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,40145,-0.00422202373272475,0.00395806353620816,-0.0119798282636927,0.00353578079824324,0.286135708858559
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NENF,Neudesin,40451,-0.0121168497277251,0.0113711895813238,-0.0344043813071197,0.0101706818516695,0.286638882417632
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACTA2,"Actin, aortic smooth muscle",42357,-0.00482224566828588,0.00453842579847266,-0.0137175602332923,0.00407306889672054,0.288011429565396
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,40284,0.0058737294880938,0.00553011237988436,-0.00496529077647955,0.0167127497526671,0.288197237930498
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,40116,0.00741612400940126,0.0069890251512416,-0.00628236528703228,0.0211146133058348,0.288663407320512
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,40199,-0.00438405652393747,0.00414745399135453,-0.0125130663469924,0.00374495329911741,0.290513040646946
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FZD10,Frizzled-10,40182,-0.00662047759749046,0.00627022652229337,-0.0189101215811855,0.00566916638620454,0.291055670565793
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",40199,-0.00514120033485744,0.00487780072477224,-0.014701689755411,0.00441928908569614,0.291906209801691
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,40182,0.00496468137856587,0.00476235281621537,-0.00436953014121627,0.014298892898348,0.297209811439185
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,42443,-0.00325883099633879,0.00315176616846652,-0.00943629268653318,0.0029186306938556,0.301169159822427
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,40080,-0.00831144283946759,0.00803935715096642,-0.0240685828553618,0.00744569717642659,0.301231966268591
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,40539,0.00210603679985032,0.00204087871443601,-0.00189408548044426,0.00610615908014489,0.302128554803995
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TLR4,Toll-like receptor 4,40199,0.00311356031251067,0.00302864152411089,-0.00282257707474668,0.00904969769976803,0.303954277569577
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,40451,-0.00386054672934259,0.00378280715800524,-0.0112748487590329,0.00355375530034768,0.307489259079223
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TET2,Methylcytosine dioxygenase TET2,40286,-0.0107885829748071,0.0105800415405588,-0.0315254643943024,0.00994829844468813,0.307887862357236
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,40136,-0.00739584078745751,0.00725805911729718,-0.02162163665736,0.00682995508244497,0.30823343993493
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,40482,-0.00359879475498429,0.00353851132240448,-0.0105342769468971,0.00333668743692849,0.309157919621
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,40136,0.00668007464338273,0.00659756410663528,-0.00625115100562241,0.0196113002923879,0.311318466164277
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAD2,Glutamate decarboxylase 2,40199,0.00481866951753686,0.00476603379559207,-0.0045227567218236,0.0141600957568973,0.312017635034601
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HEBP1,Heme-binding protein 1,42357,0.00547454041159695,0.00544575777815197,-0.0051991448335809,0.0161482256567748,0.314777955572148
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD14,Monocyte differentiation antigen CD14,42416,0.00431780125536576,0.00429797857177852,-0.00410623674532015,0.0127418392560517,0.315102055654625
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NOS2,"Nitric oxide synthase, inducible",40116,-0.00412911469218873,0.0041188769600687,-0.0122021135339234,0.00394388414954592,0.316131344261801
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB5,Serpin B5,42357,-0.00503731435871321,0.00502609586606348,-0.0148884622561976,0.00481383353877122,0.316249955581981
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,42172,-0.00687521804580466,0.00686961205539772,-0.0203396576743842,0.00658922158277488,0.316934405054094
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOB,Apolipoprotein B-100,40532,0.0023016386647182,0.00230815140927284,-0.00222233809745657,0.00682561542689297,0.318699217854152
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFNL2,Interferon lambda-2,40136,-0.00638258809200256,0.00640366803302494,-0.0189337774367314,0.00616860125272632,0.318928235102854
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EVI2B,Protein EVI2B,40080,0.0042143288516919,0.00423552190499701,-0.00408729408210223,0.012515951785486,0.319760153445696
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NRN1,Neuritin,40482,-0.0037383632354715,0.0037581081379248,-0.0111042551858041,0.00362752871486111,0.319881112811517
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPHA10,Ephrin type-A receptor 10,42311,0.0068428414794654,0.00690759345131367,-0.00669604168510938,0.0203817246440402,0.321886523649411
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",40223,0.00451351295898266,0.00455735585858111,-0.00441890452383631,0.0134459304418016,0.322010266052129
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LCP1,Plastin-2,40527,-0.00489646694803731,0.00494518803477548,-0.0145890354961972,0.00479610160012263,0.322123032059396
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL2,Interleukin-2,42370,-0.00326112530807329,0.00330201548855977,-0.00973307566565043,0.00321082504950386,0.323358588967226
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,40302,-0.00722083063229431,0.00731431454678212,-0.0215568871439873,0.00711522587939865,0.323556769377679
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCN2B,Sodium channel subunit beta-2,40182,0.00296367166419142,0.00301052742256037,-0.0029369620840269,0.00886430541240974,0.324922845488204
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42794,0.00415782870602943,0.0042340573553124,-0.00414092371038288,0.0124565811224417,0.326119133822245
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCUN1D1,DCN1-like protein 1,40136,-0.00758804467031268,0.00775153146568927,-0.0227810463430636,0.00760495700243828,0.327646539010975
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INSR,Insulin receptor,40199,-0.00174440702649132,0.00179419782243469,-0.00526103475846332,0.00177222070548067,0.330948060896459
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,40116,0.00363325604456141,0.00374879814330161,-0.00371438831630975,0.0109809004054326,0.332477399972087
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,40182,-0.00840783220473854,0.00868473613610862,-0.0254299150315114,0.00861425062203436,0.333007736769125
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42754,0.0036243016870872,0.00375743904714131,-0.00374027884530976,0.0109888822194842,0.334778939012496
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39845,0.00513186721054335,0.00533482284331556,-0.00532438556235516,0.0155881199834419,0.336093321397737
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,42475,-0.00399581531031898,0.00416418267377958,-0.012157613350927,0.00416598273028899,0.337290285570662
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42737,-0.00342526274395346,0.00357139336821068,-0.0104251937456464,0.00357466825773948,0.337534044109498
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,40449,0.0146554072486023,0.0153422822746544,-0.0154154660097204,0.044726280506925,0.339481948130908
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",42311,-0.00296103048469266,0.00310201054826758,-0.00904097115929711,0.00311891018991179,0.339821873067547
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTR,Methionine synthase,40116,-0.00654543843885942,0.00686164631638788,-0.0199942652189797,0.00690338834126082,0.340146962553867
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",40116,-0.00688152941788658,0.00722852557688099,-0.0210494395485733,0.00728638071280016,0.341119937970317
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42721,-0.00332037578487696,0.00349190075675216,-0.0101645012681112,0.00352374969835726,0.341682692507282
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,42587,0.00255876548302404,0.0026919589959472,-0.00271747414903248,0.00783500511508055,0.341864377265715
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,40116,0.00381381589471587,0.00401777204327259,-0.0040610173100984,0.0116886490995301,0.342521341362123
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MERTK,Tyrosine-protein kinase Mer,42754,-0.00248851966176722,0.00262545396656436,-0.00763440943623336,0.00265737011269892,0.343225986661151
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,40182,-0.0035324762712233,0.0037409600822083,-0.0108647580323516,0.00379980548990498,0.345052468663007
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ICOSLG,ICOS ligand,42587,-0.00187671420386505,0.00199247231394731,-0.00578195993920178,0.00202853153147168,0.3462596645532
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZNF75D,Zinc finger protein 75D,40302,-0.00597144078684176,0.00633975366824113,-0.0183973579765944,0.00645447640291085,0.346262158709997
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",40116,0.00505918529068003,0.00537400241803065,-0.00547385944866005,0.0155922300300201,0.346511258293514
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD276,CD276 antigen,42618,0.003548284832284,0.00378034291220227,-0.00386118727563244,0.0109577569402004,0.347945570946153
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",40223,-0.0066801077369232,0.00713804531765547,-0.0206706765595279,0.00731046108568153,0.349373220625061
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,42357,0.00577898619891724,0.00618350923564399,-0.00634069190294498,0.0178986643007795,0.35002175568848
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CENPJ,Centromere protein J,40302,-0.00683406976393616,0.00732010149980233,-0.0211814687035487,0.00751332917567642,0.350528936629605
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMIGO1,Amphoterin-induced protein 1,40182,0.00485645527465587,0.00522506543500391,-0.00538467297795181,0.0150975835272635,0.352674538707135
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGA2,Integrin alpha-2,40283,-0.00334204467647364,0.00360342688589575,-0.0104047613728293,0.00372067201988203,0.353706441949789
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EVPL,Envoplakin,40302,0.0033726987448673,0.00363711422633644,-0.00375604513875212,0.0105014426284867,0.353790553215477
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSLP,Thymic stromal lymphopoietin,42357,-0.00582688524837138,0.00630248470449306,-0.0181797552691778,0.00652598477243502,0.355223336328848
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PVALB,Parvalbumin alpha,42654,-0.010374403121488,0.0112806227015615,-0.0324844236165486,0.0117356173735726,0.357763900454096
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,40080,0.00556837900987262,0.00607356524356292,-0.0063358088675107,0.017472566887256,0.359256165454478
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAGEA3,Melanoma-associated antigen 3,40302,-0.00820832840752838,0.00897147094073882,-0.0257924114513765,0.0093757546363197,0.360244699428769
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BMP4,Bone morphogenetic protein 4,42475,0.0043783568438359,0.00478558931270096,-0.00500139820905798,0.0137581118967298,0.360258416466449
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,40116,0.00459682950100873,0.00502883604292244,-0.00525968914311926,0.0144533481451367,0.360687565858114
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42644,-0.00462972881224128,0.00507164347917491,-0.0145701500314241,0.00531069240694154,0.36132959963179
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42794,0.00149794971415614,0.00164106083067707,-0.00171852951397091,0.0047144289422832,0.361367320367022
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK12,Kallikrein-12,42346,-0.0130976200204263,0.0143783629147393,-0.0412792113333152,0.0150839712924627,0.362351228410326
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HMMR,Hyaluronan mediated motility receptor,40059,-0.00464408120467237,0.00514046039082492,-0.0147193835706892,0.00543122116134447,0.36631413350574
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPM1A,Protein phosphatase 1A,42346,-0.00295773014132506,0.00327666851896028,-0.00938000043848721,0.0034645401558371,0.36672087198342
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,40482,-0.00702351799897079,0.00779556635434751,-0.0223028280534919,0.00825579205555034,0.367627135799608
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42689,0.00256877272057389,0.00285122364621432,-0.00301962562600618,0.00815717106715396,0.367637924206469
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD82,CD82 antigen,40302,0.00381052894777006,0.00423291600440302,-0.00448598642085987,0.0121070443164,0.368026056070226
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPTN,Neuroplastin,42346,0.00724519011462354,0.00809988812175553,-0.0086305906040173,0.0231209708332644,0.371081349979298
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,40136,0.00495351159180727,0.00554315452531565,-0.0059110712778114,0.0158180944614259,0.371541241632501
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42570,-0.00789608704874874,0.00887887879398386,-0.0252986894849571,0.00950651538745963,0.373851804888133
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F2,Prothrombin,40539,-0.00136334061692708,0.00153327527960802,-0.00436856016495879,0.00164187893110463,0.373931193875412
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BRD1,Bromodomain-containing protein 1,40302,0.00280368757387766,0.00316042184216079,-0.0033907392367575,0.00899811438451281,0.375031093799594
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HDAC9,Histone deacetylase 9,40136,0.00599723749053985,0.00678820001171747,-0.00730763453242639,0.0193021095135061,0.376996509844663
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,42346,-0.00408912608343514,0.00464299956430362,-0.0131894052294702,0.00501115306259996,0.378492069337681
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH22,Cadherin-22,40302,0.00253590390265152,0.00290410659400094,-0.00315614502159032,0.00822795282689336,0.382565815398449
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",40136,-0.00402269086546956,0.00461346192305561,-0.0130650762346585,0.00501969450371943,0.383256827602574
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NINJ1,Ninjurin-1,42346,0.00484523790915794,0.00555785117077167,-0.00604815038555454,0.0157386262038704,0.383342905771699
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC44A4,Choline transporter-like protein 4,40182,0.00638504258227929,0.00736926131594264,-0.00805870959696828,0.0208287947615269,0.386266361656873
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TBR1,T-box brain protein 1,40182,0.00432712445225325,0.00501391643426731,-0.00550015175891067,0.0141544006634172,0.388143739703216
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDC123,Cell division cycle protein 123 homolog,40080,-0.00563605948987443,0.00653155519860577,-0.0184379076791417,0.00716578869939287,0.388213100994917
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,40511,0.00247480102674088,0.00287486651432312,-0.00315993734133244,0.0081095393948142,0.389344228813358
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,40080,-0.00567693415685773,0.00662205226530859,-0.0186561565968626,0.00730228828314711,0.391310600320564
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRR4,Proline-rich protein 4,40198,0.00616152955363655,0.00720070002107735,-0.00795184248767506,0.0202749015949482,0.39219078137661
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BTLA,B- and T-lymphocyte attenuator,40080,-0.00778877971211298,0.00911057456505648,-0.0256455058596237,0.0100679464353977,0.392616238686853
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPRR1B,Cornifin-B,40302,-0.00730284469552064,0.00858284406603992,-0.0241252190649589,0.00951952967391759,0.394862490677781
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,40116,-0.00331906226249383,0.00391799925695639,-0.0109983408061283,0.00436021628114069,0.39694015264277
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,40116,-0.00429580472314873,0.0050754728097313,-0.0142437314302221,0.00565212198392461,0.397356473523509
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPR101,Probable G-protein coupled receptor 101,40136,0.00528477680035699,0.00624751826840804,-0.00696035900572277,0.0175299126064368,0.397626932223249
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNAP25,Synaptosomal-associated protein 25,40136,-0.00412616522673936,0.00489021316653616,-0.0137109830331502,0.00545865257967151,0.398822095322579
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,40080,0.00370201629957566,0.00439203805454366,-0.00490637828732993,0.0123104108864812,0.399307041002211
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,40199,0.00255304435802605,0.00302948943729788,-0.00338475493907779,0.00849084365512989,0.399397276523044
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THPO,Thrombopoietin,42357,-0.00338064472411722,0.00401496349984132,-0.0112499731838062,0.00448868373557176,0.39979691354991
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,40182,0.00275250164484119,0.00327619170435473,-0.00366883409569407,0.00917383738537646,0.400840997160838
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,42311,-0.00664365617869428,0.00796765801026419,-0.0222602658788121,0.00897295352142353,0.404393109952627
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,40116,-0.00290086826216167,0.00348004452508146,-0.00972175553132133,0.003920019006998,0.404540343065846
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMEM132A,Transmembrane protein 132A,40223,0.00539452086024291,0.00647196269741064,-0.00729052602668195,0.0180795677471678,0.404568658058532
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUMF1,Formylglycine-generating enzyme,40199,-0.00550572641736354,0.00663226046095277,-0.018504956920831,0.0074935040861039,0.406475790143838
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HIP1,Huntingtin-interacting protein 1,40116,-0.00286387303116566,0.00345487199487334,-0.0096354221411174,0.00390767607878608,0.40715787639635
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,40136,0.00664879273027977,0.00806008012131607,-0.00914896430749973,0.0224465497680593,0.409444049562325
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,40136,-0.00954960876384517,0.0115859517237387,-0.0322580741423729,0.0131588566146826,0.409820977162594
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NOP56,Nucleolar protein 56,40116,-0.00949313764832546,0.0115706143089706,-0.0321715416939078,0.0131852663972568,0.4119761906117
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAM171A2,Protein FAM171A2,40482,0.0135513620235567,0.0165216522957247,-0.0188310764760637,0.045933800523177,0.412108974697188
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,42357,-0.00656375322418351,0.00802788714658497,-0.0222984120314901,0.00917090558312304,0.413589562325659
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,40136,0.00639111801718751,0.00782131233233597,-0.00893865415419099,0.021720890188566,0.413865424022146
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAMDC2,MAM domain-containing protein 2,40511,0.00307796135556324,0.00376923394256,-0.00430973717185435,0.0104656598829808,0.414173497855562
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42565,-0.0021908351235013,0.00269018940096258,-0.00746360634938795,0.00308193610238535,0.415442077051614
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ROBO4,Roundabout homolog 4,40223,0.00152553234328091,0.00187977167336339,-0.00215882013651134,0.00520988482307316,0.417066293275664
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",40116,0.00412832374733539,0.00512298437981516,-0.00591272563710232,0.0141693731317731,0.420350627005195
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPB41L5,Band 4.1-like protein 5,40182,-0.00508796001425344,0.00633236289069223,-0.0174993912800102,0.00732347125150333,0.421711714501636
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MLLT1,Protein ENL,40080,0.00550547269563476,0.00686762734164557,-0.00795507689399055,0.0189660222852601,0.422769638233141
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK4,Kallikrein-4,42721,0.0052408125050858,0.00653869898853853,-0.00757503751244972,0.0180566625226213,0.422852316695673
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPLX2,Complexin-2,40080,0.00262819457395047,0.00328497312791262,-0.00381035275675828,0.00906674190465921,0.423690147171509
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPPB,Natriuretic peptides B,42357,-0.0115737009271317,0.0146085913750837,-0.0402065400222957,0.0170591381680323,0.428227424818431
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39633,-0.004435721442733,0.00564675666172107,-0.0155033644997063,0.00663192161424029,0.432158154710332
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,40116,0.00809525653787982,0.0103345233863306,-0.0121604092993282,0.0283509223750878,0.433455202081098
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL25,Interleukin-25,40036,-0.00281837140545487,0.00361707418956733,-0.00990783681700683,0.0042710940060971,0.435887514824561
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,42475,0.00273840454879747,0.00352525070579986,-0.00417108683457026,0.0096478959321652,0.43729231860822
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNM1,Dynamin-1,40449,-0.00905348951410478,0.0117303989851746,-0.032045071525047,0.0139380924968375,0.440250733142496
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,40182,-0.00238205563607938,0.00310805090585791,-0.00847383541156089,0.00370972413940212,0.443446104420043
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMY2B,Alpha-amylase 2B,41779,0.00392564837594472,0.00515499672882143,-0.00617814521254528,0.0140294419644347,0.446359039003973
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SULT1A1,Sulfotransferase 1A1,42711,-0.00994377024487015,0.0131026487290672,-0.0356249617538418,0.0157374212641015,0.447917844509452
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,40302,-0.0029799842628384,0.00393928867799068,-0.0107009900717001,0.00474102154602334,0.449378846799621
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",40080,0.00381690190958502,0.00506478600666747,-0.00611007866348321,0.0137438824826533,0.451096353640157
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,42594,0.00370003308233727,0.00492436457621362,-0.00595172148704143,0.013351787651716,0.452441586239422
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,40080,0.00194476806196697,0.00260865349249082,-0.00316819278331505,0.00705772890724898,0.455981696045933
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRX,Cone-rod homeobox protein,42357,0.00813769102069467,0.0109759236262497,-0.0133751192867548,0.0296505013281441,0.458456371230372
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPBGL,Trophoblast glycoprotein-like,40182,0.003202052373172,0.00434086734602606,-0.00530604762503908,0.0117101523713831,0.460741294273326
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAP1A,Ras-related protein Rap-1A,40199,-0.00539142496594408,0.0073386905754046,-0.0197752584937371,0.00899240856184894,0.462563688998384
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SOX9,Transcription factor SOX-9,40182,-0.00208886607464683,0.0028615510889005,-0.00769750620889181,0.00351977405959814,0.465419891687705
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYL3,Myosin light chain 3,40223,0.00552601755049036,0.0075760349129841,-0.00932301087895847,0.0203750459799392,0.465767851382128
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NGF,Beta-nerve growth factor,42495,0.000899451326957488,0.00123321670127343,-0.00151765340753843,0.00331655606145341,0.465798093795692
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMY2A,Pancreatic alpha-amylase,42114,0.00364791586555939,0.00503545956442531,-0.00622158488071422,0.013517416611833,0.468805411924228
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UNG,Uracil-DNA glycosylase,40451,-0.00255052823960271,0.00352508627496785,-0.00945969733853969,0.00435864085933428,0.469365432292312
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PMCH,Pro-MCH,40116,-0.00633265878243995,0.00876220439684204,-0.0235065794002504,0.0108412618353705,0.469864706065759
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,40302,0.00297810144961539,0.00412651186996926,-0.00510986181552435,0.0110660647147551,0.470494455734522
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPT1,Translationally-controlled tumor protein,42370,0.00485289668337101,0.00672678393064388,-0.008331599820691,0.018037393187433,0.470658439718474
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,40511,-0.00246670743689591,0.00343474952338966,-0.00919881650273963,0.00426540162894782,0.472672077892177
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL9,Interleukin-9,40302,0.00417029207961682,0.00581231611101626,-0.00722184749797505,0.0155624316572087,0.473085470880188
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,40182,0.002683761272441,0.00374879669193509,-0.00466388024375177,0.0100314027886338,0.474068686890674
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42698,-0.00303774044809565,0.00424762468917896,-0.0113630848388864,0.00528760394269511,0.474521211617841
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSMA1,Proteasome subunit alpha type-1,42346,-0.00335712417749795,0.00476108771330913,-0.0126888560955839,0.00597460774058795,0.48074987669381
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42594,0.00415521417281842,0.00592707368198128,-0.00746185024386489,0.0157722785895017,0.483279861837885
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,40302,-0.00380185492006129,0.00543189482648511,-0.0144483687799721,0.00684465893984952,0.483996167297739
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL13,Interleukin-13,42370,0.00340715305175782,0.0048869767457407,-0.00617132136989394,0.0129856274734096,0.485695974983265
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,40483,-0.00287147121501733,0.00411892879098096,-0.01094457164534,0.00520162921530535,0.485729357283682
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,40281,0.00392122686621185,0.00562910564755171,-0.00711182020298949,0.0149542739354132,0.486068663670393
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,40527,-0.00210911005275431,0.00303236297554401,-0.00805254148482057,0.00383432137931194,0.486735282110442
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD33,Myeloid cell surface antigen CD33,42679,0.0057191603015612,0.00824969494643162,-0.0104502417934448,0.0218885623965672,0.488160106134054
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",40482,-0.00515213939771302,0.00744859160294299,-0.0197513789394813,0.00944710014405525,0.489144308589677
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",40182,0.00356388788225708,0.00515559836927208,-0.0065410849215162,0.0136688606860304,0.489413239329625
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CAPN3,Calpain-3,40451,0.00271524423004313,0.00395030736598384,-0.00502735820728519,0.0104578466673714,0.491876284472384
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SYT1,Synaptotagmin-1,40483,0.00300216342196529,0.00437107304712518,-0.00556513975040006,0.0115694665943307,0.492206951786017
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TCN1,Transcobalamin-1,40337,0.00242573795590707,0.00353870053840634,-0.00451011509936936,0.00936159101118349,0.493050076317475
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,40116,0.00430487840214558,0.00633755263150656,-0.00811672475560727,0.0167264815598984,0.496984291590185
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",40116,0.00286064827674648,0.00421794896520267,-0.00540653169505075,0.0111278282485437,0.49765395667961
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,42346,-0.00393889574291868,0.00583134790909522,-0.0153683376447453,0.00749054615890796,0.49938960662147
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYL6B,Myosin light chain 6B,40182,-0.00632923802786189,0.00939943387432139,-0.0247521284215318,0.012093652365808,0.50073006793082
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ESPL1,Separin,40080,0.00400491934590964,0.00595070419666615,-0.00765846087955601,0.0156682995713753,0.500951375861906
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,40451,-0.00442619767486607,0.00658384384109143,-0.0173305316034053,0.00847813625367314,0.501418180904997
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",40511,-0.00497256541815539,0.00740005807509151,-0.0194766792453348,0.00953154840902397,0.501620952036072
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRYBB2,Beta-crystallin B2,40483,-0.00563971085779922,0.00842427585615075,-0.0221512915358547,0.0108718698202563,0.503216147465607
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF12,Fibroblast growth factor 12,40199,0.00323678819986468,0.00483986733842186,-0.00624935178344217,0.0127229281831715,0.503652263857284
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCARB1,Scavenger receptor class B member 1,42311,-0.0039721001552026,0.00599712770113036,-0.0157264704494181,0.0077822701390129,0.507768980117016
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,40283,0.00363332339944857,0.00549366106565718,-0.00713425228923949,0.0144008990881366,0.508391044272721
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHIT1,Chitotriosidase-1,42699,-0.0104664300240447,0.0158818783059785,-0.0415949115037625,0.0206620514556732,0.509895997997203
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,42311,-0.00444452242969321,0.00676977331376707,-0.0177132781246767,0.00882423326529025,0.511498189128359
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL17F,Interleukin-17F,42370,-0.00510558529654591,0.007778653925719,-0.0203517469909551,0.0101405763978633,0.51160497475357
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MEP1B,Meprin A subunit beta,42636,0.00797031819043092,0.0121447770091266,-0.0158334447474572,0.0317740811283191,0.511658186835735
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,40223,-0.0183627540428561,0.0279836983854734,-0.073210802878384,0.0364852947926719,0.511712559984966
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,40116,0.00738054444677357,0.0113983446555433,-0.0149602110780913,0.0297212999716384,0.517315403515453
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOS,Proto-oncogene c-Fos,40065,-0.00239011439857408,0.00369732545904781,-0.00963687229830779,0.00485664350115963,0.518005405252177
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RGS8,Regulator of G-protein signaling 8,42370,0.00426407371624551,0.00663644191872299,-0.00874335244445154,0.0172714998769426,0.520544141253159
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,40223,-0.00169820943262518,0.0026475518974268,-0.00688741115158171,0.00349099228633135,0.521259075632511
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSPAN15,Tetraspanin-15,40116,0.0034425407561632,0.00538861572985154,-0.00711914607434581,0.0140042275866722,0.522931065102699
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOSB,Protein fosB,42311,-0.00252321761780346,0.00395398555274564,-0.0102730293011849,0.00522659406557799,0.523390187991428
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",40483,-0.00171878481216258,0.00269552500301207,-0.00700201381806624,0.00356444419374108,0.52371850765484
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",42370,-0.00745871896866816,0.0117280243752748,-0.0304456467442068,0.0155282088068705,0.524804392853307
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FH,"Fumarate hydratase, mitochondrial",40136,-0.00555566960340006,0.00885432839201778,-0.0229101532517549,0.0117988140449548,0.530375821318132
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,40080,0.00545026103458188,0.00874982219742445,-0.01169939047237,0.0225999125415338,0.533363527771679
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42711,-0.00456040879937658,0.0073368458452977,-0.0189406266561601,0.0098198090574069,0.534231053809739
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPGN,Epigen,40451,-0.00290727521834262,0.00470199189338765,-0.0121231793293824,0.00630862889269718,0.536385397592203
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42495,0.00184084613649591,0.00298100424812491,-0.00400192218982892,0.00768361446282074,0.536898739092971
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CAPS,Calcyphosin,40483,0.00657102260359398,0.0106806604999122,-0.0143630719762339,0.0275051171834218,0.53841772222306
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZNF830,Zinc finger protein 830,40451,-0.00492658227969598,0.00801192391891308,-0.0206299531607656,0.0107767886013736,0.538629048664492
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENAH,Protein enabled homolog,42370,-0.00297917556442448,0.00485119147893364,-0.0124875108631344,0.00652915973428545,0.539151831579656
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,42346,-0.0033395001976737,0.00544946777663112,-0.0140204570398707,0.0073414566445233,0.540011135847192
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",40223,-0.00211796063107964,0.00345959460473158,-0.00889876605635354,0.00466284479419426,0.540418671438102
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGAX,Integrin alpha-X,40302,0.00344204672187593,0.0056242847791939,-0.00758155144534411,0.014465644889096,0.540552114384545
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CR1,Complement receptor type 1,40509,0.00227380084582842,0.00373814285600924,-0.0050529591519497,0.00960056084360653,0.543020501444082
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,42346,0.00326223858895189,0.00537170276603293,-0.00726629883247265,0.0137907760103764,0.543661890539443
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMBN,Ameloblastin,42370,0.00179038996788708,0.00294858826888037,-0.00398884303911845,0.0075696229748926,0.543727041793309
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP152,Centrosomal protein of 152 kDa,40080,-0.00261142294622393,0.00431145763753138,-0.0110618799157854,0.00583903402333758,0.544730762351401
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RUVBL1,RuvB-like 1,42346,-0.00657750642479363,0.0108844009768058,-0.027910932339333,0.0147559194897457,0.545650788016497
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,40080,0.00361607332200518,0.00599051315362957,-0.00812533245910877,0.0153574791031191,0.546100034729349
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",40116,-0.00244908851589886,0.00407626484332445,-0.0104385676088148,0.00554039057701705,0.547974461628328
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYH4,Myosin-4,40116,0.00281430287793664,0.00468893071728113,-0.00637600132793437,0.0120046070838077,0.548384459528925
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SHD,SH2 domain-containing adapter protein D,40083,0.0054159419815441,0.00908176536088961,-0.0123843181257995,0.0232162020888877,0.55095153680081
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,42357,0.00190941185324035,0.00320536426500888,-0.00437310210617704,0.00819192581265775,0.55139082775607
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,40136,0.00558870558755357,0.00939687070219288,-0.0128291609887445,0.0240065721638516,0.552028815661768
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,40080,0.00399741627187057,0.00682741282439394,-0.00938431286394154,0.0173791454076827,0.558227044642879
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GSAP,Gamma-secretase-activating protein,42346,0.00515657948795298,0.00881551398835072,-0.0121218279292144,0.0224349869051204,0.55859559905868
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPSD1,Tryptase delta,40482,-0.00227971941799084,0.00396735658008929,-0.0100557383149658,0.00549629947898417,0.565560288956788
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,40182,0.00218014974343097,0.00380919561824178,-0.00528587366832293,0.00964617315518486,0.567104303413888
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,40302,-0.00280000072002721,0.0048923787572827,-0.0123890630843013,0.00678906164424688,0.567117545229993
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",42311,0.00240209190082218,0.00422007994649324,-0.00586926479430457,0.0106734485959489,0.569226565997877
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,40116,0.00407625776896677,0.0071922348811436,-0.0100205225980747,0.0181730381360082,0.570890150556597
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DHODH,Dihydroorotate dehydrogenase,40116,-0.0028180905855997,0.00502897860877683,-0.0126748886588023,0.00703870748760288,0.57523833378738
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DLL4,Delta-like protein 4,40223,-0.00491692953173498,0.00885458294568192,-0.0222719121052715,0.0124380530418016,0.578702315144186
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCN,Decorin,42357,0.00136619164996775,0.00248198846496085,-0.00349850574135551,0.00623088904129101,0.582025324815845
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL3,Interleukin-3,40080,-0.00350415147551496,0.00639269854469314,-0.0160338406231135,0.00902553767208359,0.583600819961411
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LMOD2,Leiomodin-2,40136,0.00351768183932636,0.00645256408022036,-0.00912934375790555,0.0161647074365583,0.585654377297906
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,40482,-0.00152917808466565,0.00280756764856331,-0.00703201067584973,0.00397365450651842,0.585996108874824
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CORO6,Coronin-6,40136,0.00207796340193354,0.0038489855058864,-0.00546604818960381,0.00962197499347089,0.589295596783437
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TTN,Titin,40116,0.00364530793651849,0.00678651052862921,-0.00965625269959477,0.0169468685726317,0.591181684522005
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL36A,Interleukin-36 alpha,40199,0.00319599641158431,0.00595047186968955,-0.0084669284530072,0.0148589212761758,0.591209634983534
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DUOX2,Dual oxidase 2,42357,0.00394780475504397,0.00738403585370767,-0.0105249055182231,0.018420515028311,0.592907490194863
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,40116,0.00179277657249718,0.00336793582841887,-0.00480837765120381,0.00839393079619816,0.594524057540684
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BRK1,Protein BRICK1,42311,-0.00245799274518318,0.00463143564937219,-0.0115356066179527,0.0066196211275863,0.595622225931972
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,40182,-0.00233547530980712,0.00442419745784443,-0.0110069023271822,0.00633595170756796,0.597588586761073
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SSB,Lupus La protein,42311,-0.0031358742649464,0.00600705938613595,-0.0149097106617729,0.00863796213188006,0.601657208656891
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,JCHAIN,Immunoglobulin J chain,42370,0.00335540206289704,0.00644552990660066,-0.00927783655404026,0.0159886406798343,0.602669418067398
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,40080,0.00516762738308233,0.00996001632888017,-0.0143540046215228,0.0246892593876875,0.603884792760502
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,40283,0.0020239735928146,0.00390149140074892,-0.00562294955265328,0.00967089673828248,0.60393204693769
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNPY2,Protein canopy homolog 2,42357,-0.00325953114930789,0.00636875240013713,-0.0157422858535767,0.00922322355496089,0.608799172699597
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASP4,Caspase-4,40302,0.00912651295965845,0.0178498219650208,-0.0258591380917824,0.0441121640110993,0.609155129495588
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,40482,-0.00125076869695784,0.00245211610413904,-0.00605691626107035,0.00355537886715467,0.610007299282918
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,42346,-0.0065988733707085,0.0130664557110838,-0.0322091265644328,0.0190113798230158,0.613550460603759
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,42346,0.00187715704836622,0.00371722107714538,-0.00540859626283874,0.00916291035957117,0.613574778854731
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDAN1,Codanin-1,40483,-0.00116412538604253,0.00233364726219261,-0.00573807401994005,0.00340982324785499,0.617899173045342
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,40199,0.00213616293632212,0.00430971145013287,-0.00631087150593831,0.0105831973785826,0.62014235065386
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,42311,-0.00206388382848198,0.00416725327327598,-0.0102317002441029,0.00610393258713894,0.620423209649042
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42679,0.00493859733375756,0.0100214623549986,-0.0147034688820398,0.0245806635495549,0.622160475967216
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD5L,CD5 antigen-like,40479,0.00242168574430684,0.00492691651665124,-0.0072350706283296,0.0120784421169433,0.623067159008499
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",40223,-0.00385406145103131,0.00787650312100077,-0.0192920075681928,0.0115838846661302,0.624631100774038
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LHB,Lutropin subunit beta,42346,0.00423450611469729,0.00867515645431726,-0.0127688005357645,0.0212378127651591,0.625473901659568
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",40116,-0.00302197330514358,0.00620036936180141,-0.0151746972542743,0.00913075064398717,0.625994585311023
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,40302,-0.00203188255699168,0.00418727129793936,-0.0102389343009528,0.00617516918696947,0.627507036701009
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEPTIN7,Septin-7,40302,-0.00272333782979083,0.00562240023133615,-0.0137432422832097,0.00829656662362803,0.628130857561468
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDC25A,M-phase inducer phosphatase 1,40080,-0.00195291301381861,0.0040329805618258,-0.00985755491499718,0.00595172888735997,0.628228371727667
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTPN,Myotrophin,42357,-0.00165831006934652,0.00342656637861323,-0.00837438017142845,0.00505776003273541,0.628424585704576
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HRAS,GTPase Hras,40286,-0.00497902180200643,0.0103028637216705,-0.0251726346964807,0.0152145910924678,0.628916550323455
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FZD8,Frizzled-8,40136,-0.00222721600269046,0.00473302232436335,-0.0115039397584426,0.00704950775306171,0.637957563908721
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42618,0.00123962052870504,0.00264997006254276,-0.00395432079387876,0.00643356185128884,0.6399447864591
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SDC4,Syndecan-4,42636,-0.00225205778379817,0.00484340676493655,-0.0117451350430738,0.00724101947547747,0.641957671747612
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENOPH1,Enolase-phosphatase E1,40451,0.0026081171677799,0.00568127893591711,-0.00852718954661764,0.0137434238821774,0.646191189812593
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MORN4,MORN repeat-containing protein 4,40080,-0.00365058700519865,0.00795437149438505,-0.0192411551341934,0.0119399811237961,0.64628571644121
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,40449,-0.00166384921635534,0.00366475839210899,-0.00884677566488896,0.00551907723217827,0.649827976201438
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",42311,-0.00237513432450057,0.00523815752174118,-0.0126419230671133,0.00789165441811215,0.650247111859427
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,40136,0.00253336415703168,0.00558783209474405,-0.00841878674866666,0.01348551506273,0.650290201931816
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,40199,0.00229288972460793,0.00506007753350954,-0.00762486224107076,0.0122106416902866,0.650461678370225
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,METAP1,Methionine aminopeptidase 1,42311,-0.00135989698377401,0.00301124009674855,-0.00726192757340118,0.00454213360585315,0.651559622211673
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLPS,Colipase,42590,-0.00334983096839808,0.00749517163103333,-0.0180403673652234,0.0113407054284272,0.654931487584051
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,40182,0.00188335905700532,0.00423559233497839,-0.00641840191955232,0.010185120033563,0.65658096661277
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ISM2,Isthmin-2,40527,0.00198690973264157,0.00447052601850582,-0.00677532126362984,0.010749140728913,0.656728272844554
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,40449,-0.00201445265348163,0.00453538837399842,-0.0109038138665185,0.00687490855955526,0.656933129195908
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRL,Prolactin,42711,-0.00341695982784927,0.00769615154329509,-0.0185014168527077,0.0116674971970091,0.657062040444468
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,40527,-0.00649791033583388,0.0146495468077164,-0.0352110220789581,0.0222152014072903,0.657371303401665
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,40080,0.00230675464504386,0.00522988379817691,-0.00794381759938288,0.0125573268894706,0.659169724308636
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MANSC4,MANSC domain-containing protein 4,40116,0.00326029845770285,0.00740293415989297,-0.0112494524956874,0.0177700494110931,0.659651616062056
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FABP9,Fatty acid-binding protein 9,42594,-0.00255813378744213,0.00582995786670716,-0.0139848512061882,0.00886858363130391,0.660819964006515
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NME1,Nucleoside diphosphate kinase A,40199,-0.000990899503300195,0.00227509805752382,-0.00545009169604687,0.00346829268944648,0.66317800219625
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,40527,0.00134966078698468,0.00310017822061765,-0.00472668852542592,0.00742601009939528,0.663317109550841
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LMNB1,Lamin-B1,40434,-0.0026601548152508,0.00616676665179927,-0.0147470174527774,0.00942670782227578,0.666208023596646
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",40223,-0.00377585231840772,0.00875780146364285,-0.0209411431871477,0.0133894385503323,0.666373858575655
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,40080,0.00246912964735836,0.00574756723517762,-0.00879610213358978,0.0137343614283065,0.667498334153304
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL24,C-C motif chemokine 24,42654,0.00365825164802597,0.00851563025540314,-0.0130323836525642,0.0203488869486161,0.667498905493559
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PYDC1,Pyrin domain-containing protein 1,40223,-0.0018980238550191,0.00442011096285876,-0.0105614413422223,0.00676539363218407,0.667635898483721
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,40080,0.00139948322552617,0.00326323716525519,-0.004996461618374,0.00779542806942634,0.668031069497494
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,40199,0.00181594770431004,0.00424663545620153,-0.00650745778984495,0.010139353198465,0.668935920739526
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42662,-0.00215146473738526,0.00507367630037964,-0.0120958702861294,0.00779294081135884,0.671540102763344
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TERF1,Telomeric repeat-binding factor 1,40199,0.00129372722421506,0.00305642513407683,-0.00469686603857552,0.00728432048700564,0.672098398325578
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TEF,Thyrotroph embryonic factor,40116,-0.00187801412714253,0.00449175568518351,-0.0106818552701022,0.00692582701581716,0.675880422142833
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSC1,Hamartin,40199,-0.00316770560051133,0.00758640081245243,-0.0180370511929181,0.0117016399918954,0.67628392600063
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",40080,-0.00397567737472296,0.00955868791638425,-0.0227107056908361,0.0147593509413902,0.677474607154107
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD177,CD177 antigen,42595,0.00559384892663524,0.0135632362468353,-0.020990094117162,0.0321777919704325,0.680032852931926
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",40199,-0.00119548675145155,0.00293905910295904,-0.00695604259325128,0.00456506909034817,0.684193410025947
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",40136,0.00230719000890655,0.00567801550887779,-0.00882172038849391,0.013436100406307,0.684502661903616
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMOD4,Tropomodulin-4,40080,0.0017184298960585,0.00426794769061973,-0.00664674757755617,0.0100836073696732,0.687223840340614
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BTNL10,Butyrophilin-like protein 10,40080,0.00177120880672706,0.00441206081520991,-0.00687643039108436,0.0104188480045385,0.688098893678287
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,40302,-0.00262569424638036,0.00654917469025493,-0.01546207663928,0.0102106881465193,0.688486833617505
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,40182,0.00173365487405481,0.00434286065518047,-0.00677835201009891,0.0102456617582085,0.689756163001882
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,42346,-0.00502731638084351,0.012644621051317,-0.0298107736414247,0.0197561408797377,0.690942296481333
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF9,Fibroblast growth factor 9,40065,0.00168461700072064,0.00426367377707844,-0.0066721836023531,0.0100414176037944,0.692770005685544
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,40302,-0.00259386971418521,0.00657673181761001,-0.0154842640767008,0.0102965246483304,0.693292565034836
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,40429,0.00159298571536401,0.00407894260847878,-0.00640174179725439,0.00958771322798241,0.6961455088067
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TXK,Tyrosine-protein kinase TXK,40302,-0.0030184125683905,0.00775360304934161,-0.0182154745451001,0.012178649408319,0.697067908979581
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,40065,0.00206840726159245,0.00538494245237988,-0.00848607994507212,0.012622894468257,0.700904843298625
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TAP1,Antigen peptide transporter 1,40302,0.00242111035451422,0.00636682667073116,-0.0100578699201189,0.0149000906291473,0.70375260235817
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGFL4,Insulin growth factor-like family member 4,40199,-0.00285326037183738,0.00760885592682423,-0.0177666179884129,0.0120600972447381,0.707673616177711
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",40199,0.00164175894879946,0.00438862735207762,-0.00695995066127267,0.0102434685588716,0.708341625481402
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP350,Centrosome-associated protein 350,40080,-0.00146597623179252,0.00393287479528396,-0.00917441083054909,0.00624245836696405,0.709342315290402
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",40136,-0.00218460095231555,0.00589167012757571,-0.0137322744023639,0.00936307249773283,0.710797514069875
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL21R,Interleukin-21 receptor,40199,0.0021364621489121,0.00578390826543812,-0.00919999805134662,0.0134729223491708,0.711851337762824
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BSND,Barttin,40080,-0.00130236023514643,0.00353189762993289,-0.00822487958981489,0.00562015911952204,0.712326949188439
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GBP6,Guanylate-binding protein 6,40116,-0.00174701650016061,0.00477069198252256,-0.0110975727859048,0.00760353978558362,0.714224640395543
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CYTH3,Cytohesin-3,40080,-0.00278662138950566,0.00772724186288166,-0.0179320154407537,0.0123587726617424,0.71838826638946
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NEO1,Neogenin,40482,-0.000822403491376566,0.0022952601840011,-0.00532111345201873,0.00367630646926559,0.720121682024538
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,42357,-0.00129840248213772,0.00362445601927388,-0.00840233627991452,0.00580553131563908,0.720174134472791
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,40116,-0.00217537281571598,0.0061215412209957,-0.0141735936088676,0.0098228479774356,0.722324090350154
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],42370,-0.00204626925746499,0.00584804280789565,-0.0135084331609405,0.00941589464601049,0.726414324513106
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAPPA,Pappalysin-1,42370,0.0016660209674426,0.00480881092030435,-0.00775924843635393,0.0110912903712391,0.729008770239288
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,40223,0.00132082648198055,0.00382862361222999,-0.00618327579799023,0.00882492876195134,0.730110505034817
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,40302,-0.00238589469545886,0.006926962818096,-0.015962741818927,0.0111909524280093,0.730525012255488
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FRZB,Secreted frizzled-related protein 3,42454,-0.00087897438885864,0.0025570118014105,-0.00589071751962323,0.00413276874190595,0.731039290342174
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42794,-0.000964968445662395,0.00282103923381929,-0.00649420534394821,0.00456426845262342,0.732310020151067
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,40116,0.00202261388142534,0.00592562375422587,-0.00959160867685736,0.013636836439708,0.73285909924503
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,42311,-0.00235201251704523,0.00689561831015767,-0.0158674244049543,0.0111633993708638,0.733042813285409
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUSD4,Sushi domain-containing protein 4,40451,0.00147250388606618,0.00433689430645523,-0.00702780895458606,0.00997281672671843,0.734217154345351
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GH2,Growth hormone variant,42346,0.00582197997651879,0.0171812016155817,-0.0278531751900213,0.0394971351430588,0.73472245033222
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KDM3A,Lysine-specific demethylase 3A,40199,-0.00306065899014308,0.00905795112490938,-0.0208142431949655,0.0146929252146793,0.735446880860707
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,40136,0.00246861085004983,0.00736525517805469,-0.0119672892989374,0.016904510999037,0.737503453170211
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL24,Interleukin-24,42370,0.00173427581757426,0.00520193917427162,-0.00846152496399812,0.0119300765991466,0.738845024643388
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,40302,0.00223861395557948,0.00680006528834556,-0.0110895140095778,0.0155667419207368,0.742007121509145
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLHL41,Kelch-like protein 41,40482,0.00161982057382607,0.00495042191326161,-0.00808300637616668,0.0113226475238188,0.743516191814486
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HK2,Hexokinase-2,42357,0.000928465982246651,0.00284966762933302,-0.00465688257124607,0.00651381453573937,0.744569103713025
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLSPN,Claspin,42292,0.0011623357214021,0.00361319629791604,-0.00591952902251332,0.00824420046531753,0.747691302885865
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,40302,-0.00144751115778762,0.00453565997797741,-0.0103374047146233,0.00744238239904811,0.749626248004046
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EXTL1,Exostosin-like 1,40116,-0.00153919229731961,0.00489418087075334,-0.0111317868039962,0.00805340220935694,0.753151603969477
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNLZ,DNL-type zinc finger protein,40136,0.00289813737843937,0.00941699253686064,-0.0155591679938075,0.0213554427506862,0.758273747051326
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,40116,0.00152039247200861,0.00502807307330507,-0.00833463075166932,0.0113754156956865,0.762367590878064
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,40177,-0.00117651477993573,0.00392918880453532,-0.00887772483682496,0.0065246952769535,0.764618072574501
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PFDN6,Prefoldin subunit 6,40182,-0.00199869896027323,0.00669469127870991,-0.0151202938665447,0.0111228959459982,0.765289193723986
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,40302,-0.00245732861965057,0.00825661769895597,-0.0186402993096043,0.0137256420703031,0.765999323070192
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,40532,0.00115244333428414,0.00390303725031309,-0.00649750967632951,0.00880239634489779,0.767794305679786
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ECM1,Extracellular matrix protein 1,40269,-0.00112932756959942,0.00385697981453135,-0.00868900800608086,0.00643035286688202,0.769679744725458
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STEAP4,Metalloreductase STEAP4,40136,0.00218465431736433,0.00753297267709954,-0.0125799721297508,0.0169492807644794,0.771812365308216
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DEFB118,Beta-defensin 118,40136,-0.00170385839509959,0.00589789595702897,-0.0132637344708764,0.00985601768067719,0.772669052775338
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHRDL1,Chordin-like protein 1,42654,0.000952724899129275,0.00332930979412302,-0.00557272229735184,0.00747817209561039,0.774757772249434
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,40182,0.00231759509538925,0.0081198171163795,-0.0135972464527146,0.0182324366434931,0.775324285941585
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F11,Coagulation factor XI,40383,-0.000880207725248447,0.00310606665850277,-0.00696809837591387,0.00520768292541698,0.776888196043632
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,40080,0.00168526655543994,0.00596620001487499,-0.010008485473715,0.0133790185845949,0.777589283310164
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,40136,-0.0011081901615387,0.00392422169368828,-0.00879966468116772,0.00658328435809033,0.777644118756963
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZPR1,Zinc finger protein ZPR1,40136,0.00284365309237109,0.0100853344270219,-0.0169236023845918,0.022610908569334,0.777980107390391
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYO6,Unconventional myosin-VI,40482,-0.00104803173540417,0.00375505658609407,-0.00840794264414853,0.0063118791733402,0.780174127609075
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUP50,Nuclear pore complex protein Nup50,40116,0.000996965503720855,0.00358958174076954,-0.00603861470818744,0.00803254571562915,0.781218263625218
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,40302,0.00123970999780534,0.00448772440267546,-0.00755622983143856,0.0100356498270492,0.782365280324862
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IKZF2,Zinc finger protein Helios,42346,0.00249044518339419,0.00905988239615923,-0.0152669243130779,0.0202478146798663,0.783407263390258
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL26,C-C motif chemokine 26,42594,-0.00259758633061987,0.00956658937287709,-0.021348101501459,0.0161529288402192,0.785989998179832
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",40482,0.00103273771447766,0.0038345345019669,-0.00648294990937747,0.00854842533833278,0.787684175012864
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL4,Interleukin-4,42370,0.00258658580801593,0.00964050383043738,-0.0163088016996413,0.0214819733156732,0.788469522328293
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,42357,0.000983825463391191,0.00366769909169814,-0.00620486475633717,0.00817251568311955,0.788518400466287
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,40182,0.00197784995799454,0.00741018195887435,-0.0125461066813992,0.0165018065973883,0.789543643385948
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,40136,0.00117575567013824,0.00447300563058554,-0.00759133536580941,0.0099428467060859,0.792666640074268
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARTN,Artemin,42370,-0.00118982439845018,0.00460140719129504,-0.0102085824933884,0.00782893369648809,0.795964608448047
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SOX2,Transcription factor SOX-2,40461,0.000635935972376952,0.00247239749982485,-0.00420996312727976,0.00548183507203366,0.797018048663158
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HDAC8,Histone deacetylase 8,40199,-0.00155102828157582,0.00610933811357117,-0.0135253309841753,0.0104232744210237,0.799594334361372
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,42676,0.00073512949325599,0.0029838746380148,-0.00511326479725302,0.006583523783765,0.805401575643953
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DSG3,Desmoglein-3,42651,0.000880721436223128,0.00361482136907373,-0.00620432844716139,0.00796577131960764,0.807511997720014
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,40532,-0.000713587640496329,0.00294967661182422,-0.00649495379967181,0.00506777851867915,0.808846035421372
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42760,-0.00112862035564834,0.00471165156105692,-0.0103634574153199,0.00810621670402322,0.810691927322097
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GUK1,Guanylate kinase,40116,0.000944555492326228,0.00397283326198579,-0.00684219770116592,0.00873130868581838,0.81207665227418
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,40136,-0.00151546063450232,0.00639502001131444,-0.0140496998566786,0.011018778587674,0.812680528173425
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TLR2,Toll-like receptor 2,40302,-0.000568327169065174,0.00241982502900815,-0.00531118422592116,0.00417452988779081,0.814319460246304
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYH7B,Myosin-7B,40080,-0.00107821389897075,0.0046404400274069,-0.0101734763526883,0.00801704855474678,0.816269266511262
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",42459,-0.000989545269842363,0.00426975269633425,-0.0093582605546575,0.00737917001497277,0.816730296334824
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PITHD1,PITH domain-containing protein 1,40065,0.00192732556972169,0.00835384306265346,-0.0144462068330791,0.0183008579725225,0.817543475054848
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",40080,-0.00122499756018208,0.00532824396723751,-0.0116683557359676,0.00921836061560345,0.818168797717221
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMIGO2,Amphoterin-induced protein 2,42587,-0.000553198243563871,0.00241510841955105,-0.00528681074588392,0.00418041425875618,0.818827868739402
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DBH,Dopamine beta-hydroxylase,40515,-0.00256060887568968,0.0113421620710858,-0.0247912465350178,0.0196700287836384,0.821392002280955
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF3,Fibroblast growth factor 3,40199,0.000665020008257341,0.00300750259937941,-0.0052296850865263,0.00655972510304098,0.825002832667041
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,40080,0.00108371186752707,0.00493439216204405,-0.00858769677007927,0.0107551205051334,0.826167970548553
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,40080,0.00143140515542984,0.00655142827670611,-0.0114093942669141,0.0142722045777738,0.827053395833889
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SHH,Sonic hedgehog protein,40199,0.000948780797691204,0.00436636041817992,-0.00760928562194145,0.00950684721732386,0.827983818304533
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TP73,Tumor protein p73,40182,0.000756922203053101,0.00357267372587334,-0.00624551829965864,0.00775936270576485,0.832216791899179
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",40059,-0.000575132098216359,0.00273953911666071,-0.00594462876687134,0.00479436457043862,0.833720360070886
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ICAM5,Intercellular adhesion molecule 5,42636,-0.000978025868061249,0.00472082997221586,-0.0102308526136043,0.00827480087748184,0.835878327590326
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,42587,-0.000822670872459202,0.0040385075121005,-0.00873814559617618,0.00709280385125778,0.838585833140778
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HLA_A,,40482,0.000694653193170456,0.00342723840791544,-0.00602273408634381,0.00741204047268473,0.839384130985251
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MUCL3,Mucin-like protein 3,40080,-0.000884835773981886,0.00440408110936487,-0.00951683474833704,0.00774716320037327,0.840770599878504
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCIN,Adseverin,40136,-0.00151211070867934,0.00754307358147091,-0.0162965349283623,0.0132723135110036,0.841121850013299
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,40136,-0.00120202677532513,0.00600324156284293,-0.0129683802384973,0.010564326687847,0.84130472411422
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBM19,Probable RNA-binding protein 19,40116,0.00097712182568841,0.00499270031423448,-0.00880857079021117,0.010762814441588,0.844840727562455
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42711,0.000925749187734884,0.00489699510863779,-0.00867236122519519,0.010523859600665,0.850060906525612
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,40182,-0.00100732317991867,0.00535317401242605,-0.0114995442442737,0.00948489788443639,0.850744458458438
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42794,0.00135046148983628,0.00723129936398516,-0.0128228852635746,0.0155238082432472,0.851857665863216
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NXPE4,NXPE family member 4,40116,-0.000644467531194543,0.00348583955701254,-0.00747671306293913,0.00618777800055004,0.853325350281429
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAM171B,Protein FAM171B,40451,-0.000503718536592514,0.00272915440046172,-0.00585286116149748,0.00484542408831245,0.853570071506919
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCARE,Photoreceptor cilium actin regulator,40136,0.00158454284435782,0.0086950828155635,-0.0154578194741466,0.0186269051628623,0.8554021856218
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,40136,0.00105874738124244,0.00581261866928702,-0.0103339852105601,0.012451479973045,0.855471234833884
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,42346,0.00106481604314602,0.00593755530630482,-0.0105727923572114,0.0127024244435035,0.857676825561286
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PGR,Progesterone receptor,40199,-0.00181244951136917,0.0101100952187007,-0.0216282361400224,0.0180033371172841,0.857728012551167
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLI2,Zinc finger protein GLI2,40199,0.000588542228973503,0.00331725023872126,-0.00591326823892017,0.00709035269686718,0.859182784076423
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FRMD7,FERM domain-containing protein 7,40182,0.000587205265242391,0.00345882493276123,-0.00619209160296963,0.00736650213345441,0.865194019770113
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,40116,0.000834797779621556,0.00492008343721436,-0.00880856575731859,0.0104781613165617,0.865271656258802
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AFAP1,Actin filament-associated protein 1,40283,0.00142996369509502,0.00858361696372991,-0.0153939255538156,0.0182538529440056,0.867693963207861
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,40080,-0.00097960477318286,0.00593900134841366,-0.0126200474160736,0.0106608378697079,0.868990839391621
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFNGR1,Interferon gamma receptor 1,42676,-0.000354985078226456,0.00225633017645632,-0.00477739222408084,0.00406742206762792,0.874988303587176
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BRD2,Bromodomain-containing protein 2,40136,-0.000581950477131821,0.00369913366305821,-0.0078322524567259,0.00666835150246226,0.874994971567667
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MATN2,Matrilin-2,42638,-0.000463120676748554,0.00304530139204092,-0.00643191140514876,0.00550567005165165,0.879128388923856
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,42370,0.000610163052852476,0.00404059414325547,-0.00730940146792825,0.0085297275736332,0.879971519230531
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA11,Carbonic anhydrase-related protein 11,42346,-0.00050215665286185,0.00334472808500119,-0.00705782369946418,0.00605351039374048,0.88066137581113
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF6,Fibroblast growth factor 6,40199,0.000641235194954363,0.00428688071296509,-0.00776105100245722,0.00904352139236594,0.881098070826378
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,40110,0.000529430775886767,0.00355228386765574,-0.00643304560471848,0.00749190715649201,0.881525181169444
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CALCB,Calcitonin gene-related peptide 2,40483,0.000627425397879893,0.00423043987738493,-0.00766423676179456,0.00891908755755435,0.88209911999521
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OSTN,Osteocrin,40182,0.000635438245690843,0.00432313930052594,-0.00783791478333999,0.00910879127472168,0.883146261646562
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLAMF7,SLAM family member 7,42594,-0.000876804254515404,0.00610735054956912,-0.0128472113316709,0.0110936028226401,0.885845819250293
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,40116,-0.000538450070205356,0.00390906471806818,-0.00820021691761898,0.00712331677720827,0.890445311368311
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,40302,-0.000523779050669059,0.00380705937742884,-0.00798561543042959,0.00693805732909147,0.890574063138661
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42611,-0.000498059231397682,0.00365795637193252,-0.00766765372038542,0.00667153525759006,0.891698590999861
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",40199,0.00049588500428171,0.0036478497897564,-0.00665390058364084,0.00764567059220426,0.891872000939553
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MILR1,Allergin-1,42370,0.000709550225711401,0.00529900614248034,-0.00967650181355006,0.0110956022649729,0.893481710119499
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NEB,Nebulin,40116,0.000531276316456011,0.00397070284261577,-0.00725130125507091,0.00831385388798293,0.89356393397326
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK15,Kallikrein-15,40429,0.000734947567554881,0.00551508260699214,-0.0100746143421497,0.0115445094772595,0.893989049150642
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRTG,Protogenin,42721,0.000337268120217331,0.00255925006755562,-0.00467886201219168,0.00535339825262634,0.895157130288381
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,40080,0.000356084201599435,0.0027048418918392,-0.0049454059064054,0.00565757430960427,0.895265976029928
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,40223,0.00054110918366543,0.00413094470858857,-0.00755554244516817,0.00863776081249903,0.895786232196706
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1R,Complement C1r subcomponent,40539,0.000252992778494762,0.00200430675917199,-0.00367544846948234,0.00418143402647187,0.899556391858138
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,40136,0.00075549591848707,0.00604857339710688,-0.0110997079398424,0.0126106997768166,0.90060120390448
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42570,0.00230711223159296,0.0188572345138331,-0.0346530674155199,0.0392672918787058,0.902626630134522
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,40116,-0.000425452985984891,0.00350949410225432,-0.00730406142640337,0.00645315545443358,0.903511766343343
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACTN4,Alpha-actinin-4,42370,0.000408215090405671,0.00336971195914266,-0.00619642034951394,0.00701285053032528,0.903580070728074
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCLRE1C,Protein artemis,40080,-0.000381019433555595,0.00323294451675703,-0.00671759068639937,0.00595555181928818,0.906184538157907
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB6B,Ras-related protein Rab-6B,42311,0.000595168786439681,0.00508228937146513,-0.00936611838163198,0.0105564559545113,0.906777503892606
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,40182,-0.000837788542057015,0.00736545261128802,-0.0152740756601815,0.0135984985760675,0.909441464581075
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,40116,-0.00103935694794737,0.00989066096443865,-0.0204250524382471,0.0183463385423524,0.9163105448132
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,42346,-0.000466043492093548,0.00497425904013024,-0.0102155912107488,0.00928350422656173,0.925356016863318
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SHPK,Sedoheptulokinase,40302,-0.000392942146738088,0.00424423893184209,-0.00871165045314859,0.00792576615967241,0.926236936107411
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEPTIN3,Neuronal-specific septin-3,40482,-0.000682272106055372,0.00773846825408886,-0.0158496698840695,0.0144851256719588,0.929746066458631
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAGE2A,G antigen 2A,40080,-0.000607346410820475,0.0068965451401056,-0.0141245748854274,0.0129098820637865,0.929826384814902
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,40527,0.000323250352160058,0.00381324421666348,-0.00715070831250035,0.00779720901682047,0.932445399646151
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,40136,-0.000467462543511806,0.00557044847204467,-0.0113855415487194,0.0104506164616957,0.933122927957147
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,40136,-0.00042857483987112,0.005165762809087,-0.0105534699456816,0.0096963202659394,0.933881298406957
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHP1,Calcineurin B homologous protein 1,40136,0.00059518823838533,0.0076670399168129,-0.014432209998568,0.0156225864753386,0.938124219553169
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,40116,0.000417380908147113,0.00541988605282327,-0.0102055957553865,0.0110403575716807,0.938617663283403
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OMP,Olfactory marker protein,40136,-0.000400434546734669,0.00520562958199443,-0.0106034685274438,0.00980259943397442,0.938685916092058
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ESR1,Estrogen receptor,40199,-0.000434783768047819,0.00571695746360571,-0.011640020396715,0.0107704528606194,0.939379427784978
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,40199,-0.000427832795178416,0.00566641502388063,-0.0115340062419844,0.0106783406516276,0.939815677874741
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,40451,0.000597452269941022,0.00791745749783827,-0.014920764425822,0.016115668965704,0.939849969876381
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,40136,0.000476735747325251,0.00647557486207067,-0.0122153909823333,0.0131688624769838,0.941313619895696
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLINT1,Clathrin interactor 1,40080,-0.000346777018936726,0.0047788198865791,-0.00971326399663177,0.00901970995875831,0.942153286987183
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,40449,-0.000415355296260738,0.00574796358699675,-0.0116813639267744,0.0108506533342529,0.942395249715766
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,42370,0.000217698745661255,0.00306258227600769,-0.00578496251531382,0.00622036000663633,0.943332462431581
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RTKN2,Rhotekin-2,40116,0.000378863363748217,0.00533602923362894,-0.0100797539341645,0.0108374806616609,0.943398266705463
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPR158,Probable G-protein coupled receptor 158,40482,0.000259588010272935,0.00372060441863025,-0.00703279665024235,0.00755197267078822,0.944377653342119
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOLR2,Folate receptor beta,42711,0.000211037897428927,0.00304350237665634,-0.0057542267608175,0.00617630255567536,0.94471963535652
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BEX3,Protein BEX3,40080,0.000331219121639547,0.00494592988948183,-0.00936280346174483,0.0100252417050239,0.94660839382474
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITM2A,Integral membrane protein 2A,42594,0.000421767858908309,0.00633790279859671,-0.0120005216263412,0.0128440573441579,0.946943402981084
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COPE,Coatomer subunit epsilon,42311,0.000323324133824927,0.00489297929264018,-0.00926691527974982,0.00991356354739968,0.947315781510701
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,40223,-0.000379544055267536,0.00574857879353516,-0.0116467584905965,0.0108876703800614,0.947359929970082
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,42636,0.000213758405703231,0.00325961991663388,-0.00617509663089917,0.00660261344230563,0.947715011911451
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PKD1,Polycystin-1,40511,-0.000174088290559576,0.00276947627093612,-0.00560226178159436,0.00525408520047521,0.949879381349423
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRKCQ,Protein kinase C theta type,42370,0.000275599782993547,0.0045085387581163,-0.0085611361829144,0.00911233574890149,0.951257874693239
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,40116,0.000234876536506343,0.00390192901528542,-0.00741290433345309,0.00788265740646577,0.952001445692008
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,40136,0.000312789345929767,0.00520314790742655,-0.00988538055262627,0.0105109592444858,0.952064818258176
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,40136,-0.000317544101498267,0.00533604334112958,-0.0107761890501122,0.0101411008471157,0.952547560326777
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAPT,Microtubule-associated protein tau,42311,-0.00031528658939242,0.00549051493065558,-0.0110766958534774,0.0104461226746925,0.954208427342205
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RASA1,Ras GTPase-activating protein 1,42311,0.00018926728300197,0.00334071603813073,-0.00635853615173427,0.00673707071773821,0.954821118793963
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C7,Complement component C7,40251,0.000192454463789066,0.00339910582467704,-0.00646979295257793,0.00685470188015606,0.954849606963521
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,40483,-0.000202421737567166,0.00389372171669311,-0.00783411630228566,0.00742927282715132,0.958540211819007
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,40182,0.000282159796746589,0.00578188363510909,-0.0110503321280672,0.0116146517215604,0.961079034972088
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZNF174,Zinc finger protein 174,40199,-0.000177391191325499,0.00386965133855048,-0.00776190781488445,0.00740712543223345,0.963437295810186
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,40302,-0.000338242822659065,0.00832642104977363,-0.0166580280802154,0.0159815424348973,0.96759731011143
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BGLAP,Osteocalcin,40527,0.000347700590538666,0.009323560758356,-0.0179264784958391,0.0186218796769164,0.970252296839718
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",40116,-0.000333946678780476,0.00909786270291322,-0.0181657575764904,0.0174978642189294,0.970720048890125
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,40116,0.000157382391397658,0.0049663104637353,-0.00957658611752353,0.00989135090031885,0.974719846717162
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,40080,0.000111637844462557,0.00357845402563267,-0.00690213204577747,0.00712540773470259,0.97511282286413
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NMI,N-myc-interactor,40421,0.000212693139670878,0.0074289497010792,-0.0143480482744444,0.0147734345537861,0.977159946258576
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPHS1,Nephrin,40199,9.87704754395771e-05,0.00347241063248013,-0.00670715436422148,0.00690469531510063,0.977308265311552
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,40199,0.000173328510384067,0.00635795359531927,-0.0122882605364417,0.0126349175572098,0.978251512982084
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP1B4,Protein ATP1B4,40080,0.000118302911150073,0.00437401306689872,-0.00845476269997141,0.00869136852227156,0.978422928963331
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCNA,Proliferating cell nuclear antigen,40080,-0.000169030923189212,0.00647046447971928,-0.012851141303439,0.0125130794570606,0.979159343515718
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPSG1,Tryptase gamma,40199,6.99341993384119e-05,0.00274822214872411,-0.00531658121216085,0.00545644961083767,0.979698828799688
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,42594,0.000109089078318549,0.00429671386223624,-0.00831247009166448,0.00853064824830158,0.979745098323368
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOLR3,Folate receptor gamma,42629,0.000425157253267257,0.019099630625059,-0.0370101187718485,0.037860433278383,0.982240908823843
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,40199,9.57415656324648e-05,0.0050614516147174,-0.00982470359921364,0.0100161867304786,0.984908593046803
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,40136,0.000139609262808578,0.00769311629979892,-0.0149388986847973,0.0152181172104145,0.985521677843771
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,40302,-8.43319469616739e-05,0.0065031034178234,-0.0128304146458955,0.0126617507519722,0.989653592481962
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,42311,-3.04165198917611e-05,0.00470331325724965,-0.00924891050410108,0.00918807746431755,0.994840182107242
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HBZ,Hemoglobin subunit zeta,40511,6.78776508252308e-05,0.0109803745297328,-0.0214536564274511,0.0215894117291015,0.995067837792608
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41948,-8.84234091476578e-06,0.00302746441387377,-0.00594267259210736,0.00592498791027783,0.997669660808649
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,40449,3.91754896416625e-05,0.0180854675674539,-0.035408340942568,0.0354866919218514,0.998271717361493
